QTLs in Region (GRCh38)
597271449 | GWAS1367523_H | systolic blood pressure QTL GWAS1367523 (human) | | 1e-11 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 4 | 110485340 | 110485341 | Human |
597267357 | GWAS1363431_H | triglyceride measurement QTL GWAS1363431 (human) | | 7e-26 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 4 | 109174464 | 109174465 | Human |
407099463 | GWAS748439_H | mean corpuscular hemoglobin QTL GWAS748439 (human) | | 1e-62 | mean corpuscular hemoglobin | mean corpuscular hemoglobin (CMO:0000290) | 4 | 121849522 | 121849523 | Human |
597267358 | GWAS1363432_H | triglyceride measurement QTL GWAS1363432 (human) | | 9e-33 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 4 | 109717668 | 109717669 | Human |
597390224 | GWAS1486298_H | diet measurement QTL GWAS1486298 (human) | | 3e-08 | eating behavior trait (VT:0001431) | food intake measurement (CMO:0000772) | 4 | 112518056 | 112518057 | Human |
406976589 | GWAS625565_H | reticulocyte count QTL GWAS625565 (human) | | 5e-10 | reticulocyte quantity (VT:0003135) | total reticulocyte count (CMO:0003020) | 4 | 109990411 | 109990412 | Human |
597046170 | GWAS1142244_H | atopic asthma QTL GWAS1142244 (human) | | 9e-13 | atopic asthma | | 4 | 122466445 | 122466446 | Human |
596964249 | GWAS1083768_H | major depressive disorder QTL GWAS1083768 (human) | | 0.000007 | major depressive disorder | | 4 | 115213661 | 115213662 | Human |
596972440 | GWAS1091959_H | radiation-induced disorder QTL GWAS1091959 (human) | | 0.000006 | radiation-induced disorder | | 4 | 118888417 | 118888418 | Human |
597062555 | GWAS1158629_H | depressive symptom measurement QTL GWAS1158629 (human) | | 4e-09 | depressive symptom measurement | | 4 | 122201701 | 122201702 | Human |
597046171 | GWAS1142245_H | atopic asthma QTL GWAS1142245 (human) | | 5e-08 | atopic asthma | | 4 | 122387310 | 122387311 | Human |
597046169 | GWAS1142243_H | atopic asthma QTL GWAS1142243 (human) | | 5e-16 | atopic asthma | | 4 | 122219915 | 122219916 | Human |
596964251 | GWAS1083770_H | major depressive disorder QTL GWAS1083770 (human) | | 0.000005 | major depressive disorder | | 4 | 127836228 | 127836229 | Human |
597414795 | GWAS1510869_H | breast carcinoma QTL GWAS1510869 (human) | | 7e-10 | mammary gland integrity trait (VT:0010552) | | 4 | 125922349 | 125922350 | Human |
597336970 | GWAS1433044_H | COVID-19, mortality QTL GWAS1433044 (human) | | 0.000005 | COVID-19, mortality | ratio of deaths to total study population during a period of time (CMO:0001023) | 4 | 127021337 | 127021338 | Human |
597222281 | GWAS1318355_H | platelet count QTL GWAS1318355 (human) | | 1e-12 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 4 | 109938024 | 109938025 | Human |
597222282 | GWAS1318356_H | platelet count QTL GWAS1318356 (human) | | 1e-21 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 4 | 109945564 | 109945565 | Human |
597222283 | GWAS1318357_H | platelet count QTL GWAS1318357 (human) | | 2e-35 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 4 | 109990751 | 109990752 | Human |
597222284 | GWAS1318358_H | platelet count QTL GWAS1318358 (human) | | 2e-100 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 4 | 110008938 | 110008939 | Human |
597222285 | GWAS1318359_H | platelet count QTL GWAS1318359 (human) | | 4e-09 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 4 | 119502932 | 119502933 | Human |
597422990 | GWAS1519064_H | cortical thickness QTL GWAS1519064 (human) | | 5e-09 | cortical thickness | | 4 | 127101149 | 127101150 | Human |
597422989 | GWAS1519063_H | cortical thickness QTL GWAS1519063 (human) | | 7e-17 | cortical thickness | | 4 | 112512138 | 112512139 | Human |
597201806 | GWAS1297880_H | gestational diabetes QTL GWAS1297880 (human) | | 0.000003 | gestational diabetes | | 4 | 118370662 | 118370663 | Human |
597074830 | GWAS1170904_H | lateral ventricle volume measurement, response to trauma exposure QTL GWAS1170904 (human) | | 0.0000002 | lateral ventricle volume measurement, response to trauma exposure | | 4 | 117069298 | 117069299 | Human |
597357445 | GWAS1453519_H | longitudinal BMI measurement QTL GWAS1453519 (human) | | 0.000009 | longitudinal BMI measurement | body mass index (BMI) (CMO:0000105) | 4 | 118506802 | 118506803 | Human |
406947937 | GWAS596913_H | PR interval QTL GWAS596913 (human) | | 2e-25 | PR interval | PR interval (CMO:0000233) | 4 | 113504778 | 113504779 | Human |
596968374 | GWAS1087893_H | cortical thickness QTL GWAS1087893 (human) | | 4e-11 | cortical thickness | | 4 | 120730658 | 120730659 | Human |
597386174 | GWAS1482248_H | atrial fibrillation QTL GWAS1482248 (human) | | 6e-38 | atrial fibrillation | | 4 | 110784612 | 110784613 | Human |
407005291 | GWAS654267_H | serum copper measurement QTL GWAS654267 (human) | | 0.000001 | serum copper measurement | serum copper level (CMO:0003465) | 4 | 113027634 | 113027635 | Human |
597078973 | GWAS1175047_H | triglyceride measurement QTL GWAS1175047 (human) | | 0.000005 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 4 | 125211924 | 125211925 | Human |
597492659 | GWAS1588733_H | systolic blood pressure QTL GWAS1588733 (human) | | 6e-09 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 4 | 110427909 | 110427910 | Human |
597590959 | GWAS1647819_H | response to stimulus QTL GWAS1647819 (human) | | 4e-11 | response to stimulus | | 4 | 106731302 | 106731303 | Human |
596964262 | GWAS1083781_H | mood disorder, major depressive disorder QTL GWAS1083781 (human) | | 1e-10 | mood disorder, major depressive disorder | | 4 | 122201701 | 122201702 | Human |
597492654 | GWAS1588728_H | diastolic blood pressure QTL GWAS1588728 (human) | | 6e-12 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 4 | 110427909 | 110427910 | Human |
597324719 | GWAS1420793_H | systolic blood pressure QTL GWAS1420793 (human) | | 9e-17 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 4 | 110510288 | 110510289 | Human |
597087150 | GWAS1183224_H | allergic disease, age at onset QTL GWAS1183224 (human) | | 2e-08 | allergic disease, age at onset | | 4 | 122219915 | 122219916 | Human |
407025790 | GWAS674766_H | exercise test QTL GWAS674766 (human) | | 0.000003 | exercise test | | 4 | 109878941 | 109878942 | Human |
596968361 | GWAS1087880_H | cortical thickness QTL GWAS1087880 (human) | | 6e-09 | cortical thickness | | 4 | 120730658 | 120730659 | Human |
597435298 | GWAS1531372_H | atrial fibrillation QTL GWAS1531372 (human) | | 2e-101 | atrial fibrillation | | 4 | 110789946 | 110789947 | Human |
597476259 | GWAS1572333_H | DNA methylation QTL GWAS1572333 (human) | | 3e-09 | DNA methylation | | 4 | 119957380 | 119957381 | Human |
596951979 | GWAS1071498_H | body mass index QTL GWAS1071498 (human) | | 1e-11 | body mass index | | 4 | 122906887 | 122906888 | Human |
407144455 | GWAS793431_H | Ischemic stroke QTL GWAS793431 (human) | | 1e-08 | Ischemic stroke | | 4 | 112810934 | 112810935 | Human |
597128148 | GWAS1224222_H | carotid artery disease QTL GWAS1224222 (human) | | 1e-11 | carotid artery disease | | 4 | 119576145 | 119576146 | Human |
597115860 | GWAS1211934_H | self reported educational attainment QTL GWAS1211934 (human) | | 1e-08 | self reported educational attainment | | 4 | 128884001 | 128884002 | Human |
597115859 | GWAS1211933_H | self reported educational attainment QTL GWAS1211933 (human) | | 6e-12 | self reported educational attainment | | 4 | 122105714 | 122105715 | Human |
597402590 | GWAS1498664_H | congestive heart failure QTL GWAS1498664 (human) | | 1e-08 | heart integrity trait (VT:0010757) | | 4 | 110783043 | 110783044 | Human |
597115858 | GWAS1211932_H | self reported educational attainment QTL GWAS1211932 (human) | | 1e-08 | self reported educational attainment | | 4 | 118084947 | 118084948 | Human |
597115857 | GWAS1211931_H | self reported educational attainment QTL GWAS1211931 (human) | | 2e-09 | self reported educational attainment | | 4 | 111500989 | 111500990 | Human |
597128159 | GWAS1224233_H | glycerophospholipid measurement QTL GWAS1224233 (human) | | 5e-25 | glycerophospholipid measurement | | 4 | 114573271 | 114573272 | Human |
597128158 | GWAS1224232_H | glycerophospholipid measurement QTL GWAS1224232 (human) | | 5e-25 | glycerophospholipid measurement | | 4 | 114541864 | 114541865 | Human |
597128157 | GWAS1224231_H | glycerophospholipid measurement QTL GWAS1224231 (human) | | 4e-25 | glycerophospholipid measurement | | 4 | 114547331 | 114547332 | Human |
597128156 | GWAS1224230_H | glycerophospholipid measurement QTL GWAS1224230 (human) | | 4e-25 | glycerophospholipid measurement | | 4 | 114563925 | 114563926 | Human |
597312470 | GWAS1408544_H | vaginal microbiome measurement QTL GWAS1408544 (human) | | 5e-09 | vaginal microbiome measurement | | 4 | 109225176 | 109225177 | Human |
597128155 | GWAS1224229_H | glycerophospholipid measurement QTL GWAS1224229 (human) | | 4e-25 | glycerophospholipid measurement | | 4 | 114553520 | 114553521 | Human |
597128154 | GWAS1224228_H | glycerophospholipid measurement QTL GWAS1224228 (human) | | 4e-25 | glycerophospholipid measurement | | 4 | 114546019 | 114546020 | Human |
597312471 | GWAS1408545_H | vaginal microbiome measurement QTL GWAS1408545 (human) | | 0.000007 | vaginal microbiome measurement | | 4 | 123235757 | 123235758 | Human |
597455826 | GWAS1551900_H | lymphocyte count QTL GWAS1551900 (human) | | 7e-23 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 4 | 110020646 | 110020647 | Human |
597468114 | GWAS1564188_H | response to antiviral drug QTL GWAS1564188 (human) | | 0.000002 | response to antiviral drug | | 4 | 110212212 | 110212213 | Human |
597128153 | GWAS1224227_H | glycerophospholipid measurement QTL GWAS1224227 (human) | | 4e-25 | glycerophospholipid measurement | | 4 | 114493059 | 114493060 | Human |
597160901 | GWAS1256975_H | monocyte count QTL GWAS1256975 (human) | | 5e-10 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 4 | 110035176 | 110035177 | Human |
597214155 | GWAS1310229_H | blood protein measurement QTL GWAS1310229 (human) | | 5e-08 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 4 | 110079447 | 110079448 | Human |
596956096 | GWAS1075615_H | lymphocyte measurement, neutrophil measurement QTL GWAS1075615 (human) | | 3e-14 | lymphocyte measurement, neutrophil measurement | | 4 | 122707302 | 122707305 | Human |
596956097 | GWAS1075616_H | lymphocyte measurement, neutrophil measurement QTL GWAS1075616 (human) | | 2e-14 | lymphocyte measurement, neutrophil measurement | | 4 | 112190016 | 112190017 | Human |
597160898 | GWAS1256972_H | factor XI measurement, coronary artery disease QTL GWAS1256972 (human) | | 2e-11 | factor XI measurement, coronary artery disease | | 4 | 119988346 | 119988347 | Human |
597222351 | GWAS1318425_H | platelet count QTL GWAS1318425 (human) | | 2e-33 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 4 | 110023574 | 110023575 | Human |
597263299 | GWAS1359373_H | complement factor I measurement QTL GWAS1359373 (human) | | 3e-66 | complement protein amount (VT:0010033) | | 4 | 109742841 | 109742842 | Human |
597279683 | GWAS1375757_H | calcium measurement QTL GWAS1375757 (human) | | 1e-12 | calcium measurement | blood calcium level (CMO:0000502) | 4 | 114469815 | 114469816 | Human |
597324736 | GWAS1420810_H | methionine measurement QTL GWAS1420810 (human) | | 0.0000002 | methionine measurement | blood amino acid measurement (CMO:0003730) | 4 | 122052538 | 122052539 | Human |
597324737 | GWAS1420811_H | phenylalanine measurement QTL GWAS1420811 (human) | | 1e-08 | phenylalanine measurement | | 4 | 122052538 | 122052539 | Human |
597492672 | GWAS1588746_H | sexual dimorphism measurement QTL GWAS1588746 (human) | | 4e-12 | sexual dimorphism measurement | | 4 | 121774530 | 121774531 | Human |
407095326 | GWAS744302_H | chromosome-type aberration frequency QTL GWAS744302 (human) | | 0.000008 | chromosome-type aberration frequency | | 4 | 131649836 | 131649837 | Human |
597156852 | GWAS1252926_H | testosterone measurement QTL GWAS1252926 (human) | | 0.000004 | testosterone measurement | serum testosterone level (CMO:0000568) | 4 | 108117498 | 108117499 | Human |
597390328 | GWAS1486402_H | appendicular lean mass QTL GWAS1486402 (human) | | 9e-13 | appendicular lean mass | | 4 | 119206606 | 119206607 | Human |
597398520 | GWAS1494594_H | vaginal microbiome measurement QTL GWAS1494594 (human) | | 0.000004 | vaginal microbiome measurement | | 4 | 132000696 | 132000697 | Human |
597091314 | GWAS1187388_H | Ischemic stroke QTL GWAS1187388 (human) | | 3e-14 | Ischemic stroke | | 4 | 110755885 | 110755886 | Human |
406972453 | GWAS621429_H | trait in response to paliperidone, schizophrenia symptom severity measurement QTL GWAS621429 (human) | | 0.000009 | trait in response to paliperidone, schizophrenia symptom severity measurement | | 4 | 116607403 | 116607404 | Human |
597050355 | GWAS1146429_H | endometriosis QTL GWAS1146429 (human) | | 0.0000008 | endometriosis | | 4 | 114744719 | 114744720 | Human |
597128176 | GWAS1224250_H | glycerophospholipid measurement QTL GWAS1224250 (human) | | 2e-10 | glycerophospholipid measurement | | 4 | 114517522 | 114517523 | Human |
597361650 | GWAS1457724_H | atrial fibrillation QTL GWAS1457724 (human) | | 7e-92 | atrial fibrillation | | 4 | 110789386 | 110789387 | Human |
597087228 | GWAS1183302_H | platelet count QTL GWAS1183302 (human) | | 2e-40 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 4 | 110035176 | 110035177 | Human |
597427190 | GWAS1523264_H | gestational age QTL GWAS1523264 (human) | | 0.000007 | gestational age | | 4 | 112357355 | 112357356 | Human |
406947883 | GWAS596859_H | PR interval QTL GWAS596859 (human) | | 2e-08 | PR interval | PR interval (CMO:0000233) | 4 | 119148924 | 119148925 | Human |
597513207 | GWAS1609281_H | colorectal cancer QTL GWAS1609281 (human) | | 0.0000007 | colorectal cancer | | 4 | 123506329 | 123506330 | Human |
596956152 | GWAS1075671_H | anti-Epstein Barr virus antibody measurement QTL GWAS1075671 (human) | | 0.0000008 | anti-Epstein Barr virus antibody measurement | | 4 | 110793733 | 110793734 | Human |
407386148 | GWAS1035124_H | waist-hip ratio QTL GWAS1035124 (human) | | 8e-12 | waist-hip ratio | waist to hip ratio (WHR) (CMO:0000020) | 4 | 124299553 | 124299554 | Human |
597091323 | GWAS1187397_H | intelligence QTL GWAS1187397 (human) | | 0.0000009 | intelligence | | 4 | 117956978 | 117956979 | Human |
597267447 | GWAS1363521_H | cortical thickness QTL GWAS1363521 (human) | | 3e-12 | cortical thickness | | 4 | 120722571 | 120722572 | Human |
597156839 | GWAS1252913_H | testosterone measurement QTL GWAS1252913 (human) | | 3e-13 | testosterone measurement | serum testosterone level (CMO:0000568) | 4 | 108117498 | 108117499 | Human |
597128167 | GWAS1224241_H | glycerophospholipid measurement QTL GWAS1224241 (human) | | 4e-11 | glycerophospholipid measurement | | 4 | 114580433 | 114580434 | Human |
597128166 | GWAS1224240_H | glycerophospholipid measurement QTL GWAS1224240 (human) | | 4e-11 | glycerophospholipid measurement | | 4 | 114525610 | 114525611 | Human |
597128165 | GWAS1224239_H | glycerophospholipid measurement QTL GWAS1224239 (human) | | 5e-25 | glycerophospholipid measurement | | 4 | 114494051 | 114494052 | Human |
597267435 | GWAS1363509_H | cortical thickness QTL GWAS1363509 (human) | | 6e-09 | cortical thickness | | 4 | 120730658 | 120730659 | Human |
597087205 | GWAS1183279_H | bone mineral content measurement QTL GWAS1183279 (human) | | 0.000001 | bone mineral content measurement | | 4 | 106982388 | 106982389 | Human |
597128164 | GWAS1224238_H | glycerophospholipid measurement QTL GWAS1224238 (human) | | 5e-25 | glycerophospholipid measurement | | 4 | 114552321 | 114552322 | Human |
597128163 | GWAS1224237_H | glycerophospholipid measurement QTL GWAS1224237 (human) | | 5e-25 | glycerophospholipid measurement | | 4 | 114553935 | 114553936 | Human |
597414894 | GWAS1510968_H | Parkinson disease QTL GWAS1510968 (human) | | 1e-12 | Parkinson disease | | 4 | 113447909 | 113447910 | Human |
597128162 | GWAS1224236_H | glycerophospholipid measurement QTL GWAS1224236 (human) | | 5e-25 | glycerophospholipid measurement | | 4 | 114493994 | 114493995 | Human |
597128161 | GWAS1224235_H | glycerophospholipid measurement QTL GWAS1224235 (human) | | 5e-25 | glycerophospholipid measurement | | 4 | 114552206 | 114552207 | Human |
597128160 | GWAS1224234_H | glycerophospholipid measurement QTL GWAS1224234 (human) | | 3e-25 | glycerophospholipid measurement | | 4 | 114554137 | 114554138 | Human |
597128175 | GWAS1224249_H | glycerophospholipid measurement QTL GWAS1224249 (human) | | 4e-25 | glycerophospholipid measurement | | 4 | 114553424 | 114553425 | Human |
597128174 | GWAS1224248_H | glycerophospholipid measurement QTL GWAS1224248 (human) | | 1e-10 | glycerophospholipid measurement | | 4 | 114553199 | 114553200 | Human |
597128173 | GWAS1224247_H | glycerophospholipid measurement QTL GWAS1224247 (human) | | 1e-10 | glycerophospholipid measurement | | 4 | 114522432 | 114522433 | Human |
407025720 | GWAS674696_H | ulcerative colitis QTL GWAS674696 (human) | | 0.0000009 | ulcerative colitis | | 4 | 122408207 | 122408208 | Human |
597128172 | GWAS1224246_H | glycerophospholipid measurement QTL GWAS1224246 (human) | | 1e-10 | glycerophospholipid measurement | | 4 | 114481442 | 114481443 | Human |
597128171 | GWAS1224245_H | glycerophospholipid measurement QTL GWAS1224245 (human) | | 4e-25 | glycerophospholipid measurement | | 4 | 114493217 | 114493218 | Human |
597128170 | GWAS1224244_H | glycerophospholipid measurement QTL GWAS1224244 (human) | | 3e-25 | glycerophospholipid measurement | | 4 | 114558326 | 114558327 | Human |
597128169 | GWAS1224243_H | glycerophospholipid measurement QTL GWAS1224243 (human) | | 1e-10 | glycerophospholipid measurement | | 4 | 114479583 | 114479584 | Human |
597267431 | GWAS1363505_H | cortical thickness QTL GWAS1363505 (human) | | 4e-11 | cortical thickness | | 4 | 120730658 | 120730659 | Human |
597128168 | GWAS1224242_H | glycerophospholipid measurement QTL GWAS1224242 (human) | | 5e-11 | glycerophospholipid measurement | | 4 | 114538308 | 114538309 | Human |
597201688 | GWAS1297762_H | memory performance, sex interaction measurement QTL GWAS1297762 (human) | | 0.000004 | memory performance, sex interaction measurement | | 4 | 109128952 | 109128953 | Human |
597275417 | GWAS1371491_H | insomnia QTL GWAS1371491 (human) | | 2e-08 | insomnia | | 4 | 112329113 | 112329114 | Human |
597439260 | GWAS1535334_H | FEV change measurement, response to bronchodilator QTL GWAS1535334 (human) | | 0.0000007 | FEV change measurement, response to bronchodilator | respiratory system measurement (CMO:0000094) | 4 | 116884973 | 116884974 | Human |
597201689 | GWAS1297763_H | memory performance, sex interaction measurement QTL GWAS1297763 (human) | | 0.000005 | memory performance, sex interaction measurement | | 4 | 125584117 | 125584118 | Human |
597275419 | GWAS1371493_H | insomnia QTL GWAS1371493 (human) | | 2e-10 | insomnia | | 4 | 122265238 | 122265239 | Human |
597164827 | GWAS1260901_H | factor VIII measurement, Ischemic stroke QTL GWAS1260901 (human) | | 9e-17 | factor VIII measurement, Ischemic stroke | | 4 | 110775495 | 110775496 | Human |
597275418 | GWAS1371492_H | insomnia QTL GWAS1371492 (human) | | 1e-08 | insomnia | | 4 | 122259374 | 122259375 | Human |
597086994 | GWAS1183068_H | platelet count QTL GWAS1183068 (human) | | 3e-27 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 4 | 119622957 | 119622958 | Human |
597086995 | GWAS1183069_H | platelet count QTL GWAS1183069 (human) | | 1e-11 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 4 | 122595396 | 122595397 | Human |
597426969 | GWAS1523043_H | gout QTL GWAS1523043 (human) | | 3e-08 | gout | | 4 | 123815050 | 123815051 | Human |
597476122 | GWAS1572196_H | electroencephalogram measurement QTL GWAS1572196 (human) | | 0.000005 | electroencephalogram measurement | brain activity measurement (CMO:0001737) | 4 | 107150343 | 107150344 | Human |
597267216 | GWAS1363290_H | cortical thickness QTL GWAS1363290 (human) | | 3e-08 | cortical thickness | | 4 | 120730658 | 120730659 | Human |
597316369 | GWAS1412443_H | vaginal microbiome measurement QTL GWAS1412443 (human) | | 0.000009 | vaginal microbiome measurement | | 4 | 109225176 | 109225177 | Human |
597615378 | GWAS1672238_H | pyogenic granuloma QTL GWAS1672238 (human) | | 3e-11 | pyogenic granuloma | | 4 | 117340216 | 117340217 | Human |
597201685 | GWAS1297759_H | memory performance, sex interaction measurement QTL GWAS1297759 (human) | | 0.000004 | memory performance, sex interaction measurement | | 4 | 109129261 | 109129262 | Human |
597201686 | GWAS1297760_H | memory performance, sex interaction measurement QTL GWAS1297760 (human) | | 0.000004 | memory performance, sex interaction measurement | | 4 | 109135631 | 109135632 | Human |
597201687 | GWAS1297761_H | memory performance, sex interaction measurement QTL GWAS1297761 (human) | | 0.000004 | memory performance, sex interaction measurement | | 4 | 109128713 | 109128714 | Human |
597164823 | GWAS1260897_H | Ischemic stroke, plasminogen activator inhibitor 1 measurement QTL GWAS1260897 (human) | | 6e-17 | Ischemic stroke, plasminogen activator inhibitor 1 measurement | blood plasminogen activator inhibitor 1 level (CMO:0003034) | 4 | 110775495 | 110775496 | Human |
407001293 | GWAS650269_H | celiac disease QTL GWAS650269 (human) | | 3e-11 | celiac disease | | 4 | 122194347 | 122194348 | Human |
597336842 | GWAS1432916_H | S-7-hydroxywarfarin measurement QTL GWAS1432916 (human) | | 0.000009 | S-7-hydroxywarfarin measurement | | 4 | 121518134 | 121518135 | Human |
597054214 | GWAS1150288_H | asthma QTL GWAS1150288 (human) | | 5e-20 | asthma | | 4 | 122527407 | 122527408 | Human |
596960006 | GWAS1079525_H | glomerular filtration rate QTL GWAS1079525 (human) | | 1e-08 | glomerular filtration rate | | 4 | 119674620 | 119674621 | Human |
597615372 | GWAS1672232_H | platelet count QTL GWAS1672232 (human) | | 3e-12 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 4 | 123835365 | 123835366 | Human |
596960007 | GWAS1079526_H | glomerular filtration rate QTL GWAS1079526 (human) | | 2e-08 | glomerular filtration rate | | 4 | 123414226 | 123414227 | Human |
597361423 | GWAS1457497_H | atrial fibrillation QTL GWAS1457497 (human) | | 8e-57 | atrial fibrillation | | 4 | 110796911 | 110796912 | Human |
597406479 | GWAS1502553_H | BMI-adjusted hip circumference QTL GWAS1502553 (human) | | 3e-12 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 4 | 121792708 | 121792709 | Human |
597361422 | GWAS1457496_H | atrial fibrillation QTL GWAS1457496 (human) | | 4e-08 | atrial fibrillation | | 4 | 110796911 | 110796912 | Human |
597615371 | GWAS1672231_H | platelet count QTL GWAS1672231 (human) | | 4e-16 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 4 | 119439096 | 119439097 | Human |
597406478 | GWAS1502552_H | BMI-adjusted hip circumference QTL GWAS1502552 (human) | | 3e-11 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 4 | 121774530 | 121774531 | Human |
597222158 | GWAS1318232_H | Thrombocytopenia QTL GWAS1318232 (human) | | 1e-44 | Thrombocytopenia | | 4 | 110026904 | 110026905 | Human |
596968205 | GWAS1087724_H | cortical thickness QTL GWAS1087724 (human) | | 2e-08 | cortical thickness | | 4 | 120741206 | 120741207 | Human |
597439236 | GWAS1535310_H | mosquito bite reaction size measurement QTL GWAS1535310 (human) | | 4e-08 | mosquito bite reaction size measurement | | 4 | 129337181 | 129337182 | Human |
597054223 | GWAS1150297_H | multiple sclerosis QTL GWAS1150297 (human) | | 1e-10 | multiple sclerosis | | 4 | 121198294 | 121198295 | Human |
597324547 | GWAS1420621_H | 1-oleoylglycerophosphocholine measurement QTL GWAS1420621 (human) | | 0.0000008 | 1-oleoylglycerophosphocholine measurement | | 4 | 130062033 | 130062034 | Human |
596960008 | GWAS1079527_H | glomerular filtration rate QTL GWAS1079527 (human) | | 4e-08 | glomerular filtration rate | | 4 | 125673826 | 125673827 | Human |
596960009 | GWAS1079528_H | glomerular filtration rate QTL GWAS1079528 (human) | | 2e-20 | glomerular filtration rate | | 4 | 127146530 | 127146531 | Human |
597439234 | GWAS1535308_H | mosquito bite reaction size measurement QTL GWAS1535308 (human) | | 3e-39 | mosquito bite reaction size measurement | | 4 | 122707847 | 122707848 | Human |
597439235 | GWAS1535309_H | mosquito bite reaction size measurement QTL GWAS1535309 (human) | | 0.000004 | mosquito bite reaction size measurement | | 4 | 123350979 | 123350980 | Human |
597349170 | GWAS1445244_H | preeclampsia QTL GWAS1445244 (human) | | 0.000003 | preeclampsia | | 4 | 112913825 | 112913826 | Human |
597156670 | GWAS1252744_H | electrocardiography QTL GWAS1252744 (human) | | 2e-08 | electrocardiography | | 4 | 115646453 | 115646454 | Human |
597123897 | GWAS1219971_H | clear cell renal carcinoma QTL GWAS1219971 (human) | | 8e-11 | clear cell renal carcinoma | | 4 | 108791438 | 108791439 | Human |
597140269 | GWAS1236343_H | QT interval QTL GWAS1236343 (human) | | 4e-08 | QT interval | QT interval (CMO:0000235) | 4 | 113523545 | 113523546 | Human |
597381927 | GWAS1478001_H | autoimmune disease QTL GWAS1478001 (human) | | 1e-09 | autoimmune disease | | 4 | 122633552 | 122633553 | Human |
597099306 | GWAS1195380_H | alkaline phosphatase measurement QTL GWAS1195380 (human) | | 1e-08 | alkaline phosphatase measurement | blood alkaline phosphatase activity level (CMO:0000576) | 4 | 109788119 | 109788120 | Human |
597361499 | GWAS1457573_H | atrial fibrillation QTL GWAS1457573 (human) | | 7e-136 | atrial fibrillation | | 4 | 110791276 | 110791277 | Human |
406988931 | GWAS637907_H | cyclic adenosine monophosphate measurement QTL GWAS637907 (human) | | 0.000002 | cyclic adenosine monophosphate measurement | | 4 | 121525001 | 121525002 | Human |
597042004 | GWAS1138078_H | appendicular lean mass QTL GWAS1138078 (human) | | 5e-10 | appendicular lean mass | | 4 | 110660471 | 110660472 | Human |
597361503 | GWAS1457577_H | atrial fibrillation QTL GWAS1457577 (human) | | 3e-155 | atrial fibrillation | | 4 | 110796911 | 110796912 | Human |
597128031 | GWAS1224105_H | glycerophospholipid measurement QTL GWAS1224105 (human) | | 2e-11 | glycerophospholipid measurement | | 4 | 114548870 | 114548871 | Human |
597128030 | GWAS1224104_H | glycerophospholipid measurement QTL GWAS1224104 (human) | | 2e-11 | glycerophospholipid measurement | | 4 | 114493830 | 114493831 | Human |
406915210 | GWAS564186_H | unipolar depression QTL GWAS564186 (human) | | 0.000003 | unipolar depression | | 4 | 124344158 | 124344159 | Human |
597386071 | GWAS1482145_H | susceptibility to scarlet fever measurement QTL GWAS1482145 (human) | | 0.000003 | susceptibility to scarlet fever measurement | | 4 | 109403118 | 109403119 | Human |
597451603 | GWAS1547677_H | heel bone mineral density, urate measurement QTL GWAS1547677 (human) | | 4e-08 | heel bone mineral density, urate measurement | blood uric acid level (CMO:0000501) | 4 | 107158166 | 107158167 | Human |
597377867 | GWAS1473941_H | systemic lupus erythematosus QTL GWAS1473941 (human) | | 0.000001 | systemic lupus erythematosus | | 4 | 108801970 | 108801971 | Human |
597152582 | GWAS1248656_H | memory performance QTL GWAS1248656 (human) | | 0.0000003 | memory performance | | 4 | 130946957 | 130946958 | Human |
597152581 | GWAS1248655_H | memory performance QTL GWAS1248655 (human) | | 0.0000005 | memory performance | | 4 | 109067562 | 109067563 | Human |
597295944 | GWAS1392018_H | venous thromboembolism QTL GWAS1392018 (human) | | 0.0000007 | venous thromboembolism | | 4 | 122619586 | 122619587 | Human |
407369876 | GWAS1018852_H | systemic juvenile idiopathic arthritis QTL GWAS1018852 (human) | | 0.000003 | systemic juvenile idiopathic arthritis | | 4 | 115655118 | 115655119 | Human |
597070658 | GWAS1166732_H | BMI-adjusted hip circumference QTL GWAS1166732 (human) | | 0.0000005 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 4 | 113634919 | 113634920 | Human |
597369679 | GWAS1465753_H | erectile dysfunction QTL GWAS1465753 (human) | | 0.000009 | erectile dysfunction | | 4 | 123943461 | 123943462 | Human |
597496651 | GWAS1592725_H | hip geometry QTL GWAS1592725 (human) | | 5e-09 | hip geometry | hip circumference (CMO:0000014) | 4 | 126753016 | 126753017 | Human |
597156672 | GWAS1252746_H | electrocardiography QTL GWAS1252746 (human) | | 1e-08 | electrocardiography | | 4 | 115646453 | 115646454 | Human |
597115712 | GWAS1211786_H | electroencephalogram measurement QTL GWAS1211786 (human) | | 0.000002 | electroencephalogram measurement | brain activity measurement (CMO:0001737) | 4 | 121613423 | 121613424 | Human |
597164867 | GWAS1260941_H | lipid measurement QTL GWAS1260941 (human) | | 0.000003 | lipid measurement | blood lipid measurement (CMO:0000050) | 4 | 116458669 | 116458670 | Human |
407054488 | GWAS703464_H | gut microbiome measurement QTL GWAS703464 (human) | | 0.000006 | gut microbiome measurement | | 4 | 126828799 | 126828800 | Human |
597295942 | GWAS1392016_H | BMI-adjusted hip circumference QTL GWAS1392016 (human) | | 5e-09 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 4 | 119820087 | 119820088 | Human |
597041994 | GWAS1138068_H | appendicular lean mass QTL GWAS1138068 (human) | | 1e-11 | appendicular lean mass | | 4 | 124044107 | 124044108 | Human |
597041995 | GWAS1138069_H | appendicular lean mass QTL GWAS1138069 (human) | | 2e-12 | appendicular lean mass | | 4 | 119325534 | 119325535 | Human |
597295943 | GWAS1392017_H | BMI-adjusted hip circumference QTL GWAS1392017 (human) | | 4e-10 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 4 | 119798713 | 119798714 | Human |
597316420 | GWAS1412494_H | white matter lesion progression measurement QTL GWAS1412494 (human) | | 0.000006 | central nervous system integrity trait (VT:0010772) | | 4 | 128668470 | 128668471 | Human |
597295941 | GWAS1392015_H | BMI-adjusted hip circumference QTL GWAS1392015 (human) | | 1e-08 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 4 | 119821103 | 119821104 | Human |
597074761 | GWAS1170835_H | major depressive disorder QTL GWAS1170835 (human) | | 0.000005 | major depressive disorder | | 4 | 127836228 | 127836229 | Human |
597447550 | GWAS1543624_H | sex hormone-binding globulin measurement QTL GWAS1543624 (human) | | 4e-08 | sex hormone-binding globulin measurement | | 4 | 119202262 | 119202263 | Human |
597447551 | GWAS1543625_H | sex hormone-binding globulin measurement QTL GWAS1543625 (human) | | 3e-10 | sex hormone-binding globulin measurement | | 4 | 123845801 | 123845802 | Human |
597508985 | GWAS1605059_H | eosinophil count QTL GWAS1605059 (human) | | 8e-11 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 4 | 122639784 | 122639785 | Human |
597386110 | GWAS1482184_H | Parkinson disease QTL GWAS1482184 (human) | | 5e-11 | Parkinson disease | | 4 | 113439216 | 113439217 | Human |
597504890 | GWAS1600964_H | Alzheimer disease QTL GWAS1600964 (human) | | 1e-10 | Alzheimer disease | | 4 | 108219159 | 108219160 | Human |
597332848 | GWAS1428922_H | R-warfarin measurement QTL GWAS1428922 (human) | | 0.000009 | R-warfarin measurement | | 4 | 108984279 | 108984280 | Human |
597226354 | GWAS1322428_H | chronotype measurement QTL GWAS1322428 (human) | | 1e-10 | chronotype measurement | | 4 | 129982356 | 129982357 | Human |
597439351 | GWAS1535425_H | coronary artery calcification QTL GWAS1535425 (human) | | 0.000006 | coronary artery calcification | | 4 | 117351922 | 117351923 | Human |
597279607 | GWAS1375681_H | X-26054 measurement QTL GWAS1375681 (human) | | 1e-125 | X-26054 measurement | | 4 | 129143723 | 129143724 | Human |
597226359 | GWAS1322433_H | chronotype measurement QTL GWAS1322433 (human) | | 4e-09 | chronotype measurement | | 4 | 113518738 | 113518739 | Human |
597087097 | GWAS1183171_H | type 2 diabetes mellitus QTL GWAS1183171 (human) | | 3e-09 | type 2 diabetes mellitus | | 4 | 120844633 | 120844634 | Human |
596988773 | GWAS1108292_H | monocyte count QTL GWAS1108292 (human) | | 2e-26 | monocyte count | | 4 | 110035176 | 110035177 | Human |
597128039 | GWAS1224113_H | glycerophospholipid measurement QTL GWAS1224113 (human) | | 3e-25 | glycerophospholipid measurement | | 4 | 114563572 | 114563573 | Human |
406997170 | GWAS646146_H | reticulocyte measurement QTL GWAS646146 (human) | | 1e-09 | reticulocyte morphology trait (VT:0002424) | red blood cell measurement (CMO:0001356) | 4 | 127789418 | 127789419 | Human |
597128038 | GWAS1224112_H | glycerophospholipid measurement QTL GWAS1224112 (human) | | 3e-25 | glycerophospholipid measurement | | 4 | 114532837 | 114532838 | Human |
597115749 | GWAS1211823_H | apolipoprotein A 1 measurement QTL GWAS1211823 (human) | | 3e-67 | apolipoprotein A 1 measurement | blood apolipoprotein AI level (CMO:0000520) | 4 | 109717668 | 109717669 | Human |
596988775 | GWAS1108294_H | monocyte count QTL GWAS1108294 (human) | | 5e-16 | monocyte count | | 4 | 109926568 | 109926569 | Human |
597128037 | GWAS1224111_H | glycerophospholipid measurement QTL GWAS1224111 (human) | | 3e-25 | glycerophospholipid measurement | | 4 | 114532769 | 114532770 | Human |
597115748 | GWAS1211822_H | apolipoprotein A 1 measurement QTL GWAS1211822 (human) | | 3e-23 | apolipoprotein A 1 measurement | blood apolipoprotein AI level (CMO:0000520) | 4 | 109717608 | 109717609 | Human |
406997169 | GWAS646145_H | reticulocyte measurement QTL GWAS646145 (human) | | 2e-12 | reticulocyte morphology trait (VT:0002424) | red blood cell measurement (CMO:0001356) | 4 | 109944309 | 109944310 | Human |
597128036 | GWAS1224110_H | glycerophospholipid measurement QTL GWAS1224110 (human) | | 3e-25 | glycerophospholipid measurement | | 4 | 114490021 | 114490022 | Human |
597037925 | GWAS1133999_H | gut microbiome measurement QTL GWAS1133999 (human) | | 0.0000001 | gut microbiome measurement | | 4 | 126368923 | 126368924 | Human |
597128035 | GWAS1224109_H | glycerophospholipid measurement QTL GWAS1224109 (human) | | 3e-25 | glycerophospholipid measurement | | 4 | 114563873 | 114563874 | Human |
597472104 | GWAS1568178_H | body mass index QTL GWAS1568178 (human) | | 0.000003 | body mass index | body mass index (BMI) (CMO:0000105) | 4 | 129838492 | 129838493 | Human |
597128034 | GWAS1224108_H | glycerophospholipid measurement QTL GWAS1224108 (human) | | 4e-11 | glycerophospholipid measurement | | 4 | 114551237 | 114551238 | Human |
597128033 | GWAS1224107_H | glycerophospholipid measurement QTL GWAS1224107 (human) | | 4e-11 | glycerophospholipid measurement | | 4 | 114576580 | 114576581 | Human |
597128032 | GWAS1224106_H | glycerophospholipid measurement QTL GWAS1224106 (human) | | 2e-11 | glycerophospholipid measurement | | 4 | 114572686 | 114572687 | Human |
407222461 | GWAS871437_H | rheumatoid arthritis QTL GWAS871437 (human) | | 0.000004 | rheumatoid arthritis | | 4 | 122478336 | 122478337 | Human |
597361506 | GWAS1457580_H | atrial fibrillation QTL GWAS1457580 (human) | | 2e-62 | atrial fibrillation | | 4 | 110796911 | 110796912 | Human |
597513060 | GWAS1609134_H | sex hormone-binding globulin measurement QTL GWAS1609134 (human) | | 9e-09 | sex hormone-binding globulin measurement | | 4 | 123871744 | 123871745 | Human |
597373793 | GWAS1469867_H | resistin measurement QTL GWAS1469867 (human) | | 6e-18 | resistin measurement | | 4 | 115275150 | 115275151 | Human |
597050220 | GWAS1146294_H | BMI-adjusted waist-hip ratio QTL GWAS1146294 (human) | | 1e-11 | body size trait (VT:0100005) | | 4 | 124270608 | 124270609 | Human |
597050221 | GWAS1146295_H | BMI-adjusted waist-hip ratio QTL GWAS1146295 (human) | | 2e-10 | body size trait (VT:0100005) | | 4 | 124118741 | 124118742 | Human |
597017449 | GWAS1113523_H | facial morphology measurement QTL GWAS1113523 (human) | | 2e-08 | facial morphology trait (VT:0003743) | | 4 | 126939204 | 126939205 | Human |
597128042 | GWAS1224116_H | glycerophospholipid measurement QTL GWAS1224116 (human) | | 3e-25 | glycerophospholipid measurement | | 4 | 114552518 | 114552519 | Human |
597128041 | GWAS1224115_H | glycerophospholipid measurement QTL GWAS1224115 (human) | | 3e-25 | glycerophospholipid measurement | | 4 | 114526758 | 114526759 | Human |
597128040 | GWAS1224114_H | glycerophospholipid measurement QTL GWAS1224114 (human) | | 3e-25 | glycerophospholipid measurement | | 4 | 114538869 | 114538870 | Human |
407251129 | GWAS900105_H | asthma QTL GWAS900105 (human) | | 1e-28 | asthma | | 4 | 122394921 | 122394922 | Human |
597373595 | GWAS1469669_H | intelligence QTL GWAS1469669 (human) | | 0.000008 | intelligence | | 4 | 128544541 | 128544542 | Human |
597103252 | GWAS1199326_H | gut microbiome measurement QTL GWAS1199326 (human) | | 0.0000009 | gut microbiome measurement | | 4 | 112858735 | 112858736 | Human |
597324447 | GWAS1420521_H | non-high density lipoprotein cholesterol measurement QTL GWAS1420521 (human) | | 3e-10 | non-high density lipoprotein cholesterol measurement | blood non-high density lipoprotein cholesterol level (CMO:0003967) | 4 | 109174464 | 109174465 | Human |
597435033 | GWAS1531107_H | facial morphology measurement QTL GWAS1531107 (human) | | 8e-09 | facial morphology trait (VT:0003743) | | 4 | 119407511 | 119407512 | Human |
597357202 | GWAS1453276_H | Alzheimer disease QTL GWAS1453276 (human) | | 0.000008 | Alzheimer disease | | 4 | 122647254 | 122647255 | Human |
597357206 | GWAS1453280_H | asthma, response to diisocyanate QTL GWAS1453280 (human) | | 0.000001 | asthma, response to diisocyanate | | 4 | 123742201 | 123742202 | Human |
597070488 | GWAS1166562_H | susceptibility to mononucleosis measurement QTL GWAS1166562 (human) | | 0.000008 | susceptibility to mononucleosis measurement | | 4 | 124860479 | 124860480 | Human |
596980357 | GWAS1099876_H | memory performance QTL GWAS1099876 (human) | | 0.000004 | memory performance | | 4 | 112467350 | 112467351 | Human |
597226120 | GWAS1322194_H | electrocardiography QTL GWAS1322194 (human) | | 2e-18 | electrocardiography | | 4 | 113523605 | 113523606 | Human |
597615246 | GWAS1672106_H | bladder calculus QTL GWAS1672106 (human) | | 4e-17 | bladder calculus | | 4 | 114696462 | 114696463 | Human |
597226121 | GWAS1322195_H | electrocardiography QTL GWAS1322195 (human) | | 8e-21 | electrocardiography | | 4 | 113523605 | 113523606 | Human |
597402249 | GWAS1498323_H | total brain volume change measurement, age at assessment QTL GWAS1498323 (human) | | 0.000002 | total brain volume change measurement, age at assessment | | 4 | 111512339 | 111512340 | Human |
597226122 | GWAS1322196_H | electrocardiography QTL GWAS1322196 (human) | | 2e-12 | electrocardiography | | 4 | 113523605 | 113523606 | Human |
596951687 | GWAS1071206_H | HbA1c measurement QTL GWAS1071206 (human) | | 0.000001 | HbA1c measurement | | 4 | 109980042 | 109980043 | Human |
597226123 | GWAS1322197_H | electrocardiography QTL GWAS1322197 (human) | | 7e-09 | electrocardiography | | 4 | 113523605 | 113523606 | Human |
597389960 | GWAS1486034_H | hemoglobin measurement QTL GWAS1486034 (human) | | 2e-11 | hemoglobin measurement | hemoglobin measurement (CMO:0000508) | 4 | 123844107 | 123844108 | Human |
597226124 | GWAS1322198_H | electrocardiography QTL GWAS1322198 (human) | | 1e-09 | electrocardiography | | 4 | 113523605 | 113523606 | Human |
597226125 | GWAS1322199_H | electrocardiography QTL GWAS1322199 (human) | | 2e-09 | electrocardiography | | 4 | 113523605 | 113523606 | Human |
597070467 | GWAS1166541_H | susceptibility to mononucleosis measurement QTL GWAS1166541 (human) | | 0.000008 | susceptibility to mononucleosis measurement | | 4 | 121625333 | 121625334 | Human |
597262991 | GWAS1359065_H | aspartate measurement QTL GWAS1359065 (human) | | 0.0000001 | blood L-aspartic acid amount (VT:0010969) | | 4 | 110477052 | 110477053 | Human |
597226126 | GWAS1322200_H | electrocardiography QTL GWAS1322200 (human) | | 1e-24 | electrocardiography | | 4 | 113523605 | 113523606 | Human |
597365389 | GWAS1461463_H | eosinophil count QTL GWAS1461463 (human) | | 1e-23 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 4 | 122639784 | 122639785 | Human |
597275278 | GWAS1371352_H | rheumatoid arthritis, anti-citrullinated protein antibody seropositivity, rheumatoid factor seropositivity measurement QTL GWAS1371352 (human) | | 7e-08 | rheumatoid arthritis, anti-citrullinated protein antibody seropositivity, rheumatoid factor seropositivity measurement | | 4 | 108140462 | 108140463 | Human |
406927702 | GWAS576678_H | age-related macular degeneration QTL GWAS576678 (human) | | 9e-09 | age-related macular degeneration | | 4 | 109737911 | 109737912 | Human |
597390011 | GWAS1486085_H | Parkinson disease QTL GWAS1486085 (human) | | 0.0000005 | Parkinson disease | | 4 | 113422713 | 113422714 | Human |
596964021 | GWAS1083540_H | allergic disease QTL GWAS1083540 (human) | | 7e-13 | allergic disease | | 4 | 122219915 | 122219916 | Human |
597578429 | GWAS1635289_H | prothrombin time measurement QTL GWAS1635289 (human) | | 2e-31 | prothrombin time measurement | prothrombin time (CMO:0000211) | 4 | 110791276 | 110791277 | Human |
597140159 | GWAS1236233_H | heart failure QTL GWAS1236233 (human) | | 2e-18 | heart failure | | 4 | 110843816 | 110843817 | Human |
597414579 | GWAS1510653_H | Abnormality of refraction QTL GWAS1510653 (human) | | 1e-08 | Abnormality of refraction | | 4 | 111208199 | 111208200 | Human |
597521076 | GWAS1617150_H | open-angle glaucoma QTL GWAS1617150 (human) | | 2e-09 | open-angle glaucoma | | 4 | 127549411 | 127549412 | Human |
597619381 | GWAS1676241_H | cardiac arrhythmia QTL GWAS1676241 (human) | | 3e-130 | cardiac arrhythmia | | 4 | 110796911 | 110796912 | Human |
597021369 | GWAS1117443_H | Crohn's disease QTL GWAS1117443 (human) | | 0.0000009 | intestine integrity trait (VT:0010554) | | 4 | 122430276 | 122430277 | Human |
597476017 | GWAS1572091_H | blood protein measurement QTL GWAS1572091 (human) | | 1e-164 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 4 | 106917957 | 106917958 | Human |
597406389 | GWAS1502463_H | Ischemic stroke QTL GWAS1502463 (human) | | 1e-15 | Ischemic stroke | | 4 | 110793263 | 110793264 | Human |
597512876 | GWAS1608950_H | body mass index QTL GWAS1608950 (human) | | 4e-11 | body mass index | body mass index (BMI) (CMO:0000105) | 4 | 114132729 | 114132730 | Human |
597275306 | GWAS1371380_H | testosterone measurement QTL GWAS1371380 (human) | | 1e-14 | testosterone measurement | serum testosterone level (CMO:0000568) | 4 | 124126476 | 124126477 | Human |
597402285 | GWAS1498359_H | gut microbiome measurement QTL GWAS1498359 (human) | | 0.0000003 | gut microbiome measurement | | 4 | 112357355 | 112357356 | Human |
597066414 | GWAS1162488_H | susceptibility to Mycobacterium tuberculosis infection measurement QTL GWAS1162488 (human) | | 0.000003 | susceptibility to Mycobacterium tuberculosis infection measurement | | 4 | 120002322 | 120002323 | Human |
597430948 | GWAS1527022_H | attention deficit hyperactivity disorder, bipolar disorder QTL GWAS1527022 (human) | | 1e-08 | attention deficit hyperactivity disorder, bipolar disorder | | 4 | 122589611 | 122589612 | Human |
597312163 | GWAS1408237_H | vaginal microbiome measurement QTL GWAS1408237 (human) | | 0.000002 | vaginal microbiome measurement | | 4 | 113348345 | 113348346 | Human |
597324448 | GWAS1420522_H | non-high density lipoprotein cholesterol measurement QTL GWAS1420522 (human) | | 2e-13 | non-high density lipoprotein cholesterol measurement | blood non-high density lipoprotein cholesterol level (CMO:0003967) | 4 | 109717668 | 109717669 | Human |
406960384 | GWAS609360_H | systolic blood pressure QTL GWAS609360 (human) | | 2e-11 | fibrinopeptide A measurement | systolic blood pressure (CMO:0000004) | 4 | 110510288 | 110510289 | Human |
597402330 | GWAS1498404_H | mean reticulocyte volume QTL GWAS1498404 (human) | | 1e-09 | reticulocyte morphology trait (VT:0002424) | mean corpuscular volume (CMO:0000038) | 4 | 128306129 | 128306130 | Human |
597422809 | GWAS1518883_H | HbA1c measurement QTL GWAS1518883 (human) | | 6e-10 | HbA1c measurement | blood hemoglobin A1c level (CMO:0002786) | 4 | 116926523 | 116926524 | Human |
597402329 | GWAS1498403_H | mean reticulocyte volume QTL GWAS1498403 (human) | | 3e-10 | reticulocyte morphology trait (VT:0002424) | mean corpuscular volume (CMO:0000038) | 4 | 127552302 | 127552303 | Human |
597144276 | GWAS1240350_H | COVID-19 QTL GWAS1240350 (human) | | 0.0000006 | COVID-19 | | 4 | 107888805 | 107888806 | Human |
597111508 | GWAS1207582_H | asthma QTL GWAS1207582 (human) | | 0.000008 | asthma | | 4 | 122456327 | 122456328 | Human |
597086940 | GWAS1183014_H | type 2 diabetes mellitus QTL GWAS1183014 (human) | | 9e-09 | type 2 diabetes mellitus | | 4 | 128103118 | 128103119 | Human |
597578451 | GWAS1635311_H | high density lipoprotein cholesterol measurement QTL GWAS1635311 (human) | | 5e-17 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 4 | 109657070 | 109657071 | Human |
597336791 | GWAS1432865_H | COVID-19 QTL GWAS1432865 (human) | | 0.000009 | COVID-19 | | 4 | 122020759 | 122020760 | Human |
597291721 | GWAS1387795_H | size QTL GWAS1387795 (human) | | 2e-10 | size | | 4 | 123999891 | 123999892 | Human |
597140161 | GWAS1236235_H | heart failure QTL GWAS1236235 (human) | | 4e-16 | heart failure | | 4 | 110707472 | 110707473 | Human |
597222094 | GWAS1318168_H | major depressive disorder QTL GWAS1318168 (human) | | 3e-16 | major depressive disorder | | 4 | 122467738 | 122467739 | Human |
597607104 | GWAS1663964_H | systolic blood pressure QTL GWAS1663964 (human) | | 6e-13 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 4 | 110791276 | 110791277 | Human |
407226650 | GWAS875626_H | schizophrenia QTL GWAS875626 (human) | | 3e-08 | schizophrenia | | 4 | 117725752 | 117725753 | Human |
597021386 | GWAS1117460_H | ovarian carcinoma QTL GWAS1117460 (human) | | 0.000003 | ovarian carcinoma | | 4 | 119028805 | 119028806 | Human |
596968181 | GWAS1087700_H | cortical thickness QTL GWAS1087700 (human) | | 3e-08 | cortical thickness | | 4 | 120730658 | 120730659 | Human |
407370021 | GWAS1018997_H | forced expiratory volume, response to bronchodilator QTL GWAS1018997 (human) | | 0.000005 | forced expiratory volume, response to bronchodilator | forced expiratory volume (CMO:0000254) | 4 | 122584901 | 122584902 | Human |
596968183 | GWAS1087702_H | cortical thickness QTL GWAS1087702 (human) | | 3e-08 | cortical thickness | | 4 | 126550097 | 126550098 | Human |
596984561 | GWAS1104080_H | memory performance, sex interaction measurement QTL GWAS1104080 (human) | | 0.000004 | memory performance, sex interaction measurement | | 4 | 109128713 | 109128714 | Human |
597291773 | GWAS1387847_H | BMI-adjusted waist-hip ratio QTL GWAS1387847 (human) | | 5e-11 | body size trait (VT:0100005) | | 4 | 119213641 | 119213642 | Human |
597205756 | GWAS1301830_H | generalized anxiety disorder QTL GWAS1301830 (human) | | 4e-08 | generalized anxiety disorder | | 4 | 122265238 | 122265239 | Human |
596984560 | GWAS1104079_H | memory performance, sex interaction measurement QTL GWAS1104079 (human) | | 0.000004 | memory performance, sex interaction measurement | | 4 | 109135631 | 109135632 | Human |
596984563 | GWAS1104082_H | memory performance, sex interaction measurement QTL GWAS1104082 (human) | | 0.000005 | memory performance, sex interaction measurement | | 4 | 125584117 | 125584118 | Human |
596984562 | GWAS1104081_H | memory performance, sex interaction measurement QTL GWAS1104081 (human) | | 0.000004 | memory performance, sex interaction measurement | | 4 | 109128952 | 109128953 | Human |
597291774 | GWAS1387848_H | BMI-adjusted waist-hip ratio QTL GWAS1387848 (human) | | 6e-10 | body size trait (VT:0100005) | | 4 | 119763897 | 119763898 | Human |
597422835 | GWAS1518909_H | atrial fibrillation QTL GWAS1518909 (human) | | 5e-29 | atrial fibrillation | | 4 | 110401104 | 110401105 | Human |
597402355 | GWAS1498429_H | Crohn's disease QTL GWAS1498429 (human) | | 2e-09 | intestine integrity trait (VT:0010554) | | 4 | 122240464 | 122240465 | Human |
597082879 | GWAS1178953_H | reticulocyte measurement QTL GWAS1178953 (human) | | 2e-10 | reticulocyte morphology trait (VT:0002424) | red blood cell measurement (CMO:0001356) | 4 | 119185193 | 119185194 | Human |
597431024 | GWAS1527098_H | testosterone measurement QTL GWAS1527098 (human) | | 6e-09 | testosterone measurement | serum testosterone level (CMO:0000568) | 4 | 109321740 | 109321741 | Human |
597476080 | GWAS1572154_H | sex hormone-binding globulin measurement QTL GWAS1572154 (human) | | 3e-12 | sex hormone-binding globulin measurement | | 4 | 123845801 | 123845802 | Human |
597431025 | GWAS1527099_H | testosterone measurement QTL GWAS1527099 (human) | | 2e-10 | testosterone measurement | serum testosterone level (CMO:0000568) | 4 | 113035247 | 113035248 | Human |
597050104 | GWAS1146178_H | endometriosis QTL GWAS1146178 (human) | | 0.0000006 | endometriosis | | 4 | 114744719 | 114744720 | Human |
597086948 | GWAS1183022_H | atopic eczema QTL GWAS1183022 (human) | | 1e-08 | atopic eczema | | 4 | 122576542 | 122576543 | Human |
597455598 | GWAS1551672_H | lymphocyte measurement, neutrophil measurement QTL GWAS1551672 (human) | | 3e-14 | lymphocyte measurement, neutrophil measurement | | 4 | 122707302 | 122707305 | Human |
597476079 | GWAS1572153_H | sex hormone-binding globulin measurement QTL GWAS1572153 (human) | | 1e-10 | sex hormone-binding globulin measurement | | 4 | 119202262 | 119202263 | Human |
597492462 | GWAS1588536_H | COVID-19 QTL GWAS1588536 (human) | | 0.000007 | COVID-19 | | 4 | 122087606 | 122087607 | Human |
596959969 | GWAS1079488_H | glomerular filtration rate QTL GWAS1079488 (human) | | 1e-12 | glomerular filtration rate | | 4 | 108783751 | 108783752 | Human |
596955874 | GWAS1075393_H | lymphocyte measurement, neutrophil measurement QTL GWAS1075393 (human) | | 6e-12 | lymphocyte measurement, neutrophil measurement | | 4 | 109980042 | 109980043 | Human |
597066464 | GWAS1162538_H | vaso-occlusive pain measurement QTL GWAS1162538 (human) | | 6e-08 | vaso-occlusive pain measurement | | 4 | 122088578 | 122088579 | Human |
597431014 | GWAS1527088_H | carotid artery disease QTL GWAS1527088 (human) | | 1e-16 | carotid artery disease | | 4 | 106712535 | 106712536 | Human |
597123818 | GWAS1219892_H | blood protein measurement QTL GWAS1219892 (human) | | 8e-54 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 4 | 109737911 | 109737912 | Human |
596968168 | GWAS1087687_H | cortical thickness QTL GWAS1087687 (human) | | 2e-10 | cortical thickness | | 4 | 120722571 | 120722572 | Human |
597217819 | GWAS1313893_H | adult onset asthma QTL GWAS1313893 (human) | | 2e-10 | adult onset asthma | | 4 | 122432277 | 122432278 | Human |
597258780 | GWAS1354854_H | triglycerides:total lipids ratio, high density lipoprotein cholesterol measurement QTL GWAS1354854 (human) | | 3e-14 | triglycerides:total lipids ratio, high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 4 | 109657070 | 109657071 | Human |
597307932 | GWAS1404006_H | cardiovascular age measurement QTL GWAS1404006 (human) | | 3e-14 | cardiovascular age measurement | | 4 | 113465982 | 113465983 | Human |
597037598 | GWAS1133672_H | treatment resistant depression, response to antidepressant QTL GWAS1133672 (human) | | 0.000004 | treatment resistant depression, response to antidepressant | | 4 | 130515632 | 130515633 | Human |
597078534 | GWAS1174608_H | sex interaction measurement, bilirubin measurement QTL GWAS1174608 (human) | | 0.000005 | sex interaction measurement, bilirubin measurement | serum total bilirubin level (CMO:0000376) | 4 | 109805166 | 109805167 | Human |
597590537 | GWAS1647397_H | blood coagulation disease QTL GWAS1647397 (human) | | 5e-19 | blood coagulation disease | | 4 | 110784139 | 110784140 | Human |
597230094 | GWAS1326168_H | alpha synuclein measurement QTL GWAS1326168 (human) | | 0.000005 | alpha synuclein measurement | | 4 | 119884972 | 119884973 | Human |
596984335 | GWAS1103854_H | memory performance QTL GWAS1103854 (human) | | 0.000009 | memory performance | | 4 | 131259522 | 131259523 | Human |
597619205 | GWAS1676065_H | stricture QTL GWAS1676065 (human) | | 2e-11 | stricture | | 4 | 114481688 | 114481689 | Human |
597119499 | GWAS1215573_H | high density lipoprotein cholesterol measurement QTL GWAS1215573 (human) | | 2e-44 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 4 | 109717668 | 109717669 | Human |
597119498 | GWAS1215572_H | high density lipoprotein cholesterol measurement QTL GWAS1215572 (human) | | 2e-17 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 4 | 109717608 | 109717609 | Human |
596967946 | GWAS1087465_H | cortical thickness QTL GWAS1087465 (human) | | 4e-12 | cortical thickness | | 4 | 120758655 | 120758656 | Human |
597377595 | GWAS1473669_H | systolic blood pressure QTL GWAS1473669 (human) | | 7e-08 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 4 | 110460482 | 110460483 | Human |
597103159 | GWAS1199233_H | myocardial infarction QTL GWAS1199233 (human) | | 0.0000002 | myocardial infarction | | 4 | 119988346 | 119988347 | Human |
597070390 | GWAS1166464_H | mosquito bite reaction size measurement QTL GWAS1166464 (human) | | 4e-11 | mosquito bite reaction size measurement | | 4 | 123250679 | 123250680 | Human |
597070391 | GWAS1166465_H | mosquito bite reaction size measurement QTL GWAS1166465 (human) | | 0.000003 | mosquito bite reaction size measurement | | 4 | 130874394 | 130874395 | Human |
406997473 | GWAS646449_H | reticulocyte count QTL GWAS646449 (human) | | 2e-13 | reticulocyte quantity (VT:0003135) | total reticulocyte count (CMO:0003020) | 4 | 109944309 | 109944310 | Human |
597619259 | GWAS1676119_H | congestive heart failure QTL GWAS1676119 (human) | | 5e-15 | heart integrity trait (VT:0010757) | | 4 | 110761735 | 110761736 | Human |
597336639 | GWAS1432713_H | RS-10-hydroxywarfarin to RS-warfarin ratio measurement QTL GWAS1432713 (human) | | 0.000003 | RS-10-hydroxywarfarin to RS-warfarin ratio measurement | | 4 | 121903623 | 121903624 | Human |
597512763 | GWAS1608837_H | anthropometric measurement QTL GWAS1608837 (human) | | 3e-10 | anthropometric measurement | body morphological measurement (CMO:0000021) | 4 | 108565997 | 108565998 | Human |
597619256 | GWAS1676116_H | sinoatrial node disorder QTL GWAS1676116 (human) | | 1e-17 | sinoatrial node disorder | | 4 | 110774266 | 110774267 | Human |
597271103 | GWAS1367177_H | cardioembolic stroke QTL GWAS1367177 (human) | | 3e-48 | cardioembolic stroke | | 4 | 110775495 | 110775496 | Human |
597377596 | GWAS1473670_H | diastolic blood pressure QTL GWAS1473670 (human) | | 9e-09 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 4 | 110460482 | 110460483 | Human |
597262910 | GWAS1358984_H | amino acid measurement QTL GWAS1358984 (human) | | 0.0000004 | amino acid measurement | | 4 | 125452415 | 125452416 | Human |
596963900 | GWAS1083419_H | major depressive disorder QTL GWAS1083419 (human) | | 0.000003 | major depressive disorder | | 4 | 124344158 | 124344159 | Human |
596976188 | GWAS1095707_H | body height QTL GWAS1095707 (human) | | 2e-10 | body height | | 4 | 121736832 | 121736833 | Human |
597135932 | GWAS1232006_H | juvenile idiopathic arthritis QTL GWAS1232006 (human) | | 0.0000007 | juvenile idiopathic arthritis | | 4 | 122535302 | 122535303 | Human |
597262901 | GWAS1358975_H | lymphocyte count QTL GWAS1358975 (human) | | 3e-09 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 4 | 110003204 | 110003205 | Human |
597377591 | GWAS1473665_H | hypertension QTL GWAS1473665 (human) | | 0.000006 | hypertension | | 4 | 112002081 | 112002082 | Human |
597619251 | GWAS1676111_H | congestive heart failure QTL GWAS1676111 (human) | | 6e-16 | heart integrity trait (VT:0010757) | | 4 | 110737902 | 110737903 | Human |
597586481 | GWAS1643341_H | eosinophil count QTL GWAS1643341 (human) | | 1e-17 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 4 | 122663791 | 122663792 | Human |
597070374 | GWAS1166448_H | mosquito bite reaction size measurement QTL GWAS1166448 (human) | | 0.0000002 | mosquito bite reaction size measurement | | 4 | 123041811 | 123041812 | Human |
597447213 | GWAS1543287_H | total cholesterol measurement, diet measurement QTL GWAS1543287 (human) | | 0.000003 | eating behavior trait (VT:0001431) | food intake measurement (CMO:0000772) | 4 | 118490708 | 118490709 | Human |
597070372 | GWAS1166446_H | mosquito bite reaction size measurement QTL GWAS1166446 (human) | | 0.0000003 | mosquito bite reaction size measurement | | 4 | 122182953 | 122182955 | Human |
597070373 | GWAS1166447_H | mosquito bite reaction size measurement QTL GWAS1166447 (human) | | 4e-08 | mosquito bite reaction size measurement | | 4 | 122852424 | 122852425 | Human |
596967976 | GWAS1087495_H | cortical thickness QTL GWAS1087495 (human) | | 1e-12 | cortical thickness | | 4 | 120722571 | 120722572 | Human |
597266983 | GWAS1363057_H | cortical thickness QTL GWAS1363057 (human) | | 3e-08 | cortical thickness | | 4 | 120722084 | 120722085 | Human |
597287463 | GWAS1383537_H | ulcerative colitis QTL GWAS1383537 (human) | | 2e-09 | ulcerative colitis | | 4 | 122523884 | 122523885 | Human |
596976213 | GWAS1095732_H | cardiovascular disease QTL GWAS1095732 (human) | | 1e-08 | cardiovascular disease | | 4 | 109616095 | 109616096 | Human |
597365338 | GWAS1461412_H | insomnia measurement QTL GWAS1461412 (human) | | 3e-08 | sleep behavior trait (VT:0001501) | | 4 | 111901575 | 111901576 | Human |
597615199 | GWAS1672059_H | nephrolithiasis QTL GWAS1672059 (human) | | 3e-16 | nephrolithiasis | | 4 | 114696462 | 114696463 | Human |
597336667 | GWAS1432741_H | COVID-19 QTL GWAS1432741 (human) | | 0.000007 | COVID-19 | | 4 | 117237956 | 117237957 | Human |
597463647 | GWAS1559721_H | Barrett's esophagus QTL GWAS1559721 (human) | | 3e-09 | Barrett's esophagus | | 4 | 123619833 | 123619834 | Human |
597131857 | GWAS1227931_H | erythrocyte count QTL GWAS1227931 (human) | | 1e-12 | HbA1c measurement | blood hemoglobin A1c level (CMO:0002786) | 4 | 109996470 | 109996471 | Human |
597348946 | GWAS1445020_H | restless legs syndrome QTL GWAS1445020 (human) | | 3e-09 | restless legs syndrome | | 4 | 130726717 | 130726718 | Human |
597348944 | GWAS1445018_H | restless legs syndrome QTL GWAS1445018 (human) | | 2e-09 | restless legs syndrome | | 4 | 115033802 | 115033803 | Human |
597348945 | GWAS1445019_H | restless legs syndrome QTL GWAS1445019 (human) | | 7e-10 | restless legs syndrome | | 4 | 118382649 | 118382650 | Human |
596951647 | GWAS1071166_H | dementia QTL GWAS1071166 (human) | | 0.000002 | dementia | | 4 | 120519704 | 120519705 | Human |
597394006 | GWAS1490080_H | bipolar I disorder QTL GWAS1490080 (human) | | 0.0000001 | bipolar I disorder | | 4 | 122588558 | 122588559 | Human |
596963930 | GWAS1083449_H | bipolar disorder, major depressive disorder QTL GWAS1083449 (human) | | 0.000008 | bipolar disorder, major depressive disorder | | 4 | 125438301 | 125438302 | Human |
597295688 | GWAS1391762_H | renin measurement, hypertension QTL GWAS1391762 (human) | | 0.000006 | renin activity (VT:0005581) | | 4 | 108375058 | 108375059 | Human |
597516878 | GWAS1612952_H | Parkinson disease QTL GWAS1612952 (human) | | 3e-11 | Parkinson disease | | 4 | 113447909 | 113447910 | Human |
597324364 | GWAS1420438_H | cup-to-disc ratio measurement QTL GWAS1420438 (human) | | 7e-09 | cup-to-disc ratio measurement | | 4 | 111478355 | 111478356 | Human |
407374224 | GWAS1023200_H | unipolar depression QTL GWAS1023200 (human) | | 0.0000004 | unipolar depression | | 4 | 130232015 | 130232016 | Human |
597439040 | GWAS1535114_H | BMI-adjusted hip circumference QTL GWAS1535114 (human) | | 0.000003 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 4 | 110946968 | 110946969 | Human |
597393991 | GWAS1490065_H | bipolar I disorder QTL GWAS1490065 (human) | | 0.0000008 | bipolar I disorder | | 4 | 117548415 | 117548416 | Human |
597021256 | GWAS1117330_H | fibroblast growth factor basic measurement QTL GWAS1117330 (human) | | 0.000002 | fibroblast growth factor basic measurement | | 4 | 107833368 | 107833369 | Human |
597393990 | GWAS1490064_H | bipolar I disorder QTL GWAS1490064 (human) | | 0.0000006 | bipolar I disorder | | 4 | 117624232 | 117624233 | Human |
597029493 | GWAS1125567_H | sugar consumption measurement QTL GWAS1125567 (human) | | 0.000004 | sugar consumption measurement | sucrose drink intake volume (CMO:0002200) | 4 | 130735539 | 130735540 | Human |
597381753 | GWAS1477827_H | mammographic density percentage QTL GWAS1477827 (human) | | 2e-08 | mammographic density percentage | | 4 | 127271525 | 127271526 | Human |
596976240 | GWAS1095759_H | stroke QTL GWAS1095759 (human) | | 0.0000004 | stroke | | 4 | 112810934 | 112810935 | Human |
596976243 | GWAS1095762_H | cardioembolic stroke QTL GWAS1095762 (human) | | 2e-47 | cardioembolic stroke | | 4 | 110793263 | 110793264 | Human |
597275263 | GWAS1371337_H | N-acetylgalactosamine measurement, N-acetylglucosamine measurement QTL GWAS1371337 (human) | | 5e-19 | N-acetylgalactosamine measurement, N-acetylglucosamine measurement | | 4 | 129143723 | 129143724 | Human |
596963955 | GWAS1083474_H | major depressive disorder QTL GWAS1083474 (human) | | 0.000007 | major depressive disorder | | 4 | 124494379 | 124494380 | Human |
597029501 | GWAS1125575_H | body mass index QTL GWAS1125575 (human) | | 1e-08 | body mass index | body mass index (BMI) (CMO:0000105) | 4 | 112335581 | 112335582 | Human |
597029500 | GWAS1125574_H | body mass index QTL GWAS1125574 (human) | | 1e-10 | body mass index | body mass index (BMI) (CMO:0000105) | 4 | 111765198 | 111765199 | Human |
406931880 | GWAS580856_H | pulse pressure measurement QTL GWAS580856 (human) | | 1e-52 | pulse pressure measurement | pulse pressure (CMO:0000292) | 4 | 112822498 | 112822499 | Human |
597615220 | GWAS1672080_H | platelet count QTL GWAS1672080 (human) | | 4e-36 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 4 | 109927496 | 109927497 | Human |
597054077 | GWAS1150151_H | smoking status measurement QTL GWAS1150151 (human) | | 7e-12 | smoking status measurement | | 4 | 111500989 | 111500990 | Human |
597140092 | GWAS1236166_H | facial morphology measurement QTL GWAS1236166 (human) | | 5e-08 | facial morphology trait (VT:0003743) | | 4 | 125202598 | 125202599 | Human |
597029502 | GWAS1125576_H | body mass index QTL GWAS1125576 (human) | | 4e-08 | body mass index | body mass index (BMI) (CMO:0000105) | 4 | 130102129 | 130102130 | Human |
597140091 | GWAS1236165_H | facial morphology measurement QTL GWAS1236165 (human) | | 4e-08 | facial morphology trait (VT:0003743) | | 4 | 125199979 | 125199980 | Human |
597140090 | GWAS1236164_H | facial morphology measurement QTL GWAS1236164 (human) | | 3e-08 | facial morphology trait (VT:0003743) | | 4 | 125220568 | 125220569 | Human |
597529200 | GWAS1625274_H | body mass index QTL GWAS1625274 (human) | | 2e-12 | body mass index | body mass index (BMI) (CMO:0000105) | 4 | 129803585 | 129803586 | Human |
597381749 | GWAS1477823_H | mammographic density measurement QTL GWAS1477823 (human) | | 6e-10 | mammographic density measurement | | 4 | 126851213 | 126851214 | Human |
596968059 | GWAS1087578_H | body mass index QTL GWAS1087578 (human) | | 6e-09 | body mass index | | 4 | 129803585 | 129803586 | Human |
597398132 | GWAS1494206_H | Beta blocking agent use measurement QTL GWAS1494206 (human) | | 1e-19 | Beta blocking agent use measurement | | 4 | 110789765 | 110789766 | Human |
597250678 | GWAS1346752_H | corneal resistance factor QTL GWAS1346752 (human) | | 4e-08 | corneal resistance factor | | 4 | 118802505 | 118802506 | Human |
597402228 | GWAS1498302_H | protein measurement QTL GWAS1498302 (human) | | 6e-10 | protein measurement | | 4 | 132286668 | 132286669 | Human |
597402217 | GWAS1498291_H | systolic blood pressure QTL GWAS1498291 (human) | | 2e-16 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 4 | 110416708 | 110416709 | Human |
597107299 | GWAS1203373_H | cytokine measurement QTL GWAS1203373 (human) | | 0.000003 | cytokine measurement | blood cytokine measurement (CMO:0001924) | 4 | 113032921 | 113032922 | Human |
406976949 | GWAS625925_H | hemoglobin measurement QTL GWAS625925 (human) | | 1e-09 | hemoglobin measurement | hemoglobin measurement (CMO:0000508) | 4 | 114647874 | 114647875 | Human |
597516906 | GWAS1612980_H | testosterone measurement QTL GWAS1612980 (human) | | 6e-16 | testosterone measurement | serum testosterone level (CMO:0000568) | 4 | 109345757 | 109345758 | Human |
597291630 | GWAS1387704_H | lymphocyte count QTL GWAS1387704 (human) | | 1e-14 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 4 | 109919540 | 109919541 | Human |
596976236 | GWAS1095755_H | Ischemic stroke QTL GWAS1095755 (human) | | 0.0000001 | Ischemic stroke | | 4 | 112810934 | 112810935 | Human |
597500519 | GWAS1596593_H | memory performance QTL GWAS1596593 (human) | | 0.000001 | memory performance | | 4 | 124874941 | 124874942 | Human |
597193314 | GWAS1289388_H | executive function measurement QTL GWAS1289388 (human) | | 0.000002 | executive function measurement | | 4 | 130874841 | 130874842 | Human |
597463650 | GWAS1559724_H | esophageal adenocarcinoma, Barrett's esophagus QTL GWAS1559724 (human) | | 6e-13 | esophageal adenocarcinoma, Barrett's esophagus | | 4 | 123640998 | 123640999 | Human |
597451165 | GWAS1547239_H | conotruncal heart malformations QTL GWAS1547239 (human) | | 0.000003 | conotruncal heart malformations | | 4 | 111868878 | 111868879 | Human |
597258651 | GWAS1354725_H | total cholesterol measurement QTL GWAS1354725 (human) | | 9e-10 | total cholesterol measurement | blood total cholesterol level (CMO:0000051) | 4 | 128078464 | 128078465 | Human |
597324190 | GWAS1420264_H | histidine measurement QTL GWAS1420264 (human) | | 3e-08 | histidine measurement | blood amino acid measurement (CMO:0003730) | 4 | 122051907 | 122051908 | Human |
597279134 | GWAS1375208_H | hypertension, COVID-19 QTL GWAS1375208 (human) | | 5e-08 | hypertension, COVID-19 | | 4 | 110493243 | 110493244 | Human |
597508501 | GWAS1604575_H | self reported educational attainment QTL GWAS1604575 (human) | | 1e-08 | self reported educational attainment | | 4 | 129748953 | 129748954 | Human |
597508500 | GWAS1604574_H | self reported educational attainment QTL GWAS1604574 (human) | | 1e-08 | self reported educational attainment | | 4 | 117593081 | 117593082 | Human |
597508502 | GWAS1604576_H | self reported educational attainment QTL GWAS1604576 (human) | | 4e-08 | self reported educational attainment | | 4 | 130401277 | 130401278 | Human |
597483920 | GWAS1579994_H | periodontitis QTL GWAS1579994 (human) | | 0.000009 | periodontitis | | 4 | 110885393 | 110885394 | Human |
597320086 | GWAS1416160_H | executive function measurement QTL GWAS1416160 (human) | | 1e-08 | executive function measurement | | 4 | 118025394 | 118025395 | Human |
597033369 | GWAS1129443_H | balding measurement QTL GWAS1129443 (human) | | 9e-15 | hair amount (VT:0000416) | coat/hair morphological measurement (CMO:0001807) | 4 | 106348870 | 106348871 | Human |
597066118 | GWAS1162192_H | systemic juvenile idiopathic arthritis, polyarticular juvenile idiopathic arthritis, rheumatoid factor negative, oligoarticular juvenile idiopathic arthritis QTL GWAS1162192 (human) | | 6e-11 | systemic juvenile idiopathic arthritis, polyarticular juvenile idiopathic arthritis, rheumatoid factor negative, oligoarticular juvenile idiopathic arthritis | | 4 | 122466445 | 122466446 | Human |
597098886 | GWAS1194960_H | gut microbiome measurement QTL GWAS1194960 (human) | | 0.000009 | gut microbiome measurement | | 4 | 112858735 | 112858736 | Human |
597434761 | GWAS1530835_H | upper face morphology measurement QTL GWAS1530835 (human) | | 2e-09 | facial morphology trait (VT:0003743) | | 4 | 110922515 | 110922516 | Human |
596980109 | GWAS1099628_H | memory performance QTL GWAS1099628 (human) | | 0.000002 | memory performance | | 4 | 124874941 | 124874942 | Human |
597406082 | GWAS1502156_H | cardioembolic stroke QTL GWAS1502156 (human) | | 2e-47 | cardioembolic stroke | | 4 | 110793263 | 110793264 | Human |
597393793 | GWAS1489867_H | gut microbiome measurement QTL GWAS1489867 (human) | | 0.000001 | gut microbiome measurement | | 4 | 106920747 | 106920748 | Human |
597074316 | GWAS1170390_H | type 2 diabetes mellitus QTL GWAS1170390 (human) | | 2e-08 | type 2 diabetes mellitus | | 4 | 121739095 | 121739096 | Human |
597406080 | GWAS1502154_H | stroke QTL GWAS1502154 (human) | | 2e-13 | stroke | | 4 | 110793263 | 110793264 | Human |
597045645 | GWAS1141719_H | hemoglobin measurement QTL GWAS1141719 (human) | | 1e-09 | hemoglobin measurement | hemoglobin measurement (CMO:0000508) | 4 | 114596387 | 114596388 | Human |
597389696 | GWAS1485770_H | bipolar disorder QTL GWAS1485770 (human) | | 0.000005 | bipolar disorder | | 4 | 122589611 | 122589612 | Human |
597590462 | GWAS1647322_H | blood coagulation disease QTL GWAS1647322 (human) | | 1e-13 | blood coagulation disease | | 4 | 110796911 | 110796912 | Human |
597021108 | GWAS1117182_H | sclerosing cholangitis QTL GWAS1117182 (human) | | 1e-13 | sclerosing cholangitis | | 4 | 122578590 | 122578591 | Human |
597160374 | GWAS1256448_H | 3-methyl-2-oxobutyrate measurement QTL GWAS1256448 (human) | | 0.000009 | 3-methyl-2-oxobutyrate measurement | | 4 | 124716785 | 124716786 | Human |
597361074 | GWAS1457148_H | atrial fibrillation QTL GWAS1457148 (human) | | 1e-126 | atrial fibrillation | | 4 | 110796911 | 110796912 | Human |
597361077 | GWAS1457151_H | atrial fibrillation QTL GWAS1457151 (human) | | 2e-134 | atrial fibrillation | | 4 | 110793733 | 110793734 | Human |
597336492 | GWAS1432566_H | Hepatitis QTL GWAS1432566 (human) | | 1e-09 | Hepatitis | | 4 | 125282172 | 125282173 | Human |
597316002 | GWAS1412076_H | testosterone measurement QTL GWAS1412076 (human) | | 5e-13 | testosterone measurement | serum testosterone level (CMO:0000568) | 4 | 114419750 | 114419751 | Human |
597131693 | GWAS1227767_H | memory performance QTL GWAS1227767 (human) | | 0.000009 | memory performance | | 4 | 109134293 | 109134294 | Human |
597344672 | GWAS1440746_H | color vision disorder QTL GWAS1440746 (human) | | 1e-10 | color vision disorder | | 4 | 109831805 | 109831806 | Human |
597324192 | GWAS1420266_H | tryptophan measurement QTL GWAS1420266 (human) | | 6e-09 | tryptophan measurement | | 4 | 122051907 | 122051908 | Human |
597619108 | GWAS1675968_H | body weight QTL GWAS1675968 (human) | | 4e-19 | body mass (VT:0001259) | body weight (CMO:0000012) | 4 | 129818987 | 129818988 | Human |
597266852 | GWAS1362926_H | epidermal growth factor measurement QTL GWAS1362926 (human) | | 5e-25 | epidermal growth factor measurement | | 4 | 109938419 | 109938420 | Human |
597590492 | GWAS1647352_H | encounter with health service QTL GWAS1647352 (human) | | 7e-141 | encounter with health service | | 4 | 110778170 | 110778171 | Human |
597311967 | GWAS1408041_H | vaginal microbiome measurement QTL GWAS1408041 (human) | | 0.000009 | vaginal microbiome measurement | | 4 | 118330002 | 118330003 | Human |
597316060 | GWAS1412134_H | diastolic blood pressure QTL GWAS1412134 (human) | | 1e-13 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 4 | 119588124 | 119588125 | Human |
597311965 | GWAS1408039_H | vaginal microbiome measurement QTL GWAS1408039 (human) | | 0.000005 | vaginal microbiome measurement | | 4 | 108166673 | 108166674 | Human |
597291486 | GWAS1387560_H | hypertension QTL GWAS1387560 (human) | | 6e-12 | hypertension | | 4 | 110484920 | 110484925 | Human |
407382528 | GWAS1031504_H | obsolete_red blood cell distribution width QTL GWAS1031504 (human) | | 6e-21 | obsolete_red blood cell distribution width | | 4 | 128306129 | 128306130 | Human |
597602775 | GWAS1659635_H | drug use measurement, cardiovascular disease QTL GWAS1659635 (human) | | 8e-18 | drug use measurement, cardiovascular disease | | 4 | 110775495 | 110775496 | Human |
597262806 | GWAS1358880_H | type 2 diabetes mellitus QTL GWAS1358880 (human) | | 2e-18 | type 2 diabetes mellitus | | 4 | 119146548 | 119146549 | Human |
597365204 | GWAS1461278_H | eosinophil percentage of leukocytes QTL GWAS1461278 (human) | | 2e-22 | eosinophil quantity (VT:0002602) | blood eosinophil count to total leukocyte count ratio (CMO:0000369) | 4 | 122680542 | 122680543 | Human |
597508556 | GWAS1604630_H | physical activity measurement QTL GWAS1604630 (human) | | 3e-09 | wellness/fitness trait (VT:1000152) | voluntary body movement measurement (CMO:0000954) | 4 | 108177667 | 108177668 | Human |
597090757 | GWAS1186831_H | concussion QTL GWAS1186831 (human) | | 1e-10 | brain integrity trait (VT:0010579) | | 4 | 123151329 | 123151330 | Human |
597410253 | GWAS1506327_H | reaction time measurement QTL GWAS1506327 (human) | | 0.0000002 | reaction time measurement | | 4 | 117419552 | 117419553 | Human |
597291461 | GWAS1387535_H | monocyte count QTL GWAS1387535 (human) | | 2e-26 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 4 | 110035176 | 110035177 | Human |
597291463 | GWAS1387537_H | monocyte count QTL GWAS1387537 (human) | | 5e-16 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 4 | 109926568 | 109926569 | Human |
597373380 | GWAS1469454_H | asthma, age at diagnosis QTL GWAS1469454 (human) | | 0.0000002 | asthma, age at diagnosis | | 4 | 122680257 | 122680258 | Human |
597316090 | GWAS1412164_H | BMI-adjusted waist circumference QTL GWAS1412164 (human) | | 2e-11 | body size trait (VT:0100005) | | 4 | 119213641 | 119213642 | Human |
597316091 | GWAS1412165_H | BMI-adjusted waist circumference QTL GWAS1412165 (human) | | 1e-08 | body size trait (VT:0100005) | | 4 | 119503425 | 119503426 | Human |
596972022 | GWAS1091541_H | major depressive disorder QTL GWAS1091541 (human) | | 0.0000004 | major depressive disorder | | 4 | 130232015 | 130232016 | Human |
597316094 | GWAS1412168_H | BMI-adjusted waist circumference QTL GWAS1412168 (human) | | 4e-09 | body size trait (VT:0100005) | | 4 | 119805780 | 119805781 | Human |
597316092 | GWAS1412166_H | BMI-adjusted waist circumference QTL GWAS1412166 (human) | | 2e-14 | body size trait (VT:0100005) | | 4 | 119674620 | 119674621 | Human |
597316093 | GWAS1412167_H | BMI-adjusted waist circumference QTL GWAS1412167 (human) | | 5e-10 | body size trait (VT:0100005) | | 4 | 119761309 | 119761310 | Human |
597410300 | GWAS1506374_H | Alzheimer disease QTL GWAS1506374 (human) | | 0.0000007 | Alzheimer disease | | 4 | 128702401 | 128702402 | Human |
596967933 | GWAS1087452_H | cortical thickness QTL GWAS1087452 (human) | | 3e-08 | cortical thickness | | 4 | 120722084 | 120722085 | Human |
597311987 | GWAS1408061_H | vaginal microbiome measurement QTL GWAS1408061 (human) | | 0.000009 | vaginal microbiome measurement | | 4 | 110167303 | 110167304 | Human |
597533172 | GWAS1629246_H | rheumatoid arthritis QTL GWAS1629246 (human) | | 0.000005 | rheumatoid arthritis | | 4 | 124601887 | 124601888 | Human |
407001640 | GWAS650616_H | diastolic blood pressure QTL GWAS650616 (human) | | 6e-08 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 4 | 108104223 | 108104224 | Human |
597410294 | GWAS1506368_H | Alzheimer disease QTL GWAS1506368 (human) | | 0.000006 | Alzheimer disease | | 4 | 119130833 | 119130834 | Human |
597348855 | GWAS1444929_H | atopic eczema QTL GWAS1444929 (human) | | 1e-14 | atopic eczema | | 4 | 122263256 | 122263257 | Human |
597496306 | GWAS1592380_H | hip geometry QTL GWAS1592380 (human) | | 3e-08 | hip geometry | hip circumference (CMO:0000014) | 4 | 121074997 | 121074998 | Human |
597533165 | GWAS1629239_H | rheumatoid arthritis QTL GWAS1629239 (human) | | 0.000002 | rheumatoid arthritis | | 4 | 108192758 | 108192759 | Human |
597152228 | GWAS1248302_H | free cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement QTL GWAS1248302 (human) | | 2e-10 | chylomicron measurement, triglyceride measurement, very low density lipoprotein cholesterol measurement | blood triglyceride level (CMO:0000118) | 4 | 109657070 | 109657071 | Human |
597111277 | GWAS1207351_H | mathematical ability QTL GWAS1207351 (human) | | 2e-14 | mathematical ability | | 4 | 128819435 | 128819436 | Human |
596984296 | GWAS1103815_H | memory performance, sex interaction measurement QTL GWAS1103815 (human) | | 0.000004 | memory performance, sex interaction measurement | | 4 | 109129261 | 109129262 | Human |
597504482 | GWAS1600556_H | body mass index QTL GWAS1600556 (human) | | 4e-08 | body mass index | body mass index (BMI) (CMO:0000105) | 4 | 129803585 | 129803586 | Human |
597127444 | GWAS1223518_H | glycerophospholipid measurement QTL GWAS1223518 (human) | | 4e-10 | glycerophospholipid measurement | | 4 | 114480792 | 114480793 | Human |
597528859 | GWAS1624933_H | aspartate measurement QTL GWAS1624933 (human) | | 4e-18 | blood L-aspartic acid amount (VT:0010969) | | 4 | 110414566 | 110414567 | Human |
597434644 | GWAS1530718_H | Antithrombotic agent use measurement QTL GWAS1530718 (human) | | 6e-19 | Antithrombotic agent use measurement | | 4 | 110791080 | 110791081 | Human |
597037340 | GWAS1133414_H | caudate nucleus volume QTL GWAS1133414 (human) | | 0.000004 | caudate nucleus volume | | 4 | 122735253 | 122735254 | Human |
597487895 | GWAS1583969_H | Ventricular arrhythmia QTL GWAS1583969 (human) | | 2e-10 | Ventricular arrhythmia | | 4 | 110791080 | 110791081 | Human |
596975902 | GWAS1095421_H | Ischemic stroke QTL GWAS1095421 (human) | | 1e-15 | Ischemic stroke | | 4 | 110793263 | 110793264 | Human |
597172489 | GWAS1268563_H | body mass index QTL GWAS1268563 (human) | | 7e-10 | body mass index | body mass index (BMI) (CMO:0000105) | 4 | 112392830 | 112392831 | Human |
406919888 | GWAS568864_H | neutrophil count QTL GWAS568864 (human) | | 0.000008 | neutrophil quantity (VT:0000222) | blood neutrophil count (CMO:0000030) | 4 | 117730668 | 117730669 | Human |
597336331 | GWAS1432405_H | COVID-19 QTL GWAS1432405 (human) | | 0.000009 | COVID-19 | | 4 | 127021337 | 127021338 | Human |
597307663 | GWAS1403737_H | triglyceride measurement QTL GWAS1403737 (human) | | 3e-20 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 4 | 109603883 | 109603884 | Human |
597393677 | GWAS1489751_H | bipolar disorder QTL GWAS1489751 (human) | | 0.0000001 | bipolar disorder | | 4 | 117551578 | 117551579 | Human |
597508357 | GWAS1604431_H | diastolic blood pressure QTL GWAS1604431 (human) | | 3e-16 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 4 | 110414448 | 110414449 | Human |
597225728 | GWAS1321802_H | smoking status measurement QTL GWAS1321802 (human) | | 2e-15 | smoking status measurement | | 4 | 111500989 | 111500990 | Human |
597225729 | GWAS1321803_H | smoking status measurement QTL GWAS1321803 (human) | | 5e-08 | smoking status measurement | | 4 | 120722084 | 120722085 | Human |
597459206 | GWAS1555280_H | dementia QTL GWAS1555280 (human) | | 0.000002 | dementia | | 4 | 120519704 | 120519705 | Human |
597160201 | GWAS1256275_H | 4-ethylphenylsulfate measurement QTL GWAS1256275 (human) | | 0.000004 | 4-ethylphenylsulfate measurement | | 4 | 108059616 | 108059617 | Human |
597172487 | GWAS1268561_H | body mass index QTL GWAS1268561 (human) | | 4e-12 | body mass index | body mass index (BMI) (CMO:0000105) | 4 | 111792280 | 111792281 | Human |
597619001 | GWAS1675861_H | artificial cardiac pacemaker QTL GWAS1675861 (human) | | 1e-16 | artificial cardiac pacemaker | | 4 | 110780642 | 110780643 | Human |
596967730 | GWAS1087249_H | cortical thickness QTL GWAS1087249 (human) | | 2e-14 | cortical thickness | | 4 | 120722571 | 120722572 | Human |
597594420 | GWAS1651280_H | body mass index QTL GWAS1651280 (human) | | 2e-25 | body mass index | body mass index (BMI) (CMO:0000105) | 4 | 129824994 | 129824995 | Human |
597139772 | GWAS1235846_H | N-acetylgalactosamine measurement, N-acetylglucosamine measurement QTL GWAS1235846 (human) | | 1e-12 | N-acetylgalactosamine measurement, N-acetylglucosamine measurement | | 4 | 129113772 | 129113775 | Human |
597107002 | GWAS1203076_H | protein measurement QTL GWAS1203076 (human) | | 1e-08 | protein measurement | | 4 | 112859722 | 112859723 | Human |
597401908 | GWAS1497982_H | neutrophil percentage of leukocytes QTL GWAS1497982 (human) | | 3e-17 | neutrophil quantity (VT:0000222) | blood neutrophil count to total leukocyte count ratio (CMO:0000370) | 4 | 122760001 | 122760002 | Human |
597254441 | GWAS1350515_H | alkaline phosphatase measurement QTL GWAS1350515 (human) | | 8e-15 | alkaline phosphatase measurement | blood alkaline phosphatase activity level (CMO:0000576) | 4 | 128168289 | 128168290 | Human |
407366388 | GWAS1015364_H | endometriosis, unipolar depression QTL GWAS1015364 (human) | | 5e-08 | endometriosis, unipolar depression | | 4 | 130288732 | 130288733 | Human |
597315884 | GWAS1411958_H | vaginal microbiome measurement QTL GWAS1411958 (human) | | 0.0000002 | vaginal microbiome measurement | | 4 | 109225176 | 109225177 | Human |
597618984 | GWAS1675844_H | atrial flutter QTL GWAS1675844 (human) | | 7e-207 | atrial flutter | | 4 | 110793263 | 110793264 | Human |
597016879 | GWAS1112953_H | mosquito bite reaction itch intensity measurement QTL GWAS1112953 (human) | | 8e-08 | mosquito bite reaction itch intensity measurement | | 4 | 123350979 | 123350980 | Human |
596980009 | GWAS1099528_H | memory performance QTL GWAS1099528 (human) | | 0.000009 | memory performance | | 4 | 109134293 | 109134294 | Human |
597115179 | GWAS1211253_H | DNA methylation QTL GWAS1211253 (human) | | 3e-09 | DNA methylation | | 4 | 120727011 | 120727012 | Human |
406964988 | GWAS613964_H | age-related macular degeneration QTL GWAS613964 (human) | | 4e-10 | age-related macular degeneration | | 4 | 109737911 | 109737912 | Human |
597324068 | GWAS1420142_H | complement factor I measurement QTL GWAS1420142 (human) | | 4e-20 | complement protein amount (VT:0010033) | | 4 | 109737911 | 109737912 | Human |
597324069 | GWAS1420143_H | complement factor I measurement QTL GWAS1420143 (human) | | 5e-12 | complement protein amount (VT:0010033) | | 4 | 109799365 | 109799366 | Human |
597447000 | GWAS1543074_H | sex hormone-binding globulin measurement QTL GWAS1543074 (human) | | 3e-11 | sex hormone-binding globulin measurement | | 4 | 123845801 | 123845802 | Human |
597582171 | GWAS1639031_H | pulse pressure measurement, sex interaction measurement QTL GWAS1639031 (human) | | 0.000007 | pulse pressure measurement, sex interaction measurement | pulse pressure (CMO:0000292) | 4 | 110755885 | 110755886 | Human |
597021008 | GWAS1117082_H | inflammatory bowel disease QTL GWAS1117082 (human) | | 0.0000001 | inflammatory bowel disease | | 4 | 122430276 | 122430277 | Human |
597504347 | GWAS1600421_H | low density lipoprotein cholesterol measurement QTL GWAS1600421 (human) | | 6e-09 | low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 4 | 119206905 | 119206906 | Human |
597119312 | GWAS1215386_H | sex hormone-binding globulin measurement QTL GWAS1215386 (human) | | 3e-16 | sex hormone-binding globulin measurement | | 4 | 109717608 | 109717609 | Human |
597504346 | GWAS1600420_H | low density lipoprotein cholesterol measurement QTL GWAS1600420 (human) | | 1e-10 | low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 4 | 110021121 | 110021122 | Human |
406891146 | GWAS540122_H | obesity QTL GWAS540122 (human) | | 0.000003 | obesity | | 4 | 117171981 | 117171982 | Human |
597111132 | GWAS1207206_H | diastolic blood pressure QTL GWAS1207206 (human) | | 3e-09 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 4 | 119037654 | 119037655 | Human |
597446999 | GWAS1543073_H | sex hormone-binding globulin measurement QTL GWAS1543073 (human) | | 6e-08 | sex hormone-binding globulin measurement | | 4 | 119202262 | 119202263 | Human |
597188948 | GWAS1285022_H | body mass index QTL GWAS1285022 (human) | | 8e-09 | body mass index | body mass index (BMI) (CMO:0000105) | 4 | 110683327 | 110683328 | Human |
597463376 | GWAS1559450_H | stroke QTL GWAS1559450 (human) | | 1e-13 | stroke | | 4 | 110791276 | 110791277 | Human |
597168468 | GWAS1264542_H | blood urea nitrogen measurement QTL GWAS1264542 (human) | | 2e-09 | blood urea nitrogen measurement | blood urea nitrogen level (CMO:0000049) | 4 | 119092116 | 119092117 | Human |
597188949 | GWAS1285023_H | body mass index QTL GWAS1285023 (human) | | 2e-18 | body mass index | body mass index (BMI) (CMO:0000105) | 4 | 111781479 | 111781480 | Human |
597213526 | GWAS1309600_H | high density lipoprotein cholesterol measurement QTL GWAS1309600 (human) | | 2e-08 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 4 | 109717608 | 109717609 | Human |
597188950 | GWAS1285024_H | body mass index QTL GWAS1285024 (human) | | 1e-11 | body mass index | body mass index (BMI) (CMO:0000105) | 4 | 112339309 | 112339310 | Human |
597397844 | GWAS1493918_H | vaginal microbiome measurement QTL GWAS1493918 (human) | | 3e-10 | vaginal microbiome measurement | | 4 | 107261570 | 107261571 | Human |
407124619 | GWAS773595_H | type 1 diabetes mellitus QTL GWAS773595 (human) | | 0.000006 | type 1 diabetes mellitus | | 4 | 122408207 | 122408208 | Human |
597266761 | GWAS1362835_H | cortical thickness QTL GWAS1362835 (human) | | 3e-08 | cortical thickness | | 4 | 120748941 | 120748942 | Human |
597393739 | GWAS1489813_H | hematocrit QTL GWAS1489813 (human) | | 1e-10 | hematocrit | hematocrit (CMO:0000037) | 4 | 123846352 | 123846353 | Human |
597393738 | GWAS1489812_H | hematocrit QTL GWAS1489812 (human) | | 2e-16 | hematocrit | hematocrit (CMO:0000037) | 4 | 114598115 | 114598116 | Human |
406960789 | GWAS609765_H | breast carcinoma QTL GWAS609765 (human) | | 0.000002 | mammary gland integrity trait (VT:0010552) | | 4 | 121189820 | 121189821 | Human |
406960788 | GWAS609764_H | breast carcinoma QTL GWAS609764 (human) | | 0.000002 | mammary gland integrity trait (VT:0010552) | | 4 | 121205653 | 121205654 | Human |
597139776 | GWAS1235850_H | N-acetylgalactosamine measurement, N-acetylglucosamine measurement QTL GWAS1235850 (human) | | 3e-12 | N-acetylgalactosamine measurement, N-acetylglucosamine measurement | | 4 | 129143723 | 129143724 | Human |
406960797 | GWAS609773_H | breast carcinoma QTL GWAS609773 (human) | | 0.000002 | mammary gland integrity trait (VT:0010552) | | 4 | 121222509 | 121222510 | Human |
597373254 | GWAS1469328_H | BMI-adjusted waist circumference QTL GWAS1469328 (human) | | 1e-14 | body size trait (VT:0100005) | | 4 | 119354508 | 119354509 | Human |
597266756 | GWAS1362830_H | cortical thickness QTL GWAS1362830 (human) | | 9e-10 | cortical thickness | | 4 | 120654416 | 120654417 | Human |
597377348 | GWAS1473422_H | glycine measurement QTL GWAS1473422 (human) | | 0.000003 | glycine measurement | blood amino acid measurement (CMO:0003730) | 4 | 107930418 | 107930419 | Human |
597401979 | GWAS1498053_H | corneal topography QTL GWAS1498053 (human) | | 0.0000003 | corneal topography | | 4 | 127192269 | 127192270 | Human |
1643256 | BW127_H | Body Weight QTL 127 (human) | 1.31 | 0.007 | Body weight | body mass index | 4 | 106319694 | 132319694 | Human |
406964898 | GWAS613874_H | reticulocyte count QTL GWAS613874 (human) | | 3e-10 | reticulocyte quantity (VT:0003135) | total reticulocyte count (CMO:0003020) | 4 | 109990411 | 109990412 | Human |
597406072 | GWAS1502146_H | stroke QTL GWAS1502146 (human) | | 2e-15 | stroke | | 4 | 110793263 | 110793264 | Human |
597156210 | GWAS1252284_H | sex hormone-binding globulin measurement QTL GWAS1252284 (human) | | 0.000005 | sex hormone-binding globulin measurement | | 4 | 128122459 | 128122460 | Human |
597361021 | GWAS1457095_H | autosomal dominant compelling helio-ophthalmic outburst syndrome QTL GWAS1457095 (human) | | 3e-31 | autosomal dominant compelling helio-ophthalmic outburst syndrome | | 4 | 111737998 | 111737999 | Human |
597131633 | GWAS1227707_H | cortical thickness QTL GWAS1227707 (human) | | 9e-10 | cortical thickness | | 4 | 123181336 | 123181337 | Human |
597131632 | GWAS1227706_H | cortical thickness QTL GWAS1227706 (human) | | 1e-08 | cortical thickness | | 4 | 120653051 | 120653052 | Human |
597393788 | GWAS1489862_H | gut microbiome measurement QTL GWAS1489862 (human) | | 0.000005 | gut microbiome measurement | | 4 | 127613641 | 127613642 | Human |
597205367 | GWAS1301441_H | protein measurement QTL GWAS1301441 (human) | | 2e-15 | protein measurement | | 4 | 121395817 | 121395818 | Human |
597143909 | GWAS1239983_H | Alzheimer disease, APOE carrier status QTL GWAS1239983 (human) | | 0.000006 | Alzheimer disease, APOE carrier status | | 4 | 129588615 | 129588616 | Human |
597229930 | GWAS1326004_H | endometriosis, major depressive disorder QTL GWAS1326004 (human) | | 5e-08 | endometriosis, major depressive disorder | | 4 | 130288732 | 130288733 | Human |
597160288 | GWAS1256362_H | total cholesterol measurement, high density lipoprotein cholesterol measurement QTL GWAS1256362 (human) | | 3e-11 | total cholesterol measurement, high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 4 | 109657070 | 109657071 | Human |
597131631 | GWAS1227705_H | cortical thickness QTL GWAS1227705 (human) | | 2e-16 | cortical thickness | | 4 | 118393759 | 118393760 | Human |
597496165 | GWAS1592239_H | hip geometry QTL GWAS1592239 (human) | | 4e-08 | hip geometry | hip circumference (CMO:0000014) | 4 | 126569184 | 126569185 | Human |
597279072 | GWAS1375146_H | QT interval QTL GWAS1375146 (human) | | 2e-09 | QT interval | QT interval (CMO:0000235) | 4 | 113464520 | 113464521 | Human |
597520737 | GWAS1616811_H | able to hear with hearing aids QTL GWAS1616811 (human) | | 0.0000003 | able to hear with hearing aids | | 4 | 116261685 | 116261686 | Human |
597409945 | GWAS1506019_H | Alzheimer disease QTL GWAS1506019 (human) | | 0.000001 | Alzheimer disease | | 4 | 128702401 | 128702402 | Human |
597127313 | GWAS1223387_H | glycerophospholipid measurement QTL GWAS1223387 (human) | | 4e-10 | glycerophospholipid measurement | | 4 | 114480417 | 114480418 | Human |
597127312 | GWAS1223386_H | glycerophospholipid measurement QTL GWAS1223386 (human) | | 4e-10 | glycerophospholipid measurement | | 4 | 114480357 | 114480358 | Human |
597110941 | GWAS1207015_H | self reported educational attainment QTL GWAS1207015 (human) | | 1e-11 | self reported educational attainment | | 4 | 122105714 | 122105715 | Human |
597110940 | GWAS1207014_H | self reported educational attainment QTL GWAS1207014 (human) | | 9e-12 | self reported educational attainment | | 4 | 122042189 | 122042190 | Human |
597110939 | GWAS1207013_H | self reported educational attainment QTL GWAS1207013 (human) | | 3e-08 | self reported educational attainment | | 4 | 111402093 | 111402094 | Human |
597094553 | GWAS1190627_H | 3-hydroxypropylmercapturic acid measurement QTL GWAS1190627 (human) | | 0.000002 | 3-hydroxypropylmercapturic acid measurement | | 4 | 121999890 | 121999891 | Human |
597127303 | GWAS1223377_H | glycerophospholipid measurement QTL GWAS1223377 (human) | | 3e-10 | glycerophospholipid measurement | | 4 | 114535366 | 114535367 | Human |
597512333 | GWAS1608407_H | peptic ulcer disease QTL GWAS1608407 (human) | | 1e-08 | peptic ulcer disease | | 4 | 123616812 | 123616813 | Human |
597127302 | GWAS1223376_H | glycerophospholipid measurement QTL GWAS1223376 (human) | | 3e-10 | glycerophospholipid measurement | | 4 | 114535359 | 114535360 | Human |
597299336 | GWAS1395410_H | lymphocyte count QTL GWAS1395410 (human) | | 1e-18 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 4 | 109921984 | 109921985 | Human |
597127301 | GWAS1223375_H | glycerophospholipid measurement QTL GWAS1223375 (human) | | 3e-10 | glycerophospholipid measurement | | 4 | 114508383 | 114508384 | Human |
596988039 | GWAS1107558_H | memory performance, sex interaction measurement QTL GWAS1107558 (human) | | 0.000004 | memory performance, sex interaction measurement | | 4 | 125584117 | 125584118 | Human |
597299337 | GWAS1395411_H | lymphocyte count QTL GWAS1395411 (human) | | 6e-16 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 4 | 112153589 | 112153590 | Human |
597127300 | GWAS1223374_H | glycerophospholipid measurement QTL GWAS1223374 (human) | | 3e-10 | glycerophospholipid measurement | | 4 | 114480704 | 114480705 | Human |
597127299 | GWAS1223373_H | glycerophospholipid measurement QTL GWAS1223373 (human) | | 3e-10 | glycerophospholipid measurement | | 4 | 114523566 | 114523567 | Human |
597057666 | GWAS1153740_H | Eczematoid dermatitis, allergic rhinitis QTL GWAS1153740 (human) | | 6e-20 | Eczematoid dermatitis, allergic rhinitis | | 4 | 122219915 | 122219916 | Human |
597385359 | GWAS1481433_H | gastric carcinoma QTL GWAS1481433 (human) | | 9e-10 | stomach integrity trait (VT:0010603) | | 4 | 124535968 | 124535969 | Human |
597127298 | GWAS1223372_H | glycerophospholipid measurement QTL GWAS1223372 (human) | | 3e-10 | glycerophospholipid measurement | | 4 | 114528134 | 114528135 | Human |
597381262 | GWAS1477336_H | platelet count QTL GWAS1477336 (human) | | 8e-16 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 4 | 123749526 | 123749527 | Human |
597381261 | GWAS1477335_H | platelet count QTL GWAS1477335 (human) | | 2e-63 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 4 | 110021121 | 110021122 | Human |
597127297 | GWAS1223371_H | glycerophospholipid measurement QTL GWAS1223371 (human) | | 3e-10 | glycerophospholipid measurement | | 4 | 114516461 | 114516462 | Human |
597483658 | GWAS1579732_H | ceramide measurement QTL GWAS1579732 (human) | | 9e-60 | ceramide measurement | | 4 | 114564528 | 114564529 | Human |
597127296 | GWAS1223370_H | glycerophospholipid measurement QTL GWAS1223370 (human) | | 3e-10 | glycerophospholipid measurement | | 4 | 114533303 | 114533304 | Human |
597127311 | GWAS1223385_H | glycerophospholipid measurement QTL GWAS1223385 (human) | | 4e-10 | glycerophospholipid measurement | | 4 | 114511670 | 114511671 | Human |
597401730 | GWAS1497804_H | Ischemic stroke, cardiac embolism QTL GWAS1497804 (human) | | 3e-32 | Ischemic stroke, cardiac embolism | | 4 | 110789013 | 110789014 | Human |
597127310 | GWAS1223384_H | glycerophospholipid measurement QTL GWAS1223384 (human) | | 4e-10 | glycerophospholipid measurement | | 4 | 114519788 | 114519789 | Human |
597127309 | GWAS1223383_H | glycerophospholipid measurement QTL GWAS1223383 (human) | | 4e-10 | glycerophospholipid measurement | | 4 | 114532438 | 114532439 | Human |
597057676 | GWAS1153750_H | rosacea severity measurement QTL GWAS1153750 (human) | | 0.000004 | rosacea severity measurement | | 4 | 122146898 | 122146899 | Human |
597512327 | GWAS1608401_H | peptic ulcer disease QTL GWAS1608401 (human) | | 1e-08 | peptic ulcer disease | | 4 | 123616965 | 123616966 | Human |
597188738 | GWAS1284812_H | educational attainment QTL GWAS1284812 (human) | | 0.000008 | educational attainment | | 4 | 131866663 | 131866664 | Human |
597127308 | GWAS1223382_H | glycerophospholipid measurement QTL GWAS1223382 (human) | | 3e-10 | glycerophospholipid measurement | | 4 | 114522914 | 114522915 | Human |
597127307 | GWAS1223381_H | glycerophospholipid measurement QTL GWAS1223381 (human) | | 3e-10 | glycerophospholipid measurement | | 4 | 114506467 | 114506468 | Human |
597127306 | GWAS1223380_H | glycerophospholipid measurement QTL GWAS1223380 (human) | | 3e-10 | glycerophospholipid measurement | | 4 | 114569441 | 114569442 | Human |
597532803 | GWAS1628877_H | atrial fibrillation QTL GWAS1628877 (human) | | 2e-210 | atrial fibrillation | | 4 | 110795357 | 110795358 | Human |
597127305 | GWAS1223379_H | glycerophospholipid measurement QTL GWAS1223379 (human) | | 3e-10 | glycerophospholipid measurement | | 4 | 114487736 | 114487737 | Human |
597127304 | GWAS1223378_H | glycerophospholipid measurement QTL GWAS1223378 (human) | | 3e-10 | glycerophospholipid measurement | | 4 | 114530264 | 114530265 | Human |
597016714 | GWAS1112788_H | mosquito bite reaction itch intensity measurement, mosquito bite reaction size measurement QTL GWAS1112788 (human) | | 0.0000006 | mosquito bite reaction itch intensity measurement, mosquito bite reaction size measurement | | 4 | 123865108 | 123865109 | Human |
597532860 | GWAS1628934_H | metabolite measurement QTL GWAS1628934 (human) | | 6e-08 | metabolite measurement | | 4 | 129868385 | 129868386 | Human |
597164218 | GWAS1260292_H | androsterone sulfate measurement QTL GWAS1260292 (human) | | 0.000004 | androsterone sulfate measurement | | 4 | 119318723 | 119318724 | Human |
596979891 | GWAS1099410_H | body height QTL GWAS1099410 (human) | | 2e-16 | body height | | 4 | 108560745 | 108560746 | Human |
597135537 | GWAS1231611_H | memory performance, sex interaction measurement QTL GWAS1231611 (human) | | 0.000004 | memory performance, sex interaction measurement | | 4 | 109129061 | 109129062 | Human |
597414076 | GWAS1510150_H | adolescent idiopathic scoliosis QTL GWAS1510150 (human) | | 0.0000005 | adolescent idiopathic scoliosis | | 4 | 119460368 | 119460369 | Human |
597156031 | GWAS1252105_H | fatty acid measurement QTL GWAS1252105 (human) | | 3e-08 | fatty acid measurement | | 4 | 109657070 | 109657071 | Human |
597164212 | GWAS1260286_H | carbohydrate measurement QTL GWAS1260286 (human) | | 0.000004 | carbohydrate measurement | | 4 | 110062423 | 110062424 | Human |
406924141 | GWAS573117_H | celiac disease QTL GWAS573117 (human) | | 2e-27 | celiac disease | | 4 | 122194347 | 122194348 | Human |
597414071 | GWAS1510145_H | adolescent idiopathic scoliosis QTL GWAS1510145 (human) | | 0.0000001 | adolescent idiopathic scoliosis | | 4 | 123733416 | 123733417 | Human |
596967589 | GWAS1087108_H | cortical thickness QTL GWAS1087108 (human) | | 4e-13 | cortical thickness | | 4 | 120730658 | 120730659 | Human |
597135523 | GWAS1231597_H | diastolic blood pressure QTL GWAS1231597 (human) | | 3e-21 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 4 | 119588124 | 119588125 | Human |
597266605 | GWAS1362679_H | fibroblast growth factor 2 measurement QTL GWAS1362679 (human) | | 9e-18 | fibroblast growth factor 2 measurement | | 4 | 122836593 | 122836594 | Human |
597074083 | GWAS1170157_H | coronary artery disease QTL GWAS1170157 (human) | | 6e-14 | coronary artery disease | | 4 | 119980181 | 119980182 | Human |
597389486 | GWAS1485560_H | susceptibility to rubella infection measurement QTL GWAS1485560 (human) | | 0.000009 | susceptibility to rubella infection measurement | | 4 | 127589123 | 127589124 | Human |
597344431 | GWAS1440505_H | color vision disorder QTL GWAS1440505 (human) | | 0.0000002 | color vision disorder | | 4 | 130864190 | 130864191 | Human |
597524645 | GWAS1620719_H | body mass index QTL GWAS1620719 (human) | | 6e-10 | body mass index | body mass index (BMI) (CMO:0000105) | 4 | 119372621 | 119372622 | Human |
407092090 | GWAS741066_H | chromosome-type aberration frequency QTL GWAS741066 (human) | | 0.000004 | chromosome-type aberration frequency | | 4 | 131649836 | 131649837 | Human |
597377184 | GWAS1473258_H | lymphocyte percentage of leukocytes QTL GWAS1473258 (human) | | 6e-19 | lymphocyte quantity (VT:0000717) | blood lymphocyte count to total leukocyte count ratio (CMO:0000371) | 4 | 122760001 | 122760002 | Human |
597524646 | GWAS1620720_H | body mass index QTL GWAS1620720 (human) | | 3e-15 | body mass index | body mass index (BMI) (CMO:0000105) | 4 | 129810129 | 129810130 | Human |
597254308 | GWAS1350382_H | apolipoprotein A 1 measurement QTL GWAS1350382 (human) | | 3e-15 | apolipoprotein A 1 measurement | blood apolipoprotein AI level (CMO:0000520) | 4 | 109648464 | 109648465 | Human |
596951209 | GWAS1070728_H | dementia QTL GWAS1070728 (human) | | 0.000009 | dementia | | 4 | 129535320 | 129535321 | Human |
597069993 | GWAS1166067_H | mosquito bite reaction itch intensity measurement, mosquito bite reaction size measurement QTL GWAS1166067 (human) | | 2e-11 | mosquito bite reaction itch intensity measurement, mosquito bite reaction size measurement | | 4 | 122692515 | 122692516 | Human |
597156051 | GWAS1252125_H | lifestyle measurement, depressive symptom measurement QTL GWAS1252125 (human) | | 3e-08 | lifestyle measurement, depressive symptom measurement | | 4 | 117961493 | 117961494 | Human |
597250258 | GWAS1346332_H | apolipoprotein A 1 measurement QTL GWAS1346332 (human) | | 9e-13 | apolipoprotein A 1 measurement | blood apolipoprotein AI level (CMO:0000520) | 4 | 109717608 | 109717609 | Human |
597168341 | GWAS1264415_H | alkaline phosphatase measurement QTL GWAS1264415 (human) | | 8e-16 | alkaline phosphatase measurement | blood alkaline phosphatase activity level (CMO:0000576) | 4 | 110190912 | 110190913 | Human |
597602515 | GWAS1659375_H | cardiovascular disease QTL GWAS1659375 (human) | | 3e-12 | cardiovascular disease | | 4 | 110787848 | 110787849 | Human |
597168342 | GWAS1264416_H | alkaline phosphatase measurement QTL GWAS1264416 (human) | | 4e-19 | alkaline phosphatase measurement | blood alkaline phosphatase activity level (CMO:0000576) | 4 | 128065247 | 128065248 | Human |
597078233 | GWAS1174307_H | nicotine withdrawal symptom count QTL GWAS1174307 (human) | | 0.000003 | nicotine withdrawal symptom count | | 4 | 107843866 | 107843867 | Human |
597258441 | GWAS1354515_H | atrial fibrillation QTL GWAS1354515 (human) | | 1e-09 | atrial fibrillation | | 4 | 110743002 | 110743003 | Human |
597106883 | GWAS1202957_H | systemic lupus erythematosus QTL GWAS1202957 (human) | | 4e-11 | systemic lupus erythematosus | | 4 | 108125804 | 108125805 | Human |
597311695 | GWAS1407769_H | vaginal microbiome measurement QTL GWAS1407769 (human) | | 0.000003 | vaginal microbiome measurement | | 4 | 121763984 | 121763985 | Human |
597094592 | GWAS1190666_H | schizophrenia QTL GWAS1190666 (human) | | 0.000008 | schizophrenia | | 4 | 117723665 | 117723666 | Human |
597151950 | GWAS1248024_H | free cholesterol measurement, high density lipoprotein cholesterol measurement QTL GWAS1248024 (human) | | 2e-08 | apolipoprotein A 1 measurement | blood apolipoprotein AI level (CMO:0000520) | 4 | 109657070 | 109657071 | Human |
597467331 | GWAS1563405_H | systolic blood pressure QTL GWAS1563405 (human) | | 2e-08 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 4 | 110439533 | 110439534 | Human |
597111028 | GWAS1207102_H | mathematical ability QTL GWAS1207102 (human) | | 2e-09 | mathematical ability | | 4 | 115132583 | 115132584 | Human |
407378733 | GWAS1027709_H | chronic kidney disease QTL GWAS1027709 (human) | | 0.0000009 | chronic kidney disease | | 4 | 117920116 | 117920117 | Human |
597520635 | GWAS1616709_H | interleukin 10 measurement QTL GWAS1616709 (human) | | 2e-08 | interleukin 10 measurement | | 4 | 106774728 | 106774729 | Human |
597283071 | GWAS1379145_H | glycine measurement QTL GWAS1379145 (human) | | 4e-11 | glycine measurement | blood amino acid measurement (CMO:0003730) | 4 | 110510288 | 110510289 | Human |
407083812 | GWAS732788_H | stroke QTL GWAS732788 (human) | | 2e-13 | stroke | | 4 | 110793263 | 110793264 | Human |
597074161 | GWAS1170235_H | major depressive disorder QTL GWAS1170235 (human) | | 0.000007 | major depressive disorder | | 4 | 115213661 | 115213662 | Human |
407223074 | GWAS872050_H | alcohol dependence QTL GWAS872050 (human) | | 0.000004 | alcohol dependence | | 4 | 130091985 | 130091986 | Human |
597426420 | GWAS1522494_H | glycerophospholipid measurement QTL GWAS1522494 (human) | | 3e-22 | glycerophospholipid measurement | | 4 | 114536699 | 114536700 | Human |
597385458 | GWAS1481532_H | hypothyroidism QTL GWAS1481532 (human) | | 8e-10 | Thyroid preparation use measurement | | 4 | 122625127 | 122625128 | Human |
597377271 | GWAS1473345_H | atrial fibrillation QTL GWAS1473345 (human) | | 3e-41 | atrial fibrillation | | 4 | 110789013 | 110789014 | Human |
597426416 | GWAS1522490_H | glycerophospholipid measurement QTL GWAS1522490 (human) | | 3e-25 | glycerophospholipid measurement | | 4 | 114598194 | 114598195 | Human |
597176564 | GWAS1272638_H | response to sertraline, psychotic symptom measurement, response to olanzapine QTL GWAS1272638 (human) | | 0.000005 | response to sertraline, psychotic symptom measurement, response to olanzapine | | 4 | 119052935 | 119052936 | Human |
597029115 | GWAS1125189_H | BMI-adjusted waist-hip ratio QTL GWAS1125189 (human) | | 6e-13 | body size trait (VT:0100005) | | 4 | 124261535 | 124261536 | Human |
597426419 | GWAS1522493_H | glycerophospholipid measurement QTL GWAS1522493 (human) | | 1e-22 | glycerophospholipid measurement | | 4 | 114491050 | 114491051 | Human |
597528813 | GWAS1624887_H | opioid use disorder QTL GWAS1624887 (human) | | 1e-11 | conditioned place preference behavior trait (VT:0010723) | | 4 | 111546456 | 111546457 | Human |
597426412 | GWAS1522486_H | glycerophospholipid measurement QTL GWAS1522486 (human) | | 1e-26 | glycerophospholipid measurement | | 4 | 114598400 | 114598401 | Human |
407112500 | GWAS761476_H | waist-hip ratio QTL GWAS761476 (human) | | 2e-09 | waist-hip ratio | waist to hip ratio (WHR) (CMO:0000020) | 4 | 119185193 | 119185194 | Human |
597426413 | GWAS1522487_H | glycerophospholipid measurement QTL GWAS1522487 (human) | | 2e-25 | glycerophospholipid measurement | | 4 | 114549757 | 114549758 | Human |
597070055 | GWAS1166129_H | mosquito bite reaction itch intensity measurement, mosquito bite reaction size measurement QTL GWAS1166129 (human) | | 1e-08 | mosquito bite reaction itch intensity measurement, mosquito bite reaction size measurement | | 4 | 122690387 | 122690388 | Human |
597426414 | GWAS1522488_H | glycerophospholipid measurement QTL GWAS1522488 (human) | | 2e-25 | glycerophospholipid measurement | | 4 | 114495590 | 114495591 | Human |
407112502 | GWAS761478_H | waist-hip ratio QTL GWAS761478 (human) | | 4e-17 | waist-hip ratio | waist to hip ratio (WHR) (CMO:0000020) | 4 | 122836593 | 122836594 | Human |
597426415 | GWAS1522489_H | glycerophospholipid measurement QTL GWAS1522489 (human) | | 3e-25 | glycerophospholipid measurement | | 4 | 114495600 | 114495601 | Human |
597426409 | GWAS1522483_H | glycerophospholipid measurement QTL GWAS1522483 (human) | | 3e-31 | glycerophospholipid measurement | | 4 | 114564528 | 114564529 | Human |
597471467 | GWAS1567541_H | schizophrenia, intelligence, self reported educational attainment QTL GWAS1567541 (human) | | 3e-11 | schizophrenia, intelligence, self reported educational attainment | | 4 | 129748953 | 129748954 | Human |
597450981 | GWAS1547055_H | platelet count QTL GWAS1547055 (human) | | 9e-11 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 4 | 109813770 | 109813771 | Human |
597295335 | GWAS1391409_H | ceramide measurement QTL GWAS1391409 (human) | | 2e-25 | ceramide measurement | | 4 | 114549176 | 114549177 | Human |
597147667 | GWAS1243741_H | right ventricular systolic volume measurement QTL GWAS1243741 (human) | | 1e-08 | right ventricular systolic volume measurement | | 4 | 119517499 | 119517500 | Human |
597118993 | GWAS1215067_H | bipolar disorder, inflammatory bowel disease QTL GWAS1215067 (human) | | 8e-14 | bipolar disorder, inflammatory bowel disease | | 4 | 122154852 | 122154853 | Human |
597401616 | GWAS1497690_H | hippocampus volume change measurement QTL GWAS1497690 (human) | | 0.000001 | hippocampus volume change measurement | | 4 | 117571720 | 117571722 | Human |
597377046 | GWAS1473120_H | atrial fibrillation QTL GWAS1473120 (human) | | 3e-28 | atrial fibrillation | | 4 | 110796911 | 110796912 | Human |
597159961 | GWAS1256035_H | amino acid measurement QTL GWAS1256035 (human) | | 0.000009 | amino acid measurement | | 4 | 118154781 | 118154782 | Human |
597336074 | GWAS1432148_H | smoking initiation QTL GWAS1432148 (human) | | 8e-16 | smoking initiation | | 4 | 129269203 | 129269204 | Human |
597336075 | GWAS1432149_H | smoking initiation QTL GWAS1432149 (human) | | 5e-09 | smoking initiation | | 4 | 130533359 | 130533360 | Human |
597336072 | GWAS1432146_H | smoking initiation QTL GWAS1432146 (human) | | 3e-12 | smoking initiation | | 4 | 115630160 | 115630161 | Human |
597336073 | GWAS1432147_H | smoking initiation QTL GWAS1432147 (human) | | 8e-12 | smoking initiation | | 4 | 122105714 | 122105715 | Human |
596979713 | GWAS1099232_H | body height QTL GWAS1099232 (human) | | 8e-10 | body height | | 4 | 108355674 | 108355675 | Human |
597516297 | GWAS1612371_H | protein measurement QTL GWAS1612371 (human) | | 6e-17 | protein measurement | | 4 | 110555545 | 110555546 | Human |
597151746 | GWAS1247820_H | cholesteryl ester measurement, high density lipoprotein cholesterol measurement QTL GWAS1247820 (human) | | 8e-12 | blood lipid amount (VT:0003949) | blood high density lipoprotein cholesterol level (CMO:0000052) | 4 | 109657070 | 109657071 | Human |
597532680 | GWAS1628754_H | smoking initiation QTL GWAS1628754 (human) | | 2e-11 | smoking initiation | | 4 | 111546456 | 111546457 | Human |
597045248 | GWAS1141322_H | Abnormality of refraction QTL GWAS1141322 (human) | | 5e-18 | Abnormality of refraction | | 4 | 119980371 | 119980372 | Human |
597336076 | GWAS1432150_H | smoking initiation QTL GWAS1432150 (human) | | 3e-11 | smoking initiation | | 4 | 131604639 | 131604640 | Human |
597516298 | GWAS1612372_H | protein measurement QTL GWAS1612372 (human) | | 9e-46 | protein measurement | | 4 | 110414448 | 110414449 | Human |
597618695 | GWAS1675555_H | cardiac arrhythmia QTL GWAS1675555 (human) | | 4e-14 | cardiac arrhythmia | | 4 | 110784139 | 110784140 | Human |
597135374 | GWAS1231448_H | memory performance QTL GWAS1231448 (human) | | 0.000009 | memory performance | | 4 | 131259522 | 131259523 | Human |
597192762 | GWAS1288836_H | cortical thickness QTL GWAS1288836 (human) | | 2e-08 | cortical thickness | | 4 | 120722084 | 120722085 | Human |
596979767 | GWAS1099286_H | Red cell distribution width QTL GWAS1099286 (human) | | 3e-09 | Red cell distribution width | | 4 | 122438414 | 122438415 | Human |
597393471 | GWAS1489545_H | high density lipoprotein cholesterol measurement QTL GWAS1489545 (human) | | 2e-08 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 4 | 119112961 | 119112962 | Human |
597237820 | GWAS1333894_H | neutrophil-to-lymphocyte ratio QTL GWAS1333894 (human) | | 1e-15 | neutrophil-to-lymphocyte ratio | | 4 | 112194095 | 112194096 | Human |
597217343 | GWAS1313417_H | adult onset asthma QTL GWAS1313417 (human) | | 8e-10 | adult onset asthma | | 4 | 122438414 | 122438415 | Human |
597401648 | GWAS1497722_H | vital capacity QTL GWAS1497722 (human) | | 8e-12 | vital capacity | | 4 | 124209285 | 124209286 | Human |
597405744 | GWAS1501818_H | body weight QTL GWAS1501818 (human) | | 2e-12 | body mass (VT:0001259) | body weight (CMO:0000012) | 4 | 129838492 | 129838493 | Human |
597028921 | GWAS1124995_H | rheumatoid arthritis QTL GWAS1124995 (human) | | 0.000004 | rheumatoid arthritis | | 4 | 122478336 | 122478337 | Human |
596979768 | GWAS1099287_H | Red cell distribution width QTL GWAS1099287 (human) | | 7e-19 | Red cell distribution width | | 4 | 128306129 | 128306130 | Human |
597053478 | GWAS1149552_H | asthma QTL GWAS1149552 (human) | | 3e-19 | asthma | | 4 | 122120316 | 122120317 | Human |
597401647 | GWAS1497721_H | vital capacity QTL GWAS1497721 (human) | | 0.0000001 | vital capacity | | 4 | 112674713 | 112674714 | Human |
597405743 | GWAS1501817_H | body weight QTL GWAS1501817 (human) | | 1e-11 | body mass (VT:0001259) | body weight (CMO:0000012) | 4 | 121792708 | 121792709 | Human |
597413935 | GWAS1510009_H | Hallux valgus QTL GWAS1510009 (human) | | 0.000003 | Hallux valgus | | 4 | 126494361 | 126494362 | Human |
597401646 | GWAS1497720_H | vital capacity QTL GWAS1497720 (human) | | 5e-08 | vital capacity | | 4 | 108557833 | 108557834 | Human |
597413933 | GWAS1510007_H | Hallux valgus QTL GWAS1510007 (human) | | 0.000001 | Hallux valgus | | 4 | 125790890 | 125790891 | Human |
407276529 | GWAS925505_H | serum alanine aminotransferase measurement QTL GWAS925505 (human) | | 0.000004 | serum alanine aminotransferase measurement | serum alanine aminotransferase activity level (CMO:0000575) | 4 | 115087321 | 115087322 | Human |
407153660 | GWAS802636_H | gut microbiome measurement QTL GWAS802636 (human) | | 0.000007 | gut microbiome measurement | | 4 | 108743511 | 108743512 | Human |
597504037 | GWAS1600111_H | response to cranial radiation therapy, short-term memory QTL GWAS1600111 (human) | | 0.0000007 | response to cranial radiation therapy, short-term memory | | 4 | 120035508 | 120035509 | Human |
597110829 | GWAS1206903_H | protein measurement QTL GWAS1206903 (human) | | 8e-09 | protein measurement | | 4 | 112234608 | 112234609 | Human |
597504038 | GWAS1600112_H | intelligence, response to cranial radiation therapy QTL GWAS1600112 (human) | | 0.000001 | intelligence, response to cranial radiation therapy | | 4 | 120035508 | 120035509 | Human |
596983849 | GWAS1103368_H | memory performance QTL GWAS1103368 (human) | | 0.000004 | memory performance | | 4 | 124870671 | 124870672 | Human |
597520419 | GWAS1616493_H | appendectomy QTL GWAS1616493 (human) | | 4e-12 | appendectomy | | 4 | 111904289 | 111904290 | Human |
597332005 | GWAS1428079_H | S-7-hydroxywarfarin to S-warfarin ratio measurement QTL GWAS1428079 (human) | | 0.000009 | S-7-hydroxywarfarin to S-warfarin ratio measurement | | 4 | 126276324 | 126276325 | Human |
596959316 | GWAS1078835_H | glomerular filtration rate QTL GWAS1078835 (human) | | 2e-08 | glomerular filtration rate | | 4 | 119674620 | 119674621 | Human |
596959317 | GWAS1078836_H | glomerular filtration rate QTL GWAS1078836 (human) | | 0.0000002 | glomerular filtration rate | | 4 | 125673826 | 125673827 | Human |
597512286 | GWAS1608360_H | vital capacity QTL GWAS1608360 (human) | | 2e-09 | vital capacity | | 4 | 108545191 | 108545192 | Human |
597463124 | GWAS1559198_H | diastolic blood pressure QTL GWAS1559198 (human) | | 2e-21 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 4 | 110414448 | 110414449 | Human |
597463125 | GWAS1559199_H | diastolic blood pressure QTL GWAS1559199 (human) | | 1e-08 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 4 | 119037654 | 119037655 | Human |
597499988 | GWAS1596062_H | protein measurement QTL GWAS1596062 (human) | | 1e-146 | protein measurement | | 4 | 119446728 | 119446729 | Human |
597499987 | GWAS1596061_H | protein measurement QTL GWAS1596061 (human) | | 7e-1675 | protein measurement | | 4 | 119342003 | 119342004 | Human |
597344330 | GWAS1440404_H | color vision disorder QTL GWAS1440404 (human) | | 0.000003 | color vision disorder | | 4 | 124815973 | 124815974 | Human |
597221449 | GWAS1317523_H | platelet count QTL GWAS1317523 (human) | | 2e-19 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 4 | 109945564 | 109945565 | Human |
597221450 | GWAS1317524_H | platelet count QTL GWAS1317524 (human) | | 2e-30 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 4 | 109990751 | 109990752 | Human |
597360713 | GWAS1456787_H | rheumatoid arthritis, celiac disease QTL GWAS1456787 (human) | | 6e-09 | rheumatoid arthritis, celiac disease | | 4 | 122117140 | 122117141 | Human |
597418057 | GWAS1514131_H | gastric carcinoma QTL GWAS1514131 (human) | | 3e-11 | stomach integrity trait (VT:0010603) | | 4 | 124530209 | 124530210 | Human |
597221451 | GWAS1317525_H | platelet count QTL GWAS1317525 (human) | | 2e-80 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 4 | 110027819 | 110027820 | Human |
597221452 | GWAS1317526_H | platelet count QTL GWAS1317526 (human) | | 1e-11 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 4 | 119622957 | 119622958 | Human |
597389379 | GWAS1485453_H | monokine induced by gamma interferon measurement QTL GWAS1485453 (human) | | 0.000004 | monokine induced by gamma interferon measurement | | 4 | 122707083 | 122707084 | Human |
596975695 | GWAS1095214_H | body height QTL GWAS1095214 (human) | | 1e-34 | body height | | 4 | 121801213 | 121801214 | Human |
597471296 | GWAS1567370_H | chronotype measurement QTL GWAS1567370 (human) | | 1e-08 | chronotype measurement | | 4 | 131590963 | 131590964 | Human |
597315652 | GWAS1411726_H | body mass index QTL GWAS1411726 (human) | | 2e-09 | body mass index | body mass index (BMI) (CMO:0000105) | 4 | 112402274 | 112402275 | Human |
597155959 | GWAS1252033_H | open-angle glaucoma QTL GWAS1252033 (human) | | 2e-08 | open-angle glaucoma | | 4 | 125465224 | 125465225 | Human |
597532798 | GWAS1628872_H | atrial fibrillation QTL GWAS1628872 (human) | | 2e-249 | atrial fibrillation | | 4 | 110795357 | 110795358 | Human |
596967542 | GWAS1087061_H | cortical thickness QTL GWAS1087061 (human) | | 3e-08 | cortical thickness | | 4 | 120748941 | 120748942 | Human |
596979825 | GWAS1099344_H | small vessel stroke QTL GWAS1099344 (human) | | 0.0000007 | small vessel stroke | | 4 | 113472094 | 113472095 | Human |
597291135 | GWAS1387209_H | size QTL GWAS1387209 (human) | | 1e-09 | size | | 4 | 119820087 | 119820088 | Human |
597225584 | GWAS1321658_H | smoking initiation QTL GWAS1321658 (human) | | 3e-09 | smoking initiation | | 4 | 111500989 | 111500990 | Human |
597123199 | GWAS1219273_H | gestational age QTL GWAS1219273 (human) | | 0.00001 | gestational age | | 4 | 112354624 | 112354625 | Human |
597127295 | GWAS1223369_H | glycerophospholipid measurement QTL GWAS1223369 (human) | | 3e-10 | glycerophospholipid measurement | | 4 | 114596387 | 114596388 | Human |
597340275 | GWAS1436349_H | heart failure QTL GWAS1436349 (human) | | 2e-24 | heart failure | | 4 | 110780277 | 110780278 | Human |
597262455 | GWAS1358529_H | sucrose measurement QTL GWAS1358529 (human) | | 0.000002 | sucrose measurement | | 4 | 111477457 | 111477458 | Human |
597614704 | GWAS1671564_H | skin disease QTL GWAS1671564 (human) | | 2e-11 | skin disease | | 4 | 124660603 | 124660604 | Human |
597074023 | GWAS1170097_H | coronary artery disease QTL GWAS1170097 (human) | | 3e-15 | coronary artery disease | | 4 | 119988346 | 119988347 | Human |
597057636 | GWAS1153710_H | Eczematoid dermatitis, allergic rhinitis QTL GWAS1153710 (human) | | 2e-30 | Eczematoid dermatitis, allergic rhinitis | | 4 | 122432277 | 122432278 | Human |
597319785 | GWAS1415859_H | X-24422 measurement QTL GWAS1415859 (human) | | 3e-13 | X-24422 measurement | | 4 | 122894208 | 122894209 | Human |
597274732 | GWAS1370806_H | fibroblast growth factor 2 measurement QTL GWAS1370806 (human) | | 6e-36 | fibroblast growth factor 2 measurement | | 4 | 122827461 | 122827462 | Human |
596959341 | GWAS1078860_H | glomerular filtration rate QTL GWAS1078860 (human) | | 3e-15 | glomerular filtration rate | | 4 | 127146530 | 127146531 | Human |
597323873 | GWAS1419947_H | complement factor I measurement QTL GWAS1419947 (human) | | 7e-21 | complement protein amount (VT:0010033) | | 4 | 109737700 | 109737701 | Human |
597610597 | GWAS1667457_H | monocyte count QTL GWAS1667457 (human) | | 1e-14 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 4 | 109966833 | 109966834 | Human |
597467233 | GWAS1563307_H | tooth agenesis QTL GWAS1563307 (human) | | 6e-10 | tooth agenesis | | 4 | 108350621 | 108350622 | Human |
597450851 | GWAS1546925_H | large artery stroke QTL GWAS1546925 (human) | | 0.000002 | large artery stroke | | 4 | 107143047 | 107143048 | Human |
597125015 | GWAS1221089_H | glycerophospholipid measurement QTL GWAS1221089 (human) | | 8e-27 | glycerophospholipid measurement | | 4 | 114598684 | 114598685 | Human |
597141398 | GWAS1237472_H | epidermal growth factor measurement QTL GWAS1237472 (human) | | 5e-08 | epidermal growth factor measurement | | 4 | 109973293 | 109973294 | Human |
597125014 | GWAS1221088_H | glycerophospholipid measurement QTL GWAS1221088 (human) | | 4e-27 | glycerophospholipid measurement | | 4 | 114577512 | 114577513 | Human |
407084097 | GWAS733073_H | Ischemic stroke QTL GWAS733073 (human) | | 5e-14 | Ischemic stroke | | 4 | 110793263 | 110793264 | Human |
597125013 | GWAS1221087_H | glycerophospholipid measurement QTL GWAS1221087 (human) | | 4e-27 | glycerophospholipid measurement | | 4 | 114522087 | 114522088 | Human |
597125012 | GWAS1221086_H | glycerophospholipid measurement QTL GWAS1221086 (human) | | 4e-27 | glycerophospholipid measurement | | 4 | 114522147 | 114522148 | Human |
597125011 | GWAS1221085_H | glycerophospholipid measurement QTL GWAS1221085 (human) | | 3e-27 | glycerophospholipid measurement | | 4 | 114537012 | 114537013 | Human |
597125010 | GWAS1221084_H | glycerophospholipid measurement QTL GWAS1221084 (human) | | 3e-27 | glycerophospholipid measurement | | 4 | 114512391 | 114512392 | Human |
597194654 | GWAS1290728_H | free androgen index QTL GWAS1290728 (human) | | 4e-09 | free androgen index | | 4 | 109174464 | 109174465 | Human |
597125009 | GWAS1221083_H | glycerophospholipid measurement QTL GWAS1221083 (human) | | 3e-27 | glycerophospholipid measurement | | 4 | 114512224 | 114512225 | Human |
597419933 | GWAS1516007_H | protein measurement QTL GWAS1516007 (human) | | 7e-09 | protein measurement | | 4 | 132318854 | 132318855 | Human |
597125008 | GWAS1221082_H | glycerophospholipid measurement QTL GWAS1221082 (human) | | 3e-27 | glycerophospholipid measurement | | 4 | 114496527 | 114496528 | Human |
597211039 | GWAS1307113_H | pelvic organ prolapse QTL GWAS1307113 (human) | | 1e-10 | pelvic organ prolapse | | 4 | 126155033 | 126155034 | Human |
597125023 | GWAS1221097_H | glycerophospholipid measurement QTL GWAS1221097 (human) | | 9e-27 | glycerophospholipid measurement | | 4 | 114574339 | 114574340 | Human |
597125022 | GWAS1221096_H | glycerophospholipid measurement QTL GWAS1221096 (human) | | 9e-27 | glycerophospholipid measurement | | 4 | 114527954 | 114527955 | Human |
597125021 | GWAS1221095_H | glycerophospholipid measurement QTL GWAS1221095 (human) | | 9e-27 | glycerophospholipid measurement | | 4 | 114493975 | 114493976 | Human |
597125020 | GWAS1221094_H | glycerophospholipid measurement QTL GWAS1221094 (human) | | 8e-27 | glycerophospholipid measurement | | 4 | 114534996 | 114534997 | Human |
597125019 | GWAS1221093_H | glycerophospholipid measurement QTL GWAS1221093 (human) | | 8e-27 | glycerophospholipid measurement | | 4 | 114535080 | 114535081 | Human |
597403543 | GWAS1499617_H | inflammatory bowel disease QTL GWAS1499617 (human) | | 2e-13 | inflammatory bowel disease | | 4 | 122240464 | 122240465 | Human |
597497744 | GWAS1593818_H | diastolic blood pressure QTL GWAS1593818 (human) | | 7e-13 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 4 | 110414566 | 110414567 | Human |
597125018 | GWAS1221092_H | glycerophospholipid measurement QTL GWAS1221092 (human) | | 8e-27 | glycerophospholipid measurement | | 4 | 114534955 | 114534956 | Human |
597125017 | GWAS1221091_H | glycerophospholipid measurement QTL GWAS1221091 (human) | | 8e-27 | glycerophospholipid measurement | | 4 | 114499194 | 114499195 | Human |
597125016 | GWAS1221090_H | glycerophospholipid measurement QTL GWAS1221090 (human) | | 8e-27 | glycerophospholipid measurement | | 4 | 114493876 | 114493877 | Human |
597137283 | GWAS1233357_H | glycolithocholate sulfate measurement QTL GWAS1233357 (human) | | 0.0000001 | glycolithocholate sulfate measurement | | 4 | 124486812 | 124486813 | Human |
597211021 | GWAS1307095_H | protein measurement QTL GWAS1307095 (human) | | 9e-14 | protein measurement | | 4 | 120729320 | 120729321 | Human |
597264270 | GWAS1360344_H | cortical thickness QTL GWAS1360344 (human) | | 2e-14 | cortical thickness | | 4 | 120722571 | 120722572 | Human |
597411715 | GWAS1507789_H | smoking status measurement QTL GWAS1507789 (human) | | 5e-08 | smoking status measurement | | 4 | 111582716 | 111582717 | Human |
597125007 | GWAS1221081_H | glycerophospholipid measurement QTL GWAS1221081 (human) | | 3e-27 | glycerophospholipid measurement | | 4 | 114526022 | 114526023 | Human |
597514117 | GWAS1610191_H | systemic lupus erythematosus QTL GWAS1610191 (human) | | 2e-08 | systemic lupus erythematosus | | 4 | 122631659 | 122631660 | Human |
597202872 | GWAS1298946_H | alpha fetoprotein measurement QTL GWAS1298946 (human) | | 1e-10 | blood alpha-fetoprotein amount (VT:0010776) | | 4 | 108743359 | 108743360 | Human |
597383099 | GWAS1479173_H | monocyte count QTL GWAS1479173 (human) | | 3e-09 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 4 | 119447401 | 119447402 | Human |
597206970 | GWAS1303044_H | protein measurement QTL GWAS1303044 (human) | | 2e-08 | protein measurement | | 4 | 118048334 | 118048335 | Human |
597149620 | GWAS1245694_H | lipoprotein A measurement, diet measurement QTL GWAS1245694 (human) | | 0.000002 | eating behavior trait (VT:0001431) | food intake measurement (CMO:0000772) | 4 | 129572458 | 129572459 | Human |
597346226 | GWAS1442300_H | trans fatty acid measurement, trans/trans-18:2 fatty acid measurement QTL GWAS1442300 (human) | | 0.0000003 | trans fatty acid measurement, trans/trans-18:2 fatty acid measurement | milk trans fatty acid measurement (CMO:0000824) | 4 | 127602809 | 127602810 | Human |
597051324 | GWAS1147398_H | response to anticonvulsant QTL GWAS1147398 (human) | | 0.0000001 | response to anticonvulsant | | 4 | 113140380 | 113140381 | Human |
597276597 | GWAS1372671_H | rheumatoid arthritis, anti-citrullinated protein antibody seropositivity, rheumatoid factor seropositivity measurement QTL GWAS1372671 (human) | | 8e-08 | rheumatoid arthritis, anti-citrullinated protein antibody seropositivity, rheumatoid factor seropositivity measurement | | 4 | 108140462 | 108140463 | Human |
597510065 | GWAS1606139_H | electrocardiography QTL GWAS1606139 (human) | | 7e-12 | electrocardiography | | 4 | 110791530 | 110791531 | Human |
597510064 | GWAS1606138_H | electrocardiography QTL GWAS1606138 (human) | | 3e-10 | electrocardiography | | 4 | 110791530 | 110791531 | Human |
597510066 | GWAS1606140_H | electrocardiography QTL GWAS1606140 (human) | | 1e-10 | electrocardiography | | 4 | 110791530 | 110791531 | Human |
597018533 | GWAS1114607_H | household income QTL GWAS1114607 (human) | | 4e-08 | household income | | 4 | 131729441 | 131729442 | Human |
597051303 | GWAS1147377_H | facial morphology measurement QTL GWAS1147377 (human) | | 3e-10 | facial morphology trait (VT:0003743) | | 4 | 127027041 | 127027042 | Human |
597125029 | GWAS1221103_H | glycerophospholipid measurement QTL GWAS1221103 (human) | | 1e-26 | glycerophospholipid measurement | | 4 | 114555226 | 114555227 | Human |
597125028 | GWAS1221102_H | glycerophospholipid measurement QTL GWAS1221102 (human) | | 1e-26 | glycerophospholipid measurement | | 4 | 114579576 | 114579577 | Human |
597125027 | GWAS1221101_H | glycerophospholipid measurement QTL GWAS1221101 (human) | | 1e-26 | glycerophospholipid measurement | | 4 | 114488186 | 114488187 | Human |
597125026 | GWAS1221100_H | glycerophospholipid measurement QTL GWAS1221100 (human) | | 1e-26 | glycerophospholipid measurement | | 4 | 114556972 | 114556973 | Human |
597034912 | GWAS1130986_H | high density lipoprotein cholesterol measurement QTL GWAS1130986 (human) | | 3e-13 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 4 | 109648464 | 109648465 | Human |
597206958 | GWAS1303032_H | attempted suicide QTL GWAS1303032 (human) | | 0.000004 | attempted suicide | | 4 | 110361260 | 110361261 | Human |
597125025 | GWAS1221099_H | glycerophospholipid measurement QTL GWAS1221099 (human) | | 1e-26 | glycerophospholipid measurement | | 4 | 114493973 | 114493974 | Human |
597125024 | GWAS1221098_H | glycerophospholipid measurement QTL GWAS1221098 (human) | | 1e-26 | glycerophospholipid measurement | | 4 | 114531061 | 114531062 | Human |
597145515 | GWAS1241589_H | high density lipoprotein cholesterol measurement QTL GWAS1241589 (human) | | 4e-08 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 4 | 109648464 | 109648465 | Human |
597432224 | GWAS1528298_H | sex hormone-binding globulin measurement QTL GWAS1528298 (human) | | 3e-17 | sex hormone-binding globulin measurement | | 4 | 123845801 | 123845802 | Human |
596965289 | GWAS1084808_H | total cholesterol measurement, diet measurement QTL GWAS1084808 (human) | | 0.000003 | total cholesterol measurement, diet measurement | | 4 | 118490708 | 118490709 | Human |
597051307 | GWAS1147381_H | facial morphology measurement QTL GWAS1147381 (human) | | 2e-09 | facial morphology trait (VT:0003743) | | 4 | 127005360 | 127005361 | Human |
406994045 | GWAS643021_H | mean corpuscular hemoglobin concentration QTL GWAS643021 (human) | | 5e-15 | mean corpuscular hemoglobin concentration | mean corpuscular hemoglobin concentration (CMO:0000291) | 4 | 109944312 | 109944313 | Human |
597125079 | GWAS1221153_H | glycerophospholipid measurement QTL GWAS1221153 (human) | | 3e-24 | glycerophospholipid measurement | | 4 | 114528894 | 114528895 | Human |
597100503 | GWAS1196577_H | sex hormone-binding globulin measurement QTL GWAS1196577 (human) | | 2e-18 | sex hormone-binding globulin measurement | | 4 | 119185611 | 119185612 | Human |
597125078 | GWAS1221152_H | glycerophospholipid measurement QTL GWAS1221152 (human) | | 3e-24 | glycerophospholipid measurement | | 4 | 114487028 | 114487029 | Human |
597125077 | GWAS1221151_H | glycerophospholipid measurement QTL GWAS1221151 (human) | | 3e-24 | glycerophospholipid measurement | | 4 | 114486755 | 114486756 | Human |
597493727 | GWAS1589801_H | level of fatty acid-binding protein, intestinal in blood serum QTL GWAS1589801 (human) | | 2e-19 | level of fatty acid-binding protein, intestinal in blood serum | | 4 | 119349548 | 119349549 | Human |
597125076 | GWAS1221150_H | glycerophospholipid measurement QTL GWAS1221150 (human) | | 3e-24 | glycerophospholipid measurement | | 4 | 114484189 | 114484190 | Human |
597125075 | GWAS1221149_H | glycerophospholipid measurement QTL GWAS1221149 (human) | | 2e-24 | glycerophospholipid measurement | | 4 | 114565923 | 114565924 | Human |
597125074 | GWAS1221148_H | glycerophospholipid measurement QTL GWAS1221148 (human) | | 6e-25 | glycerophospholipid measurement | | 4 | 114519057 | 114519058 | Human |
407272451 | GWAS921427_H | hemoglobin measurement QTL GWAS921427 (human) | | 5e-17 | hemoglobin measurement | hemoglobin measurement (CMO:0000508) | 4 | 114577301 | 114577302 | Human |
597125073 | GWAS1221147_H | glycerophospholipid measurement QTL GWAS1221147 (human) | | 6e-25 | glycerophospholipid measurement | | 4 | 114494469 | 114494470 | Human |
597125072 | GWAS1221146_H | glycerophospholipid measurement QTL GWAS1221146 (human) | | 6e-25 | glycerophospholipid measurement | | 4 | 114554143 | 114554144 | Human |
596985821 | GWAS1105340_H | lymphocyte count QTL GWAS1105340 (human) | | 1e-14 | lymphocyte count | | 4 | 109919540 | 109919541 | Human |
596985820 | GWAS1105339_H | lymphocyte count QTL GWAS1105339 (human) | | 7e-23 | lymphocyte count | | 4 | 110020646 | 110020647 | Human |
597325776 | GWAS1421850_H | color vision disorder QTL GWAS1421850 (human) | | 0.0000009 | color vision disorder | | 4 | 131063773 | 131063774 | Human |
597227476 | GWAS1323550_H | atrial fibrillation QTL GWAS1323550 (human) | | 7e-443 | atrial fibrillation | | 4 | 110778529 | 110778530 | Human |
597125083 | GWAS1221157_H | glycerophospholipid measurement QTL GWAS1221157 (human) | | 4e-24 | glycerophospholipid measurement | | 4 | 114545757 | 114545758 | Human |
597247957 | GWAS1344031_H | response to antiviral drug, cirrhosis of liver QTL GWAS1344031 (human) | | 0.000005 | response to antiviral drug, cirrhosis of liver | | 4 | 114986399 | 114986400 | Human |
597227477 | GWAS1323551_H | atrial fibrillation QTL GWAS1323551 (human) | | 2e-13 | atrial fibrillation | | 4 | 113527500 | 113527501 | Human |
597125082 | GWAS1221156_H | glycerophospholipid measurement QTL GWAS1221156 (human) | | 4e-24 | glycerophospholipid measurement | | 4 | 114541947 | 114541948 | Human |
597125081 | GWAS1221155_H | glycerophospholipid measurement QTL GWAS1221155 (human) | | 4e-24 | glycerophospholipid measurement | | 4 | 114540109 | 114540110 | Human |
597125080 | GWAS1221154_H | glycerophospholipid measurement QTL GWAS1221154 (human) | | 4e-24 | glycerophospholipid measurement | | 4 | 114540002 | 114540003 | Human |
597481420 | GWAS1577494_H | level of glutamyl aminopeptidase in blood serum QTL GWAS1577494 (human) | | 3e-16 | level of glutamyl aminopeptidase in blood serum | | 4 | 110520270 | 110520271 | Human |
597125063 | GWAS1221137_H | glycerophospholipid measurement QTL GWAS1221137 (human) | | 2e-12 | glycerophospholipid measurement | | 4 | 114594792 | 114594793 | Human |
596973509 | GWAS1093028_H | major depressive disorder QTL GWAS1093028 (human) | | 1e-09 | major depressive disorder | | 4 | 130316226 | 130316227 | Human |
597579724 | GWAS1636584_H | high density lipoprotein cholesterol measurement QTL GWAS1636584 (human) | | 9e-18 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 4 | 109657070 | 109657071 | Human |
597084098 | GWAS1180172_H | white matter hyperintensity measurement QTL GWAS1180172 (human) | | 0.000002 | white matter hyperintensity measurement | | 4 | 113089932 | 113089933 | Human |
596969408 | GWAS1088927_H | major depressive disorder QTL GWAS1088927 (human) | | 3e-16 | major depressive disorder | | 4 | 122467738 | 122467739 | Human |
597157825 | GWAS1253899_H | cardiovascular age measurement QTL GWAS1253899 (human) | | 3e-11 | cardiovascular age measurement | | 4 | 113465982 | 113465983 | Human |
596973507 | GWAS1093026_H | major depressive disorder QTL GWAS1093026 (human) | | 3e-08 | major depressive disorder | | 4 | 122265238 | 122265239 | Human |
597206990 | GWAS1303064_H | major depressive disorder QTL GWAS1303064 (human) | | 0.0000004 | major depressive disorder | | 4 | 130232015 | 130232016 | Human |
597125071 | GWAS1221145_H | glycerophospholipid measurement QTL GWAS1221145 (human) | | 2e-12 | glycerophospholipid measurement | | 4 | 114547620 | 114547621 | Human |
597620678 | GWAS1677538_H | keratoconus QTL GWAS1677538 (human) | | 2e-12 | keratoconus | | 4 | 117877256 | 117877257 | Human |
597587910 | GWAS1644770_H | eosinophil count QTL GWAS1644770 (human) | | 7e-21 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 4 | 122680542 | 122680543 | Human |
597125070 | GWAS1221144_H | glycerophospholipid measurement QTL GWAS1221144 (human) | | 2e-12 | glycerophospholipid measurement | | 4 | 114566777 | 114566778 | Human |
597170113 | GWAS1266187_H | smoking initiation QTL GWAS1266187 (human) | | 2e-11 | smoking initiation | | 4 | 130541408 | 130541409 | Human |
407026712 | GWAS675688_H | serum IgG glycosylation measurement QTL GWAS675688 (human) | | 0.0000004 | serum IgG glycosylation measurement | | 4 | 109976429 | 109976430 | Human |
407092249 | GWAS741225_H | stroke QTL GWAS741225 (human) | | 2e-15 | stroke | | 4 | 110793263 | 110793264 | Human |
597125069 | GWAS1221143_H | glycerophospholipid measurement QTL GWAS1221143 (human) | | 2e-12 | glycerophospholipid measurement | | 4 | 114575280 | 114575281 | Human |
597170114 | GWAS1266188_H | smoking initiation QTL GWAS1266188 (human) | | 1e-11 | smoking initiation | | 4 | 130542181 | 130542182 | Human |
597125068 | GWAS1221142_H | glycerophospholipid measurement QTL GWAS1221142 (human) | | 2e-12 | glycerophospholipid measurement | | 4 | 114519211 | 114519212 | Human |
597362624 | GWAS1458698_H | basophil count, eosinophil count QTL GWAS1458698 (human) | | 4e-09 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 4 | 122678166 | 122678167 | Human |
597170115 | GWAS1266189_H | smoking initiation QTL GWAS1266189 (human) | | 8e-12 | smoking initiation | | 4 | 131635724 | 131635725 | Human |
597125067 | GWAS1221141_H | glycerophospholipid measurement QTL GWAS1221141 (human) | | 2e-12 | glycerophospholipid measurement | | 4 | 114549280 | 114549281 | Human |
597465025 | GWAS1561099_H | mean arterial pressure QTL GWAS1561099 (human) | | 0.000002 | mean arterial pressure | mean arterial blood pressure (CMO:0000009) | 4 | 110460482 | 110460483 | Human |
597125066 | GWAS1221140_H | glycerophospholipid measurement QTL GWAS1221140 (human) | | 2e-12 | glycerophospholipid measurement | | 4 | 114583571 | 114583572 | Human |
597313479 | GWAS1409553_H | cortical thickness QTL GWAS1409553 (human) | | 6e-18 | cortical thickness | | 4 | 118393759 | 118393760 | Human |
597088203 | GWAS1184277_H | type 2 diabetes mellitus QTL GWAS1184277 (human) | | 3e-08 | type 2 diabetes mellitus | | 4 | 128258303 | 128258304 | Human |
597125065 | GWAS1221139_H | glycerophospholipid measurement QTL GWAS1221139 (human) | | 2e-12 | glycerophospholipid measurement | | 4 | 114538077 | 114538078 | Human |
597194694 | GWAS1290768_H | cortical thickness QTL GWAS1290768 (human) | | 2e-11 | cortical thickness | | 4 | 120704578 | 120704579 | Human |
597387205 | GWAS1483279_H | smoking status measurement, diastolic blood pressure QTL GWAS1483279 (human) | | 4e-08 | smoking status measurement, diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 4 | 123660107 | 123660108 | Human |
597125064 | GWAS1221138_H | glycerophospholipid measurement QTL GWAS1221138 (human) | | 2e-12 | glycerophospholipid measurement | | 4 | 114554629 | 114554630 | Human |
597583870 | GWAS1640730_H | mean corpuscular hemoglobin concentration QTL GWAS1640730 (human) | | 7e-12 | mean corpuscular hemoglobin concentration | mean corpuscular hemoglobin concentration (CMO:0000291) | 4 | 121827841 | 121827842 | Human |
597108726 | GWAS1204800_H | response to radiation, Abnormality of the urinary system QTL GWAS1204800 (human) | | 0.0000003 | response to radiation, Abnormality of the urinary system | | 4 | 122999342 | 122999343 | Human |
597334008 | GWAS1430082_H | smoking cessation QTL GWAS1430082 (human) | | 3e-12 | smoking cessation | | 4 | 112123310 | 112123311 | Human |
597313534 | GWAS1409608_H | cortical thickness QTL GWAS1409608 (human) | | 5e-10 | cortical thickness | | 4 | 127022223 | 127022224 | Human |
407022628 | GWAS671604_H | serum IgG glycosylation measurement QTL GWAS671604 (human) | | 0.000006 | serum IgG glycosylation measurement | | 4 | 110306660 | 110306661 | Human |
597424119 | GWAS1520193_H | BMI-adjusted waist circumference QTL GWAS1520193 (human) | | 8e-09 | body size trait (VT:0100005) | | 4 | 123359695 | 123359696 | Human |
597207030 | GWAS1303104_H | Agents acting on the renin-angiotensin system use measurement QTL GWAS1303104 (human) | | 2e-12 | Agents acting on the renin-angiotensin system use measurement | | 4 | 110485340 | 110485341 | Human |
597448691 | GWAS1544765_H | total cholesterol measurement, diet measurement QTL GWAS1544765 (human) | | 0.000004 | eating behavior trait (VT:0001431) | food intake measurement (CMO:0000772) | 4 | 118492283 | 118492284 | Human |
597096441 | GWAS1192515_H | sex hormone-binding globulin measurement QTL GWAS1192515 (human) | | 0.000002 | sex hormone-binding globulin measurement | | 4 | 128122459 | 128122460 | Human |
597039076 | GWAS1135150_H | apolipoprotein A 1 measurement QTL GWAS1135150 (human) | | 2e-08 | apolipoprotein A 1 measurement | blood apolipoprotein AI level (CMO:0000520) | 4 | 108637907 | 108637908 | Human |
597518313 | GWAS1614387_H | gestational diabetes QTL GWAS1614387 (human) | | 0.000001 | gestational diabetes | | 4 | 106609371 | 106609372 | Human |
597198816 | GWAS1294890_H | memory performance QTL GWAS1294890 (human) | | 0.000002 | memory performance | | 4 | 124856977 | 124856978 | Human |
597198818 | GWAS1294892_H | memory performance QTL GWAS1294892 (human) | | 0.000003 | memory performance | | 4 | 124858709 | 124858710 | Human |
597198820 | GWAS1294894_H | memory performance QTL GWAS1294894 (human) | | 0.000003 | memory performance | | 4 | 124861382 | 124861383 | Human |
597366757 | GWAS1462831_H | cognitive function measurement QTL GWAS1462831 (human) | | 0.000006 | cognitive function measurement | | 4 | 126558097 | 126558098 | Human |
406953154 | GWAS602130_H | wet macular degeneration QTL GWAS602130 (human) | | 6e-09 | wet macular degeneration | | 4 | 109737911 | 109737912 | Human |
597124884 | GWAS1220958_H | glycerophospholipid measurement QTL GWAS1220958 (human) | | 6e-28 | glycerophospholipid measurement | | 4 | 114482175 | 114482176 | Human |
597382943 | GWAS1479017_H | cardiovascular disease QTL GWAS1479017 (human) | | 7e-13 | cardiovascular disease | | 4 | 110467945 | 110467946 | Human |
597124883 | GWAS1220957_H | glycerophospholipid measurement QTL GWAS1220957 (human) | | 6e-28 | glycerophospholipid measurement | | 4 | 114482122 | 114482123 | Human |
597423903 | GWAS1519977_H | cleft lip QTL GWAS1519977 (human) | | 0.000001 | cleft lip | | 4 | 125904223 | 125904224 | Human |
597124882 | GWAS1220956_H | glycerophospholipid measurement QTL GWAS1220956 (human) | | 6e-28 | glycerophospholipid measurement | | 4 | 114490577 | 114490578 | Human |
597210909 | GWAS1306983_H | birth weight, parental genotype effect measurement QTL GWAS1306983 (human) | | 9e-09 | birth weight, parental genotype effect measurement | neonatal body weight (CMO:0002079) | 4 | 119695650 | 119695651 | Human |
597124881 | GWAS1220955_H | glycerophospholipid measurement QTL GWAS1220955 (human) | | 6e-28 | glycerophospholipid measurement | | 4 | 114490374 | 114490375 | Human |
406953158 | GWAS602134_H | atrophic macular degeneration QTL GWAS602134 (human) | | 0.000004 | atrophic macular degeneration | | 4 | 109737911 | 109737912 | Human |
597124880 | GWAS1220954_H | glycerophospholipid measurement QTL GWAS1220954 (human) | | 1e-28 | glycerophospholipid measurement | | 4 | 114520865 | 114520866 | Human |
597141275 | GWAS1237349_H | major depressive disorder QTL GWAS1237349 (human) | | 3e-08 | major depressive disorder | | 4 | 122265238 | 122265239 | Human |
597124871 | GWAS1220945_H | glycerophospholipid measurement QTL GWAS1220945 (human) | | 1e-32 | glycerophospholipid measurement | | 4 | 114518110 | 114518111 | Human |
597178120 | GWAS1274194_H | smoking initiation QTL GWAS1274194 (human) | | 2e-16 | smoking initiation | | 4 | 115062097 | 115062098 | Human |
407227605 | GWAS876581_H | bronchopulmonary dysplasia QTL GWAS876581 (human) | | 0.000001 | bronchopulmonary dysplasia | | 4 | 116954105 | 116954106 | Human |
597124870 | GWAS1220944_H | glycerophospholipid measurement QTL GWAS1220944 (human) | | 6e-41 | glycerophospholipid measurement | | 4 | 114483120 | 114483121 | Human |
597178121 | GWAS1274195_H | smoking initiation QTL GWAS1274195 (human) | | 3e-09 | smoking initiation | | 4 | 117028412 | 117028413 | Human |
597399305 | GWAS1495379_H | diastolic blood pressure QTL GWAS1495379 (human) | | 5e-17 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 4 | 110461529 | 110461530 | Human |
597124869 | GWAS1220943_H | glycerophospholipid measurement QTL GWAS1220943 (human) | | 2e-36 | glycerophospholipid measurement | | 4 | 114546112 | 114546113 | Human |
597178122 | GWAS1274196_H | smoking initiation QTL GWAS1274196 (human) | | 3e-16 | smoking initiation | | 4 | 120722571 | 120722572 | Human |
597124868 | GWAS1220942_H | glycerophospholipid measurement QTL GWAS1220942 (human) | | 2e-36 | glycerophospholipid measurement | | 4 | 114546303 | 114546304 | Human |
597178123 | GWAS1274197_H | smoking initiation QTL GWAS1274197 (human) | | 5e-11 | smoking initiation | | 4 | 122105714 | 122105715 | Human |
597317390 | GWAS1413464_H | triglyceride measurement QTL GWAS1413464 (human) | | 6e-27 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 4 | 109603883 | 109603884 | Human |
597124867 | GWAS1220941_H | glycerophospholipid measurement QTL GWAS1220941 (human) | | 2e-36 | glycerophospholipid measurement | | 4 | 114486174 | 114486175 | Human |
597178124 | GWAS1274198_H | smoking initiation QTL GWAS1274198 (human) | | 8e-15 | smoking initiation | | 4 | 129269203 | 129269204 | Human |
597124866 | GWAS1220940_H | glycerophospholipid measurement QTL GWAS1220940 (human) | | 8e-41 | glycerophospholipid measurement | | 4 | 114488433 | 114488434 | Human |
597178125 | GWAS1274199_H | smoking initiation QTL GWAS1274199 (human) | | 4e-11 | smoking initiation | | 4 | 129534689 | 129534690 | Human |
597100289 | GWAS1196363_H | protein measurement QTL GWAS1196363 (human) | | 2e-08 | protein measurement | | 4 | 112377272 | 112377273 | Human |
597124865 | GWAS1220939_H | glycerophospholipid measurement QTL GWAS1220939 (human) | | 8e-41 | glycerophospholipid measurement | | 4 | 114487644 | 114487645 | Human |
597124864 | GWAS1220938_H | glycerophospholipid measurement QTL GWAS1220938 (human) | | 8e-41 | glycerophospholipid measurement | | 4 | 114560759 | 114560760 | Human |
597604102 | GWAS1660962_H | prothrombin time measurement QTL GWAS1660962 (human) | | 2e-20 | prothrombin time measurement | prothrombin time (CMO:0000211) | 4 | 110796911 | 110796912 | Human |
597124879 | GWAS1220953_H | glycerophospholipid measurement QTL GWAS1220953 (human) | | 7e-41 | glycerophospholipid measurement | | 4 | 114515190 | 114515191 | Human |
597124878 | GWAS1220952_H | glycerophospholipid measurement QTL GWAS1220952 (human) | | 3e-31 | glycerophospholipid measurement | | 4 | 114598670 | 114598671 | Human |
597124877 | GWAS1220951_H | glycerophospholipid measurement QTL GWAS1220951 (human) | | 3e-31 | glycerophospholipid measurement | | 4 | 114531393 | 114531394 | Human |
597620485 | GWAS1677345_H | corneal ulcer QTL GWAS1677345 (human) | | 2e-11 | corneal ulcer | | 4 | 112325350 | 112325351 | Human |
597124876 | GWAS1220950_H | glycerophospholipid measurement QTL GWAS1220950 (human) | | 2e-31 | glycerophospholipid measurement | | 4 | 114531300 | 114531301 | Human |
597178116 | GWAS1274190_H | smoking initiation QTL GWAS1274190 (human) | | 6e-24 | smoking initiation | | 4 | 111500989 | 111500990 | Human |
597124875 | GWAS1220949_H | glycerophospholipid measurement QTL GWAS1220949 (human) | | 2e-31 | glycerophospholipid measurement | | 4 | 114527990 | 114527991 | Human |
597178117 | GWAS1274191_H | smoking initiation QTL GWAS1274191 (human) | | 4e-09 | smoking initiation | | 4 | 114063555 | 114063556 | Human |
597124874 | GWAS1220948_H | glycerophospholipid measurement QTL GWAS1220948 (human) | | 2e-32 | glycerophospholipid measurement | | 4 | 114527831 | 114527832 | Human |
597124873 | GWAS1220947_H | glycerophospholipid measurement QTL GWAS1220947 (human) | | 2e-32 | glycerophospholipid measurement | | 4 | 114527690 | 114527691 | Human |
597178118 | GWAS1274192_H | smoking initiation QTL GWAS1274192 (human) | | 2e-16 | smoking initiation | | 4 | 115058312 | 115058313 | Human |
597124872 | GWAS1220946_H | glycerophospholipid measurement QTL GWAS1220946 (human) | | 6e-41 | glycerophospholipid measurement | | 4 | 114507972 | 114507973 | Human |
597178119 | GWAS1274193_H | smoking initiation QTL GWAS1274193 (human) | | 2e-16 | smoking initiation | | 4 | 115060393 | 115060394 | Human |
597124919 | GWAS1220993_H | glycerophospholipid measurement QTL GWAS1220993 (human) | | 3e-13 | glycerophospholipid measurement | | 4 | 114513555 | 114513556 | Human |
597124918 | GWAS1220992_H | glycerophospholipid measurement QTL GWAS1220992 (human) | | 3e-13 | glycerophospholipid measurement | | 4 | 114513322 | 114513323 | Human |
597124917 | GWAS1220991_H | glycerophospholipid measurement QTL GWAS1220991 (human) | | 3e-13 | glycerophospholipid measurement | | 4 | 114492288 | 114492289 | Human |
597124916 | GWAS1220990_H | glycerophospholipid measurement QTL GWAS1220990 (human) | | 3e-13 | glycerophospholipid measurement | | 4 | 114492246 | 114492247 | Human |
596981553 | GWAS1101072_H | memory performance QTL GWAS1101072 (human) | | 0.000003 | memory performance | | 4 | 113305092 | 113305093 | Human |
597411644 | GWAS1507718_H | endometriosis QTL GWAS1507718 (human) | | 0.000006 | endometriosis | | 4 | 126617656 | 126617657 | Human |
597124927 | GWAS1221001_H | glycerophospholipid measurement QTL GWAS1221001 (human) | | 2e-12 | glycerophospholipid measurement | | 4 | 114489752 | 114489753 | Human |
597133118 | GWAS1229192_H | 2-O-methylascorbic acid measurement, sex interaction measurement QTL GWAS1229192 (human) | | 0.0000008 | 2-O-methylascorbic acid measurement, sex interaction measurement | | 4 | 113095111 | 113095112 | Human |
597124926 | GWAS1221000_H | glycerophospholipid measurement QTL GWAS1221000 (human) | | 2e-12 | glycerophospholipid measurement | | 4 | 114514184 | 114514185 | Human |
597309235 | GWAS1405309_H | body mass index QTL GWAS1405309 (human) | | 1e-08 | body mass index | body mass index (BMI) (CMO:0000105) | 4 | 119738082 | 119738083 | Human |
597411634 | GWAS1507708_H | Alzheimer disease QTL GWAS1507708 (human) | | 0.000003 | Alzheimer disease | | 4 | 128702401 | 128702402 | Human |
597034812 | GWAS1130886_H | triglyceride measurement QTL GWAS1130886 (human) | | 6e-12 | blood triglyceride amount (VT:0002644) | blood triglyceride level (CMO:0000118) | 4 | 109648464 | 109648465 | Human |
597124925 | GWAS1220999_H | glycerophospholipid measurement QTL GWAS1220999 (human) | | 2e-12 | glycerophospholipid measurement | | 4 | 114575934 | 114575935 | Human |
597124924 | GWAS1220998_H | glycerophospholipid measurement QTL GWAS1220998 (human) | | 2e-12 | glycerophospholipid measurement | | 4 | 114517650 | 114517651 | Human |
597366576 | GWAS1462650_H | balding measurement QTL GWAS1462650 (human) | | 2e-10 | hair amount (VT:0000416) | coat/hair morphological measurement (CMO:0001807) | 4 | 123610267 | 123610268 | Human |
597124923 | GWAS1220997_H | glycerophospholipid measurement QTL GWAS1220997 (human) | | 2e-12 | glycerophospholipid measurement | | 4 | 114512821 | 114512822 | Human |
597124922 | GWAS1220996_H | glycerophospholipid measurement QTL GWAS1220996 (human) | | 2e-12 | glycerophospholipid measurement | | 4 | 114484592 | 114484593 | Human |
597325623 | GWAS1421697_H | color vision disorder QTL GWAS1421697 (human) | | 0.000009 | color vision disorder | | 4 | 129061664 | 129061665 | Human |
597124921 | GWAS1220995_H | glycerophospholipid measurement QTL GWAS1220995 (human) | | 1e-12 | glycerophospholipid measurement | | 4 | 114512809 | 114512810 | Human |
597124920 | GWAS1220994_H | glycerophospholipid measurement QTL GWAS1220994 (human) | | 3e-13 | glycerophospholipid measurement | | 4 | 114491902 | 114491903 | Human |
597296936 | GWAS1393010_H | acylcarnitine measurement QTL GWAS1393010 (human) | | 6e-08 | acylcarnitine measurement | | 4 | 130265205 | 130265206 | Human |
597030694 | GWAS1126768_H | BMI-adjusted waist-hip ratio QTL GWAS1126768 (human) | | 1e-14 | body size trait (VT:0100005) | | 4 | 121702910 | 121702911 | Human |
597112612 | GWAS1208686_H | erythrocyte count QTL GWAS1208686 (human) | | 5e-14 | erythrocyte count | red blood cell count (CMO:0000025) | 4 | 121811061 | 121811062 | Human |
597112611 | GWAS1208685_H | erythrocyte count QTL GWAS1208685 (human) | | 1e-15 | erythrocyte count | red blood cell count (CMO:0000025) | 4 | 114598669 | 114598670 | Human |
597198637 | GWAS1294711_H | memory performance QTL GWAS1294711 (human) | | 0.000006 | memory performance | | 4 | 124891420 | 124891421 | Human |
597591849 | GWAS1648709_H | Eosinophilia QTL GWAS1648709 (human) | | 2e-12 | Eosinophilia | | 4 | 108762086 | 108762087 | Human |
596989740 | GWAS1109259_H | platelet count QTL GWAS1109259 (human) | | 9e-11 | platelet count | | 4 | 109813770 | 109813771 | Human |
407043320 | GWAS692296_H | unipolar depression, irritable bowel syndrome QTL GWAS692296 (human) | | 3e-09 | unipolar depression, irritable bowel syndrome | | 4 | 122201701 | 122201702 | Human |
596977449 | GWAS1096968_H | body height QTL GWAS1096968 (human) | | 8e-15 | body height | | 4 | 113968498 | 113968499 | Human |
596989738 | GWAS1109257_H | platelet count QTL GWAS1109257 (human) | | 3e-40 | platelet count | | 4 | 110027510 | 110027511 | Human |
597276505 | GWAS1372579_H | Alzheimer disease, polygenic risk score QTL GWAS1372579 (human) | | 7e-09 | Alzheimer disease, polygenic risk score | | 4 | 118306104 | 118306105 | Human |
597378906 | GWAS1474980_H | age-related macular degeneration QTL GWAS1474980 (human) | | 0.000001 | age-related macular degeneration | | 4 | 116012923 | 116012924 | Human |
597280605 | GWAS1376679_H | hemoglobin A1 measurement QTL GWAS1376679 (human) | | 2e-17 | hemoglobin A1 measurement | | 4 | 109908302 | 109908303 | Human |
406965385 | GWAS614361_H | chronic lymphocytic leukemia QTL GWAS614361 (human) | | 4e-10 | leukocyte integrity trait (VT:0010898) | | 4 | 108095668 | 108095669 | Human |
596965213 | GWAS1084732_H | calcium measurement, diet measurement QTL GWAS1084732 (human) | | 0.000009 | calcium measurement, diet measurement | | 4 | 111131258 | 111131259 | Human |
597055322 | GWAS1151396_H | systolic blood pressure QTL GWAS1151396 (human) | | 5e-08 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 4 | 108146742 | 108146743 | Human |
597055323 | GWAS1151397_H | systolic blood pressure QTL GWAS1151397 (human) | | 7e-09 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 4 | 119996191 | 119996192 | Human |
597178186 | GWAS1274260_H | platelet count QTL GWAS1274260 (human) | | 4e-19 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 4 | 110027510 | 110027511 | Human |
596965190 | GWAS1084709_H | diet measurement, bilirubin measurement QTL GWAS1084709 (human) | | 0.000002 | diet measurement, bilirubin measurement | | 4 | 114333088 | 114333089 | Human |
597124929 | GWAS1221003_H | glycerophospholipid measurement QTL GWAS1221003 (human) | | 2e-12 | glycerophospholipid measurement | | 4 | 114557343 | 114557344 | Human |
597448522 | GWAS1544596_H | blood protein measurement QTL GWAS1544596 (human) | | 4e-16 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 4 | 119210489 | 119210490 | Human |
597124928 | GWAS1221002_H | glycerophospholipid measurement QTL GWAS1221002 (human) | | 2e-12 | glycerophospholipid measurement | | 4 | 114556918 | 114556919 | Human |
597083982 | GWAS1180056_H | lymphocyte percentage of leukocytes QTL GWAS1180056 (human) | | 3e-21 | lymphocyte quantity (VT:0000717) | blood lymphocyte count to total leukocyte count ratio (CMO:0000371) | 4 | 112190016 | 112190017 | Human |
597280576 | GWAS1376650_H | rheumatoid arthritis QTL GWAS1376650 (human) | | 4e-14 | rheumatoid arthritis | | 4 | 108140462 | 108140463 | Human |
406985883 | GWAS634859_H | mean corpuscular hemoglobin concentration QTL GWAS634859 (human) | | 5e-64 | mean corpuscular hemoglobin concentration | mean corpuscular hemoglobin concentration (CMO:0000291) | 4 | 121854912 | 121854913 | Human |
597481281 | GWAS1577355_H | glucose-dependent insulinotropic peptide measurement QTL GWAS1577355 (human) | | 4e-10 | glucose-dependent insulinotropic peptide measurement | | 4 | 123717198 | 123717199 | Human |
597342021 | GWAS1438095_H | appendectomy QTL GWAS1438095 (human) | | 6e-34 | appendectomy | | 4 | 110799663 | 110799664 | Human |
407379095 | GWAS1028071_H | unipolar depression, mood disorder QTL GWAS1028071 (human) | | 1e-10 | unipolar depression, mood disorder | | 4 | 122201701 | 122201702 | Human |
597501762 | GWAS1597836_H | chronic obstructive pulmonary disease QTL GWAS1597836 (human) | | 5e-19 | lung integrity trait (VT:0010906) | | 4 | 123900578 | 123900579 | Human |
597411652 | GWAS1507726_H | endometriosis QTL GWAS1507726 (human) | | 0.000007 | endometriosis | | 4 | 126617656 | 126617657 | Human |
597383035 | GWAS1479109_H | electrocardiography QTL GWAS1479109 (human) | | 5e-09 | electrocardiography | | 4 | 110793263 | 110793264 | Human |
596977526 | GWAS1097045_H | Ischemic stroke QTL GWAS1097045 (human) | | 5e-14 | Ischemic stroke | | 4 | 110793263 | 110793264 | Human |
597059445 | GWAS1155519_H | memory impairment QTL GWAS1155519 (human) | | 0.000009 | memory impairment | | 4 | 125446831 | 125446832 | Human |
597378943 | GWAS1475017_H | cardiovascular disease biomarker measurement, ankle brachial index QTL GWAS1475017 (human) | | 0.000007 | cardiovascular disease biomarker measurement, ankle brachial index | | 4 | 126012137 | 126012138 | Human |
597084027 | GWAS1180101_H | coronary artery disease QTL GWAS1180101 (human) | | 1e-14 | coronary artery disease | | 4 | 119979127 | 119979128 | Human |
597366633 | GWAS1462707_H | heel bone mineral density QTL GWAS1462707 (human) | | 2e-15 | heel bone mineral density | bone mineral density (CMO:0001226) | 4 | 126527797 | 126527798 | Human |
597366632 | GWAS1462706_H | heel bone mineral density QTL GWAS1462706 (human) | | 3e-11 | heel bone mineral density | bone mineral density (CMO:0001226) | 4 | 124600184 | 124600185 | Human |
597395310 | GWAS1491384_H | drug allergy, trait in response to platinum QTL GWAS1491384 (human) | | 0.000004 | drug allergy, trait in response to platinum | | 4 | 113445575 | 113445576 | Human |
407059643 | GWAS708619_H | heart failure QTL GWAS708619 (human) | | 6e-20 | heart failure | | 4 | 110747470 | 110747471 | Human |
597387107 | GWAS1483181_H | primary biliary cirrhosis QTL GWAS1483181 (human) | | 4e-13 | primary biliary cirrhosis | | 4 | 122667371 | 122667372 | Human |
596977519 | GWAS1097038_H | cardioembolic stroke QTL GWAS1097038 (human) | | 5e-41 | cardioembolic stroke | | 4 | 110793263 | 110793264 | Human |
597366631 | GWAS1462705_H | heel bone mineral density QTL GWAS1462705 (human) | | 4e-11 | heel bone mineral density | bone mineral density (CMO:0001226) | 4 | 123613837 | 123613838 | Human |
597120874 | GWAS1216948_H | lipoprotein A measurement QTL GWAS1216948 (human) | | 1e-11 | lipoprotein A measurement | | 4 | 109717668 | 109717669 | Human |
596952937 | GWAS1072456_H | size QTL GWAS1072456 (human) | | 2e-10 | size | | 4 | 123999891 | 123999892 | Human |
597161833 | GWAS1257907_H | gut microbiome measurement QTL GWAS1257907 (human) | | 9e-09 | gut microbiome measurement | | 4 | 126866560 | 126866561 | Human |
597161832 | GWAS1257906_H | gut microbiome measurement QTL GWAS1257906 (human) | | 3e-08 | gut microbiome measurement | | 4 | 126866560 | 126866561 | Human |
597603998 | GWAS1660858_H | prothrombin time measurement QTL GWAS1660858 (human) | | 2e-36 | prothrombin time measurement | prothrombin time (CMO:0000211) | 4 | 110796911 | 110796912 | Human |
407223620 | GWAS872596_H | atopic eczema QTL GWAS872596 (human) | | 0.0000001 | atopic eczema | | 4 | 122089432 | 122089433 | Human |
596965008 | GWAS1084527_H | diet measurement, sex hormone-binding globulin measurement QTL GWAS1084527 (human) | | 0.0000007 | diet measurement, sex hormone-binding globulin measurement | | 4 | 127714844 | 127714845 | Human |
597493401 | GWAS1589475_H | pulse pressure measurement QTL GWAS1589475 (human) | | 0.0000009 | pulse pressure measurement | pulse pressure (CMO:0000292) | 4 | 132110786 | 132110787 | Human |
597608091 | GWAS1664951_H | triglyceride measurement QTL GWAS1664951 (human) | | 4e-37 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 4 | 109657070 | 109657071 | Human |
597513883 | GWAS1609957_H | body mass index QTL GWAS1609957 (human) | | 9e-21 | body mass index | body mass index (BMI) (CMO:0000105) | 4 | 129810129 | 129810130 | Human |
597513882 | GWAS1609956_H | body mass index QTL GWAS1609956 (human) | | 3e-08 | body mass index | body mass index (BMI) (CMO:0000105) | 4 | 121743168 | 121743169 | Human |
407002442 | GWAS651418_H | systolic blood pressure QTL GWAS651418 (human) | | 0.000005 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 4 | 108104223 | 108104224 | Human |
597202576 | GWAS1298650_H | lean body mass QTL GWAS1298650 (human) | | 4e-13 | body lean mass (VT:0010483) | total body lean mass (CMO:0003950) | 4 | 123145793 | 123145794 | Human |
597190293 | GWAS1286367_H | hippocampal amigdala transition area volume QTL GWAS1286367 (human) | | 5e-08 | hippocampal amigdala transition area volume | | 4 | 110099246 | 110099247 | Human |
597509778 | GWAS1605852_H | COVID-19 QTL GWAS1605852 (human) | | 0.00001 | COVID-19 | | 4 | 107157415 | 107157416 | Human |
597321356 | GWAS1417430_H | 2-linoleoyl-GPC (18:2) measurement QTL GWAS1417430 (human) | | 1e-08 | glycerophosphocholine amount (VT:0011004) | | 4 | 107543736 | 107543737 | Human |
597157504 | GWAS1253578_H | triglyceride:HDL cholesterol ratio QTL GWAS1253578 (human) | | 1e-09 | blood triglyceride amount (VT:0002644) | blood high density lipoprotein cholesterol level (CMO:0000052) | 4 | 109648464 | 109648465 | Human |
597075585 | GWAS1171659_H | selective IgA deficiency disease QTL GWAS1171659 (human) | | 0.000001 | selective IgA deficiency disease | | 4 | 122571262 | 122571263 | Human |
597091969 | GWAS1188043_H | FEV/FVC ratio, response to bronchodilator QTL GWAS1188043 (human) | | 0.000002 | FEV/FVC ratio, response to bronchodilator | forced expiratory volume to forced vital capacity ratio (CMO:0000241) | 4 | 131140615 | 131140616 | Human |
407072091 | GWAS721067_H | depressive symptom measurement, response to ketamine QTL GWAS721067 (human) | | 0.000006 | depressive symptom measurement, response to ketamine | | 4 | 130998547 | 130998548 | Human |
597620355 | GWAS1677215_H | triglyceride measurement QTL GWAS1677215 (human) | | 2e-15 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 4 | 109657070 | 109657071 | Human |
597288582 | GWAS1384656_H | Ischemic stroke QTL GWAS1384656 (human) | | 0.0000001 | Ischemic stroke | | 4 | 112810934 | 112810935 | Human |
597124791 | GWAS1220865_H | glycerophospholipid measurement QTL GWAS1220865 (human) | | 2e-12 | glycerophospholipid measurement | | 4 | 114566454 | 114566455 | Human |
597124790 | GWAS1220864_H | glycerophospholipid measurement QTL GWAS1220864 (human) | | 2e-12 | glycerophospholipid measurement | | 4 | 114581427 | 114581428 | Human |
407252324 | GWAS901300_H | lymphocyte count QTL GWAS901300 (human) | | 6e-27 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 4 | 112192759 | 112192760 | Human |
597124789 | GWAS1220863_H | glycerophospholipid measurement QTL GWAS1220863 (human) | | 2e-12 | glycerophospholipid measurement | | 4 | 114554497 | 114554498 | Human |
597513919 | GWAS1609993_H | X-26054 measurement QTL GWAS1609993 (human) | | 3e-168 | X-26054 measurement | | 4 | 129109789 | 129109790 | Human |
597124788 | GWAS1220862_H | glycerophospholipid measurement QTL GWAS1220862 (human) | | 2e-12 | glycerophospholipid measurement | | 4 | 114594500 | 114594501 | Human |
597124787 | GWAS1220861_H | glycerophospholipid measurement QTL GWAS1220861 (human) | | 2e-12 | glycerophospholipid measurement | | 4 | 114556583 | 114556584 | Human |
407252323 | GWAS901299_H | lymphocyte count QTL GWAS901299 (human) | | 1e-25 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 4 | 109914892 | 109914893 | Human |
597591739 | GWAS1648599_H | blood coagulation disease QTL GWAS1648599 (human) | | 8e-29 | blood coagulation disease | | 4 | 110784139 | 110784140 | Human |
597124786 | GWAS1220860_H | glycerophospholipid measurement QTL GWAS1220860 (human) | | 3e-13 | glycerophospholipid measurement | | 4 | 114533453 | 114533454 | Human |
597272255 | GWAS1368329_H | epidermal growth factor measurement QTL GWAS1368329 (human) | | 5e-17 | epidermal growth factor measurement | | 4 | 109961320 | 109961321 | Human |
597124785 | GWAS1220859_H | glycerophospholipid measurement QTL GWAS1220859 (human) | | 3e-13 | glycerophospholipid measurement | | 4 | 114533510 | 114533511 | Human |
597124784 | GWAS1220858_H | glycerophospholipid measurement QTL GWAS1220858 (human) | | 3e-13 | glycerophospholipid measurement | | 4 | 114533531 | 114533532 | Human |
406969702 | GWAS618678_H | trait in response to hydrochlorothiazide, fasting blood glucose measurement QTL GWAS618678 (human) | | 0.000004 | trait in response to hydrochlorothiazide, fasting blood glucose measurement | | 4 | 128775066 | 128775067 | Human |
597124799 | GWAS1220873_H | glycerophospholipid measurement QTL GWAS1220873 (human) | | 1e-11 | glycerophospholipid measurement | | 4 | 114511785 | 114511786 | Human |
597092031 | GWAS1188105_H | chronic lymphocytic leukemia QTL GWAS1188105 (human) | | 0.0000001 | leukocyte integrity trait (VT:0010898) | | 4 | 108105258 | 108105259 | Human |
597124798 | GWAS1220872_H | glycerophospholipid measurement QTL GWAS1220872 (human) | | 1e-11 | glycerophospholipid measurement | | 4 | 114511945 | 114511946 | Human |
597214897 | GWAS1310971_H | body mass index QTL GWAS1310971 (human) | | 2e-09 | body mass index | body mass index (BMI) (CMO:0000105) | 4 | 119292875 | 119292876 | Human |
597124797 | GWAS1220871_H | glycerophospholipid measurement QTL GWAS1220871 (human) | | 2e-12 | glycerophospholipid measurement | | 4 | 114509770 | 114509771 | Human |
597206707 | GWAS1302781_H | Beta blocking agent use measurement QTL GWAS1302781 (human) | | 5e-09 | Beta blocking agent use measurement | | 4 | 110743002 | 110743003 | Human |
597616309 | GWAS1673169_H | appendicitis QTL GWAS1673169 (human) | | 3e-21 | appendicitis | | 4 | 110804662 | 110804663 | Human |
597124796 | GWAS1220870_H | glycerophospholipid measurement QTL GWAS1220870 (human) | | 2e-12 | glycerophospholipid measurement | | 4 | 114538112 | 114538113 | Human |
597124795 | GWAS1220869_H | glycerophospholipid measurement QTL GWAS1220869 (human) | | 2e-12 | glycerophospholipid measurement | | 4 | 114581520 | 114581521 | Human |
597505712 | GWAS1601786_H | heart failure QTL GWAS1601786 (human) | | 2e-15 | heart failure | | 4 | 110787848 | 110787849 | Human |
597124794 | GWAS1220868_H | glycerophospholipid measurement QTL GWAS1220868 (human) | | 2e-12 | glycerophospholipid measurement | | 4 | 114519018 | 114519019 | Human |
597124793 | GWAS1220867_H | glycerophospholipid measurement QTL GWAS1220867 (human) | | 2e-12 | glycerophospholipid measurement | | 4 | 114594055 | 114594056 | Human |
597616305 | GWAS1673165_H | appendicitis QTL GWAS1673165 (human) | | 6e-20 | appendicitis | | 4 | 110810809 | 110810810 | Human |
597124792 | GWAS1220866_H | glycerophospholipid measurement QTL GWAS1220866 (human) | | 2e-12 | glycerophospholipid measurement | | 4 | 114548111 | 114548112 | Human |
597042849 | GWAS1138923_H | appendicular lean mass QTL GWAS1138923 (human) | | 2e-12 | appendicular lean mass | | 4 | 119638715 | 119638716 | Human |
597124783 | GWAS1220857_H | glycerophospholipid measurement QTL GWAS1220857 (human) | | 3e-13 | glycerophospholipid measurement | | 4 | 114555821 | 114555822 | Human |
597051054 | GWAS1147128_H | mood disorder, major depressive disorder QTL GWAS1147128 (human) | | 1e-10 | mood disorder, major depressive disorder | | 4 | 122201701 | 122201702 | Human |
597124782 | GWAS1220856_H | glycerophospholipid measurement QTL GWAS1220856 (human) | | 3e-13 | glycerophospholipid measurement | | 4 | 114530452 | 114530453 | Human |
597214881 | GWAS1310955_H | BMI-adjusted waist-hip ratio QTL GWAS1310955 (human) | | 5e-09 | body size trait (VT:0100005) | | 4 | 119607172 | 119607173 | Human |
597124781 | GWAS1220855_H | glycerophospholipid measurement QTL GWAS1220855 (human) | | 1e-13 | glycerophospholipid measurement | | 4 | 114496204 | 114496205 | Human |
597329569 | GWAS1425643_H | aspartate measurement QTL GWAS1425643 (human) | | 9e-31 | blood L-aspartic acid amount (VT:0010969) | | 4 | 110510288 | 110510289 | Human |
407027071 | GWAS676047_H | fasting blood glucose measurement QTL GWAS676047 (human) | | 0.000006 | fasting blood glucose measurement | | 4 | 120880635 | 120880636 | Human |
597591712 | GWAS1648572_H | seborrheic keratosis QTL GWAS1648572 (human) | | 2e-20 | seborrheic keratosis | | 4 | 124698876 | 124698877 | Human |
597370533 | GWAS1466607_H | mean corpuscular hemoglobin concentration QTL GWAS1466607 (human) | | 2e-28 | mean corpuscular volume | mean corpuscular hemoglobin concentration (CMO:0000291) | 4 | 127625245 | 127625246 | Human |
597423833 | GWAS1519907_H | atrial fibrillation QTL GWAS1519907 (human) | | 5e-09 | atrial fibrillation | | 4 | 110992909 | 110992910 | Human |
597296856 | GWAS1392930_H | cardiac troponin I measurement QTL GWAS1392930 (human) | | 0.0000004 | cardiac troponin I measurement | blood troponin T level (CMO:0001284) | 4 | 118958433 | 118958434 | Human |
597505759 | GWAS1601833_H | facial morphology measurement QTL GWAS1601833 (human) | | 3e-08 | facial morphology trait (VT:0003743) | | 4 | 125198542 | 125198543 | Human |
597464792 | GWAS1560866_H | mean arterial pressure QTL GWAS1560866 (human) | | 7e-09 | mean arterial pressure | diastolic blood pressure (CMO:0000005) | 4 | 110422107 | 110422108 | Human |
597116626 | GWAS1212700_H | atopic eczema QTL GWAS1212700 (human) | | 9e-11 | atopic eczema | | 4 | 122219899 | 122219900 | Human |
597276383 | GWAS1372457_H | rheumatoid arthritis, anti-citrullinated protein antibody seropositivity, rheumatoid factor seropositivity measurement QTL GWAS1372457 (human) | | 2e-08 | rheumatoid arthritis, anti-citrullinated protein antibody seropositivity, rheumatoid factor seropositivity measurement | | 4 | 122122507 | 122122508 | Human |
407026952 | GWAS675928_H | serum IgG glycosylation measurement QTL GWAS675928 (human) | | 0.000005 | serum IgG glycosylation measurement | | 4 | 109976429 | 109976430 | Human |
597321425 | GWAS1417499_H | testosterone measurement QTL GWAS1417499 (human) | | 1e-09 | testosterone measurement | serum testosterone level (CMO:0000568) | 4 | 124046883 | 124046884 | Human |
597321431 | GWAS1417505_H | testosterone measurement QTL GWAS1417505 (human) | | 7e-09 | testosterone measurement | serum testosterone level (CMO:0000568) | 4 | 109108768 | 109108769 | Human |
597288663 | GWAS1384737_H | blood urea nitrogen measurement QTL GWAS1384737 (human) | | 4e-08 | blood urea nitrogen measurement | blood urea nitrogen level (CMO:0000049) | 4 | 119076757 | 119076758 | Human |
597391051 | GWAS1487125_H | systolic blood pressure QTL GWAS1487125 (human) | | 6e-18 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 4 | 110416322 | 110416323 | Human |
597345994 | GWAS1442068_H | body mass index QTL GWAS1442068 (human) | | 3e-08 | body mass index | body mass index (BMI) (CMO:0000105) | 4 | 112335581 | 112335582 | Human |
597616332 | GWAS1673192_H | congenital anomaly of cardiovascular system QTL GWAS1673192 (human) | | 3e-11 | congenital anomaly of cardiovascular system | | 4 | 112981089 | 112981090 | Human |
597259980 | GWAS1356054_H | low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio QTL GWAS1356054 (human) | | 2e-13 | low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | blood low density lipoprotein cholesterol level (CMO:0000053) | 4 | 109657070 | 109657071 | Human |
597124801 | GWAS1220875_H | glycerophospholipid measurement QTL GWAS1220875 (human) | | 1e-11 | glycerophospholipid measurement | | 4 | 114511985 | 114511986 | Human |
597124800 | GWAS1220874_H | glycerophospholipid measurement QTL GWAS1220874 (human) | | 1e-11 | glycerophospholipid measurement | | 4 | 114511787 | 114511788 | Human |
597071567 | GWAS1167641_H | platelet count QTL GWAS1167641 (human) | | 2e-28 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 4 | 110010783 | 110010784 | Human |
407407889 | GWAS1056865_H | unipolar depression QTL GWAS1056865 (human) | | 3e-08 | unipolar depression | | 4 | 122265238 | 122265239 | Human |
597399232 | GWAS1495306_H | vaginal microbiome measurement QTL GWAS1495306 (human) | | 0.000007 | vaginal microbiome measurement | | 4 | 132000696 | 132000697 | Human |
407145752 | GWAS794728_H | schizophrenia, age at onset QTL GWAS794728 (human) | | 0.000004 | schizophrenia, age at onset | | 4 | 108959574 | 108959575 | Human |
597071563 | GWAS1167637_H | sclerosing cholangitis QTL GWAS1167637 (human) | | 9e-13 | sclerosing cholangitis | | 4 | 122578590 | 122578591 | Human |
597190393 | GWAS1286467_H | testosterone measurement QTL GWAS1286467 (human) | | 4e-09 | testosterone measurement | serum testosterone level (CMO:0000568) | 4 | 108146742 | 108146743 | Human |
597120758 | GWAS1216832_H | gut microbiome measurement QTL GWAS1216832 (human) | | 3e-09 | gut microbiome measurement | | 4 | 126415447 | 126415448 | Human |
597096178 | GWAS1192252_H | sex hormone-binding globulin measurement QTL GWAS1192252 (human) | | 2e-13 | sex hormone-binding globulin measurement | | 4 | 119185611 | 119185612 | Human |
597223165 | GWAS1319239_H | platelet count QTL GWAS1319239 (human) | | 6e-38 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 4 | 110039895 | 110039896 | Human |
597186288 | GWAS1282362_H | educational attainment QTL GWAS1282362 (human) | | 0.000002 | educational attainment | | 4 | 115489506 | 115489507 | Human |
597186290 | GWAS1282364_H | educational attainment QTL GWAS1282364 (human) | | 6e-10 | educational attainment | | 4 | 119987548 | 119987549 | Human |
597386992 | GWAS1483066_H | mean arterial pressure QTL GWAS1483066 (human) | | 0.000003 | mean arterial pressure | systolic blood pressure (CMO:0000004) | 4 | 110460482 | 110460483 | Human |
597509873 | GWAS1605947_H | Calcium channel blocker use measurement QTL GWAS1605947 (human) | | 6e-12 | Calcium channel blocker use measurement | | 4 | 110467945 | 110467946 | Human |
407026991 | GWAS675967_H | serum IgG glycosylation measurement QTL GWAS675967 (human) | | 0.000001 | serum IgG glycosylation measurement | | 4 | 109976429 | 109976430 | Human |
597423850 | GWAS1519924_H | trait in response to carbamazepine QTL GWAS1519924 (human) | | 0.0000009 | trait in response to carbamazepine | | 4 | 127124380 | 127124381 | Human |
597186283 | GWAS1282357_H | educational attainment QTL GWAS1282357 (human) | | 4e-10 | educational attainment | | 4 | 109603314 | 109603315 | Human |
597235434 | GWAS1331508_H | lung carcinoma QTL GWAS1331508 (human) | | 0.0000005 | lung carcinoma | | 4 | 128666151 | 128666152 | Human |
597186284 | GWAS1282358_H | educational attainment QTL GWAS1282358 (human) | | 1e-11 | educational attainment | | 4 | 111489199 | 111489200 | Human |
597186285 | GWAS1282359_H | educational attainment QTL GWAS1282359 (human) | | 1e-10 | educational attainment | | 4 | 112220279 | 112220280 | Human |
597186286 | GWAS1282360_H | educational attainment QTL GWAS1282360 (human) | | 4e-11 | educational attainment | | 4 | 114059072 | 114059073 | Human |
597186287 | GWAS1282361_H | educational attainment QTL GWAS1282361 (human) | | 2e-08 | educational attainment | | 4 | 115086647 | 115086648 | Human |
597051105 | GWAS1147179_H | appendicular lean mass QTL GWAS1147179 (human) | | 2e-08 | appendicular lean mass | | 4 | 119742494 | 119742495 | Human |
596973289 | GWAS1092808_H | irritable bowel syndrome, major depressive disorder QTL GWAS1092808 (human) | | 3e-09 | irritable bowel syndrome, major depressive disorder | | 4 | 122201701 | 122201702 | Human |
597382887 | GWAS1478961_H | lymphocyte count QTL GWAS1478961 (human) | | 2e-14 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 4 | 122760001 | 122760002 | Human |
597505761 | GWAS1601835_H | facial morphology measurement QTL GWAS1601835 (human) | | 3e-08 | facial morphology trait (VT:0003743) | | 4 | 125219863 | 125219864 | Human |
597505760 | GWAS1601834_H | facial morphology measurement QTL GWAS1601834 (human) | | 3e-08 | facial morphology trait (VT:0003743) | | 4 | 125198582 | 125198583 | Human |
597399067 | GWAS1495141_H | waist-hip ratio QTL GWAS1495141 (human) | | 0.00001 | waist-hip ratio | waist to hip ratio (WHR) (CMO:0000020) | 4 | 108607724 | 108607725 | Human |
597403162 | GWAS1499236_H | cardiac arrhythmia QTL GWAS1499236 (human) | | 1e-187 | cardiac arrhythmia | | 4 | 110795357 | 110795358 | Human |
597304859 | GWAS1400933_H | erythrocyte count QTL GWAS1400933 (human) | | 3e-15 | erythrocyte count | red blood cell count (CMO:0000025) | 4 | 121827841 | 121827842 | Human |
407076292 | GWAS725268_H | BMI-adjusted waist-hip ratio QTL GWAS725268 (human) | | 1e-13 | body size trait (VT:0100005) | | 4 | 124299553 | 124299554 | Human |
597493269 | GWAS1589343_H | Antihypertensive use measurement QTL GWAS1589343 (human) | | 1e-17 | Antihypertensive use measurement | | 4 | 110469660 | 110469661 | Human |
597378578 | GWAS1474652_H | age-related macular degeneration QTL GWAS1474652 (human) | | 0.000002 | age-related macular degeneration | | 4 | 116003028 | 116003029 | Human |
597612055 | GWAS1668915_H | systemic inflammatory response syndrome QTL GWAS1668915 (human) | | 1e-11 | systemic inflammatory response syndrome | | 4 | 131864363 | 131864364 | Human |
597063196 | GWAS1159270_H | mosquito bite reaction itch intensity measurement, mosquito bite reaction size measurement QTL GWAS1159270 (human) | | 0.000002 | mosquito bite reaction itch intensity measurement, mosquito bite reaction size measurement | | 4 | 123047357 | 123047358 | Human |
597108252 | GWAS1204326_H | cocaine dependence QTL GWAS1204326 (human) | | 0.000006 | cocaine dependence | | 4 | 116685914 | 116685915 | Human |
407002574 | GWAS651550_H | eosinophil percentage of leukocytes QTL GWAS651550 (human) | | 3e-41 | eosinophil quantity (VT:0002602) | blood eosinophil count to total leukocyte count ratio (CMO:0000369) | 4 | 122263256 | 122263257 | Human |
597063194 | GWAS1159268_H | mosquito bite reaction itch intensity measurement, mosquito bite reaction size measurement QTL GWAS1159268 (human) | | 5e-13 | mosquito bite reaction itch intensity measurement, mosquito bite reaction size measurement | | 4 | 122692515 | 122692516 | Human |
596973081 | GWAS1092600_H | age at onset, major depressive disorder QTL GWAS1092600 (human) | | 0.000007 | age at onset, major depressive disorder | | 4 | 127602809 | 127602810 | Human |
597063195 | GWAS1159269_H | mosquito bite reaction itch intensity measurement, mosquito bite reaction size measurement QTL GWAS1159269 (human) | | 0.0000007 | mosquito bite reaction itch intensity measurement, mosquito bite reaction size measurement | | 4 | 122806140 | 122806141 | Human |
597423638 | GWAS1519712_H | type 1 diabetes mellitus QTL GWAS1519712 (human) | | 1e-08 | type 1 diabetes mellitus | | 4 | 124578751 | 124578752 | Human |
597100058 | GWAS1196132_H | sex hormone-binding globulin measurement QTL GWAS1196132 (human) | | 6e-16 | sex hormone-binding globulin measurement | | 4 | 128110633 | 128110634 | Human |
597607952 | GWAS1664812_H | triglyceride measurement QTL GWAS1664812 (human) | | 1e-33 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 4 | 109657070 | 109657071 | Human |
597059096 | GWAS1155170_H | adolescent idiopathic scoliosis QTL GWAS1155170 (human) | | 2e-16 | adolescent idiopathic scoliosis | | 4 | 129325525 | 129325526 | Human |
597227017 | GWAS1323091_H | atrial fibrillation QTL GWAS1323091 (human) | | 4e-52 | atrial fibrillation | | 4 | 110840331 | 110840332 | Human |
597403146 | GWAS1499220_H | corneal topography QTL GWAS1499220 (human) | | 1e-18 | corneal topography | | 4 | 127192269 | 127192270 | Human |
407178711 | GWAS827687_H | BMI-adjusted waist-hip ratio QTL GWAS827687 (human) | | 4e-15 | body size trait (VT:0100005) | | 4 | 121702910 | 121702911 | Human |
597227023 | GWAS1323097_H | atrial fibrillation QTL GWAS1323097 (human) | | 9e-09 | atrial fibrillation | | 4 | 112408189 | 112408190 | Human |
407371229 | GWAS1020205_H | unipolar depression QTL GWAS1020205 (human) | | 3e-24 | unipolar depression | | 4 | 122201701 | 122201702 | Human |
596952591 | GWAS1072110_H | hypertension QTL GWAS1072110 (human) | | 6e-12 | hypertension | | 4 | 110484920 | 110484925 | Human |
597399040 | GWAS1495114_H | body mass index QTL GWAS1495114 (human) | | 6e-09 | body mass index | body mass index (BMI) (CMO:0000105) | 4 | 129803585 | 129803586 | Human |
406998494 | GWAS647470_H | BMI-adjusted waist circumference QTL GWAS647470 (human) | | 1e-08 | body size trait (VT:0100005) | | 4 | 119026033 | 119026034 | Human |
597591554 | GWAS1648414_H | skin disease QTL GWAS1648414 (human) | | 2e-14 | skin disease | | 4 | 124698876 | 124698877 | Human |
597411384 | GWAS1507458_H | cardioembolic stroke QTL GWAS1507458 (human) | | 4e-20 | cardioembolic stroke | | 4 | 110793263 | 110793264 | Human |
407145955 | GWAS794931_H | age-related macular degeneration QTL GWAS794931 (human) | | 0.0000003 | age-related macular degeneration | | 4 | 109717654 | 109717655 | Human |
597603894 | GWAS1660754_H | prothrombin time measurement QTL GWAS1660754 (human) | | 1e-33 | prothrombin time measurement | prothrombin time (CMO:0000211) | 4 | 110796911 | 110796912 | Human |
597464630 | GWAS1560704_H | response to selective serotonin reuptake inhibitor QTL GWAS1560704 (human) | | 0.000005 | response to selective serotonin reuptake inhibitor | | 4 | 117586197 | 117586198 | Human |
597243442 | GWAS1339516_H | small vessel stroke QTL GWAS1339516 (human) | | 0.000008 | small vessel stroke | | 4 | 125014098 | 125014099 | Human |
597108283 | GWAS1204357_H | pulmonary function measurement QTL GWAS1204357 (human) | | 0.000003 | pulmonary function measurement | | 4 | 130774276 | 130774277 | Human |
407379431 | GWAS1028407_H | unipolar depression QTL GWAS1028407 (human) | | 2e-10 | depressive symptom measurement | | 4 | 122201701 | 122201702 | Human |
597403179 | GWAS1499253_H | alopecia QTL GWAS1499253 (human) | | 1e-10 | alopecia | | 4 | 107131838 | 107131839 | Human |
597419563 | GWAS1515637_H | mathematical ability QTL GWAS1515637 (human) | | 1e-08 | mathematical ability | | 4 | 111859867 | 111859868 | Human |
597403181 | GWAS1499255_H | alopecia QTL GWAS1499255 (human) | | 6e-10 | alopecia | | 4 | 106706914 | 106706915 | Human |
597325356 | GWAS1421430_H | fibrinopeptide A, des-ala(1) measurement QTL GWAS1421430 (human) | | 1e-21 | fibrinopeptide A, des-ala(1) measurement | | 4 | 110510288 | 110510289 | Human |
597403180 | GWAS1499254_H | alopecia QTL GWAS1499254 (human) | | 1e-10 | alopecia | | 4 | 106590268 | 106590269 | Human |
597386796 | GWAS1482870_H | Epstein-Barr virus infection QTL GWAS1482870 (human) | | 0.000001 | Epstein-Barr virus infection | | 4 | 107189709 | 107189710 | Human |
597419564 | GWAS1515638_H | mathematical ability QTL GWAS1515638 (human) | | 1e-08 | mathematical ability | | 4 | 132101754 | 132101755 | Human |
597034542 | GWAS1130616_H | TPE interval measurement QTL GWAS1130616 (human) | | 3e-10 | TPE interval measurement | | 4 | 113535350 | 113535351 | Human |
597386787 | GWAS1482861_H | Cleft palate QTL GWAS1482861 (human) | | 0.000004 | Cleft palate | | 4 | 116802931 | 116802932 | Human |
597243428 | GWAS1339502_H | gut microbiome measurement QTL GWAS1339502 (human) | | 7e-08 | gut microbiome measurement | | 4 | 117122262 | 117122263 | Human |
597046824 | GWAS1142898_H | erythrocyte count QTL GWAS1142898 (human) | | 1e-15 | red blood cell density measurement | red blood cell count (CMO:0000025) | 4 | 121811061 | 121811062 | Human |
597378651 | GWAS1474725_H | adenosine monophosphate measurement QTL GWAS1474725 (human) | | 0.000009 | adenosine monophosphate measurement | | 4 | 116035124 | 116035125 | Human |
597501533 | GWAS1597607_H | diet measurement QTL GWAS1597607 (human) | | 2e-08 | eating behavior trait (VT:0001431) | food intake measurement (CMO:0000772) | 4 | 129906935 | 129906936 | Human |
597124694 | GWAS1220768_H | glycerophospholipid measurement QTL GWAS1220768 (human) | | 2e-11 | glycerophospholipid measurement | | 4 | 114493245 | 114493246 | Human |
407027075 | GWAS676051_H | fasting blood glucose measurement QTL GWAS676051 (human) | | 0.000005 | fasting blood glucose measurement | | 4 | 120880635 | 120880636 | Human |
407039363 | GWAS688339_H | allergic sensitization measurement QTL GWAS688339 (human) | | 6e-10 | allergic sensitization measurement | | 4 | 122432277 | 122432278 | Human |
597276251 | GWAS1372325_H | healthspan QTL GWAS1372325 (human) | | 0.000003 | healthspan | | 4 | 110234426 | 110234427 | Human |
597124693 | GWAS1220767_H | glycerophospholipid measurement QTL GWAS1220767 (human) | | 2e-11 | glycerophospholipid measurement | | 4 | 114493734 | 114493735 | Human |
597124692 | GWAS1220766_H | glycerophospholipid measurement QTL GWAS1220766 (human) | | 2e-11 | glycerophospholipid measurement | | 4 | 114493571 | 114493572 | Human |
597124691 | GWAS1220765_H | glycerophospholipid measurement QTL GWAS1220765 (human) | | 2e-11 | glycerophospholipid measurement | | 4 | 114490891 | 114490892 | Human |
597124690 | GWAS1220764_H | glycerophospholipid measurement QTL GWAS1220764 (human) | | 1e-11 | glycerophospholipid measurement | | 4 | 114512090 | 114512091 | Human |
597276254 | GWAS1372328_H | healthspan QTL GWAS1372328 (human) | | 0.000002 | healthspan | | 4 | 110234426 | 110234427 | Human |
597141086 | GWAS1237160_H | irritable bowel syndrome QTL GWAS1237160 (human) | | 3e-08 | irritable bowel syndrome | | 4 | 122201701 | 122201702 | Human |
597579347 | GWAS1636207_H | high density lipoprotein cholesterol measurement QTL GWAS1636207 (human) | | 1e-14 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 4 | 109657070 | 109657071 | Human |
407039378 | GWAS688354_H | body mass index QTL GWAS688354 (human) | | 0.0000005 | body mass index | body mass index (BMI) (CMO:0000105) | 4 | 109057975 | 109057976 | Human |
597415499 | GWAS1511573_H | self reported educational attainment QTL GWAS1511573 (human) | | 4e-09 | self reported educational attainment | | 4 | 129748953 | 129748954 | Human |
597415498 | GWAS1511572_H | self reported educational attainment QTL GWAS1511572 (human) | | 2e-08 | self reported educational attainment | | 4 | 117593081 | 117593082 | Human |
597599820 | GWAS1656680_H | mean corpuscular hemoglobin concentration QTL GWAS1656680 (human) | | 2e-17 | mean corpuscular hemoglobin concentration | mean corpuscular hemoglobin concentration (CMO:0000291) | 4 | 109912954 | 109912955 | Human |
597050949 | GWAS1147023_H | protein measurement QTL GWAS1147023 (human) | | 1e-08 | protein measurement | | 4 | 109735574 | 109735575 | Human |
597141058 | GWAS1237132_H | diastolic blood pressure, systolic blood pressure QTL GWAS1237132 (human) | | 0.000007 | diastolic blood pressure, systolic blood pressure | systolic blood pressure (CMO:0000004) | 4 | 119856151 | 119856152 | Human |
407072150 | GWAS721126_H | waist-hip ratio QTL GWAS721126 (human) | | 5e-08 | waist-hip ratio | waist to hip ratio (WHR) (CMO:0000020) | 4 | 124299553 | 124299554 | Human |
597018179 | GWAS1114253_H | eosinophil count QTL GWAS1114253 (human) | | 1e-21 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 4 | 122365072 | 122365073 | Human |
597407299 | GWAS1503373_H | vaginal microbiome measurement QTL GWAS1503373 (human) | | 0.00001 | vaginal microbiome measurement | | 4 | 126069793 | 126069794 | Human |
597157452 | GWAS1253526_H | high density lipoprotein cholesterol measurement QTL GWAS1253526 (human) | | 7e-09 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 4 | 109603883 | 109603884 | Human |
597059149 | GWAS1155223_H | adolescent idiopathic scoliosis QTL GWAS1155223 (human) | | 9e-12 | adolescent idiopathic scoliosis | | 4 | 116480238 | 116480239 | Human |
406969758 | GWAS618734_H | parental longevity QTL GWAS618734 (human) | | 0.000008 | total life span (VT:0001661) | | 4 | 113151748 | 113151749 | Human |
597116529 | GWAS1212603_H | benign prostatic hyperplasia QTL GWAS1212603 (human) | | 0.000001 | prostate integrity trait (VT:0010571) | | 4 | 110180390 | 110180395 | Human |
597370492 | GWAS1466566_H | mean corpuscular hemoglobin concentration QTL GWAS1466566 (human) | | 2e-10 | mean corpuscular hemoglobin concentration | mean corpuscular hemoglobin concentration (CMO:0000291) | 4 | 123835365 | 123835366 | Human |
597169777 | GWAS1265851_H | body mass index QTL GWAS1265851 (human) | | 9e-10 | body mass index | body mass index (BMI) (CMO:0000105) | 4 | 112402274 | 112402275 | Human |
597169778 | GWAS1265852_H | body mass index QTL GWAS1265852 (human) | | 3e-08 | body mass index | body mass index (BMI) (CMO:0000105) | 4 | 114269666 | 114269667 | Human |
597366384 | GWAS1462458_H | intelligence QTL GWAS1462458 (human) | | 0.000007 | intelligence | | 4 | 129813235 | 129813236 | Human |
597481072 | GWAS1577146_H | ceramide measurement QTL GWAS1577146 (human) | | 5e-38 | ceramide measurement | | 4 | 114564528 | 114564529 | Human |
597481073 | GWAS1577147_H | ceramide measurement QTL GWAS1577147 (human) | | 1e-16 | ceramide measurement | | 4 | 114598115 | 114598116 | Human |
597599859 | GWAS1656719_H | mean corpuscular hemoglobin concentration QTL GWAS1656719 (human) | | 5e-14 | mean corpuscular hemoglobin concentration | mean corpuscular hemoglobin concentration (CMO:0000291) | 4 | 121827841 | 121827842 | Human |
597341812 | GWAS1437886_H | appendicitis QTL GWAS1437886 (human) | | 5e-58 | appendicitis | | 4 | 110810780 | 110810781 | Human |
597366388 | GWAS1462462_H | intelligence QTL GWAS1462462 (human) | | 0.000007 | intelligence | | 4 | 112683802 | 112683803 | Human |
597530216 | GWAS1626290_H | fibrinopeptide A measurement QTL GWAS1626290 (human) | | 2e-25 | fibrinopeptide A measurement | | 4 | 110434637 | 110434638 | Human |
597026403 | GWAS1122477_H | appendicitis QTL GWAS1122477 (human) | | 2e-23 | appendicitis | | 4 | 110799841 | 110799842 | Human |
597194350 | GWAS1290424_H | cortical thickness QTL GWAS1290424 (human) | | 3e-17 | cortical thickness | | 4 | 120793484 | 120793485 | Human |
597382764 | GWAS1478838_H | Red cell distribution width QTL GWAS1478838 (human) | | 2e-23 | Red cell distribution width | red blood cell distribution width- standard deviation (CMO:0003232) | 4 | 128306129 | 128306130 | Human |
597313122 | GWAS1409196_H | vaginal microbiome measurement QTL GWAS1409196 (human) | | 0.000003 | vaginal microbiome measurement | | 4 | 113348345 | 113348346 | Human |
597341795 | GWAS1437869_H | Brugada syndrome QTL GWAS1437869 (human) | | 2e-08 | Brugada syndrome | | 4 | 113523590 | 113523591 | Human |
597267865 | GWAS1363939_H | cardioembolic stroke QTL GWAS1363939 (human) | | 9e-59 | cardioembolic stroke | | 4 | 110775495 | 110775496 | Human |
597591454 | GWAS1648314_H | Barrett's esophagus QTL GWAS1648314 (human) | | 1e-15 | Barrett's esophagus | | 4 | 123628089 | 123628090 | Human |
597276056 | GWAS1372130_H | diet measurement QTL GWAS1372130 (human) | | 3e-08 | eating behavior trait (VT:0001431) | food intake measurement (CMO:0000772) | 4 | 112402274 | 112402275 | Human |
597497246 | GWAS1593320_H | memory performance QTL GWAS1593320 (human) | | 0.000008 | memory performance | | 4 | 124874941 | 124874942 | Human |
597460379 | GWAS1556453_H | response to antidepressant QTL GWAS1556453 (human) | | 0.0000005 | response to antidepressant | | 4 | 117580003 | 117580004 | Human |
597423507 | GWAS1519581_H | atrial fibrillation QTL GWAS1519581 (human) | | 5e-18 | atrial fibrillation | | 4 | 110908811 | 110908812 | Human |
597423506 | GWAS1519580_H | atrial fibrillation QTL GWAS1519580 (human) | | 3e-35 | atrial fibrillation | | 4 | 110882594 | 110882595 | Human |
597423505 | GWAS1519579_H | atrial fibrillation QTL GWAS1519579 (human) | | 7e-109 | atrial fibrillation | | 4 | 110844339 | 110844340 | Human |
597460375 | GWAS1556449_H | atrial fibrillation QTL GWAS1556449 (human) | | 3e-525 | atrial fibrillation | | 4 | 110791276 | 110791277 | Human |
597423504 | GWAS1519578_H | atrial fibrillation QTL GWAS1519578 (human) | | 9e-35 | atrial fibrillation | | 4 | 110823850 | 110823851 | Human |
407072334 | GWAS721310_H | hair color QTL GWAS721310 (human) | | 3e-20 | hair color | | 4 | 108429724 | 108429725 | Human |
597423509 | GWAS1519583_H | atrial fibrillation QTL GWAS1519583 (human) | | 7e-12 | atrial fibrillation | | 4 | 110978126 | 110978127 | Human |
597079448 | GWAS1175522_H | mean corpuscular hemoglobin QTL GWAS1175522 (human) | | 3e-51 | mean corpuscular hemoglobin | mean corpuscular hemoglobin (CMO:0000290) | 4 | 121818028 | 121818029 | Human |
597423508 | GWAS1519582_H | atrial fibrillation QTL GWAS1519582 (human) | | 8e-21 | atrial fibrillation | | 4 | 110941992 | 110941993 | Human |
597464467 | GWAS1560541_H | esophageal adenocarcinoma QTL GWAS1560541 (human) | | 1e-08 | esophageal adenocarcinoma | | 4 | 123623035 | 123623036 | Human |
597079449 | GWAS1175523_H | mean corpuscular hemoglobin QTL GWAS1175523 (human) | | 3e-27 | mean corpuscular hemoglobin | mean corpuscular hemoglobin (CMO:0000290) | 4 | 128177881 | 128177882 | Human |
407387737 | GWAS1036713_H | acute myeloid leukemia QTL GWAS1036713 (human) | | 8e-13 | leukocyte integrity trait (VT:0010898) | | 4 | 113047052 | 113047053 | Human |
597116294 | GWAS1212368_H | DNA methylation QTL GWAS1212368 (human) | | 2e-08 | DNA methylation | | 4 | 124761267 | 124761268 | Human |
597276040 | GWAS1372114_H | beverage consumption measurement QTL GWAS1372114 (human) | | 1e-08 | beverage consumption measurement | drink intake measurement (CMO:0000771) | 4 | 128935692 | 128935693 | Human |
597611919 | GWAS1668779_H | abnormal result of function studies QTL GWAS1668779 (human) | | 2e-11 | abnormal result of function studies | | 4 | 131498407 | 131498408 | Human |
407387738 | GWAS1036714_H | acute myeloid leukemia QTL GWAS1036714 (human) | | 0.0000002 | leukocyte integrity trait (VT:0010898) | | 4 | 113047052 | 113047053 | Human |
407387739 | GWAS1036715_H | acute myeloid leukemia QTL GWAS1036715 (human) | | 6e-23 | leukocyte integrity trait (VT:0010898) | | 4 | 115155558 | 115155559 | Human |
407387740 | GWAS1036716_H | acute myeloid leukemia QTL GWAS1036716 (human) | | 5e-14 | leukocyte integrity trait (VT:0010898) | | 4 | 115155558 | 115155559 | Human |
597611914 | GWAS1668774_H | Barrett's esophagus QTL GWAS1668774 (human) | | 6e-14 | Barrett's esophagus | | 4 | 123628089 | 123628090 | Human |
597063040 | GWAS1159114_H | depressive symptom measurement QTL GWAS1159114 (human) | | 3e-09 | depressive symptom measurement | | 4 | 122265238 | 122265239 | Human |
597423491 | GWAS1519565_H | atrial fibrillation QTL GWAS1519565 (human) | | 9e-57 | atrial fibrillation | | 4 | 110809291 | 110809292 | Human |
597423490 | GWAS1519564_H | atrial fibrillation QTL GWAS1519564 (human) | | 6e-35 | atrial fibrillation | | 4 | 110796991 | 110796992 | Human |
597423489 | GWAS1519563_H | atrial fibrillation QTL GWAS1519563 (human) | | 2e-18 | atrial fibrillation | | 4 | 110766821 | 110766822 | Human |
597173635 | GWAS1269709_H | sclerosing cholangitis QTL GWAS1269709 (human) | | 2e-10 | sclerosing cholangitis | | 4 | 122578590 | 122578591 | Human |
597423492 | GWAS1519566_H | atrial fibrillation QTL GWAS1519566 (human) | | 4e-14 | atrial fibrillation | | 4 | 110822697 | 110822698 | Human |
597497218 | GWAS1593292_H | hip geometry QTL GWAS1593292 (human) | | 3e-08 | hip geometry | hip circumference (CMO:0000014) | 4 | 114237534 | 114237535 | Human |
406916706 | GWAS565682_H | balding measurement QTL GWAS565682 (human) | | 4e-26 | hair amount (VT:0000416) | coat/hair morphological measurement (CMO:0001807) | 4 | 106961911 | 106961912 | Human |
597489080 | GWAS1585154_H | phosphatidylethanolamine measurement QTL GWAS1585154 (human) | | 2e-08 | phosphatidylethanolamine measurement | | 4 | 126594255 | 126594256 | Human |
597169598 | GWAS1265672_H | rheumatoid arthritis QTL GWAS1265672 (human) | | 4e-08 | rheumatoid arthritis | | 4 | 108140462 | 108140463 | Human |
407379552 | GWAS1028528_H | dental caries QTL GWAS1028528 (human) | | 0.000002 | dental caries | | 4 | 130183917 | 130183918 | Human |
597194163 | GWAS1290237_H | cortical thickness QTL GWAS1290237 (human) | | 4e-10 | cortical thickness | | 4 | 120704578 | 120704579 | Human |
597157307 | GWAS1253381_H | cholesteryl ester measurement, high density lipoprotein cholesterol measurement QTL GWAS1253381 (human) | | 3e-11 | blood lipid amount (VT:0003949) | blood high density lipoprotein cholesterol level (CMO:0000052) | 4 | 109603883 | 109603884 | Human |
597116345 | GWAS1212419_H | DNA methylation QTL GWAS1212419 (human) | | 3e-09 | DNA methylation | | 4 | 109836068 | 109836069 | Human |
597276087 | GWAS1372161_H | retinal drusen QTL GWAS1372161 (human) | | 0.00001 | retinal drusen | | 4 | 128129997 | 128129998 | Human |
597366188 | GWAS1462262_H | hemoglobin measurement QTL GWAS1462262 (human) | | 2e-10 | hemoglobin measurement | hemoglobin measurement (CMO:0000508) | 4 | 123846352 | 123846353 | Human |
597058990 | GWAS1155064_H | age at menarche QTL GWAS1155064 (human) | | 1e-08 | age at menarche | | 4 | 115075517 | 115075518 | Human |
597177760 | GWAS1273834_H | fibroblast growth factor 2 measurement QTL GWAS1273834 (human) | | 8e-667 | fibroblast growth factor 2 measurement | | 4 | 122827461 | 122827462 | Human |
597058991 | GWAS1155065_H | age at menarche QTL GWAS1155065 (human) | | 1e-10 | age at menarche | | 4 | 131843326 | 131843327 | Human |
597194148 | GWAS1290222_H | cortical thickness QTL GWAS1290222 (human) | | 8e-11 | cortical thickness | | 4 | 120708831 | 120708832 | Human |
406912514 | GWAS561490_H | progressive supranuclear palsy QTL GWAS561490 (human) | | 0.0000001 | progressive supranuclear palsy | | 4 | 122557561 | 122557562 | Human |
597476831 | GWAS1572905_H | protein measurement QTL GWAS1572905 (human) | | 7e-09 | protein measurement | | 4 | 132286668 | 132286669 | Human |
597067218 | GWAS1163292_H | susceptibility to vaginal yeast infection measurement QTL GWAS1163292 (human) | | 0.000001 | susceptibility to vaginal yeast infection measurement | | 4 | 128039093 | 128039112 | Human |
597071312 | GWAS1167386_H | mosquito bite reaction itch intensity measurement QTL GWAS1167386 (human) | | 2e-11 | mosquito bite reaction itch intensity measurement | | 4 | 123047357 | 123047358 | Human |
597071313 | GWAS1167387_H | mosquito bite reaction itch intensity measurement QTL GWAS1167387 (human) | | 1e-10 | mosquito bite reaction itch intensity measurement | | 4 | 123249252 | 123249253 | Human |
597439958 | GWAS1536032_H | susceptibility to vaginal yeast infection measurement QTL GWAS1536032 (human) | | 0.000004 | susceptibility to vaginal yeast infection measurement | | 4 | 120477000 | 120477001 | Human |
597124569 | GWAS1220643_H | glycerophospholipid measurement QTL GWAS1220643 (human) | | 1e-13 | glycerophospholipid measurement | | 4 | 114496175 | 114496176 | Human |
597304789 | GWAS1400863_H | cholesteryl ester measurement, high density lipoprotein cholesterol measurement QTL GWAS1400863 (human) | | 2e-12 | blood lipid amount (VT:0003949) | blood high density lipoprotein cholesterol level (CMO:0000052) | 4 | 109657070 | 109657071 | Human |
597214679 | GWAS1310753_H | epidermal growth factor measurement QTL GWAS1310753 (human) | | 1e-21 | epidermal growth factor measurement | | 4 | 109960338 | 109960339 | Human |
597124568 | GWAS1220642_H | glycerophospholipid measurement QTL GWAS1220642 (human) | | 1e-13 | glycerophospholipid measurement | | 4 | 114496530 | 114496531 | Human |
597075398 | GWAS1171472_H | trait in response to allopurinol, uric acid measurement QTL GWAS1171472 (human) | | 0.000009 | trait in response to allopurinol, uric acid measurement | blood uric acid level (CMO:0000501) | 4 | 115481897 | 115481898 | Human |
597153221 | GWAS1249295_H | phospholipids:total lipids ratio, intermediate density lipoprotein measurement QTL GWAS1249295 (human) | | 7e-13 | phospholipids:total lipids ratio, intermediate density lipoprotein measurement | blood intermediate density lipoprotein cholesterol level (CMO:0001562) | 4 | 109657070 | 109657071 | Human |
406994454 | GWAS643430_H | mean corpuscular hemoglobin concentration QTL GWAS643430 (human) | | 5e-72 | mean corpuscular hemoglobin concentration | mean corpuscular hemoglobin concentration (CMO:0000291) | 4 | 121870446 | 121870447 | Human |
597431748 | GWAS1527822_H | protein measurement QTL GWAS1527822 (human) | | 1e-08 | protein measurement | | 4 | 121980476 | 121980477 | Human |
597071310 | GWAS1167384_H | mosquito bite reaction itch intensity measurement QTL GWAS1167384 (human) | | 2e-37 | mosquito bite reaction itch intensity measurement | | 4 | 122690387 | 122690388 | Human |
407072282 | GWAS721258_H | cognitive function measurement QTL GWAS721258 (human) | | 0.000005 | cognitive function measurement | | 4 | 120770925 | 120770926 | Human |
597071311 | GWAS1167385_H | mosquito bite reaction itch intensity measurement QTL GWAS1167385 (human) | | 3e-13 | mosquito bite reaction itch intensity measurement | | 4 | 122806140 | 122806141 | Human |
597075404 | GWAS1171478_H | type 2 diabetes mellitus QTL GWAS1171478 (human) | | 0.0000001 | type 2 diabetes mellitus | | 4 | 121739095 | 121739096 | Human |
597071308 | GWAS1167382_H | mosquito bite reaction itch intensity measurement QTL GWAS1167382 (human) | | 3e-09 | mosquito bite reaction itch intensity measurement | | 4 | 122182953 | 122182955 | Human |
597071309 | GWAS1167383_H | mosquito bite reaction itch intensity measurement QTL GWAS1167383 (human) | | 4e-09 | mosquito bite reaction itch intensity measurement | | 4 | 122359705 | 122359706 | Human |
597136843 | GWAS1232917_H | neuroimaging measurement QTL GWAS1232917 (human) | | 2e-11 | neuroimaging measurement | | 4 | 112495627 | 112495628 | Human |
597210564 | GWAS1306638_H | protein measurement QTL GWAS1306638 (human) | | 2e-08 | protein measurement | | 4 | 130879344 | 130879345 | Human |
407195173 | GWAS844149_H | gut microbiome measurement, bone density QTL GWAS844149 (human) | | 2e-08 | gut microbiome measurement, bone density | | 4 | 116019324 | 116019325 | Human |
407195174 | GWAS844150_H | gut microbiome measurement, bone density QTL GWAS844150 (human) | | 2e-08 | gut microbiome measurement, bone density | | 4 | 116034483 | 116034484 | Human |
597370366 | GWAS1466440_H | atrial fibrillation QTL GWAS1466440 (human) | | 2e-74 | atrial fibrillation | | 4 | 110784612 | 110784613 | Human |
597263871 | GWAS1359945_H | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement QTL GWAS1359945 (human) | | 1e-12 | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 4 | 109657070 | 109657071 | Human |
597431802 | GWAS1527876_H | attempted suicide QTL GWAS1527876 (human) | | 0.000004 | attempted suicide | | 4 | 110362552 | 110362553 | Human |
597116400 | GWAS1212474_H | reaction time measurement QTL GWAS1212474 (human) | | 0.0000004 | reaction time measurement | | 4 | 124836622 | 124836623 | Human |
597227007 | GWAS1323081_H | protein measurement QTL GWAS1323081 (human) | | 9e-09 | protein measurement | | 4 | 124985713 | 124985714 | Human |
597308914 | GWAS1404988_H | Thyroid preparation use measurement QTL GWAS1404988 (human) | | 4e-09 | Thyroid preparation use measurement | | 4 | 122466445 | 122466446 | Human |
597439989 | GWAS1536063_H | trait in response to venlafaxine QTL GWAS1536063 (human) | | 0.000006 | trait in response to venlafaxine | | 4 | 113431725 | 113431726 | Human |
597063164 | GWAS1159238_H | smoking behavior, BMI-adjusted waist-hip ratio QTL GWAS1159238 (human) | | 0.000008 | body size trait (VT:0100005) | | 4 | 123145793 | 123145794 | Human |
597194227 | GWAS1290301_H | memory performance QTL GWAS1290301 (human) | | 0.000004 | memory performance | | 4 | 112467350 | 112467351 | Human |
597255666 | GWAS1351740_H | schizophrenia QTL GWAS1351740 (human) | | 0.0000005 | schizophrenia | | 4 | 117697551 | 117697552 | Human |
596977147 | GWAS1096666_H | body height QTL GWAS1096666 (human) | | 4e-10 | body height | | 4 | 108146742 | 108146743 | Human |
597366260 | GWAS1462334_H | balding measurement QTL GWAS1462334 (human) | | 2e-14 | hair amount (VT:0000416) | coat/hair morphological measurement (CMO:0001807) | 4 | 123825222 | 123825223 | Human |
597321192 | GWAS1417266_H | JT interval QTL GWAS1417266 (human) | | 2e-08 | heart electrical impulse conduction trait (VT:2000017) | heart electrical conduction measurement (CMO:0000230) | 4 | 113464520 | 113464521 | Human |
406969907 | GWAS618883_H | cannabis dependence measurement QTL GWAS618883 (human) | | 0.000004 | cannabis dependence measurement | | 4 | 118795795 | 118795796 | Human |
597157348 | GWAS1253422_H | cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement QTL GWAS1253422 (human) | | 4e-13 | cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 4 | 109657070 | 109657071 | Human |
406969906 | GWAS618882_H | cannabis dependence measurement QTL GWAS618882 (human) | | 0.0000002 | cannabis dependence measurement | | 4 | 118795795 | 118795796 | Human |
407043638 | GWAS692614_H | body weight QTL GWAS692614 (human) | | 0.000001 | body mass (VT:0001259) | body weight (CMO:0000012) | 4 | 120941346 | 120941347 | Human |
597100002 | GWAS1196076_H | sex hormone-binding globulin measurement QTL GWAS1196076 (human) | | 2e-52 | sex hormone-binding globulin measurement | | 4 | 109717668 | 109717669 | Human |
597374435 | GWAS1470509_H | pulmonary function measurement QTL GWAS1470509 (human) | | 0.000001 | pulmonary function measurement | | 4 | 108296773 | 108296774 | Human |
597296611 | GWAS1392685_H | ceramide measurement QTL GWAS1392685 (human) | | 3e-08 | ceramide measurement | | 4 | 114533531 | 114533532 | Human |
597431776 | GWAS1527850_H | Red cell distribution width QTL GWAS1527850 (human) | | 7e-19 | Red cell distribution width | red blood cell distribution width- standard deviation (CMO:0003232) | 4 | 128306129 | 128306130 | Human |
597468643 | GWAS1564717_H | coffee consumption measurement QTL GWAS1564717 (human) | | 0.000003 | coffee consumption measurement | | 4 | 117421219 | 117421220 | Human |
597136661 | GWAS1232735_H | neuroimaging measurement QTL GWAS1232735 (human) | | 4e-09 | neuroimaging measurement | | 4 | 118376502 | 118376503 | Human |
597251354 | GWAS1347428_H | corneal resistance factor QTL GWAS1347428 (human) | | 7e-11 | corneal resistance factor | | 4 | 118816705 | 118816706 | Human |
597493013 | GWAS1589087_H | mean arterial pressure QTL GWAS1589087 (human) | | 1e-11 | mean arterial pressure | mean arterial blood pressure (CMO:0000009) | 4 | 110427909 | 110427910 | Human |
597107997 | GWAS1204071_H | cytokine measurement QTL GWAS1204071 (human) | | 0.000003 | cytokine measurement | blood cytokine measurement (CMO:0001924) | 4 | 113030253 | 113030254 | Human |
597038362 | GWAS1134436_H | gut microbiome measurement QTL GWAS1134436 (human) | | 0.000002 | gut microbiome measurement | | 4 | 121059316 | 121059317 | Human |
597517584 | GWAS1613658_H | attention deficit hyperactivity disorder, risk-taking behaviour QTL GWAS1613658 (human) | | 7e-11 | attention deficit hyperactivity disorder, risk-taking behaviour | | 4 | 111296367 | 111296368 | Human |
597619980 | GWAS1676840_H | triglyceride measurement QTL GWAS1676840 (human) | | 2e-20 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 4 | 109657070 | 109657071 | Human |
597091588 | GWAS1187662_H | atrophic macular degeneration, age-related macular degeneration, wet macular degeneration QTL GWAS1187662 (human) | | 5e-17 | atrophic macular degeneration, age-related macular degeneration, wet macular degeneration | | 4 | 109737911 | 109737912 | Human |
597091589 | GWAS1187663_H | atrophic macular degeneration, age-related macular degeneration, wet macular degeneration QTL GWAS1187663 (human) | | 6e-10 | atrophic macular degeneration, age-related macular degeneration, wet macular degeneration | | 4 | 109764664 | 109764665 | Human |
406925015 | GWAS573991_H | fetal hemoglobin measurement QTL GWAS573991 (human) | | 0.000006 | fetal hemoglobin measurement | | 4 | 120592060 | 120592061 | Human |
407092962 | GWAS741938_H | hair color QTL GWAS741938 (human) | | 3e-15 | hair color | | 4 | 108136248 | 108136249 | Human |
597022000 | GWAS1118074_H | stromal cell-derived factor 1 alpha measurement QTL GWAS1118074 (human) | | 0.000002 | stromal cell-derived factor 1 alpha measurement | | 4 | 115146334 | 115146335 | Human |
597083440 | GWAS1179514_H | venous thromboembolism, response to antineoplastic agent QTL GWAS1179514 (human) | | 0.000004 | venous thromboembolism, response to antineoplastic agent | | 4 | 129240194 | 129240195 | Human |
597464378 | GWAS1560452_H | lung carcinoma, family history of lung cancer QTL GWAS1560452 (human) | | 0.000008 | lung carcinoma, family history of lung cancer | | 4 | 131748595 | 131748596 | Human |
597054769 | GWAS1150843_H | multiple sclerosis QTL GWAS1150843 (human) | | 2e-11 | multiple sclerosis | | 4 | 108137562 | 108137563 | Human |
597460283 | GWAS1556357_H | thyroxine measurement QTL GWAS1556357 (human) | | 5e-08 | thyroxine measurement | blood thyroxine level (CMO:0001288) | 4 | 123563112 | 123563113 | Human |
597128509 | GWAS1224583_H | pulse pressure measurement QTL GWAS1224583 (human) | | 1e-13 | pulse pressure measurement | pulse pressure (CMO:0000292) | 4 | 120018118 | 120018119 | Human |
597128508 | GWAS1224582_H | pulse pressure measurement QTL GWAS1224582 (human) | | 0.000002 | pulse pressure measurement | pulse pressure (CMO:0000292) | 4 | 110319122 | 110319123 | Human |
597374256 | GWAS1470330_H | hemoglobin measurement QTL GWAS1470330 (human) | | 3e-10 | hemoglobin measurement | hemoglobin measurement (CMO:0000508) | 4 | 123844107 | 123844108 | Human |
597128507 | GWAS1224581_H | pulse pressure measurement QTL GWAS1224581 (human) | | 0.0000002 | pulse pressure measurement | pulse pressure (CMO:0000292) | 4 | 108146742 | 108146743 | Human |
597153083 | GWAS1249157_H | low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio QTL GWAS1249157 (human) | | 7e-14 | low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | blood low density lipoprotein cholesterol level (CMO:0000053) | 4 | 109657070 | 109657071 | Human |
597226804 | GWAS1322878_H | atrial fibrillation QTL GWAS1322878 (human) | | 8e-11 | atrial fibrillation | | 4 | 110334761 | 110334762 | Human |
597226805 | GWAS1322879_H | atrial fibrillation QTL GWAS1322879 (human) | | 9e-11 | atrial fibrillation | | 4 | 110675204 | 110675205 | Human |
597185845 | GWAS1281919_H | major depressive disorder QTL GWAS1281919 (human) | | 5e-12 | major depressive disorder | | 4 | 122265238 | 122265239 | Human |
407035628 | GWAS684604_H | unipolar depression QTL GWAS684604 (human) | | 5e-12 | unipolar depression | | 4 | 122265238 | 122265239 | Human |
597185846 | GWAS1281920_H | major depressive disorder QTL GWAS1281920 (human) | | 2e-09 | major depressive disorder | | 4 | 130316226 | 130316227 | Human |
407035629 | GWAS684605_H | unipolar depression QTL GWAS684605 (human) | | 2e-09 | unipolar depression | | 4 | 130316226 | 130316227 | Human |
407125748 | GWAS774724_H | fetal hemoglobin measurement QTL GWAS774724 (human) | | 0.000007 | fetal hemoglobin measurement | | 4 | 120041230 | 120041231 | Human |
597476653 | GWAS1572727_H | appendicular lean mass QTL GWAS1572727 (human) | | 7e-22 | appendicular lean mass | | 4 | 119221151 | 119221152 | Human |
597476654 | GWAS1572728_H | appendicular lean mass QTL GWAS1572728 (human) | | 3e-26 | appendicular lean mass | | 4 | 121792708 | 121792709 | Human |
597275946 | GWAS1372020_H | rheumatoid arthritis QTL GWAS1372020 (human) | | 5e-14 | rheumatoid arthritis | | 4 | 108140462 | 108140463 | Human |
597439785 | GWAS1535859_H | lobe attachment QTL GWAS1535859 (human) | | 0.0000001 | lobe attachment | ear measurement (CMO:0002667) | 4 | 124806384 | 124806385 | Human |
407404287 | GWAS1053263_H | unipolar depression QTL GWAS1053263 (human) | | 3e-16 | unipolar depression | | 4 | 122467738 | 122467739 | Human |
597611814 | GWAS1668674_H | platelet count QTL GWAS1668674 (human) | | 3e-25 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 4 | 109927496 | 109927497 | Human |
597611815 | GWAS1668675_H | platelet count QTL GWAS1668675 (human) | | 1e-13 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 4 | 119439096 | 119439097 | Human |
597386535 | GWAS1482609_H | interleukin 16 measurement QTL GWAS1482609 (human) | | 0.000003 | interleukin 16 measurement | | 4 | 112762711 | 112762712 | Human |
597099819 | GWAS1195893_H | sex hormone-binding globulin measurement QTL GWAS1195893 (human) | | 0.0000007 | sex hormone-binding globulin measurement | | 4 | 119185193 | 119185194 | Human |
597075242 | GWAS1171316_H | endometriosis QTL GWAS1171316 (human) | | 0.000004 | endometriosis | | 4 | 119706266 | 119706267 | Human |
597386534 | GWAS1482608_H | interleukin 16 measurement QTL GWAS1482608 (human) | | 0.0000007 | interleukin 16 measurement | | 4 | 112649483 | 112649484 | Human |
597153110 | GWAS1249184_H | cholesteryl esters:total lipids ratio, intermediate density lipoprotein measurement QTL GWAS1249184 (human) | | 2e-09 | cholesteryl esters:total lipids ratio, intermediate density lipoprotein measurement | blood intermediate density lipoprotein cholesterol level (CMO:0001562) | 4 | 109657070 | 109657071 | Human |
597034327 | GWAS1130401_H | smoking behavior QTL GWAS1130401 (human) | | 3e-10 | smoking behavior | | 4 | 111500989 | 111500990 | Human |
597251419 | GWAS1347493_H | rheumatoid arthritis QTL GWAS1347493 (human) | | 0.0000007 | rheumatoid arthritis | | 4 | 122297158 | 122297159 | Human |
597402975 | GWAS1499049_H | hippocampal sclerosis of aging QTL GWAS1499049 (human) | | 0.000005 | hippocampal sclerosis of aging | | 4 | 126441942 | 126441943 | Human |
597501267 | GWAS1597341_H | heart failure QTL GWAS1597341 (human) | | 5e-42 | heart failure | | 4 | 110787848 | 110787849 | Human |
597435731 | GWAS1531805_H | Beta blocking agent use measurement QTL GWAS1531805 (human) | | 1e-12 | Beta blocking agent use measurement | | 4 | 110789013 | 110789014 | Human |
407084684 | GWAS733660_H | Ischemic stroke QTL GWAS733660 (human) | | 1e-15 | Ischemic stroke | | 4 | 110793263 | 110793264 | Human |
597501266 | GWAS1597340_H | heart failure QTL GWAS1597340 (human) | | 5e-14 | heart failure | | 4 | 110927114 | 110927115 | Human |
597251400 | GWAS1347474_H | HbA1c measurement QTL GWAS1347474 (human) | | 0.000001 | HbA1c measurement | blood hemoglobin A1c level (CMO:0002786) | 4 | 109980042 | 109980043 | Human |
597189961 | GWAS1286035_H | systemic lupus erythematosus QTL GWAS1286035 (human) | | 9e-12 | systemic lupus erythematosus | | 4 | 122089432 | 122089433 | Human |
597448008 | GWAS1544082_H | clostridium difficile infection QTL GWAS1544082 (human) | | 0.000008 | clostridium difficile infection | | 4 | 108850323 | 108850324 | Human |
597464392 | GWAS1560466_H | body mass index QTL GWAS1560466 (human) | | 1e-14 | body mass index | body mass index (BMI) (CMO:0000105) | 4 | 129805678 | 129805679 | Human |
406994580 | GWAS643556_H | pathological myopia QTL GWAS643556 (human) | | 0.000002 | pathological myopia | | 4 | 111781479 | 111781480 | Human |
597382466 | GWAS1478540_H | age at menarche QTL GWAS1478540 (human) | | 7e-08 | age at menarche | | 4 | 129809917 | 129809918 | Human |
597595460 | GWAS1652320_H | body mass index QTL GWAS1652320 (human) | | 2e-28 | body mass index | body mass index (BMI) (CMO:0000105) | 4 | 129818987 | 129818988 | Human |
597316934 | GWAS1413008_H | cognitive function measurement QTL GWAS1413008 (human) | | 0.000009 | cognitive function measurement | | 4 | 119010553 | 119010554 | Human |
597390661 | GWAS1486735_H | appendicular lean mass QTL GWAS1486735 (human) | | 1e-09 | appendicular lean mass | | 4 | 119455163 | 119455164 | Human |
597275974 | GWAS1372048_H | testosterone measurement QTL GWAS1372048 (human) | | 2e-08 | testosterone measurement | serum testosterone level (CMO:0000568) | 4 | 109108768 | 109108769 | Human |
597611841 | GWAS1668701_H | exostosis QTL GWAS1668701 (human) | | 4e-11 | exostosis | | 4 | 125701864 | 125701865 | Human |
597198202 | GWAS1294276_H | memory performance QTL GWAS1294276 (human) | | 0.000004 | memory performance | | 4 | 124891420 | 124891421 | Human |
597443962 | GWAS1540036_H | lipid measurement QTL GWAS1540036 (human) | | 0.000003 | lipid measurement | blood lipid measurement (CMO:0000050) | 4 | 131492574 | 131492575 | Human |
597374323 | GWAS1470397_H | reticulocyte count QTL GWAS1470397 (human) | | 1e-09 | reticulocyte quantity (VT:0003135) | total reticulocyte count (CMO:0003020) | 4 | 128330896 | 128330897 | Human |
597292405 | GWAS1388479_H | size QTL GWAS1388479 (human) | | 5e-08 | size | | 4 | 118204297 | 118204298 | Human |
597480815 | GWAS1576889_H | mean arterial pressure QTL GWAS1576889 (human) | | 1e-15 | mean arterial pressure | mean arterial blood pressure (CMO:0000009) | 4 | 110430068 | 110430069 | Human |
406998710 | GWAS647686_H | BMI-adjusted waist circumference QTL GWAS647686 (human) | | 5e-08 | body size trait (VT:0100005) | | 4 | 121696338 | 121696339 | Human |
407387824 | GWAS1036800_H | acute myeloid leukemia QTL GWAS1036800 (human) | | 6e-12 | leukocyte integrity trait (VT:0010898) | | 4 | 119601017 | 119601018 | Human |
597099886 | GWAS1195960_H | alopecia QTL GWAS1195960 (human) | | 2e-09 | alopecia | | 4 | 106967631 | 106967632 | Human |
597169506 | GWAS1265580_H | acne QTL GWAS1265580 (human) | | 6e-16 | acne | | 4 | 123258364 | 123258365 | Human |
406961850 | GWAS610826_H | chronic obstructive pulmonary disease QTL GWAS610826 (human) | | 0.0000007 | lung integrity trait (VT:0010906) | | 4 | 128969635 | 128969636 | Human |
597398887 | GWAS1494961_H | age at onset, major depressive disorder QTL GWAS1494961 (human) | | 0.000007 | age at onset, major depressive disorder | | 4 | 127602809 | 127602810 | Human |
597030251 | GWAS1126325_H | atrial fibrillation QTL GWAS1126325 (human) | | 7e-71 | atrial fibrillation | | 4 | 110735436 | 110735437 | Human |
597513372 | GWAS1609446_H | sex hormone-binding globulin measurement QTL GWAS1609446 (human) | | 7e-23 | sex hormone-binding globulin measurement | | 4 | 109321740 | 109321741 | Human |
597337241 | GWAS1433315_H | breast density QTL GWAS1433315 (human) | | 0.000006 | breast density | | 4 | 121949054 | 121949055 | Human |
597206160 | GWAS1302234_H | hemoglobin measurement QTL GWAS1302234 (human) | | 0.000009 | hemoglobin measurement | hemoglobin measurement (CMO:0000508) | 4 | 120934416 | 120934417 | Human |
597406866 | GWAS1502940_H | total blood protein measurement QTL GWAS1502940 (human) | | 6e-20 | total blood protein measurement | blood protein measurement (CMO:0000028) | 4 | 119206905 | 119206906 | Human |
597206162 | GWAS1302236_H | hemoglobin measurement QTL GWAS1302236 (human) | | 0.000008 | hemoglobin measurement | hemoglobin measurement (CMO:0000508) | 4 | 120850980 | 120850981 | Human |
597103772 | GWAS1199846_H | amyloid-beta measurement QTL GWAS1199846 (human) | | 0.000009 | amyloid-beta measurement | | 4 | 129232535 | 129232536 | Human |
407387973 | GWAS1036949_H | acute myeloid leukemia QTL GWAS1036949 (human) | | 0.000003 | leukocyte integrity trait (VT:0010898) | | 4 | 130195033 | 130195034 | Human |
597578896 | GWAS1635756_H | prothrombin time measurement QTL GWAS1635756 (human) | | 5e-51 | prothrombin time measurement | prothrombin time (CMO:0000211) | 4 | 110784139 | 110784140 | Human |
407387974 | GWAS1036950_H | acute myeloid leukemia QTL GWAS1036950 (human) | | 0.000006 | leukocyte integrity trait (VT:0010898) | | 4 | 130195033 | 130195034 | Human |
407056208 | GWAS705184_H | acne QTL GWAS705184 (human) | | 2e-09 | acne | | 4 | 123332634 | 123332635 | Human |
597087360 | GWAS1183434_H | allergic disease, age at onset QTL GWAS1183434 (human) | | 2e-17 | allergic disease, age at onset | | 4 | 122481853 | 122481854 | Human |
407048020 | GWAS696996_H | obesity QTL GWAS696996 (human) | | 0.000001 | obesity | | 4 | 112390634 | 112390635 | Human |
406908760 | GWAS557736_H | intelligence QTL GWAS557736 (human) | | 9e-08 | intelligence | | 4 | 130212336 | 130212337 | Human |
406962013 | GWAS610989_H | thyroxine measurement QTL GWAS610989 (human) | | 0.000005 | thyroxine measurement | blood thyroxine level (CMO:0001288) | 4 | 112622996 | 112622997 | Human |
597496961 | GWAS1593035_H | memory performance QTL GWAS1593035 (human) | | 0.000001 | memory performance | | 4 | 125709483 | 125709484 | Human |
597283972 | GWAS1380046_H | trefoil factor 3 measurement QTL GWAS1380046 (human) | | 3e-09 | trefoil factor 3 measurement | | 4 | 120726405 | 120726406 | Human |
597496960 | GWAS1593034_H | memory performance QTL GWAS1593034 (human) | | 0.000001 | memory performance | | 4 | 125705326 | 125705327 | Human |
596952247 | GWAS1071766_H | COVID-19 QTL GWAS1071766 (human) | | 0.000006 | COVID-19 | | 4 | 106867781 | 106867782 | Human |
597284016 | GWAS1380090_H | high density lipoprotein cholesterol measurement QTL GWAS1380090 (human) | | 5e-22 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 4 | 109657070 | 109657071 | Human |
597054655 | GWAS1150729_H | multiple sclerosis QTL GWAS1150729 (human) | | 0.0000002 | multiple sclerosis | | 4 | 112153589 | 112153590 | Human |
597226677 | GWAS1322751_H | asthma, age at onset QTL GWAS1322751 (human) | | 5e-08 | asthma, age at onset | | 4 | 122432277 | 122432278 | Human |
597038264 | GWAS1134338_H | gut microbiome measurement QTL GWAS1134338 (human) | | 0.000006 | gut microbiome measurement | | 4 | 128732972 | 128732973 | Human |
597267625 | GWAS1363699_H | cardioembolic stroke QTL GWAS1363699 (human) | | 0.0000003 | cardioembolic stroke | | 4 | 110841700 | 110841701 | Human |
407052150 | GWAS701126_H | eosinophil percentage of leukocytes QTL GWAS701126 (human) | | 6e-21 | eosinophil quantity (VT:0002602) | blood eosinophil count to total leukocyte count ratio (CMO:0000369) | 4 | 122111201 | 122111202 | Human |
597116066 | GWAS1212140_H | response to selective serotonin reuptake inhibitor, openness measurement QTL GWAS1212140 (human) | | 0.0000004 | response to selective serotonin reuptake inhibitor, openness measurement | | 4 | 129115280 | 129115281 | Human |
597472426 | GWAS1568500_H | hemorrhoid QTL GWAS1568500 (human) | | 4e-09 | hemorrhoid | | 4 | 123825222 | 123825223 | Human |
597472427 | GWAS1568501_H | hemorrhoid QTL GWAS1568501 (human) | | 3e-11 | hemorrhoid | | 4 | 126003844 | 126003845 | Human |
596968620 | GWAS1088139_H | cortical thickness QTL GWAS1088139 (human) | | 4e-08 | cortical thickness | | 4 | 120722571 | 120722572 | Human |
597341344 | GWAS1437418_H | breast density QTL GWAS1437418 (human) | | 0.000005 | breast density | | 4 | 120803641 | 120803642 | Human |
597267623 | GWAS1363697_H | cardioembolic stroke QTL GWAS1363697 (human) | | 5e-08 | cardioembolic stroke | | 4 | 110673205 | 110673206 | Human |
407023484 | GWAS672460_H | unipolar depression QTL GWAS672460 (human) | | 0.000007 | unipolar depression | | 4 | 124494379 | 124494380 | Human |
597099735 | GWAS1195809_H | cardiac arrhythmia QTL GWAS1195809 (human) | | 6e-37 | cardiac arrhythmia | | 4 | 110809256 | 110809257 | Human |
597099733 | GWAS1195807_H | cardiac arrhythmia QTL GWAS1195807 (human) | | 3e-41 | cardiac arrhythmia | | 4 | 110840331 | 110840332 | Human |
597451992 | GWAS1548066_H | diastolic blood pressure QTL GWAS1548066 (human) | | 2e-12 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 4 | 108096372 | 108096373 | Human |
597451993 | GWAS1548067_H | diastolic blood pressure QTL GWAS1548067 (human) | | 2e-13 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 4 | 110319122 | 110319123 | Human |
597451994 | GWAS1548068_H | diastolic blood pressure QTL GWAS1548068 (human) | | 2e-13 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 4 | 110400371 | 110400372 | Human |
597247198 | GWAS1343272_H | asthma QTL GWAS1343272 (human) | | 3e-14 | asthma | | 4 | 122148495 | 122148496 | Human |
597619926 | GWAS1676786_H | triglyceride measurement QTL GWAS1676786 (human) | | 5e-19 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 4 | 109657070 | 109657071 | Human |
597112030 | GWAS1208104_H | protein measurement QTL GWAS1208104 (human) | | 5e-10 | protein measurement | | 4 | 118904979 | 118904980 | Human |
597378257 | GWAS1474331_H | celiac disease QTL GWAS1474331 (human) | | 3e-13 | celiac disease | | 4 | 122588266 | 122588267 | Human |
597456087 | GWAS1552161_H | COVID-19 QTL GWAS1552161 (human) | | 0.000006 | COVID-19 | | 4 | 106867781 | 106867782 | Human |
597578965 | GWAS1635825_H | prothrombin time measurement QTL GWAS1635825 (human) | | 1e-54 | prothrombin time measurement | prothrombin time (CMO:0000211) | 4 | 110796911 | 110796912 | Human |
597337302 | GWAS1433376_H | Ischemic stroke QTL GWAS1433376 (human) | | 5e-09 | Ischemic stroke | | 4 | 110744760 | 110744761 | Human |
597611730 | GWAS1668590_H | esophageal ulcer QTL GWAS1668590 (human) | | 1e-11 | esophageal ulcer | | 4 | 130688376 | 130688377 | Human |
597497037 | GWAS1593111_H | hip geometry QTL GWAS1593111 (human) | | 3e-09 | hip geometry | hip circumference (CMO:0000014) | 4 | 108377273 | 108377274 | Human |
597439692 | GWAS1535766_H | eye color QTL GWAS1535766 (human) | | 0.000008 | eye color | | 4 | 110379206 | 110379207 | Human |
596960452 | GWAS1079971_H | glomerular filtration rate QTL GWAS1079971 (human) | | 3e-14 | glomerular filtration rate | | 4 | 127146530 | 127146531 | Human |
597193930 | GWAS1290004_H | cortical thickness QTL GWAS1290004 (human) | | 1e-13 | cortical thickness | | 4 | 120793484 | 120793485 | Human |
597439689 | GWAS1535763_H | eye color QTL GWAS1535763 (human) | | 0.000002 | eye color | | 4 | 110457206 | 110457207 | Human |
407195408 | GWAS844384_H | gut microbiome measurement, bone density QTL GWAS844384 (human) | | 2e-09 | gut microbiome measurement, bone density | | 4 | 116039953 | 116039954 | Human |
596960450 | GWAS1079969_H | glomerular filtration rate QTL GWAS1079969 (human) | | 3e-19 | glomerular filtration rate | | 4 | 108783751 | 108783752 | Human |
597451978 | GWAS1548052_H | anti-Epstein Barr virus antibody measurement QTL GWAS1548052 (human) | | 0.0000008 | anti-Epstein Barr virus antibody measurement | serum anti-Epstein-Barr virus (EBV) antibody level (CMO:0003143) | 4 | 110793733 | 110793734 | Human |
597370061 | GWAS1466135_H | obesity QTL GWAS1466135 (human) | | 0.0000002 | obesity | | 4 | 129810129 | 129810130 | Human |
596960451 | GWAS1079970_H | glomerular filtration rate QTL GWAS1079970 (human) | | 4e-09 | glomerular filtration rate | | 4 | 123414226 | 123414227 | Human |
597021901 | GWAS1117975_H | C-C motif chemokine 7 measurement QTL GWAS1117975 (human) | | 0.000002 | C-C motif chemokine 7 measurement | | 4 | 110137551 | 110137552 | Human |
597030095 | GWAS1126169_H | balding measurement QTL GWAS1126169 (human) | | 3e-16 | hair amount (VT:0000416) | coat/hair morphological measurement (CMO:0001807) | 4 | 106961911 | 106961912 | Human |
597513415 | GWAS1609489_H | smoking cessation QTL GWAS1609489 (human) | | 1e-10 | smoking cessation | | 4 | 112087702 | 112087703 | Human |
597144781 | GWAS1240855_H | age of onset of childhood onset asthma QTL GWAS1240855 (human) | | 6e-16 | age of onset of childhood onset asthma | | 4 | 122307075 | 122307076 | Human |
597578944 | GWAS1635804_H | potassium deficiency disease QTL GWAS1635804 (human) | | 3e-11 | potassium deficiency disease | | 4 | 108140367 | 108140368 | Human |
597365956 | GWAS1462030_H | hair color QTL GWAS1462030 (human) | | 3e-20 | hair color | | 4 | 108556952 | 108556953 | Human |
407252761 | GWAS901737_H | asthma QTL GWAS901737 (human) | | 5e-25 | asthma | | 4 | 122432277 | 122432278 | Human |
597591295 | GWAS1648155_H | parasitic infection QTL GWAS1648155 (human) | | 7e-12 | parasitic infection | | 4 | 108582778 | 108582779 | Human |
597128438 | GWAS1224512_H | sleep measurement QTL GWAS1224512 (human) | | 0.000006 | sleep measurement | | 4 | 118160921 | 118160922 | Human |
597411065 | GWAS1507139_H | cardioembolic stroke QTL GWAS1507139 (human) | | 2e-25 | cardioembolic stroke | | 4 | 110793263 | 110793264 | Human |
597300473 | GWAS1396547_H | complement factor I measurement QTL GWAS1396547 (human) | | 9e-37 | complement protein amount (VT:0010033) | | 4 | 109735574 | 109735575 | Human |
597411064 | GWAS1507138_H | cardioembolic stroke QTL GWAS1507138 (human) | | 2e-21 | cardioembolic stroke | | 4 | 110793263 | 110793264 | Human |
597128435 | GWAS1224509_H | sleep measurement QTL GWAS1224509 (human) | | 0.000005 | sleep measurement | | 4 | 118053665 | 118053666 | Human |
597394686 | GWAS1490760_H | balding measurement QTL GWAS1490760 (human) | | 2e-18 | hair amount (VT:0000416) | coat/hair morphological measurement (CMO:0001807) | 4 | 106652584 | 106652585 | Human |
597468409 | GWAS1564483_H | breast carcinoma QTL GWAS1564483 (human) | | 1e-09 | mammary gland integrity trait (VT:0010552) | | 4 | 125922349 | 125922350 | Human |
597103857 | GWAS1199931_H | alopecia QTL GWAS1199931 (human) | | 0.000005 | alopecia | | 4 | 106961892 | 106961893 | Human |
597075185 | GWAS1171259_H | common carotid intimal medial thickness QTL GWAS1171259 (human) | | 0.0000009 | common carotid intimal medial thickness | | 4 | 109159865 | 109159866 | Human |
597308659 | GWAS1404733_H | total blood protein measurement QTL GWAS1404733 (human) | | 8e-13 | total blood protein measurement | blood protein measurement (CMO:0000028) | 4 | 122243645 | 122243646 | Human |
597398768 | GWAS1494842_H | Diuretic use measurement QTL GWAS1494842 (human) | | 4e-10 | Diuretic use measurement | | 4 | 110465271 | 110465272 | Human |
597411063 | GWAS1507137_H | cardioembolic stroke QTL GWAS1507137 (human) | | 6e-24 | cardioembolic stroke | | 4 | 110793263 | 110793264 | Human |
597411062 | GWAS1507136_H | cardioembolic stroke QTL GWAS1507136 (human) | | 3e-25 | cardioembolic stroke | | 4 | 110793263 | 110793264 | Human |
596976891 | GWAS1096410_H | Crohn's disease QTL GWAS1096410 (human) | | 2e-16 | Crohn's disease | | 4 | 122523884 | 122523885 | Human |
597488883 | GWAS1584957_H | phosphatidylcholine measurement QTL GWAS1584957 (human) | | 4e-08 | phosphatidylcholine measurement | | 4 | 112567861 | 112567862 | Human |
596976868 | GWAS1096387_H | ulcerative colitis QTL GWAS1096387 (human) | | 2e-09 | ulcerative colitis | | 4 | 122523884 | 122523885 | Human |
597038306 | GWAS1134380_H | gut microbiome measurement QTL GWAS1134380 (human) | | 0.000008 | gut microbiome measurement | | 4 | 119132069 | 119132070 | Human |
597509355 | GWAS1605429_H | fibroblast growth factor 2 measurement QTL GWAS1605429 (human) | | 2e-11 | fibroblast growth factor 2 measurement | | 4 | 122682145 | 122682146 | Human |
597120239 | GWAS1216313_H | major depressive disorder QTL GWAS1216313 (human) | | 3e-09 | major depressive disorder | | 4 | 130315312 | 130315313 | Human |
597341408 | GWAS1437482_H | asthma QTL GWAS1437482 (human) | | 2e-26 | asthma | | 4 | 122146653 | 122146654 | Human |
597218532 | GWAS1314606_H | COVID-19 QTL GWAS1314606 (human) | | 0.000009 | COVID-19 | | 4 | 109566395 | 109566396 | Human |
597456098 | GWAS1552172_H | diastolic blood pressure QTL GWAS1552172 (human) | | 1e-12 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 4 | 110430068 | 110430069 | Human |
597177373 | GWAS1273447_H | spermidine measurement QTL GWAS1273447 (human) | | 4e-08 | spermidine measurement | | 4 | 109176399 | 109176400 | Human |
597402652 | GWAS1498726_H | ulcerative colitis QTL GWAS1498726 (human) | | 5e-10 | ulcerative colitis | | 4 | 122240464 | 122240465 | Human |
597074971 | GWAS1171045_H | coronary artery disease QTL GWAS1171045 (human) | | 1e-08 | coronary artery disease | | 4 | 119988346 | 119988347 | Human |
597091353 | GWAS1187427_H | seasonal gut microbiome measurement QTL GWAS1187427 (human) | | 0.000007 | seasonal gut microbiome measurement | | 4 | 108464247 | 108464248 | Human |
597521420 | GWAS1617494_H | open-angle glaucoma QTL GWAS1617494 (human) | | 7e-09 | open-angle glaucoma | | 4 | 111042563 | 111042564 | Human |
597165066 | GWAS1261140_H | deoxycholate measurement QTL GWAS1261140 (human) | | 0.000001 | deoxycholate measurement | | 4 | 119855597 | 119855598 | Human |
597283854 | GWAS1379928_H | diastolic blood pressure QTL GWAS1379928 (human) | | 2e-09 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 4 | 119588124 | 119588125 | Human |
597296131 | GWAS1392205_H | BMI-adjusted hip circumference QTL GWAS1392205 (human) | | 1e-09 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 4 | 121824574 | 121824575 | Human |
597140490 | GWAS1236564_H | heart failure QTL GWAS1236564 (human) | | 9e-12 | heart failure | | 4 | 110665822 | 110665823 | Human |
597320711 | GWAS1416785_H | body surface area QTL GWAS1416785 (human) | | 3e-11 | body surface area | | 4 | 122906887 | 122906888 | Human |
597525567 | GWAS1621641_H | pulse pressure measurement QTL GWAS1621641 (human) | | 0.0000008 | pulse pressure measurement | pulse pressure (CMO:0000292) | 4 | 110416708 | 110416709 | Human |
597177402 | GWAS1273476_H | protein measurement QTL GWAS1273476 (human) | | 2e-152 | protein measurement | | 4 | 110510288 | 110510289 | Human |
597337144 | GWAS1433218_H | COVID-19, mortality QTL GWAS1433218 (human) | | 0.000002 | COVID-19, mortality | ratio of deaths to total study population during a period of time (CMO:0001023) | 4 | 127021337 | 127021338 | Human |
597177403 | GWAS1273477_H | protein measurement QTL GWAS1273477 (human) | | 1e-149 | protein measurement | | 4 | 110489326 | 110489327 | Human |
597435448 | GWAS1531522_H | lipid measurement QTL GWAS1531522 (human) | | 0.000005 | lipid measurement | blood lipid measurement (CMO:0000050) | 4 | 126630119 | 126630120 | Human |
407060454 | GWAS709430_H | stroke QTL GWAS709430 (human) | | 3e-08 | stroke | | 4 | 110778170 | 110778171 | Human |
597087295 | GWAS1183369_H | allergic disease QTL GWAS1183369 (human) | | 5e-22 | allergic disease | | 4 | 122481853 | 122481854 | Human |
597464117 | GWAS1560191_H | neurofibrillary tangles measurement QTL GWAS1560191 (human) | | 0.000003 | neurofibrillary tangles measurement | | 4 | 129358580 | 129358581 | Human |
597038143 | GWAS1134217_H | treatment resistant depression, response to antidepressant QTL GWAS1134217 (human) | | 0.000004 | treatment resistant depression, response to antidepressant | | 4 | 130496927 | 130496928 | Human |
596964414 | GWAS1083933_H | gut microbiome measurement, bone density QTL GWAS1083933 (human) | | 2e-08 | gut microbiome measurement, bone density | | 4 | 116019324 | 116019325 | Human |
597038140 | GWAS1134214_H | treatment resistant depression, response to antidepressant QTL GWAS1134214 (human) | | 0.0000001 | treatment resistant depression, response to antidepressant | | 4 | 130459962 | 130459963 | Human |
596964415 | GWAS1083934_H | gut microbiome measurement, bone density QTL GWAS1083934 (human) | | 2e-08 | gut microbiome measurement, bone density | | 4 | 116034483 | 116034484 | Human |
597087293 | GWAS1183367_H | allergic disease QTL GWAS1183367 (human) | | 7e-13 | asthma | | 4 | 122219915 | 122219916 | Human |
597206069 | GWAS1302143_H | type 2 diabetes mellitus QTL GWAS1302143 (human) | | 2e-08 | type 2 diabetes mellitus | | 4 | 122911999 | 122912000 | Human |
597111843 | GWAS1207917_H | platelet count QTL GWAS1207917 (human) | | 7e-11 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 4 | 122595396 | 122595397 | Human |
597111842 | GWAS1207916_H | platelet count QTL GWAS1207916 (human) | | 3e-27 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 4 | 109966833 | 109966834 | Human |
597361710 | GWAS1457784_H | ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis QTL GWAS1457784 (human) | | 5e-08 | intestine integrity trait (VT:0010554) | | 4 | 122629959 | 122629960 | Human |
596968482 | GWAS1088001_H | systolic blood pressure QTL GWAS1088001 (human) | | 9e-17 | systolic blood pressure | | 4 | 110510288 | 110510289 | Human |
597292064 | GWAS1388138_H | respiratory system disease QTL GWAS1388138 (human) | | 5e-36 | respiratory system disease | | 4 | 122432277 | 122432278 | Human |
597062700 | GWAS1158774_H | fat body mass QTL GWAS1158774 (human) | | 0.000005 | body fat mass (VT:0010482) | total body fat mass (CMO:0000305) | 4 | 124429906 | 124429907 | Human |
597390368 | GWAS1486442_H | triglyceride measurement QTL GWAS1486442 (human) | | 2e-09 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 4 | 123822104 | 123822105 | Human |
597296161 | GWAS1392235_H | lysophosphatidylcholine 20:2 measurement QTL GWAS1392235 (human) | | 4e-09 | lysophosphatidylcholine 20:2 measurement | | 4 | 126754772 | 126754773 | Human |
597287973 | GWAS1384047_H | coronary artery disease QTL GWAS1384047 (human) | | 2e-09 | coronary artery disease | | 4 | 109616095 | 109616096 | Human |
597337126 | GWAS1433200_H | cardioembolic stroke QTL GWAS1433200 (human) | | 0.0000009 | cardioembolic stroke | | 4 | 110778170 | 110778171 | Human |
597169188 | GWAS1265262_H | facial morphology measurement QTL GWAS1265262 (human) | | 3e-29 | facial morphology trait (VT:0003743) | | 4 | 127007438 | 127007439 | Human |
407126011 | GWAS774987_H | smoking initiation QTL GWAS774987 (human) | | 0.0000005 | smoking initiation | | 4 | 121686023 | 121686024 | Human |
597103703 | GWAS1199777_H | diastolic blood pressure, systolic blood pressure QTL GWAS1199777 (human) | | 0.000003 | diastolic blood pressure, systolic blood pressure | systolic blood pressure (CMO:0000004) | 4 | 113264849 | 113264850 | Human |
597476445 | GWAS1572519_H | thyroid carcinoma QTL GWAS1572519 (human) | | 0.0000006 | thyroid carcinoma | | 4 | 112649292 | 112649293 | Human |
406957959 | GWAS606935_H | carotid plaque build QTL GWAS606935 (human) | | 0.000001 | carotid plaque build | | 4 | 109034785 | 109034786 | Human |
597333085 | GWAS1429159_H | neuroimaging measurement QTL GWAS1429159 (human) | | 5e-09 | neuroimaging measurement | | 4 | 114719632 | 114719636 | Human |
597128287 | GWAS1224361_H | glycerophospholipid measurement QTL GWAS1224361 (human) | | 2e-10 | glycerophospholipid measurement | | 4 | 114515499 | 114515500 | Human |
597578839 | GWAS1635699_H | macular degeneration QTL GWAS1635699 (human) | | 2e-11 | macular degeneration | | 4 | 109764664 | 109764665 | Human |
596980831 | GWAS1100350_H | memory performance, sex interaction measurement QTL GWAS1100350 (human) | | 0.000003 | memory performance, sex interaction measurement | | 4 | 109131697 | 109131698 | Human |
596980830 | GWAS1100349_H | memory performance, sex interaction measurement QTL GWAS1100349 (human) | | 0.000003 | memory performance, sex interaction measurement | | 4 | 109134293 | 109134294 | Human |
597333073 | GWAS1429147_H | neuroimaging measurement QTL GWAS1429147 (human) | | 2e-09 | neuroimaging measurement | | 4 | 114732469 | 114732470 | Human |
597034074 | GWAS1130148_H | lean body mass QTL GWAS1130148 (human) | | 0.0000002 | body lean mass (VT:0010483) | total body lean mass (CMO:0003950) | 4 | 122904764 | 122904765 | Human |
597042267 | GWAS1138341_H | hemoglobin measurement QTL GWAS1138341 (human) | | 3e-09 | hemoglobin measurement | hemoglobin measurement (CMO:0000508) | 4 | 114647874 | 114647875 | Human |
597038171 | GWAS1134245_H | gut microbiome measurement QTL GWAS1134245 (human) | | 0.000006 | gut microbiome measurement | | 4 | 123354475 | 123354476 | Human |
406953870 | GWAS602846_H | platelet crit QTL GWAS602846 (human) | | 6e-10 | platelet quantity (VT:0003179) | plateletcrit (CMO:0001349) | 4 | 119559078 | 119559079 | Human |
597120071 | GWAS1216145_H | triglyceride measurement QTL GWAS1216145 (human) | | 1e-38 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 4 | 109717668 | 109717669 | Human |
597423179 | GWAS1519253_H | atrial fibrillation QTL GWAS1519253 (human) | | 3e-81 | atrial fibrillation | | 4 | 110674360 | 110674361 | Human |
597423178 | GWAS1519252_H | atrial fibrillation QTL GWAS1519252 (human) | | 3e-19 | atrial fibrillation | | 4 | 110665288 | 110665289 | Human |
597423177 | GWAS1519251_H | atrial fibrillation QTL GWAS1519251 (human) | | 8e-20 | atrial fibrillation | | 4 | 110659017 | 110659018 | Human |
597050436 | GWAS1146510_H | Eczematoid dermatitis QTL GWAS1146510 (human) | | 1e-37 | Eczematoid dermatitis | | 4 | 122415763 | 122415764 | Human |
597423176 | GWAS1519250_H | atrial fibrillation QTL GWAS1519250 (human) | | 1e-11 | atrial fibrillation | | 4 | 110639637 | 110639638 | Human |
406986646 | GWAS635622_H | mean corpuscular hemoglobin concentration QTL GWAS635622 (human) | | 6e-14 | mean corpuscular hemoglobin concentration | mean corpuscular hemoglobin concentration (CMO:0000291) | 4 | 109944312 | 109944313 | Human |
597423183 | GWAS1519257_H | atrial fibrillation QTL GWAS1519257 (human) | | 6e-305 | atrial fibrillation | | 4 | 110743002 | 110743003 | Human |
597075010 | GWAS1171084_H | body mass index QTL GWAS1171084 (human) | | 1e-08 | body mass index | body mass index (BMI) (CMO:0000105) | 4 | 112392830 | 112392831 | Human |
596964416 | GWAS1083935_H | gut microbiome measurement, bone density QTL GWAS1083935 (human) | | 2e-09 | gut microbiome measurement, bone density | | 4 | 116039953 | 116039954 | Human |
597402703 | GWAS1498777_H | Erythema nodosum QTL GWAS1498777 (human) | | 5e-08 | Erythema nodosum | | 4 | 117413463 | 117413464 | Human |
597046338 | GWAS1142412_H | erythrocyte count QTL GWAS1142412 (human) | | 4e-09 | erythrocyte count | red blood cell count (CMO:0000025) | 4 | 127869642 | 127869643 | Human |
597423182 | GWAS1519256_H | atrial fibrillation QTL GWAS1519256 (human) | | 1e-70 | atrial fibrillation | | 4 | 110735436 | 110735437 | Human |
597050435 | GWAS1146509_H | Eczematoid dermatitis QTL GWAS1146509 (human) | | 2e-26 | Eczematoid dermatitis | | 4 | 122219915 | 122219916 | Human |
597423181 | GWAS1519255_H | atrial fibrillation QTL GWAS1519255 (human) | | 3e-11 | atrial fibrillation | | 4 | 110716779 | 110716780 | Human |
597423180 | GWAS1519254_H | atrial fibrillation QTL GWAS1519254 (human) | | 4e-31 | atrial fibrillation | | 4 | 110714136 | 110714137 | Human |
597328973 | GWAS1425047_H | atrial fibrillation QTL GWAS1425047 (human) | | 3e-08 | atrial fibrillation | | 4 | 110742777 | 110742778 | Human |
597423171 | GWAS1519245_H | atrial fibrillation QTL GWAS1519245 (human) | | 2e-12 | atrial fibrillation | | 4 | 110524540 | 110524541 | Human |
597423170 | GWAS1519244_H | atrial fibrillation QTL GWAS1519244 (human) | | 5e-09 | atrial fibrillation | | 4 | 110485340 | 110485341 | Human |
407011227 | GWAS660203_H | intelligence QTL GWAS660203 (human) | | 0.0000001 | intelligence | | 4 | 118088064 | 118088065 | Human |
597210179 | GWAS1306253_H | hip bone mineral density, fat body mass QTL GWAS1306253 (human) | | 6e-09 | body fat mass (VT:0010482) | total body fat mass (CMO:0000305) | 4 | 129257175 | 129257176 | Human |
597423175 | GWAS1519249_H | atrial fibrillation QTL GWAS1519249 (human) | | 3e-17 | atrial fibrillation | | 4 | 110609843 | 110609844 | Human |
597464128 | GWAS1560202_H | lung adenocarcinoma, family history of lung cancer QTL GWAS1560202 (human) | | 0.000009 | lung adenocarcinoma, family history of lung cancer | | 4 | 111828356 | 111828357 | Human |
597525568 | GWAS1621642_H | pulse pressure measurement QTL GWAS1621642 (human) | | 0.0000006 | pulse pressure measurement | pulse pressure (CMO:0000292) | 4 | 110461529 | 110461530 | Human |
597423174 | GWAS1519248_H | atrial fibrillation QTL GWAS1519248 (human) | | 1e-36 | atrial fibrillation | | 4 | 110589415 | 110589416 | Human |
597042248 | GWAS1138322_H | response to diuretic, low density lipoprotein cholesterol measurement QTL GWAS1138322 (human) | | 0.0000002 | response to diuretic, low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 4 | 107408461 | 107408462 | Human |
597423173 | GWAS1519247_H | atrial fibrillation QTL GWAS1519247 (human) | | 3e-12 | atrial fibrillation | | 4 | 110574086 | 110574087 | Human |
597423172 | GWAS1519246_H | atrial fibrillation QTL GWAS1519246 (human) | | 4e-09 | atrial fibrillation | | 4 | 110546303 | 110546304 | Human |
597390458 | GWAS1486532_H | autoimmune thyroid disease, systemic lupus erythematosus, type 1 diabetes mellitus, ankylosing spondylitis, psoriasis, common variable immunodeficiency, celiac disease, ulcerative colitis, Crohn's disease, autoimmune disease, juvenile idiopathic arthritis QTL GWAS1486532 (human) | | 3e-08 | intestine integrity trait (VT:0010554) | | 4 | 122639784 | 122639785 | Human |
597296248 | GWAS1392322_H | ceramide measurement QTL GWAS1392322 (human) | | 2e-13 | ceramide measurement | | 4 | 114549176 | 114549177 | Human |
597042290 | GWAS1138364_H | triglyceride measurement, response to diuretic QTL GWAS1138364 (human) | | 6e-08 | triglyceride measurement, response to diuretic | blood triglyceride level (CMO:0000118) | 4 | 129379460 | 129379461 | Human |
597619832 | GWAS1676692_H | mental or behavioural disorder QTL GWAS1676692 (human) | | 4e-13 | mental or behavioural disorder | | 4 | 126106138 | 126106139 | Human |
596952185 | GWAS1071704_H | COVID-19 QTL GWAS1071704 (human) | | 0.0000009 | COVID-19 | | 4 | 107808529 | 107808530 | Human |
597202037 | GWAS1298111_H | electrocardiography QTL GWAS1298111 (human) | | 2e-08 | electrocardiography | | 4 | 110782354 | 110782355 | Human |
597095547 | GWAS1191621_H | emphysema imaging measurement QTL GWAS1191621 (human) | | 0.0000009 | emphysema imaging measurement | | 4 | 122028914 | 122028915 | Human |
597202038 | GWAS1298112_H | electrocardiography QTL GWAS1298112 (human) | | 4e-31 | electrocardiography | | 4 | 113508251 | 113508252 | Human |
596968571 | GWAS1088090_H | cortical thickness QTL GWAS1088090 (human) | | 3e-12 | cortical thickness | | 4 | 120722571 | 120722572 | Human |
597128295 | GWAS1224369_H | glycerophospholipid measurement QTL GWAS1224369 (human) | | 2e-10 | glycerophospholipid measurement | | 4 | 114502041 | 114502042 | Human |
597128294 | GWAS1224368_H | glycerophospholipid measurement QTL GWAS1224368 (human) | | 2e-10 | glycerophospholipid measurement | | 4 | 114494754 | 114494755 | Human |
597591148 | GWAS1648008_H | atrial fibrillation QTL GWAS1648008 (human) | | 3e-33 | atrial fibrillation | | 4 | 110796911 | 110796912 | Human |
597128293 | GWAS1224367_H | glycerophospholipid measurement QTL GWAS1224367 (human) | | 2e-10 | glycerophospholipid measurement | | 4 | 114582848 | 114582849 | Human |
597128292 | GWAS1224366_H | glycerophospholipid measurement QTL GWAS1224366 (human) | | 2e-10 | glycerophospholipid measurement | | 4 | 114531582 | 114531583 | Human |
597128291 | GWAS1224365_H | glycerophospholipid measurement QTL GWAS1224365 (human) | | 2e-10 | glycerophospholipid measurement | | 4 | 114495098 | 114495099 | Human |
596980832 | GWAS1100351_H | memory performance, sex interaction measurement QTL GWAS1100351 (human) | | 0.000003 | memory performance, sex interaction measurement | | 4 | 109132717 | 109132718 | Human |
597591147 | GWAS1648007_H | atrial fibrillation QTL GWAS1648007 (human) | | 6e-56 | atrial fibrillation | | 4 | 110787848 | 110787849 | Human |
597128290 | GWAS1224364_H | glycerophospholipid measurement QTL GWAS1224364 (human) | | 2e-10 | glycerophospholipid measurement | | 4 | 114528667 | 114528668 | Human |
597333100 | GWAS1429174_H | atrial fibrillation QTL GWAS1429174 (human) | | 6e-47 | atrial fibrillation | | 4 | 110776497 | 110776498 | Human |
597128289 | GWAS1224363_H | glycerophospholipid measurement QTL GWAS1224363 (human) | | 2e-10 | glycerophospholipid measurement | | 4 | 114582806 | 114582807 | Human |
596980834 | GWAS1100353_H | memory performance, sex interaction measurement QTL GWAS1100353 (human) | | 0.000004 | memory performance, sex interaction measurement | | 4 | 109129061 | 109129062 | Human |
597128288 | GWAS1224362_H | glycerophospholipid measurement QTL GWAS1224362 (human) | | 2e-10 | glycerophospholipid measurement | | 4 | 114582721 | 114582722 | Human |
597128301 | GWAS1224375_H | glycerophospholipid measurement QTL GWAS1224375 (human) | | 2e-10 | glycerophospholipid measurement | | 4 | 114479168 | 114479169 | Human |
597517415 | GWAS1613489_H | neuroimaging measurement QTL GWAS1613489 (human) | | 0.000001 | neuroimaging measurement | | 4 | 120211752 | 120211753 | Human |
597128300 | GWAS1224374_H | glycerophospholipid measurement QTL GWAS1224374 (human) | | 2e-10 | glycerophospholipid measurement | | 4 | 114569301 | 114569302 | Human |
597517414 | GWAS1613488_H | neuroimaging measurement QTL GWAS1613488 (human) | | 6e-09 | neuroimaging measurement | | 4 | 120199264 | 120199265 | Human |
597128299 | GWAS1224373_H | glycerophospholipid measurement QTL GWAS1224373 (human) | | 2e-10 | glycerophospholipid measurement | | 4 | 114557814 | 114557815 | Human |
597439584 | GWAS1535658_H | celiac disease QTL GWAS1535658 (human) | | 2e-38 | celiac disease | | 4 | 122629959 | 122629960 | Human |
597128298 | GWAS1224372_H | glycerophospholipid measurement QTL GWAS1224372 (human) | | 2e-10 | glycerophospholipid measurement | | 4 | 114484294 | 114484295 | Human |
597587043 | GWAS1643903_H | eosinophil count QTL GWAS1643903 (human) | | 5e-16 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 4 | 122663791 | 122663792 | Human |
597128297 | GWAS1224371_H | glycerophospholipid measurement QTL GWAS1224371 (human) | | 2e-10 | glycerophospholipid measurement | | 4 | 114483807 | 114483808 | Human |
597128296 | GWAS1224370_H | glycerophospholipid measurement QTL GWAS1224370 (human) | | 2e-10 | glycerophospholipid measurement | | 4 | 114495078 | 114495079 | Human |
407146427 | GWAS795403_H | allergic disease QTL GWAS795403 (human) | | 4e-08 | allergic disease | | 4 | 122408207 | 122408208 | Human |
597408667 | GWAS1504741_H | uric acid measurement QTL GWAS1504741 (human) | | 3e-08 | uric acid measurement | blood uric acid level (CMO:0000501) | 4 | 127173154 | 127173155 | Human |
597068692 | GWAS1164766_H | fat body mass QTL GWAS1164766 (human) | | 0.0000001 | body fat mass (VT:0010482) | total body fat mass (CMO:0000305) | 4 | 114674241 | 114674242 | Human |
597162899 | GWAS1258973_H | factor XI measurement, Ischemic stroke QTL GWAS1258973 (human) | | 2e-16 | factor XI measurement, Ischemic stroke | | 4 | 110775495 | 110775496 | Human |
597519257 | GWAS1615331_H | serum gamma-glutamyl transferase measurement QTL GWAS1615331 (human) | | 7e-13 | serum gamma-glutamyl transferase measurement | serum gamma-glutamyltransferase activity level (CMO:0002241) | 4 | 111793842 | 111793843 | Human |
597412766 | GWAS1508840_H | adolescent idiopathic scoliosis QTL GWAS1508840 (human) | | 2e-09 | adolescent idiopathic scoliosis | | 4 | 119337052 | 119337053 | Human |
597040028 | GWAS1136102_H | urinary metabolite measurement QTL GWAS1136102 (human) | | 6e-18 | urinary metabolite measurement | | 4 | 129118729 | 129118730 | Human |
597109660 | GWAS1205734_H | Red cell distribution width QTL GWAS1205734 (human) | | 3e-09 | Red cell distribution width | red blood cell distribution width- standard deviation (CMO:0003232) | 4 | 122438414 | 122438415 | Human |
597080987 | GWAS1177061_H | gut microbiome measurement QTL GWAS1177061 (human) | | 0.000008 | gut microbiome measurement | | 4 | 118360545 | 118360546 | Human |
597478290 | GWAS1574364_H | platelet crit QTL GWAS1574364 (human) | | 9e-20 | platelet quantity (VT:0003179) | plateletcrit (CMO:0001349) | 4 | 119336584 | 119336585 | Human |
597478291 | GWAS1574365_H | platelet crit QTL GWAS1574365 (human) | | 1e-13 | platelet quantity (VT:0003179) | plateletcrit (CMO:0001349) | 4 | 123749526 | 123749527 | Human |
597470092 | GWAS1566166_H | chronotype measurement QTL GWAS1566166 (human) | | 4e-09 | chronotype measurement | | 4 | 117394404 | 117394405 | Human |
597171081 | GWAS1267155_H | QRS-T angle QTL GWAS1267155 (human) | | 9e-11 | heart excitatory physiology trait (VT:0000231) | | 4 | 110650661 | 110650662 | Human |
597171082 | GWAS1267156_H | QRS-T angle QTL GWAS1267156 (human) | | 3e-26 | heart excitatory physiology trait (VT:0000231) | | 4 | 113523590 | 113523591 | Human |
597412748 | GWAS1508822_H | hip bone mineral density QTL GWAS1508822 (human) | | 0.000006 | hip bone mineral density | bone mineral density (CMO:0001226) | 4 | 128365448 | 128365449 | Human |
597425027 | GWAS1521101_H | platelet-to-lymphocyte ratio QTL GWAS1521101 (human) | | 5e-08 | platelet-to-lymphocyte ratio | | 4 | 121774530 | 121774531 | Human |
597195648 | GWAS1291722_H | memory performance QTL GWAS1291722 (human) | | 0.000006 | memory performance | | 4 | 124895966 | 124895967 | Human |
596978572 | GWAS1098091_H | body height QTL GWAS1098091 (human) | | 3e-28 | body height | | 4 | 108535458 | 108535459 | Human |
597195650 | GWAS1291724_H | memory performance QTL GWAS1291724 (human) | | 0.000006 | memory performance | | 4 | 124897660 | 124897661 | Human |
597162892 | GWAS1258966_H | heart failure QTL GWAS1258966 (human) | | 9e-17 | heart failure | | 4 | 110776497 | 110776498 | Human |
597191555 | GWAS1287629_H | atopic eczema QTL GWAS1287629 (human) | | 6e-11 | atopic eczema | | 4 | 122111486 | 122111487 | Human |
407052383 | GWAS701359_H | hemoglobin measurement QTL GWAS701359 (human) | | 1e-12 | hemoglobin measurement | hemoglobin measurement (CMO:0000508) | 4 | 114598669 | 114598670 | Human |
597138315 | GWAS1234389_H | Premature atrial contractions QTL GWAS1234389 (human) | | 0.0000004 | Premature atrial contractions | | 4 | 121039245 | 121039246 | Human |
597138314 | GWAS1234388_H | Premature atrial contractions QTL GWAS1234388 (human) | | 0.0000005 | Premature atrial contractions | | 4 | 121016813 | 121016815 | Human |
597195653 | GWAS1291727_H | memory performance QTL GWAS1291727 (human) | | 0.000006 | memory performance | | 4 | 124885712 | 124885713 | Human |
597101492 | GWAS1197566_H | cognitive function measurement QTL GWAS1197566 (human) | | 0.000005 | cognitive function measurement | | 4 | 114569532 | 114569533 | Human |
597265338 | GWAS1361412_H | cortical thickness QTL GWAS1361412 (human) | | 1e-12 | smoking initiation | | 4 | 120722571 | 120722572 | Human |
597478328 | GWAS1574402_H | atrial fibrillation QTL GWAS1574402 (human) | | 9e-09 | atrial fibrillation | | 4 | 111683665 | 111683666 | Human |
596966320 | GWAS1085839_H | diastolic blood pressure QTL GWAS1085839 (human) | | 1e-13 | diastolic blood pressure | | 4 | 119588124 | 119588125 | Human |
597404607 | GWAS1500681_H | corneal topography QTL GWAS1500681 (human) | | 8e-09 | corneal topography | | 4 | 127192269 | 127192270 | Human |
597273521 | GWAS1369595_H | schizophrenia QTL GWAS1369595 (human) | | 0.000002 | schizophrenia | | 4 | 113059651 | 113059652 | Human |
597052350 | GWAS1148424_H | childhood onset asthma QTL GWAS1148424 (human) | | 9e-12 | childhood onset asthma | | 4 | 122219915 | 122219916 | Human |
597052351 | GWAS1148425_H | childhood onset asthma QTL GWAS1148425 (human) | | 8e-11 | childhood onset asthma | | 4 | 122451978 | 122451979 | Human |
597478327 | GWAS1574401_H | atrial fibrillation QTL GWAS1574401 (human) | | 8e-18 | atrial fibrillation | | 4 | 111244056 | 111244057 | Human |
597380023 | GWAS1476097_H | histidine measurement QTL GWAS1476097 (human) | | 0.0000004 | histidine measurement | blood amino acid measurement (CMO:0003730) | 4 | 115340263 | 115340264 | Human |
597367735 | GWAS1463809_H | heel bone mineral density QTL GWAS1463809 (human) | | 1e-09 | heel bone mineral density | bone mineral density (CMO:0001226) | 4 | 127363808 | 127363809 | Human |
597367734 | GWAS1463808_H | heel bone mineral density QTL GWAS1463808 (human) | | 4e-14 | heel bone mineral density | bone mineral density (CMO:0001226) | 4 | 126607237 | 126607238 | Human |
597367733 | GWAS1463807_H | heel bone mineral density QTL GWAS1463807 (human) | | 4e-14 | heel bone mineral density | bone mineral density (CMO:0001226) | 4 | 123706225 | 123706226 | Human |
597367732 | GWAS1463806_H | heel bone mineral density QTL GWAS1463806 (human) | | 2e-10 | heel bone mineral density | bone mineral density (CMO:0001226) | 4 | 118871804 | 118871805 | Human |
597429164 | GWAS1525238_H | protein measurement QTL GWAS1525238 (human) | | 1e-32 | protein measurement | | 4 | 121025981 | 121025982 | Human |
597588911 | GWAS1645771_H | retinopathy QTL GWAS1645771 (human) | | 3e-12 | retinopathy | | 4 | 109764664 | 109764665 | Human |
597461933 | GWAS1558007_H | Eczematoid dermatitis QTL GWAS1558007 (human) | | 0.000002 | Eczematoid dermatitis | | 4 | 122109428 | 122109429 | Human |
597289890 | GWAS1385964_H | inflammatory bowel disease QTL GWAS1385964 (human) | | 4e-11 | inflammatory bowel disease | | 4 | 122523884 | 122523885 | Human |
597592992 | GWAS1649852_H | platelet count QTL GWAS1649852 (human) | | 4e-12 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 4 | 109916511 | 109916512 | Human |
597306331 | GWAS1402405_H | platelet count QTL GWAS1402405 (human) | | 1e-52 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 4 | 110024810 | 110024811 | Human |
597335003 | GWAS1431077_H | pulmonary embolism QTL GWAS1431077 (human) | | 8e-17 | pulmonary embolism | | 4 | 119320747 | 119320748 | Human |
597040084 | GWAS1136158_H | risk-taking behaviour QTL GWAS1136158 (human) | | 2e-08 | risk-taking behaviour | | 4 | 109690042 | 109690043 | Human |
597162965 | GWAS1259039_H | lipid measurement QTL GWAS1259039 (human) | | 6e-08 | lipid measurement | blood lipid measurement (CMO:0000050) | 4 | 124266893 | 124266894 | Human |
597507033 | GWAS1603107_H | C-reactive protein measurement QTL GWAS1603107 (human) | | 4e-08 | C-reactive protein measurement | blood C-reactive protein level (CMO:0003160) | 4 | 111731920 | 111731921 | Human |
597203933 | GWAS1300007_H | asthma QTL GWAS1300007 (human) | | 3e-09 | asthma | | 4 | 122134546 | 122134549 | Human |
597306332 | GWAS1402406_H | platelet count QTL GWAS1402406 (human) | | 6e-10 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 4 | 122595396 | 122595397 | Human |
597158875 | GWAS1254949_H | total cholesterol measurement, high density lipoprotein cholesterol measurement QTL GWAS1254949 (human) | | 1e-10 | total cholesterol measurement, high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 4 | 109603883 | 109603884 | Human |
406966285 | GWAS615261_H | nitric oxide exhalation measurement QTL GWAS615261 (human) | | 5e-13 | nitric oxide exhalation measurement | | 4 | 112934321 | 112934322 | Human |
597580755 | GWAS1637615_H | lymphocyte count QTL GWAS1637615 (human) | | 6e-14 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 4 | 112198650 | 112198651 | Human |
406966290 | GWAS615266_H | nitric oxide exhalation measurement QTL GWAS615266 (human) | | 8e-08 | nitric oxide exhalation measurement | | 4 | 112934321 | 112934322 | Human |
597265357 | GWAS1361431_H | cortical thickness QTL GWAS1361431 (human) | | 3e-11 | cortical thickness | | 4 | 120773757 | 120773758 | Human |
597265356 | GWAS1361430_H | cortical thickness QTL GWAS1361430 (human) | | 8e-09 | cortical thickness | | 4 | 119920489 | 119920490 | Human |
597617606 | GWAS1674466_H | prothrombin time measurement QTL GWAS1674466 (human) | | 6e-36 | prothrombin time measurement | prothrombin time (CMO:0000211) | 4 | 110780277 | 110780278 | Human |
407404560 | GWAS1053536_H | obsolete_red blood cell distribution width QTL GWAS1053536 (human) | | 8e-08 | obsolete_red blood cell distribution width | | 4 | 121820188 | 121820189 | Human |
407404561 | GWAS1053537_H | obsolete_red blood cell distribution width QTL GWAS1053537 (human) | | 2e-09 | obsolete_red blood cell distribution width | | 4 | 122438414 | 122438415 | Human |
407404562 | GWAS1053538_H | obsolete_red blood cell distribution width QTL GWAS1053538 (human) | | 1e-20 | obsolete_red blood cell distribution width | | 4 | 128306129 | 128306130 | Human |
597588933 | GWAS1645793_H | degeneration of macula and posterior pole QTL GWAS1645793 (human) | | 1e-18 | degeneration of macula and posterior pole | | 4 | 109764664 | 109764665 | Human |
597375936 | GWAS1472010_H | type 1 diabetes mellitus QTL GWAS1472010 (human) | | 0.000002 | type 1 diabetes mellitus | | 4 | 122277280 | 122277281 | Human |
597146570 | GWAS1242644_H | COVID-19 QTL GWAS1242644 (human) | | 4e-08 | COVID-19 | | 4 | 108838313 | 108838314 | Human |
597392378 | GWAS1488452_H | balding measurement QTL GWAS1488452 (human) | | 4e-12 | hair amount (VT:0000416) | coat/hair morphological measurement (CMO:0001807) | 4 | 124209285 | 124209286 | Human |
597375992 | GWAS1472066_H | vital capacity QTL GWAS1472066 (human) | | 0.000004 | vital capacity | | 4 | 107194065 | 107194066 | Human |
597138420 | GWAS1234494_H | alpha fetoprotein measurement QTL GWAS1234494 (human) | | 9e-12 | blood alpha-fetoprotein amount (VT:0010776) | | 4 | 108749156 | 108749157 | Human |
597335033 | GWAS1431107_H | COVID-19 QTL GWAS1431107 (human) | | 0.000005 | COVID-19 | | 4 | 113129435 | 113129436 | Human |
597486586 | GWAS1582660_H | Cleft palate, cleft lip QTL GWAS1582660 (human) | | 0.00001 | Cleft palate, cleft lip | | 4 | 112223293 | 112223294 | Human |
597105660 | GWAS1201734_H | reticulocyte measurement QTL GWAS1201734 (human) | | 8e-09 | reticulocyte morphology trait (VT:0002424) | red blood cell measurement (CMO:0001356) | 4 | 119770233 | 119770234 | Human |
597105659 | GWAS1201733_H | reticulocyte measurement QTL GWAS1201733 (human) | | 4e-17 | reticulocyte morphology trait (VT:0002424) | red blood cell measurement (CMO:0001356) | 4 | 109944309 | 109944310 | Human |
407404602 | GWAS1053578_H | unipolar depression QTL GWAS1053578 (human) | | 8e-21 | unipolar depression | | 4 | 122265238 | 122265239 | Human |
597335016 | GWAS1431090_H | asthma QTL GWAS1431090 (human) | | 4e-09 | asthma | | 4 | 122451978 | 122451979 | Human |
407367729 | GWAS1016705_H | platelet count QTL GWAS1016705 (human) | | 3e-09 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 4 | 119528655 | 119528656 | Human |
597449701 | GWAS1545775_H | coronary artery calcification QTL GWAS1545775 (human) | | 0.0000002 | coronary artery calcification | | 4 | 128541212 | 128541213 | Human |
597588964 | GWAS1645824_H | blood coagulation disease QTL GWAS1645824 (human) | | 2e-11 | blood coagulation disease | | 4 | 110761735 | 110761736 | Human |
597580772 | GWAS1637632_H | mean corpuscular hemoglobin concentration QTL GWAS1637632 (human) | | 2e-11 | mean corpuscular hemoglobin concentration | mean corpuscular hemoglobin concentration (CMO:0000291) | 4 | 121827841 | 121827842 | Human |
596986857 | GWAS1106376_H | systolic blood pressure QTL GWAS1106376 (human) | | 3e-12 | systolic blood pressure | | 4 | 110417121 | 110417122 | Human |
597580771 | GWAS1637631_H | mean corpuscular hemoglobin concentration QTL GWAS1637631 (human) | | 2e-14 | mean corpuscular hemoglobin concentration | mean corpuscular hemoglobin concentration (CMO:0000291) | 4 | 109934399 | 109934400 | Human |
597490461 | GWAS1586535_H | response to calcium channel blocker QTL GWAS1586535 (human) | | 0.000002 | response to calcium channel blocker | | 4 | 119116902 | 119116903 | Human |
597596956 | GWAS1653816_H | prothrombin time measurement QTL GWAS1653816 (human) | | 6e-52 | prothrombin time measurement | prothrombin time (CMO:0000211) | 4 | 110791530 | 110791531 | Human |
597334814 | GWAS1430888_H | facial morphology measurement QTL GWAS1430888 (human) | | 1e-19 | facial morphology trait (VT:0003743) | | 4 | 127005360 | 127005361 | Human |
597158673 | GWAS1254747_H | testosterone measurement QTL GWAS1254747 (human) | | 2e-13 | testosterone measurement | serum testosterone level (CMO:0000568) | 4 | 108117498 | 108117499 | Human |
597150494 | GWAS1246568_H | post-traumatic stress disorder QTL GWAS1246568 (human) | | 0.000001 | post-traumatic stress disorder | | 4 | 106417893 | 106417894 | Human |
597494551 | GWAS1590625_H | Ischemic stroke QTL GWAS1590625 (human) | | 5e-08 | Ischemic stroke | | 4 | 110789013 | 110789014 | Human |
597519120 | GWAS1615194_H | open-angle glaucoma QTL GWAS1615194 (human) | | 8e-09 | open-angle glaucoma | | 4 | 111039218 | 111039219 | Human |
597396245 | GWAS1492319_H | cup-to-disc ratio measurement QTL GWAS1492319 (human) | | 4e-08 | cup-to-disc ratio measurement | | 4 | 111904784 | 111904785 | Human |
597469970 | GWAS1566044_H | calcium measurement QTL GWAS1566044 (human) | | 4e-09 | calcium measurement | blood calcium level (CMO:0000502) | 4 | 114458289 | 114458290 | Human |
406892752 | GWAS541728_H | BMI-adjusted waist-hip ratio QTL GWAS541728 (human) | | 5e-19 | body size trait (VT:0100005) | | 4 | 123145793 | 123145794 | Human |
597601038 | GWAS1657898_H | body mass index QTL GWAS1657898 (human) | | 3e-21 | body mass (VT:0001259) | body weight (CMO:0000012) | 4 | 129818987 | 129818988 | Human |
406921425 | GWAS570401_H | RR interval QTL GWAS570401 (human) | | 0.0000004 | RR interval | RR interval (CMO:0000232) | 4 | 130216606 | 130216607 | Human |
597617419 | GWAS1674279_H | Shock QTL GWAS1674279 (human) | | 9e-12 | Shock | | 4 | 108255692 | 108255693 | Human |
597445385 | GWAS1541459_H | calcium measurement, diet measurement QTL GWAS1541459 (human) | | 0.000006 | eating behavior trait (VT:0001431) | food intake measurement (CMO:0000772) | 4 | 111131258 | 111131259 | Human |
406937815 | GWAS586791_H | multiple sclerosis QTL GWAS586791 (human) | | 0.000002 | multiple sclerosis | | 4 | 130869346 | 130869347 | Human |
597113614 | GWAS1209688_H | major depressive disorder QTL GWAS1209688 (human) | | 2e-10 | major depressive disorder | | 4 | 130316226 | 130316227 | Human |
597113613 | GWAS1209687_H | major depressive disorder QTL GWAS1209687 (human) | | 8e-21 | major depressive disorder | | 4 | 122265238 | 122265239 | Human |
597150476 | GWAS1246550_H | cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement QTL GWAS1246550 (human) | | 2e-18 | cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 4 | 109657070 | 109657071 | Human |
597588738 | GWAS1645598_H | encounter with health service QTL GWAS1645598 (human) | | 9e-14 | encounter with health service | | 4 | 110796911 | 110796912 | Human |
597093174 | GWAS1189248_H | exploratory eye movement measurement QTL GWAS1189248 (human) | | 0.000008 | exploratory eye movement measurement | eye physiological measurement (CMO:0003652) | 4 | 114477044 | 114477045 | Human |
597293880 | GWAS1389954_H | ceramide measurement QTL GWAS1389954 (human) | | 4e-08 | ceramide measurement | | 4 | 114407538 | 114407539 | Human |
597441341 | GWAS1537415_H | lipid measurement QTL GWAS1537415 (human) | | 0.000006 | lipid measurement | blood lipid measurement (CMO:0000050) | 4 | 130393791 | 130393792 | Human |
597379896 | GWAS1475970_H | pathological myopia QTL GWAS1475970 (human) | | 8e-13 | pathological myopia | | 4 | 111690594 | 111690595 | Human |
597097273 | GWAS1193347_H | sex hormone-binding globulin measurement QTL GWAS1193347 (human) | | 4e-08 | sex hormone-binding globulin measurement | | 4 | 119185193 | 119185194 | Human |
597134136 | GWAS1230210_H | memory performance QTL GWAS1230210 (human) | | 0.000002 | memory performance | | 4 | 125664944 | 125664945 | Human |
597203767 | GWAS1299841_H | hypertrophic cardiomyopathy QTL GWAS1299841 (human) | | 0.0000006 | hypertrophic cardiomyopathy | | 4 | 130926839 | 130926840 | Human |
597478188 | GWAS1574262_H | arterial stiffness measurement QTL GWAS1574262 (human) | | 0.000006 | arterial stiffness measurement | pulse wave velocity (CMO:0003717) | 4 | 128552943 | 128552944 | Human |
597191467 | GWAS1287541_H | sex hormone-binding globulin measurement QTL GWAS1287541 (human) | | 7e-09 | sex hormone-binding globulin measurement | | 4 | 119185193 | 119185194 | Human |
597150496 | GWAS1246570_H | post-traumatic stress disorder QTL GWAS1246570 (human) | | 0.000002 | post-traumatic stress disorder | | 4 | 106419681 | 106419682 | Human |
597338915 | GWAS1434989_H | neuroticism measurement, cognitive function measurement QTL GWAS1434989 (human) | | 4e-14 | neuroticism measurement, cognitive function measurement | | 4 | 122201701 | 122201702 | Human |
597383969 | GWAS1480043_H | body mass index QTL GWAS1480043 (human) | | 4e-12 | body mass index | body mass index (BMI) (CMO:0000105) | 4 | 129805678 | 129805679 | Human |
597359393 | GWAS1455467_H | platelet count QTL GWAS1455467 (human) | | 3e-09 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 4 | 123806369 | 123806370 | Human |
597363495 | GWAS1459569_H | acute myeloid leukemia QTL GWAS1459569 (human) | | 4e-25 | leukocyte integrity trait (VT:0010898) | | 4 | 112776849 | 112776850 | Human |
597298010 | GWAS1394084_H | body mass index QTL GWAS1394084 (human) | | 7e-12 | body mass index | body mass index (BMI) (CMO:0000105) | 4 | 111770620 | 111770621 | Human |
597109591 | GWAS1205665_H | Inhalant adrenergic use measurement QTL GWAS1205665 (human) | | 2e-14 | Inhalant adrenergic use measurement | | 4 | 122446734 | 122446735 | Human |
597162838 | GWAS1258912_H | chronic bronchitis QTL GWAS1258912 (human) | | 2e-08 | chronic bronchitis | | 4 | 113635275 | 113635276 | Human |
597298011 | GWAS1394085_H | body mass index QTL GWAS1394085 (human) | | 1e-08 | body mass index | body mass index (BMI) (CMO:0000105) | 4 | 114202933 | 114202934 | Human |
407224461 | GWAS873437_H | triacylglycerol 52:4 measurement QTL GWAS873437 (human) | | 0.000006 | blood triglyceride amount (VT:0002644) | | 4 | 131018374 | 131018375 | Human |
596949849 | GWAS1069368_H | pelvic organ prolapse QTL GWAS1069368 (human) | | 2e-23 | pelvic organ prolapse | | 4 | 126003529 | 126003530 | Human |
597388117 | GWAS1484191_H | smoking status measurement, systolic blood pressure QTL GWAS1484191 (human) | | 0.000006 | smoking status measurement, systolic blood pressure | systolic blood pressure (CMO:0000004) | 4 | 123660107 | 123660108 | Human |
597498706 | GWAS1594780_H | memory performance QTL GWAS1594780 (human) | | 0.000003 | memory performance | | 4 | 124862465 | 124862466 | Human |
597252941 | GWAS1349015_H | alkaline phosphatase measurement QTL GWAS1349015 (human) | | 8e-17 | alkaline phosphatase measurement | blood alkaline phosphatase activity level (CMO:0000576) | 4 | 110191454 | 110191455 | Human |
597371726 | GWAS1467800_H | atrial fibrillation QTL GWAS1467800 (human) | | 1e-14 | atrial fibrillation | | 4 | 110789013 | 110789014 | Human |
597265231 | GWAS1361305_H | high density lipoprotein cholesterol measurement QTL GWAS1361305 (human) | | 2e-31 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 4 | 109174464 | 109174465 | Human |
597371724 | GWAS1467798_H | atrial fibrillation QTL GWAS1467798 (human) | | 4e-63 | atrial fibrillation | | 4 | 110787131 | 110787132 | Human |
597162825 | GWAS1258899_H | oleoylcarnitine measurement QTL GWAS1258899 (human) | | 0.000002 | oleoylcarnitine measurement | | 4 | 116466224 | 116466225 | Human |
597318468 | GWAS1414542_H | opioid dependence QTL GWAS1414542 (human) | | 0.0000006 | opioid dependence | | 4 | 125271758 | 125271759 | Human |
597375812 | GWAS1471886_H | gut microbiome measurement QTL GWAS1471886 (human) | | 0.0000004 | gut microbiome measurement | | 4 | 116053081 | 116053082 | Human |
597027700 | GWAS1123774_H | blood protein measurement QTL GWAS1123774 (human) | | 2e-83 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 4 | 106943827 | 106943828 | Human |
597314431 | GWAS1410505_H | vaginal microbiome measurement QTL GWAS1410505 (human) | | 0.000007 | vaginal microbiome measurement | | 4 | 109225176 | 109225177 | Human |
597281660 | GWAS1377734_H | insomnia QTL GWAS1377734 (human) | | 5e-09 | insomnia | | 4 | 118318250 | 118318251 | Human |
407052454 | GWAS701430_H | pelvic organ prolapse QTL GWAS701430 (human) | | 5e-16 | pelvic organ prolapse | | 4 | 126037217 | 126037218 | Human |
597195647 | GWAS1291721_H | memory performance QTL GWAS1291721 (human) | | 0.000006 | memory performance | | 4 | 124893791 | 124893792 | Human |
597179249 | GWAS1275323_H | protein measurement QTL GWAS1275323 (human) | | 5e-47 | protein measurement | | 4 | 119501939 | 119501940 | Human |
597068671 | GWAS1164745_H | mosquito bite reaction itch intensity measurement, mosquito bite reaction size measurement QTL GWAS1164745 (human) | | 0.0000006 | mosquito bite reaction itch intensity measurement, mosquito bite reaction size measurement | | 4 | 122692161 | 122692162 | Human |
597179250 | GWAS1275324_H | protein measurement QTL GWAS1275324 (human) | | 1e-162 | protein measurement | | 4 | 119635312 | 119635313 | Human |
596949886 | GWAS1069405_H | pelvic organ prolapse QTL GWAS1069405 (human) | | 1e-11 | pelvic organ prolapse | | 4 | 126146934 | 126146935 | Human |
597179251 | GWAS1275325_H | protein measurement QTL GWAS1275325 (human) | | 2e-78 | protein measurement | | 4 | 119638137 | 119638138 | Human |
597502833 | GWAS1598907_H | insomnia QTL GWAS1598907 (human) | | 2e-12 | insomnia | | 4 | 111901237 | 111901238 | Human |
597359478 | GWAS1455552_H | Cleft palate, cleft lip QTL GWAS1455552 (human) | | 0.0000009 | Cleft palate, cleft lip | | 4 | 123789429 | 123789430 | Human |
597277557 | GWAS1373631_H | testosterone measurement QTL GWAS1373631 (human) | | 6e-15 | testosterone measurement | serum testosterone level (CMO:0000568) | 4 | 124126476 | 124126477 | Human |
597502832 | GWAS1598906_H | insomnia QTL GWAS1598906 (human) | | 1e-09 | insomnia | | 4 | 111871413 | 111871414 | Human |
597179253 | GWAS1275327_H | protein measurement QTL GWAS1275327 (human) | | 4e-75 | protein measurement | | 4 | 119501939 | 119501940 | Human |
407052461 | GWAS701437_H | disease progression measurement, Crohn's disease QTL GWAS701437 (human) | | 0.000005 | intestine integrity trait (VT:0010554) | disease progression measurement (CMO:0001110) | 4 | 116341004 | 116341005 | Human |
597502834 | GWAS1598908_H | insomnia QTL GWAS1598908 (human) | | 2e-10 | insomnia | | 4 | 129856909 | 129856910 | Human |
597334891 | GWAS1430965_H | COVID-19 QTL GWAS1430965 (human) | | 0.000008 | COVID-19 | | 4 | 110000832 | 110000833 | Human |
597216105 | GWAS1312179_H | protein measurement QTL GWAS1312179 (human) | | 2e-08 | protein measurement | | 4 | 131061544 | 131061545 | Human |
597105509 | GWAS1201583_H | cortical surface area change measurement QTL GWAS1201583 (human) | | 0.000005 | cortical surface area change measurement | | 4 | 109118383 | 109118384 | Human |
597101413 | GWAS1197487_H | platelet component distribution width QTL GWAS1197487 (human) | | 1e-18 | platelet size trait (VT:0010457) | platelet distribution width (CMO:0001350) | 4 | 109970517 | 109970518 | Human |
597269354 | GWAS1365428_H | metabolite measurement QTL GWAS1365428 (human) | | 7e-57 | metabolite measurement | | 4 | 129109497 | 129109498 | Human |
597072750 | GWAS1168824_H | feeling miserable measurement QTL GWAS1168824 (human) | | 1e-08 | feeling miserable measurement | | 4 | 122265238 | 122265239 | Human |
597072751 | GWAS1168825_H | feeling miserable measurement QTL GWAS1168825 (human) | | 3e-08 | feeling miserable measurement | | 4 | 122465996 | 122465997 | Human |
597306208 | GWAS1402282_H | bilirubin measurement QTL GWAS1402282 (human) | | 2e-09 | bilirubin measurement | serum total bilirubin level (CMO:0000376) | 4 | 109921728 | 109921729 | Human |
597269348 | GWAS1365422_H | metabolite measurement QTL GWAS1365422 (human) | | 1e-21 | metabolite measurement | | 4 | 129109497 | 129109498 | Human |
597416603 | GWAS1512677_H | glycerophospholipid measurement QTL GWAS1512677 (human) | | 4e-10 | glycerophospholipid measurement | | 4 | 114479772 | 114479773 | Human |
597416602 | GWAS1512676_H | glycerophospholipid measurement QTL GWAS1512676 (human) | | 3e-10 | glycerophospholipid measurement | | 4 | 114495706 | 114495707 | Human |
597416601 | GWAS1512675_H | glycerophospholipid measurement QTL GWAS1512675 (human) | | 3e-10 | glycerophospholipid measurement | | 4 | 114501231 | 114501232 | Human |
597416600 | GWAS1512674_H | glycerophospholipid measurement QTL GWAS1512674 (human) | | 3e-10 | glycerophospholipid measurement | | 4 | 114595467 | 114595468 | Human |
597191325 | GWAS1287399_H | sex hormone-binding globulin measurement QTL GWAS1287399 (human) | | 5e-25 | sex hormone-binding globulin measurement | | 4 | 109717668 | 109717669 | Human |
597416606 | GWAS1512680_H | glycerophospholipid measurement QTL GWAS1512680 (human) | | 2e-10 | glycerophospholipid measurement | | 4 | 114598115 | 114598116 | Human |
597416605 | GWAS1512679_H | glycerophospholipid measurement QTL GWAS1512679 (human) | | 2e-10 | glycerophospholipid measurement | | 4 | 114501793 | 114501794 | Human |
597416604 | GWAS1512678_H | glycerophospholipid measurement QTL GWAS1512678 (human) | | 4e-10 | glycerophospholipid measurement | | 4 | 114495770 | 114495771 | Human |
597072529 | GWAS1168603_H | worry measurement QTL GWAS1168603 (human) | | 4e-08 | worry measurement | | 4 | 118048732 | 118048733 | Human |
597416595 | GWAS1512669_H | glycerophospholipid measurement QTL GWAS1512669 (human) | | 2e-12 | glycerophospholipid measurement | | 4 | 114564668 | 114564669 | Human |
597396115 | GWAS1492189_H | retinal vasculature measurement QTL GWAS1492189 (human) | | 7e-58 | retina blood vessel morphology trait (VT:0002792) | | 4 | 119356945 | 119356946 | Human |
597494420 | GWAS1590494_H | insomnia QTL GWAS1590494 (human) | | 3e-10 | insomnia | | 4 | 130028211 | 130028212 | Human |
597219987 | GWAS1316061_H | corneal resistance factor QTL GWAS1316061 (human) | | 2e-09 | corneal resistance factor | | 4 | 111768358 | 111768359 | Human |
597416599 | GWAS1512673_H | glycerophospholipid measurement QTL GWAS1512673 (human) | | 1e-13 | glycerophospholipid measurement | | 4 | 114495902 | 114495903 | Human |
597416598 | GWAS1512672_H | glycerophospholipid measurement QTL GWAS1512672 (human) | | 1e-13 | glycerophospholipid measurement | | 4 | 114495803 | 114495804 | Human |
597416597 | GWAS1512671_H | glycerophospholipid measurement QTL GWAS1512671 (human) | | 1e-13 | glycerophospholipid measurement | | 4 | 114561897 | 114561898 | Human |
597494419 | GWAS1590493_H | insomnia QTL GWAS1590493 (human) | | 2e-11 | insomnia | | 4 | 129856909 | 129856910 | Human |
597416596 | GWAS1512670_H | glycerophospholipid measurement QTL GWAS1512670 (human) | | 3e-22 | glycerophospholipid measurement | | 4 | 114564575 | 114564576 | Human |
597457548 | GWAS1553622_H | serum gamma-glutamyl transferase measurement QTL GWAS1553622 (human) | | 1e-08 | serum gamma-glutamyl transferase measurement | serum gamma-glutamyltransferase activity level (CMO:0002241) | 4 | 111793842 | 111793843 | Human |
597621384 | GWAS1678244_H | pericarditis QTL GWAS1678244 (human) | | 3e-12 | pericarditis | | 4 | 108935005 | 108935006 | Human |
597203599 | GWAS1299673_H | familial sick sinus syndrome QTL GWAS1299673 (human) | | 2e-15 | sick sinus syndrome | | 4 | 110782354 | 110782355 | Human |
597432964 | GWAS1529038_H | protein measurement QTL GWAS1529038 (human) | | 2e-23 | protein measurement | | 4 | 110510288 | 110510289 | Human |
407384400 | GWAS1033376_H | eosinophil count QTL GWAS1033376 (human) | | 9e-10 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 4 | 122265396 | 122265397 | Human |
596966031 | GWAS1085550_H | systolic blood pressure QTL GWAS1085550 (human) | | 6e-09 | systolic blood pressure | | 4 | 108328807 | 108328808 | Human |
597580421 | GWAS1637281_H | lymphocyte count QTL GWAS1637281 (human) | | 2e-11 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 4 | 112183886 | 112183887 | Human |
597301894 | GWAS1397968_H | ceramide measurement QTL GWAS1397968 (human) | | 2e-20 | ceramide measurement | | 4 | 114663873 | 114663874 | Human |
597379719 | GWAS1475793_H | phosphatidylcholine 38:2 measurement QTL GWAS1475793 (human) | | 0.000006 | glycerophosphocholine amount (VT:0011004) | | 4 | 117433671 | 117433672 | Human |
597387910 | GWAS1483984_H | initial pursuit acceleration QTL GWAS1483984 (human) | | 0.000005 | initial pursuit acceleration | | 4 | 130399088 | 130399089 | Human |
597207686 | GWAS1303760_H | Diuretic use measurement QTL GWAS1303760 (human) | | 9e-09 | Diuretic use measurement | | 4 | 110504739 | 110504740 | Human |
597301893 | GWAS1397967_H | ceramide measurement QTL GWAS1397967 (human) | | 6e-13 | ceramide measurement | | 4 | 114469978 | 114469979 | Human |
597195448 | GWAS1291522_H | memory performance QTL GWAS1291522 (human) | | 0.000007 | memory performance | | 4 | 124885712 | 124885713 | Human |
597179066 | GWAS1275140_H | underweight body mass index status QTL GWAS1275140 (human) | | 0.000006 | underweight body mass index status | body mass index (BMI) (CMO:0000105) | 4 | 113088430 | 113088431 | Human |
597265085 | GWAS1361159_H | diastolic blood pressure QTL GWAS1361159 (human) | | 2e-11 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 4 | 110319122 | 110319123 | Human |
597613241 | GWAS1670101_H | skin disease QTL GWAS1670101 (human) | | 1e-11 | skin disease | | 4 | 130491526 | 130491527 | Human |
597277361 | GWAS1373435_H | age-related macular degeneration, COVID-19 QTL GWAS1373435 (human) | | 4e-18 | age-related macular degeneration, COVID-19 | | 4 | 109737911 | 109737912 | Human |
406958440 | GWAS607416_H | type 1 diabetes mellitus QTL GWAS607416 (human) | | 0.0000005 | type 1 diabetes mellitus | | 4 | 122456825 | 122456826 | Human |
597428918 | GWAS1524992_H | protein measurement QTL GWAS1524992 (human) | | 1e-40 | protein measurement | | 4 | 106826356 | 106826357 | Human |
596966078 | GWAS1085597_H | diastolic blood pressure QTL GWAS1085597 (human) | | 5e-17 | diastolic blood pressure | | 4 | 110461529 | 110461530 | Human |
597228210 | GWAS1324284_H | eye colour measurement QTL GWAS1324284 (human) | | 0.000007 | eye colour measurement | eye morphological measurement (CMO:0003080) | 4 | 121396276 | 121396277 | Human |
597162682 | GWAS1258756_H | myocardial infarction QTL GWAS1258756 (human) | | 2e-09 | myocardial infarction | | 4 | 119979127 | 119979128 | Human |
597621424 | GWAS1678284_H | body weight QTL GWAS1678284 (human) | | 3e-15 | body mass (VT:0001259) | body weight (CMO:0000012) | 4 | 129824994 | 129824995 | Human |
597195447 | GWAS1291521_H | memory performance QTL GWAS1291521 (human) | | 0.000007 | memory performance | | 4 | 124897660 | 124897661 | Human |
597334699 | GWAS1430773_H | R-warfarin measurement QTL GWAS1430773 (human) | | 5e-09 | R-warfarin measurement | | 4 | 112902858 | 112902859 | Human |
597240488 | GWAS1336562_H | Eczematoid dermatitis QTL GWAS1336562 (human) | | 3e-13 | Eczematoid dermatitis | | 4 | 122415763 | 122415764 | Human |
597392034 | GWAS1488108_H | heel bone mineral density QTL GWAS1488108 (human) | | 3e-09 | heel bone mineral density | bone mineral density (CMO:0001226) | 4 | 118869362 | 118869363 | Human |
597506726 | GWAS1602800_H | information processing speed, response to cranial radiation therapy QTL GWAS1602800 (human) | | 0.000004 | information processing speed, response to cranial radiation therapy | | 4 | 117423051 | 117423052 | Human |
597584603 | GWAS1641463_H | mean corpuscular hemoglobin concentration QTL GWAS1641463 (human) | | 1e-36 | mean corpuscular hemoglobin concentration | mean corpuscular hemoglobin concentration (CMO:0000291) | 4 | 121854912 | 121854913 | Human |
407126284 | GWAS775260_H | type 1 diabetes mellitus QTL GWAS775260 (human) | | 0.000003 | type 1 diabetes mellitus | | 4 | 122408207 | 122408208 | Human |
597072600 | GWAS1168674_H | schizophrenia QTL GWAS1168674 (human) | | 0.000003 | schizophrenia | | 4 | 117998342 | 117998343 | Human |
597060294 | GWAS1156368_H | vital capacity QTL GWAS1156368 (human) | | 4e-11 | vital capacity | | 4 | 127731072 | 127731073 | Human |
597117638 | GWAS1213712_H | mathematical ability QTL GWAS1213712 (human) | | 4e-13 | mathematical ability | | 4 | 128819435 | 128819436 | Human |
597297864 | GWAS1393938_H | hematocrit QTL GWAS1393938 (human) | | 6e-12 | hematocrit | hematocrit (CMO:0000037) | 4 | 114598669 | 114598670 | Human |
597117637 | GWAS1213711_H | mathematical ability QTL GWAS1213711 (human) | | 5e-09 | mathematical ability | | 4 | 114994461 | 114994462 | Human |
597019335 | GWAS1115409_H | BMI-adjusted waist-hip ratio QTL GWAS1115409 (human) | | 5e-09 | body size trait (VT:0100005) | | 4 | 123145793 | 123145794 | Human |
597060293 | GWAS1156367_H | vital capacity QTL GWAS1156367 (human) | | 2e-10 | vital capacity | | 4 | 122906887 | 122906888 | Human |
597109442 | GWAS1205516_H | mathematical ability QTL GWAS1205516 (human) | | 8e-10 | mathematical ability | | 4 | 129215768 | 129215769 | Human |
407126291 | GWAS775267_H | type 2 diabetes mellitus QTL GWAS775267 (human) | | 0.000009 | type 2 diabetes mellitus | | 4 | 121744359 | 121744360 | Human |
597412547 | GWAS1508621_H | childhood onset asthma QTL GWAS1508621 (human) | | 3e-13 | childhood onset asthma | | 4 | 122639784 | 122639785 | Human |
597474044 | GWAS1570118_H | smoking status measurement QTL GWAS1570118 (human) | | 1e-10 | smoking status measurement | | 4 | 111546456 | 111546457 | Human |
407146789 | GWAS795765_H | diet measurement, HOMA-IR QTL GWAS795765 (human) | | 0.000005 | eating behavior trait (VT:0001431) | Homeostatic Model Assessment of Insulin Resistance (CMO:0003002) | 4 | 109806404 | 109806405 | Human |
597228281 | GWAS1324355_H | protein measurement QTL GWAS1324355 (human) | | 6e-10 | protein measurement | | 4 | 131061544 | 131061545 | Human |
597175036 | GWAS1271110_H | calcium/calmodulin-dependent protein kinase type II subunit delta measurement QTL GWAS1271110 (human) | | 2e-12 | calcium/calmodulin-dependent protein kinase type II subunit delta measurement | | 4 | 113747320 | 113747321 | Human |
597048050 | GWAS1144124_H | neuroticism measurement QTL GWAS1144124 (human) | | 3e-08 | neuroticism measurement | | 4 | 118263414 | 118263415 | Human |
597285616 | GWAS1381690_H | triglycerides:total lipids ratio, high density lipoprotein cholesterol measurement QTL GWAS1381690 (human) | | 6e-12 | triglycerides:total lipids ratio, high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 4 | 109717668 | 109717669 | Human |
597383920 | GWAS1479994_H | erythrocyte count QTL GWAS1479994 (human) | | 8e-17 | erythrocyte count | red blood cell count (CMO:0000025) | 4 | 114598115 | 114598116 | Human |
597408501 | GWAS1504575_H | systolic blood pressure QTL GWAS1504575 (human) | | 2e-12 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 4 | 110416322 | 110416323 | Human |
597207798 | GWAS1303872_H | protein measurement QTL GWAS1303872 (human) | | 2e-08 | protein measurement | | 4 | 124985713 | 124985714 | Human |
597412587 | GWAS1508661_H | atopic asthma QTL GWAS1508661 (human) | | 1e-14 | atopic asthma | | 4 | 122639784 | 122639785 | Human |
597617390 | GWAS1674250_H | bile duct disorder QTL GWAS1674250 (human) | | 4e-11 | bile duct disorder | | 4 | 129611431 | 129611432 | Human |
597412588 | GWAS1508662_H | atopic asthma QTL GWAS1508662 (human) | | 8e-19 | atopic asthma | | 4 | 122084379 | 122084380 | Human |
597285603 | GWAS1381677_H | small vessel stroke QTL GWAS1381677 (human) | | 0.0000007 | small vessel stroke | | 4 | 113472094 | 113472095 | Human |
407114042 | GWAS763018_H | hair color QTL GWAS763018 (human) | | 2e-09 | hair color | | 4 | 108099646 | 108099647 | Human |
597203686 | GWAS1299760_H | coronary artery disease QTL GWAS1299760 (human) | | 3e-08 | coronary artery disease | | 4 | 119988346 | 119988347 | Human |
597146135 | GWAS1242209_H | osteoarthritis, knee QTL GWAS1242209 (human) | | 1e-08 | osteoarthritis, knee | | 4 | 129381399 | 129381400 | Human |
596953623 | GWAS1073142_H | alcohol consumption measurement QTL GWAS1073142 (human) | | 0.000006 | alcohol consumption measurement | | 4 | 131688192 | 131688193 | Human |
597248529 | GWAS1344603_H | magnesium measurement QTL GWAS1344603 (human) | | 0.000004 | magnesium measurement | serum magnesium level (CMO:0000541) | 4 | 112431743 | 112431744 | Human |
597211665 | GWAS1307739_H | balding measurement QTL GWAS1307739 (human) | | 1e-13 | hair amount (VT:0000416) | coat/hair morphological measurement (CMO:0001807) | 4 | 106940792 | 106940793 | Human |
597248528 | GWAS1344602_H | calcium measurement QTL GWAS1344602 (human) | | 0.000003 | calcium measurement | blood calcium level (CMO:0000502) | 4 | 119895428 | 119895429 | Human |
597588501 | GWAS1645361_H | macular degeneration QTL GWAS1645361 (human) | | 1e-25 | macular degeneration | | 4 | 109764664 | 109764665 | Human |
597449232 | GWAS1545306_H | Alzheimer disease, educational attainment QTL GWAS1545306 (human) | | 0.0000004 | Alzheimer disease, educational attainment | | 4 | 129748953 | 129748954 | Human |
597461521 | GWAS1557595_H | smoking status measurement QTL GWAS1557595 (human) | | 2e-10 | smoking status measurement | | 4 | 111582716 | 111582717 | Human |
406909393 | GWAS558369_H | total cholesterol measurement, hematocrit, stroke, ventricular rate measurement, body mass index, atrial fibrillation, high density lipoprotein cholesterol measurement, coronary artery disease, diastolic blood pressure, triglyceride measurement, systolic blood pressure, heart failure, diabetes mellitus, glucose measurement, mortality, cancer QTL GWAS558369 (human) | | 0.0000001 | pancreas integrity trait (VT:0010560) | ratio of deaths to total study population during a period of time (CMO:0001023) | 4 | 110810780 | 110810781 | Human |
597056007 | GWAS1152081_H | asthma exacerbation measurement QTL GWAS1152081 (human) | | 0.000008 | asthma exacerbation measurement | | 4 | 125651718 | 125651719 | Human |
597379598 | GWAS1475672_H | QT interval QTL GWAS1475672 (human) | | 0.0000008 | QT interval | QT interval (CMO:0000235) | 4 | 117411099 | 117411100 | Human |
597400065 | GWAS1496139_H | cortex volume change measurement, age at assessment QTL GWAS1496139 (human) | | 0.000003 | cortex volume change measurement, age at assessment | | 4 | 111512339 | 111512340 | Human |
597264899 | GWAS1360973_H | BMI-adjusted hip circumference QTL GWAS1360973 (human) | | 2e-09 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 4 | 123145793 | 123145794 | Human |
597334528 | GWAS1430602_H | R-warfarin measurement QTL GWAS1430602 (human) | | 0.000005 | R-warfarin measurement | | 4 | 129054159 | 129054160 | Human |
597264898 | GWAS1360972_H | BMI-adjusted hip circumference QTL GWAS1360972 (human) | | 1e-08 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 4 | 119759405 | 119759406 | Human |
597268997 | GWAS1365071_H | diastolic blood pressure QTL GWAS1365071 (human) | | 2e-13 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 4 | 119588124 | 119588125 | Human |
597367303 | GWAS1463377_H | lymphocyte count QTL GWAS1463377 (human) | | 2e-19 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 4 | 122760001 | 122760002 | Human |
597371399 | GWAS1467473_H | HVA measurement, MHPG measurement QTL GWAS1467473 (human) | | 0.000009 | HVA measurement, MHPG measurement | | 4 | 130105333 | 130105334 | Human |
406888926 | GWAS537902_H | bipolar disorder QTL GWAS537902 (human) | | 0.000007 | bipolar disorder | | 4 | 119514966 | 119514967 | Human |
597613116 | GWAS1669976_H | platelet count QTL GWAS1669976 (human) | | 2e-14 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 4 | 119653719 | 119653720 | Human |
597387833 | GWAS1483907_H | susceptibility to cold sores measurement QTL GWAS1483907 (human) | | 0.000004 | susceptibility to cold sores measurement | | 4 | 120332709 | 120332710 | Human |
597613115 | GWAS1669975_H | platelet count QTL GWAS1669975 (human) | | 4e-34 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 4 | 109912954 | 109912955 | Human |
597584441 | GWAS1641301_H | mean corpuscular hemoglobin concentration QTL GWAS1641301 (human) | | 2e-42 | mean corpuscular hemoglobin concentration | mean corpuscular hemoglobin concentration (CMO:0000291) | 4 | 121854912 | 121854913 | Human |
597019186 | GWAS1115260_H | body mass index QTL GWAS1115260 (human) | | 0.0000007 | body mass index | body mass index (BMI) (CMO:0000105) | 4 | 122841742 | 122841743 | Human |
597236273 | GWAS1332347_H | biological sex QTL GWAS1332347 (human) | | 5e-13 | biological sex | | 4 | 111485805 | 111485806 | Human |
407388640 | GWAS1037616_H | allergic disease QTL GWAS1037616 (human) | | 4e-11 | allergic disease | | 4 | 122496409 | 122496410 | Human |
597600822 | GWAS1657682_H | body mass index QTL GWAS1657682 (human) | | 6e-19 | body mass index | body mass index (BMI) (CMO:0000105) | 4 | 129818987 | 129818988 | Human |
597097020 | GWAS1193094_H | testosterone measurement QTL GWAS1193094 (human) | | 2e-08 | testosterone measurement | serum testosterone level (CMO:0000568) | 4 | 108117498 | 108117499 | Human |
597359146 | GWAS1455220_H | Cleft palate, cleft lip QTL GWAS1455220 (human) | | 4e-08 | Cleft palate, cleft lip | | 4 | 123985102 | 123985103 | Human |
407028211 | GWAS677187_H | leukopenia QTL GWAS677187 (human) | | 0.000003 | leukopenia | | 4 | 112406922 | 112406923 | Human |
597371437 | GWAS1467511_H | stroke QTL GWAS1467511 (human) | | 3e-16 | stroke | | 4 | 110796911 | 110796912 | Human |
597105185 | GWAS1201259_H | cytokine measurement QTL GWAS1201259 (human) | | 0.000001 | cytokine measurement | blood cytokine measurement (CMO:0001924) | 4 | 128887051 | 128887052 | Human |
597371436 | GWAS1467510_H | stroke QTL GWAS1467510 (human) | | 0.0000002 | stroke | | 4 | 110796911 | 110796912 | Human |
597518885 | GWAS1614959_H | forced expiratory volume QTL GWAS1614959 (human) | | 6e-13 | forced expiratory volume | forced expiratory volume (CMO:0000254) | 4 | 123917030 | 123917031 | Human |
597142062 | GWAS1238136_H | HbA1c measurement QTL GWAS1238136 (human) | | 7e-15 | HbA1c measurement | blood hemoglobin A1c level (CMO:0002786) | 4 | 110010783 | 110010784 | Human |
597383712 | GWAS1479786_H | type 2 diabetes mellitus QTL GWAS1479786 (human) | | 1e-08 | type 2 diabetes mellitus | | 4 | 129865191 | 129865192 | Human |
597621340 | GWAS1678200_H | bundle branch block QTL GWAS1678200 (human) | | 4e-11 | bundle branch block | | 4 | 114685927 | 114685928 | Human |
597396063 | GWAS1492137_H | cardioembolic stroke QTL GWAS1492137 (human) | | 5e-11 | cardioembolic stroke | | 4 | 113507558 | 113507559 | Human |
597281372 | GWAS1377446_H | QT interval QTL GWAS1377446 (human) | | 1e-11 | QT interval | QT interval (CMO:0000235) | 4 | 113504778 | 113504779 | Human |
597076561 | GWAS1172635_H | lobe attachment QTL GWAS1172635 (human) | | 0.0000007 | lobe attachment | ear measurement (CMO:0002667) | 4 | 121107629 | 121107630 | Human |
597617241 | GWAS1674101_H | joint disease QTL GWAS1674101 (human) | | 1e-11 | joint disease | | 4 | 123048237 | 123048238 | Human |
597154399 | GWAS1250473_H | triglycerides:total lipids ratio, high density lipoprotein cholesterol measurement QTL GWAS1250473 (human) | | 4e-15 | triglycerides:total lipids ratio, high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 4 | 109657070 | 109657071 | Human |
597420627 | GWAS1516701_H | systolic blood pressure QTL GWAS1516701 (human) | | 1e-10 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 4 | 110368093 | 110368094 | Human |
597420626 | GWAS1516700_H | systolic blood pressure QTL GWAS1516700 (human) | | 6e-12 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 4 | 110319122 | 110319123 | Human |
597117534 | GWAS1213608_H | systemic lupus erythematosus QTL GWAS1213608 (human) | | 2e-08 | systemic lupus erythematosus | | 4 | 122470309 | 122470310 | Human |
597420625 | GWAS1516699_H | systolic blood pressure QTL GWAS1516699 (human) | | 2e-10 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 4 | 108117498 | 108117499 | Human |
597420631 | GWAS1516705_H | systolic blood pressure QTL GWAS1516705 (human) | | 2e-08 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 4 | 123878327 | 123878328 | Human |
407183753 | GWAS832729_H | unipolar depression, age at onset QTL GWAS832729 (human) | | 0.000007 | unipolar depression, age at onset | | 4 | 127602809 | 127602810 | Human |
597420630 | GWAS1516704_H | systolic blood pressure QTL GWAS1516704 (human) | | 5e-09 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 4 | 119996191 | 119996192 | Human |
597420629 | GWAS1516703_H | systolic blood pressure QTL GWAS1516703 (human) | | 7e-11 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 4 | 119633559 | 119633560 | Human |
597420628 | GWAS1516702_H | systolic blood pressure QTL GWAS1516702 (human) | | 5e-17 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 4 | 110414448 | 110414449 | Human |
597195336 | GWAS1291410_H | systolic blood pressure QTL GWAS1291410 (human) | | 2e-08 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 4 | 120018118 | 120018119 | Human |
597359176 | GWAS1455250_H | ulcerative colitis QTL GWAS1455250 (human) | | 0.0000008 | ulcerative colitis | | 4 | 116929300 | 116929301 | Human |
597256779 | GWAS1352853_H | schizophrenia QTL GWAS1352853 (human) | | 2e-09 | schizophrenia | | 4 | 117931831 | 117931832 | Human |
597600844 | GWAS1657704_H | 3-hydroxybutyrate measurement QTL GWAS1657704 (human) | | 0.000005 | urine ketone body amount (VT:0010724) | | 4 | 126344537 | 126344538 | Human |
597609032 | GWAS1665892_H | schizophrenia, family history QTL GWAS1665892 (human) | | 3e-15 | schizophrenia, family history | | 4 | 126055086 | 126055087 | Human |
597019213 | GWAS1115287_H | BMI-adjusted waist-hip ratio, sex interaction measurement, age at assessment QTL GWAS1115287 (human) | | 7e-08 | body size trait (VT:0100005) | | 4 | 123145793 | 123145794 | Human |
597330499 | GWAS1426573_H | body mass index QTL GWAS1426573 (human) | | 2e-08 | body mass index | body mass index (BMI) (CMO:0000105) | 4 | 112402274 | 112402275 | Human |
597195333 | GWAS1291407_H | systolic blood pressure QTL GWAS1291407 (human) | | 8e-15 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 4 | 108146742 | 108146743 | Human |
597195334 | GWAS1291408_H | systolic blood pressure QTL GWAS1291408 (human) | | 6e-17 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 4 | 110319122 | 110319123 | Human |
597195335 | GWAS1291409_H | systolic blood pressure QTL GWAS1291409 (human) | | 6e-09 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 4 | 119588124 | 119588125 | Human |
597310073 | GWAS1406147_H | Agents acting on the renin-angiotensin system use measurement QTL GWAS1406147 (human) | | 4e-13 | Agents acting on the renin-angiotensin system use measurement | | 4 | 110485340 | 110485341 | Human |
597473912 | GWAS1569986_H | protein measurement QTL GWAS1569986 (human) | | 1e-08 | protein measurement | | 4 | 107913373 | 107913374 | Human |
597387901 | GWAS1483975_H | smoking status measurement, diastolic blood pressure QTL GWAS1483975 (human) | | 3e-08 | smoking status measurement, diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 4 | 123660107 | 123660108 | Human |
597277310 | GWAS1373384_H | rheumatoid arthritis, anti-citrullinated protein antibody seropositivity, rheumatoid factor seropositivity measurement QTL GWAS1373384 (human) | | 4e-08 | rheumatoid arthritis, anti-citrullinated protein antibody seropositivity, rheumatoid factor seropositivity measurement | | 4 | 122122507 | 122122508 | Human |
597195383 | GWAS1291457_H | platelet count QTL GWAS1291457 (human) | | 5e-62 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 4 | 110003178 | 110003179 | Human |
597445229 | GWAS1541303_H | open-angle glaucoma QTL GWAS1541303 (human) | | 4e-15 | open-angle glaucoma | | 4 | 111042563 | 111042564 | Human |
597445230 | GWAS1541304_H | open-angle glaucoma QTL GWAS1541304 (human) | | 1e-08 | open-angle glaucoma | | 4 | 111886876 | 111886877 | Human |
597445231 | GWAS1541305_H | open-angle glaucoma QTL GWAS1541305 (human) | | 8e-10 | open-angle glaucoma | | 4 | 126000490 | 126000491 | Human |
406970805 | GWAS619781_H | sporadic amyotrophic lateral sclerosis QTL GWAS619781 (human) | | 0.000003 | sporadic amyotrophic lateral sclerosis | | 4 | 108038126 | 108038127 | Human |
597416559 | GWAS1512633_H | bipolar disorder QTL GWAS1512633 (human) | | 5e-09 | bipolar disorder | | 4 | 117534962 | 117534963 | Human |
597297774 | GWAS1393848_H | fibroblast growth factor 2 measurement QTL GWAS1393848 (human) | | 6e-39 | fibroblast growth factor 2 measurement | | 4 | 122836593 | 122836594 | Human |
407048635 | GWAS697611_H | mean arterial pressure, response to high sodium diet, response to dietary potassium supplementation QTL GWAS697611 (human) | | 0.000003 | mean arterial pressure, response to high sodium diet, response to dietary potassium supplementation | mean arterial blood pressure (CMO:0000009) | 4 | 113940144 | 113940145 | Human |
597322338 | GWAS1418412_H | systolic blood pressure QTL GWAS1418412 (human) | | 4e-08 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 4 | 120018331 | 120018332 | Human |
597436829 | GWAS1532903_H | atrial fibrillation QTL GWAS1532903 (human) | | 6e-306 | atrial fibrillation | | 4 | 110795357 | 110795358 | Human |
597031319 | GWAS1127393_H | atrial fibrillation QTL GWAS1127393 (human) | | 2e-340 | atrial fibrillation | | 4 | 110737238 | 110737239 | Human |
597416337 | GWAS1512411_H | gout QTL GWAS1512411 (human) | | 5e-08 | gout | | 4 | 123815050 | 123815051 | Human |
597174675 | GWAS1270749_H | intelligence QTL GWAS1270749 (human) | | 5e-09 | intelligence | | 4 | 112490199 | 112490200 | Human |
597375383 | GWAS1471457_H | triacylglycerol 54:1 measurement QTL GWAS1471457 (human) | | 0.000001 | blood triglyceride amount (VT:0002644) | | 4 | 122671701 | 122671702 | Human |
596957592 | GWAS1077111_H | thyroxine measurement QTL GWAS1077111 (human) | | 5e-08 | thyroxine measurement | | 4 | 123563112 | 123563113 | Human |
597617043 | GWAS1673903_H | disorder of appendix QTL GWAS1673903 (human) | | 2e-21 | disorder of appendix | | 4 | 110810809 | 110810810 | Human |
597260692 | GWAS1356766_H | dementia QTL GWAS1356766 (human) | | 0.000009 | dementia | | 4 | 129535320 | 129535321 | Human |
597293462 | GWAS1389536_H | lymphocyte measurement, neutrophil measurement QTL GWAS1389536 (human) | | 6e-12 | lymphocyte measurement, neutrophil measurement | | 4 | 109980042 | 109980043 | Human |
407106129 | GWAS755105_H | waist-hip ratio QTL GWAS755105 (human) | | 2e-10 | waist-hip ratio | waist to hip ratio (WHR) (CMO:0000020) | 4 | 123166618 | 123166619 | Human |
597064066 | GWAS1160140_H | BMI-adjusted waist-hip ratio QTL GWAS1160140 (human) | | 0.000001 | body size trait (VT:0100005) | | 4 | 110022364 | 110022365 | Human |
597166476 | GWAS1262550_H | open-angle glaucoma QTL GWAS1262550 (human) | | 1e-09 | open-angle glaucoma | | 4 | 125451587 | 125451588 | Human |
597240204 | GWAS1336278_H | treprostinil dose measurement QTL GWAS1336278 (human) | | 0.000005 | treprostinil dose measurement | | 4 | 113625548 | 113625549 | Human |
597285249 | GWAS1381323_H | cardiovascular disease QTL GWAS1381323 (human) | | 1e-08 | cardiovascular disease | | 4 | 109616095 | 109616096 | Human |
407376465 | GWAS1025441_H | asthma QTL GWAS1025441 (human) | | 1e-12 | asthma | | 4 | 122219915 | 122219916 | Human |
597440901 | GWAS1536975_H | body mass index QTL GWAS1536975 (human) | | 2e-14 | body mass index | body mass index (BMI) (CMO:0000105) | 4 | 129810129 | 129810130 | Human |
597195139 | GWAS1291213_H | memory performance QTL GWAS1291213 (human) | | 0.000003 | memory performance | | 4 | 124861110 | 124861111 | Human |
597195140 | GWAS1291214_H | memory performance QTL GWAS1291214 (human) | | 0.000004 | memory performance | | 4 | 124869106 | 124869107 | Human |
597195141 | GWAS1291215_H | memory performance QTL GWAS1291215 (human) | | 0.000004 | memory performance | | 4 | 124870671 | 124870672 | Human |
597248390 | GWAS1344464_H | complement factor H-related protein 2 measurement QTL GWAS1344464 (human) | | 0.000009 | complement factor H-related protein 2 measurement | | 4 | 127922325 | 127922326 | Human |
596961712 | GWAS1081231_H | gestational age QTL GWAS1081231 (human) | | 0.000007 | gestational age | | 4 | 112357355 | 112357356 | Human |
596961713 | GWAS1081232_H | gestational age QTL GWAS1081232 (human) | | 0.00001 | gestational age | | 4 | 112354624 | 112354625 | Human |
597170622 | GWAS1266696_H | complement factor I measurement QTL GWAS1266696 (human) | | 7e-85 | complement protein amount (VT:0010033) | | 4 | 109735574 | 109735575 | Human |
597207474 | GWAS1303548_H | PR interval QTL GWAS1303548 (human) | | 3e-09 | PR interval | PR interval (CMO:0000233) | 4 | 113496850 | 113496851 | Human |
597195187 | GWAS1291261_H | memory performance QTL GWAS1291261 (human) | | 0.000003 | memory performance | | 4 | 113305092 | 113305093 | Human |
597277106 | GWAS1373180_H | testosterone measurement QTL GWAS1373180 (human) | | 6e-17 | testosterone measurement | serum testosterone level (CMO:0000568) | 4 | 124126476 | 124126477 | Human |
597408183 | GWAS1504257_H | erythrocyte count QTL GWAS1504257 (human) | | 6e-14 | erythrocyte count | red blood cell count (CMO:0000025) | 4 | 114598115 | 114598116 | Human |
597146020 | GWAS1242094_H | osteoarthritis, knee QTL GWAS1242094 (human) | | 5e-09 | osteoarthritis, knee | | 4 | 120672441 | 120672442 | Human |
596973990 | GWAS1093509_H | memory performance QTL GWAS1093509 (human) | | 0.000004 | memory performance | | 4 | 124891420 | 124891421 | Human |
597485992 | GWAS1582066_H | cardiac troponin I measurement QTL GWAS1582066 (human) | | 0.000006 | cardiac troponin I measurement | blood troponin level (CMO:0001283) | 4 | 110926834 | 110926835 | Human |
597055919 | GWAS1151993_H | asthma exacerbation measurement QTL GWAS1151993 (human) | | 0.000002 | asthma exacerbation measurement | | 4 | 129344890 | 129344891 | Human |
406917756 | GWAS566732_H | cup-to-disc ratio measurement QTL GWAS566732 (human) | | 3e-10 | cup-to-disc ratio measurement | | 4 | 125475115 | 125475116 | Human |
596965801 | GWAS1085320_H | diet measurement, sex hormone-binding globulin measurement QTL GWAS1085320 (human) | | 0.0000009 | diet measurement, sex hormone-binding globulin measurement | | 4 | 127714844 | 127714845 | Human |
597076438 | GWAS1172512_H | lobe attachment QTL GWAS1172512 (human) | | 0.000002 | lobe attachment | ear measurement (CMO:0002667) | 4 | 121212944 | 121212945 | Human |
407085570 | GWAS734546_H | cardioembolic stroke QTL GWAS734546 (human) | | 5e-41 | cardioembolic stroke | | 4 | 110793263 | 110793264 | Human |
597416408 | GWAS1512482_H | celiac disease QTL GWAS1512482 (human) | | 3e-36 | celiac disease | | 4 | 122629959 | 122629960 | Human |
596953566 | GWAS1073085_H | Red cell distribution width QTL GWAS1073085 (human) | | 6e-21 | Red cell distribution width | | 4 | 128306129 | 128306130 | Human |
597453264 | GWAS1549338_H | urate measurement, spine bone mineral density QTL GWAS1549338 (human) | | 0.000001 | urate measurement, spine bone mineral density | bone mineral density (CMO:0001226) | 4 | 123516413 | 123516414 | Human |
597076442 | GWAS1172516_H | lobe attachment QTL GWAS1172516 (human) | | 0.000004 | lobe attachment | ear measurement (CMO:0002667) | 4 | 124943164 | 124943165 | Human |
597191125 | GWAS1287199_H | testosterone measurement QTL GWAS1287199 (human) | | 2e-11 | testosterone measurement | serum testosterone level (CMO:0000568) | 4 | 108117498 | 108117499 | Human |
597076443 | GWAS1172517_H | lobe attachment QTL GWAS1172517 (human) | | 0.000009 | lobe attachment | ear measurement (CMO:0002667) | 4 | 125111064 | 125111065 | Human |
597162457 | GWAS1258531_H | asthma QTL GWAS1258531 (human) | | 2e-14 | asthma | | 4 | 122415763 | 122415764 | Human |
596949466 | GWAS1068985_H | celiac disease QTL GWAS1068985 (human) | | 1e-08 | celiac disease | | 4 | 122451978 | 122451979 | Human |
597211607 | GWAS1307681_H | empathy measurement QTL GWAS1307681 (human) | | 0.000008 | empathy measurement | | 4 | 111486019 | 111486020 | Human |
597613003 | GWAS1669863_H | mean corpuscular hemoglobin concentration QTL GWAS1669863 (human) | | 7e-14 | mean corpuscular hemoglobin concentration | mean corpuscular hemoglobin concentration (CMO:0000291) | 4 | 121827841 | 121827842 | Human |
597359052 | GWAS1455126_H | neuroticism measurement QTL GWAS1455126 (human) | | 0.000004 | neuroticism measurement | | 4 | 124054077 | 124054078 | Human |
597518794 | GWAS1614868_H | colorectal cancer QTL GWAS1614868 (human) | | 0.000003 | colorectal cancer | | 4 | 123587620 | 123587621 | Human |
597490117 | GWAS1586191_H | educational attainment QTL GWAS1586191 (human) | | 0.000001 | educational attainment | | 4 | 121774163 | 121774164 | Human |
597101004 | GWAS1197078_H | monocyte count QTL GWAS1197078 (human) | | 6e-12 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 4 | 119506334 | 119506335 | Human |
597101003 | GWAS1197077_H | monocyte count QTL GWAS1197077 (human) | | 9e-22 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 4 | 109966833 | 109966834 | Human |
597498304 | GWAS1594378_H | HbA1c measurement QTL GWAS1594378 (human) | | 1e-09 | HbA1c measurement | blood hemoglobin A1c level (CMO:0002786) | 4 | 110020646 | 110020647 | Human |
597031371 | GWAS1127445_H | asthma, allergic disease QTL GWAS1127445 (human) | | 3e-12 | asthma, allergic disease | | 4 | 122441954 | 122441955 | Human |
597441021 | GWAS1537095_H | creatine measurement QTL GWAS1537095 (human) | | 0.0000006 | urine creatine amount (VT:0010618) | urine creatine level (CMO:0002426) | 4 | 110523020 | 110523021 | Human |
597522937 | GWAS1619011_H | intelligence QTL GWAS1619011 (human) | | 6e-09 | intelligence | | 4 | 112699050 | 112699051 | Human |
597166588 | GWAS1262662_H | urolithiasis QTL GWAS1262662 (human) | | 1e-09 | urolithiasis | | 4 | 114460763 | 114460764 | Human |
597522936 | GWAS1619010_H | intelligence QTL GWAS1619010 (human) | | 6e-09 | intelligence | | 4 | 112573451 | 112573452 | Human |
597146097 | GWAS1242171_H | self reported educational attainment QTL GWAS1242171 (human) | | 4e-09 | self reported educational attainment | | 4 | 111485805 | 111485806 | Human |
596953587 | GWAS1073106_H | respiratory system disease QTL GWAS1073106 (human) | | 5e-36 | respiratory system disease | | 4 | 122432277 | 122432278 | Human |
597584372 | GWAS1641232_H | mean corpuscular hemoglobin concentration QTL GWAS1641232 (human) | | 4e-41 | mean corpuscular hemoglobin concentration | mean corpuscular hemoglobin concentration (CMO:0000291) | 4 | 121854912 | 121854913 | Human |
597031422 | GWAS1127496_H | asthma, allergic disease QTL GWAS1127496 (human) | | 4e-10 | asthma, allergic disease | | 4 | 122219899 | 122219900 | Human |
597486071 | GWAS1582145_H | lysophosphatidylcholine 20:2 measurement QTL GWAS1582145 (human) | | 2e-08 | lysophosphatidylcholine 20:2 measurement | | 4 | 126651788 | 126651789 | Human |
597395957 | GWAS1492031_H | Antithrombotic agent use measurement QTL GWAS1492031 (human) | | 4e-20 | Antithrombotic agent use measurement | | 4 | 110784139 | 110784140 | Human |
597600752 | GWAS1657612_H | body mass index QTL GWAS1657612 (human) | | 1e-14 | body mass index | body mass index (BMI) (CMO:0000105) | 4 | 129818987 | 129818988 | Human |
597375465 | GWAS1471539_H | platelet count QTL GWAS1471539 (human) | | 2e-25 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 4 | 119337052 | 119337053 | Human |
597371374 | GWAS1467448_H | stroke QTL GWAS1467448 (human) | | 2e-10 | stroke | | 4 | 110789013 | 110789014 | Human |
597514725 | GWAS1610799_H | sex hormone-binding globulin measurement QTL GWAS1610799 (human) | | 2e-11 | sex hormone-binding globulin measurement | | 4 | 123845801 | 123845802 | Human |
597502432 | GWAS1598506_H | triglyceride measurement QTL GWAS1598506 (human) | | 6e-10 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 4 | 123895285 | 123895286 | Human |
597477858 | GWAS1573932_H | comparative body size at age 10, self-reported QTL GWAS1573932 (human) | | 1e-11 | comparative body size at age 10, self-reported | | 4 | 129819249 | 129819250 | Human |
597174759 | GWAS1270833_H | insulin resistance QTL GWAS1270833 (human) | | 0.000001 | insulin resistance | | 4 | 112927886 | 112927887 | Human |
406975169 | GWAS624145_H | trait in response to paliperidone, schizophrenia symptom severity measurement QTL GWAS624145 (human) | | 0.000003 | trait in response to paliperidone, schizophrenia symptom severity measurement | | 4 | 119504060 | 119504061 | Human |
597420314 | GWAS1516388_H | cognitive function measurement QTL GWAS1516388 (human) | | 1e-12 | cognitive function measurement | | 4 | 118020587 | 118020588 | Human |
407020224 | GWAS669200_H | attention deficit hyperactivity disorder QTL GWAS669200 (human) | | 0.000008 | attention deficit hyperactivity disorder | | 4 | 110105771 | 110105772 | Human |
406905540 | GWAS554516_H | diastolic blood pressure QTL GWAS554516 (human) | | 3e-15 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 4 | 119588124 | 119588125 | Human |
597084433 | GWAS1180507_H | serum metabolite measurement QTL GWAS1180507 (human) | | 7e-22 | serum metabolite measurement | | 4 | 129113772 | 129113775 | Human |
597104927 | GWAS1201001_H | neutrophil percentage of leukocytes QTL GWAS1201001 (human) | | 1e-16 | neutrophil quantity (VT:0000222) | blood neutrophil count to total leukocyte count ratio (CMO:0000370) | 4 | 112183604 | 112183605 | Human |
597223698 | GWAS1319772_H | cystatin C measurement QTL GWAS1319772 (human) | | 4e-09 | cystatin C measurement | blood cystatin C level (CMO:0002777) | 4 | 119754004 | 119754005 | Human |
597063942 | GWAS1160016_H | perceived unattractiveness to mosquitos measurement QTL GWAS1160016 (human) | | 0.000007 | perceived unattractiveness to mosquitos measurement | | 4 | 122817391 | 122817392 | Human |
597076231 | GWAS1172305_H | atopic eczema QTL GWAS1172305 (human) | | 0.000004 | atopic eczema | | 4 | 122576542 | 122576543 | Human |
597256458 | GWAS1352532_H | cardiovascular disease QTL GWAS1352532 (human) | | 9e-09 | cardiovascular disease | | 4 | 110764459 | 110764460 | Human |
597063941 | GWAS1160015_H | perceived unattractiveness to mosquitos measurement QTL GWAS1160015 (human) | | 2e-23 | perceived unattractiveness to mosquitos measurement | | 4 | 122695667 | 122695668 | Human |
597031169 | GWAS1127243_H | atrial fibrillation QTL GWAS1127243 (human) | | 2e-427 | atrial fibrillation | | 4 | 110775495 | 110775496 | Human |
597055746 | GWAS1151820_H | respiratory system disease QTL GWAS1151820 (human) | | 6e-17 | respiratory system disease | | 4 | 122432277 | 122432278 | Human |
597391630 | GWAS1487704_H | response to diuretic, low density lipoprotein cholesterol measurement QTL GWAS1487704 (human) | | 0.0000008 | response to diuretic, low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 4 | 107388616 | 107388617 | Human |
597379342 | GWAS1475416_H | aspartate measurement QTL GWAS1475416 (human) | | 0.000004 | blood L-aspartic acid amount (VT:0010969) | | 4 | 118018897 | 118018898 | Human |
596977935 | GWAS1097454_H | body height QTL GWAS1097454 (human) | | 2e-14 | body height | | 4 | 119759795 | 119759796 | Human |
597375233 | GWAS1471307_H | lymphocyte count QTL GWAS1471307 (human) | | 8e-23 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 4 | 122760001 | 122760002 | Human |
597223736 | GWAS1319810_H | BMI-adjusted waist circumference QTL GWAS1319810 (human) | | 4e-08 | body size trait (VT:0100005) | | 4 | 123169108 | 123169109 | Human |
597223737 | GWAS1319811_H | BMI-adjusted waist circumference QTL GWAS1319811 (human) | | 3e-11 | body size trait (VT:0100005) | | 4 | 123124286 | 123124287 | Human |
597223738 | GWAS1319812_H | BMI-adjusted waist circumference QTL GWAS1319812 (human) | | 5e-12 | body size trait (VT:0100005) | | 4 | 123166618 | 123166619 | Human |
597477684 | GWAS1573758_H | sex hormone-binding globulin measurement QTL GWAS1573758 (human) | | 3e-08 | sex hormone-binding globulin measurement | | 4 | 119202262 | 119202263 | Human |
597223730 | GWAS1319804_H | BMI-adjusted waist circumference QTL GWAS1319804 (human) | | 4e-11 | body size trait (VT:0100005) | | 4 | 119213641 | 119213642 | Human |
597223731 | GWAS1319805_H | BMI-adjusted waist circumference QTL GWAS1319805 (human) | | 2e-13 | body size trait (VT:0100005) | | 4 | 119649123 | 119649124 | Human |
597223732 | GWAS1319806_H | BMI-adjusted waist circumference QTL GWAS1319806 (human) | | 2e-08 | body size trait (VT:0100005) | | 4 | 119595538 | 119595539 | Human |
597223733 | GWAS1319807_H | BMI-adjusted waist circumference QTL GWAS1319807 (human) | | 2e-09 | body size trait (VT:0100005) | | 4 | 119768762 | 119768763 | Human |
597092667 | GWAS1188741_H | neurofibrillary tangles measurement QTL GWAS1188741 (human) | | 0.000001 | neurofibrillary tangles measurement | | 4 | 129315616 | 129315617 | Human |
597223734 | GWAS1319808_H | BMI-adjusted waist circumference QTL GWAS1319808 (human) | | 1e-09 | body size trait (VT:0100005) | | 4 | 121700964 | 121700965 | Human |
406889198 | GWAS538174_H | type 1 diabetes mellitus QTL GWAS538174 (human) | | 5e-13 | type 1 diabetes mellitus | | 4 | 122211337 | 122211338 | Human |
597223735 | GWAS1319809_H | BMI-adjusted waist circumference QTL GWAS1319809 (human) | | 5e-09 | body size trait (VT:0100005) | | 4 | 122858186 | 122858187 | Human |
407048951 | GWAS697927_H | systolic blood pressure, response to high sodium diet, response to dietary potassium supplementation QTL GWAS697927 (human) | | 0.0000002 | systolic blood pressure, response to high sodium diet, response to dietary potassium supplementation | systolic blood pressure (CMO:0000004) | 4 | 113940144 | 113940145 | Human |
597449002 | GWAS1545076_H | calcium measurement, diet measurement QTL GWAS1545076 (human) | | 0.000009 | eating behavior trait (VT:0001431) | food intake measurement (CMO:0000772) | 4 | 111131258 | 111131259 | Human |
597031212 | GWAS1127286_H | atrial fibrillation QTL GWAS1127286 (human) | | 6e-113 | atrial fibrillation | | 4 | 110840331 | 110840332 | Human |
596977964 | GWAS1097483_H | body height QTL GWAS1097483 (human) | | 5e-14 | body height | | 4 | 119501252 | 119501253 | Human |
597309728 | GWAS1405802_H | vaginal microbiome measurement QTL GWAS1405802 (human) | | 0.000005 | vaginal microbiome measurement | | 4 | 109225176 | 109225177 | Human |
407225087 | GWAS874063_H | uric acid measurement QTL GWAS874063 (human) | | 0.000006 | uric acid measurement | blood uric acid level (CMO:0000501) | 4 | 124261535 | 124261536 | Human |
407225086 | GWAS874062_H | uric acid measurement QTL GWAS874062 (human) | | 0.000003 | uric acid measurement | blood uric acid level (CMO:0000501) | 4 | 125055497 | 125055498 | Human |
597125418 | GWAS1221492_H | osteoarthritis QTL GWAS1221492 (human) | | 5e-09 | osteoarthritis | | 4 | 120663127 | 120663128 | Human |
597240102 | GWAS1336176_H | anxiety QTL GWAS1336176 (human) | | 2e-09 | anxiety | | 4 | 131717648 | 131717649 | Human |
597244251 | GWAS1340325_H | progression free survival, response to carboplatin, ovarian carcinoma, trait in response to paclitaxel QTL GWAS1340325 (human) | | 0.000009 | progression free survival, response to carboplatin, ovarian carcinoma, trait in response to paclitaxel | survival measurement (CMO:0001021) | 4 | 113992588 | 113992589 | Human |
597166427 | GWAS1262501_H | lipoprotein measurement QTL GWAS1262501 (human) | | 3e-10 | lipoprotein measurement | blood lipoprotein measurement (CMO:0002690) | 4 | 109657070 | 109657071 | Human |
597477727 | GWAS1573801_H | clostridium difficile infection QTL GWAS1573801 (human) | | 0.000003 | clostridium difficile infection | | 4 | 120516660 | 120516661 | Human |
597141854 | GWAS1237928_H | facial morphology measurement QTL GWAS1237928 (human) | | 3e-08 | facial morphology trait (VT:0003743) | | 4 | 125210511 | 125210512 | Human |
597277011 | GWAS1373085_H | diet measurement QTL GWAS1373085 (human) | | 3e-08 | eating behavior trait (VT:0001431) | food intake measurement (CMO:0000772) | 4 | 122050021 | 122050022 | Human |
597141853 | GWAS1237927_H | facial morphology measurement QTL GWAS1237927 (human) | | 3e-08 | facial morphology trait (VT:0003743) | | 4 | 125217310 | 125217311 | Human |
597072221 | GWAS1168295_H | albumin:globulin ratio measurement QTL GWAS1168295 (human) | | 2e-11 | albumin:globulin ratio measurement | | 4 | 110003204 | 110003205 | Human |
597141852 | GWAS1237926_H | facial morphology measurement QTL GWAS1237926 (human) | | 3e-08 | facial morphology trait (VT:0003743) | | 4 | 125211057 | 125211058 | Human |
597473617 | GWAS1569691_H | heel bone mineral density QTL GWAS1569691 (human) | | 8e-14 | heel bone mineral density | bone mineral density (CMO:0001226) | 4 | 126607237 | 126607238 | Human |
597580112 | GWAS1636972_H | lymphocyte count QTL GWAS1636972 (human) | | 3e-11 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 4 | 109916511 | 109916512 | Human |
597473618 | GWAS1569692_H | heel bone mineral density QTL GWAS1569692 (human) | | 3e-15 | heel bone mineral density | bone mineral density (CMO:0001226) | 4 | 126607351 | 126607352 | Human |
597264713 | GWAS1360787_H | 1-palmitoylglycerophosphocholine measurement QTL GWAS1360787 (human) | | 0.0000003 | 2-palmitoylglycerophosphocholine measurement | | 4 | 122051907 | 122051908 | Human |
597305679 | GWAS1401753_H | metabolite measurement QTL GWAS1401753 (human) | | 2e-22 | metabolite measurement | | 4 | 129118729 | 129118730 | Human |
597145975 | GWAS1242049_H | osteoarthritis, knee QTL GWAS1242049 (human) | | 8e-08 | osteoarthritis, knee | | 4 | 121786965 | 121786966 | Human |
596982132 | GWAS1101651_H | memory performance QTL GWAS1101651 (human) | | 0.0000004 | memory performance | | 4 | 124883182 | 124883183 | Human |
597080436 | GWAS1176510_H | monocyte count QTL GWAS1176510 (human) | | 2e-18 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 4 | 109966833 | 109966834 | Human |
596982135 | GWAS1101654_H | memory performance QTL GWAS1101654 (human) | | 0.0000005 | memory performance | | 4 | 124882886 | 124882887 | Human |
596982134 | GWAS1101653_H | memory performance QTL GWAS1101653 (human) | | 0.0000005 | memory performance | | 4 | 124882027 | 124882028 | Human |
597113203 | GWAS1209277_H | protein measurement QTL GWAS1209277 (human) | | 2e-09 | protein measurement | | 4 | 120939887 | 120939888 | Human |
597244285 | GWAS1340359_H | IGF-1 measurement QTL GWAS1340359 (human) | | 2e-09 | IGF-1 measurement | blood insulin-like growth factor 1 level (CMO:0001297) | 4 | 127882004 | 127882005 | Human |
597371261 | GWAS1467335_H | mean corpuscular hemoglobin QTL GWAS1467335 (human) | | 7e-27 | mean corpuscular hemoglobin | mean corpuscular hemoglobin (CMO:0000290) | 4 | 127625245 | 127625246 | Human |
597371260 | GWAS1467334_H | mean corpuscular hemoglobin QTL GWAS1467334 (human) | | 3e-08 | mean corpuscular hemoglobin | mean corpuscular hemoglobin (CMO:0000290) | 4 | 123845801 | 123845802 | Human |
407028395 | GWAS677371_H | adiponectin measurement QTL GWAS677371 (human) | | 0.000003 | adiponectin measurement | blood adiponectin level (CMO:0000485) | 4 | 110043206 | 110043207 | Human |
597072252 | GWAS1168326_H | osteoarthritis, knee QTL GWAS1168326 (human) | | 0.000001 | osteoarthritis, knee | | 4 | 115123255 | 115123256 | Human |
597334385 | GWAS1430459_H | COVID-19 QTL GWAS1430459 (human) | | 0.000001 | COVID-19 | | 4 | 113129435 | 113129436 | Human |
596982136 | GWAS1101655_H | memory performance QTL GWAS1101655 (human) | | 0.0000005 | memory performance | | 4 | 124883368 | 124883369 | Human |
597436785 | GWAS1532859_H | open-angle glaucoma QTL GWAS1532859 (human) | | 1e-08 | open-angle glaucoma | | 4 | 127613850 | 127613851 | Human |
596973947 | GWAS1093466_H | major depressive disorder QTL GWAS1093466 (human) | | 2e-09 | major depressive disorder | | 4 | 130316226 | 130316227 | Human |
596973946 | GWAS1093465_H | major depressive disorder QTL GWAS1093465 (human) | | 5e-12 | major depressive disorder | | 4 | 122265238 | 122265239 | Human |
597268845 | GWAS1364919_H | facial width measurement QTL GWAS1364919 (human) | | 0.000004 | facial morphology trait (VT:0003743) | | 4 | 130195033 | 130195034 | Human |
597621097 | GWAS1677957_H | Right bundle branch block QTL GWAS1677957 (human) | | 4e-16 | Right bundle branch block | | 4 | 114640717 | 114640718 | Human |
597580134 | GWAS1636994_H | lymphocyte count QTL GWAS1636994 (human) | | 2e-12 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 4 | 109927496 | 109927497 | Human |
597580135 | GWAS1636995_H | lymphocyte count QTL GWAS1636995 (human) | | 3e-13 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 4 | 112198650 | 112198651 | Human |
597313891 | GWAS1409965_H | X-26054 measurement QTL GWAS1409965 (human) | | 5e-87 | X-26054 measurement | | 4 | 129143723 | 129143724 | Human |
407143103 | GWAS792079_H | Ischemic stroke QTL GWAS792079 (human) | | 0.0000001 | Ischemic stroke | | 4 | 112810934 | 112810935 | Human |
597592419 | GWAS1649279_H | high density lipoprotein cholesterol measurement QTL GWAS1649279 (human) | | 5e-37 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 4 | 109657070 | 109657071 | Human |
406938433 | GWAS587409_H | cortical thickness QTL GWAS587409 (human) | | 0.0000001 | cortical thickness | | 4 | 120722084 | 120722085 | Human |
596977820 | GWAS1097339_H | Ischemic stroke QTL GWAS1097339 (human) | | 1e-08 | Ischemic stroke | | 4 | 112810934 | 112810935 | Human |
597223571 | GWAS1319645_H | Parkinson's disease symptom measurement QTL GWAS1319645 (human) | | 0.000006 | Parkinson's disease symptom measurement | | 4 | 115200194 | 115200195 | Human |
597047450 | GWAS1143524_H | BMI-adjusted waist-hip ratio QTL GWAS1143524 (human) | | 2e-08 | body size trait (VT:0100005) | | 4 | 123118168 | 123118169 | Human |
597051547 | GWAS1147621_H | response to norepinephrine-dopamine reuptake inhibitor QTL GWAS1147621 (human) | | 0.000006 | response to norepinephrine-dopamine reuptake inhibitor | | 4 | 120701163 | 120701164 | Human |
597436562 | GWAS1532636_H | lipid measurement QTL GWAS1532636 (human) | | 0.000007 | lipid measurement | blood lipid measurement (CMO:0000050) | 4 | 107039415 | 107039416 | Human |
597047448 | GWAS1143522_H | BMI-adjusted waist-hip ratio QTL GWAS1143522 (human) | | 1e-13 | body size trait (VT:0100005) | | 4 | 123002800 | 123002801 | Human |
406967118 | GWAS616094_H | chronic lymphocytic leukemia QTL GWAS616094 (human) | | 6e-09 | leukocyte integrity trait (VT:0010898) | | 4 | 108104709 | 108104710 | Human |
597047449 | GWAS1143523_H | BMI-adjusted waist-hip ratio QTL GWAS1143523 (human) | | 6e-09 | body size trait (VT:0100005) | | 4 | 122854222 | 122854223 | Human |
597125255 | GWAS1221329_H | glycerophospholipid measurement QTL GWAS1221329 (human) | | 6e-14 | glycerophospholipid measurement | | 4 | 114514205 | 114514206 | Human |
597125254 | GWAS1221328_H | glycerophospholipid measurement QTL GWAS1221328 (human) | | 4e-22 | glycerophospholipid measurement | | 4 | 114571876 | 114571877 | Human |
597125253 | GWAS1221327_H | glycerophospholipid measurement QTL GWAS1221327 (human) | | 3e-22 | glycerophospholipid measurement | | 4 | 114571532 | 114571533 | Human |
597125252 | GWAS1221326_H | glycerophospholipid measurement QTL GWAS1221326 (human) | | 3e-22 | glycerophospholipid measurement | | 4 | 114570559 | 114570560 | Human |
597125251 | GWAS1221325_H | glycerophospholipid measurement QTL GWAS1221325 (human) | | 3e-22 | glycerophospholipid measurement | | 4 | 114568870 | 114568871 | Human |
597125250 | GWAS1221324_H | glycerophospholipid measurement QTL GWAS1221324 (human) | | 3e-22 | glycerophospholipid measurement | | 4 | 114544945 | 114544946 | Human |
597125249 | GWAS1221323_H | glycerophospholipid measurement QTL GWAS1221323 (human) | | 3e-22 | glycerophospholipid measurement | | 4 | 114544338 | 114544339 | Human |
407024468 | GWAS673444_H | neuropsychological test QTL GWAS673444 (human) | | 0.000006 | neuropsychological test | | 4 | 125505540 | 125505541 | Human |
597125248 | GWAS1221322_H | glycerophospholipid measurement QTL GWAS1221322 (human) | | 1e-22 | glycerophospholipid measurement | | 4 | 114549176 | 114549177 | Human |
597125262 | GWAS1221336_H | glycerophospholipid measurement QTL GWAS1221336 (human) | | 1e-13 | glycerophospholipid measurement | | 4 | 114491625 | 114491626 | Human |
597125261 | GWAS1221335_H | glycerophospholipid measurement QTL GWAS1221335 (human) | | 1e-13 | glycerophospholipid measurement | | 4 | 114529308 | 114529309 | Human |
597125260 | GWAS1221334_H | glycerophospholipid measurement QTL GWAS1221334 (human) | | 1e-13 | glycerophospholipid measurement | | 4 | 114529420 | 114529421 | Human |
597125259 | GWAS1221333_H | glycerophospholipid measurement QTL GWAS1221333 (human) | | 1e-13 | glycerophospholipid measurement | | 4 | 114529766 | 114529767 | Human |
597125258 | GWAS1221332_H | glycerophospholipid measurement QTL GWAS1221332 (human) | | 1e-13 | glycerophospholipid measurement | | 4 | 114529776 | 114529777 | Human |
597125257 | GWAS1221331_H | glycerophospholipid measurement QTL GWAS1221331 (human) | | 6e-14 | glycerophospholipid measurement | | 4 | 114489100 | 114489101 | Human |
597125256 | GWAS1221330_H | glycerophospholipid measurement QTL GWAS1221330 (human) | | 6e-14 | glycerophospholipid measurement | | 4 | 114571551 | 114571552 | Human |
597477565 | GWAS1573639_H | monoclonal gammopathy QTL GWAS1573639 (human) | | 0.000005 | monoclonal gammopathy | | 4 | 107881225 | 107881226 | Human |
596961462 | GWAS1080981_H | metabolic syndrome QTL GWAS1080981 (human) | | 1e-08 | metabolic syndrome | | 4 | 111770620 | 111770621 | Human |
596961463 | GWAS1080982_H | metabolic syndrome QTL GWAS1080982 (human) | | 2e-09 | metabolic syndrome | | 4 | 118238526 | 118238527 | Human |
597039285 | GWAS1135359_H | obesity QTL GWAS1135359 (human) | | 0.000003 | obesity | | 4 | 131830983 | 131830984 | Human |
407053161 | GWAS702137_H | mean corpuscular hemoglobin QTL GWAS702137 (human) | | 2e-09 | mean corpuscular hemoglobin | mean corpuscular hemoglobin (CMO:0000290) | 4 | 122058283 | 122058284 | Human |
596961464 | GWAS1080983_H | metabolic syndrome QTL GWAS1080983 (human) | | 4e-08 | metabolic syndrome | | 4 | 119318723 | 119318724 | Human |
597190837 | GWAS1286911_H | cesarean section, anxiety QTL GWAS1286911 (human) | | 1e-09 | cesarean section, anxiety | | 4 | 106962429 | 106962430 | Human |
596961465 | GWAS1080984_H | metabolic syndrome QTL GWAS1080984 (human) | | 1e-11 | metabolic syndrome | | 4 | 129810129 | 129810130 | Human |
597477554 | GWAS1573628_H | systolic blood pressure QTL GWAS1573628 (human) | | 5e-09 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 4 | 123873489 | 123873490 | Human |
597174440 | GWAS1270514_H | body mass index QTL GWAS1270514 (human) | | 1e-08 | body mass index | body mass index (BMI) (CMO:0000105) | 4 | 129399809 | 129399810 | Human |
406954864 | GWAS603840_H | ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis QTL GWAS603840 (human) | | 7e-20 | intestine integrity trait (VT:0010554) | | 4 | 122531076 | 122531077 | Human |
597174441 | GWAS1270515_H | body mass index QTL GWAS1270515 (human) | | 6e-09 | body mass index | body mass index (BMI) (CMO:0000105) | 4 | 130097733 | 130097734 | Human |
597321896 | GWAS1417970_H | colorectal cancer QTL GWAS1417970 (human) | | 2e-08 | colorectal cancer | | 4 | 114581250 | 114581251 | Human |
597379241 | GWAS1475315_H | serum IgG glycosylation measurement QTL GWAS1475315 (human) | | 0.000005 | serum IgG glycosylation measurement | | 4 | 127545545 | 127545546 | Human |
597530792 | GWAS1626866_H | body surface area QTL GWAS1626866 (human) | | 5e-15 | body surface area | | 4 | 121792708 | 121792709 | Human |
597358764 | GWAS1454838_H | loneliness measurement QTL GWAS1454838 (human) | | 0.000004 | emotion/affect behavior trait (VT:0002572) | | 4 | 120523895 | 120523896 | Human |
597231778 | GWAS1327852_H | smoking cessation QTL GWAS1327852 (human) | | 1e-08 | smoking cessation | | 4 | 111500989 | 111500990 | Human |
597366951 | GWAS1463025_H | pulse pressure measurement QTL GWAS1463025 (human) | | 3e-73 | pulse pressure measurement | pulse pressure (CMO:0000292) | 4 | 115629004 | 115629005 | Human |
597379239 | GWAS1475313_H | serum IgG glycosylation measurement QTL GWAS1475313 (human) | | 0.000003 | serum IgG glycosylation measurement | | 4 | 116928293 | 116928294 | Human |
597174438 | GWAS1270512_H | body mass index QTL GWAS1270512 (human) | | 7e-10 | body mass index | body mass index (BMI) (CMO:0000105) | 4 | 118298754 | 118298755 | Human |
597174439 | GWAS1270513_H | body mass index QTL GWAS1270513 (human) | | 8e-11 | body mass index | body mass index (BMI) (CMO:0000105) | 4 | 119292875 | 119292876 | Human |
597371097 | GWAS1467171_H | respiratory quotient QTL GWAS1467171 (human) | | 0.000008 | respiratory quotient | | 4 | 127420965 | 127420966 | Human |
407040769 | GWAS689745_H | white matter integrity QTL GWAS689745 (human) | | 0.000004 | white matter integrity | | 4 | 113458223 | 113458224 | Human |
406917890 | GWAS566866_H | Astigmatism QTL GWAS566866 (human) | | 0.000009 | Astigmatism | | 4 | 119266456 | 119266457 | Human |
597154002 | GWAS1250076_H | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement QTL GWAS1250076 (human) | | 1e-16 | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 4 | 109657070 | 109657071 | Human |
597043422 | GWAS1139496_H | schizophrenia QTL GWAS1139496 (human) | | 8e-09 | schizophrenia | | 4 | 117906596 | 117906597 | Human |
597412050 | GWAS1508124_H | soluble triggering receptor expressed on myeloid cells 2 measurement QTL GWAS1508124 (human) | | 4e-12 | soluble triggering receptor expressed on myeloid cells 2 measurement | | 4 | 111202547 | 111202548 | Human |
597477585 | GWAS1573659_H | systemic lupus erythematosus QTL GWAS1573659 (human) | | 2e-09 | systemic lupus erythematosus | | 4 | 108190649 | 108190650 | Human |
597620945 | GWAS1677805_H | hypertrophic cardiomyopathy QTL GWAS1677805 (human) | | 8e-13 | hypertrophic cardiomyopathy | | 4 | 108196857 | 108196858 | Human |
597465294 | GWAS1561368_H | hypertension QTL GWAS1561368 (human) | | 0.000005 | hypertension | | 4 | 110460482 | 110460483 | Human |
597403848 | GWAS1499922_H | neurofibrillary tangles measurement QTL GWAS1499922 (human) | | 0.000004 | neurofibrillary tangles measurement | | 4 | 129315073 | 129315074 | Human |
597272783 | GWAS1368857_H | schizophrenia QTL GWAS1368857 (human) | | 0.000002 | schizophrenia | | 4 | 122467361 | 122467362 | Human |
597149902 | GWAS1245976_H | smoking status measurement QTL GWAS1245976 (human) | | 6e-10 | smoking status measurement | | 4 | 111485805 | 111485806 | Human |
597334211 | GWAS1430285_H | gluteofemoral adipose tissue measurement QTL GWAS1430285 (human) | | 3e-08 | gluteofemoral adipose tissue measurement | | 4 | 122891032 | 122891033 | Human |
597440710 | GWAS1536784_H | amino acid measurement QTL GWAS1536784 (human) | | 0.000003 | amino acid measurement | | 4 | 111130223 | 111130224 | Human |
597178564 | GWAS1274638_H | QRS-T angle QTL GWAS1274638 (human) | | 3e-31 | heart excitatory physiology trait (VT:0000231) | | 4 | 113523590 | 113523591 | Human |
597227718 | GWAS1323792_H | schizophrenia QTL GWAS1323792 (human) | | 4e-08 | schizophrenia | | 4 | 117998342 | 117998343 | Human |
597178567 | GWAS1274641_H | QRS-T angle QTL GWAS1274641 (human) | | 4e-09 | heart excitatory physiology trait (VT:0000231) | | 4 | 110635274 | 110635275 | Human |
406901537 | GWAS550513_H | seasonal allergic rhinitis QTL GWAS550513 (human) | | 0.000001 | seasonal allergic rhinitis | | 4 | 122451978 | 122451979 | Human |
597162229 | GWAS1258303_H | lipid measurement QTL GWAS1258303 (human) | | 0.000002 | lipid measurement | blood lipid measurement (CMO:0000050) | 4 | 123250547 | 123250548 | Human |
597293306 | GWAS1389380_H | body mass index QTL GWAS1389380 (human) | | 1e-11 | body mass index | body mass index (BMI) (CMO:0000105) | 4 | 122906887 | 122906888 | Human |
597162228 | GWAS1258302_H | lipid measurement QTL GWAS1258302 (human) | | 0.000006 | lipid measurement | blood lipid measurement (CMO:0000050) | 4 | 122960709 | 122960710 | Human |
597481723 | GWAS1577797_H | level of fatty acid-binding protein, intestinal in blood serum QTL GWAS1577797 (human) | | 6e-58 | level of fatty acid-binding protein, intestinal in blood serum | | 4 | 119373929 | 119373930 | Human |
597403900 | GWAS1499974_H | pelvic organ prolapse QTL GWAS1499974 (human) | | 0.000002 | pelvic organ prolapse | | 4 | 123466324 | 123466325 | Human |
597489908 | GWAS1585982_H | smoking initiation QTL GWAS1585982 (human) | | 4e-09 | smoking initiation | | 4 | 117868703 | 117868704 | Human |
597412083 | GWAS1508157_H | cancer QTL GWAS1508157 (human) | | 0.0000006 | cancer | | 4 | 122660080 | 122660081 | Human |
597104895 | GWAS1200969_H | platelet crit QTL GWAS1200969 (human) | | 2e-10 | platelet quantity (VT:0003179) | plateletcrit (CMO:0001349) | 4 | 124004110 | 124004111 | Human |
597412082 | GWAS1508156_H | cancer QTL GWAS1508156 (human) | | 0.0000007 | cancer | | 4 | 106909104 | 106909105 | Human |
597104894 | GWAS1200968_H | platelet crit QTL GWAS1200968 (human) | | 4e-10 | platelet quantity (VT:0003179) | plateletcrit (CMO:0001349) | 4 | 110012720 | 110012721 | Human |
597489909 | GWAS1585983_H | smoking initiation QTL GWAS1585983 (human) | | 3e-10 | smoking initiation | | 4 | 126727157 | 126727158 | Human |
596986108 | GWAS1105627_H | body mass index QTL GWAS1105627 (human) | | 2e-14 | body mass index | | 4 | 129810129 | 129810130 | Human |
597104893 | GWAS1200967_H | platelet crit QTL GWAS1200967 (human) | | 2e-36 | platelet quantity (VT:0003179) | plateletcrit (CMO:0001349) | 4 | 109966833 | 109966834 | Human |
597371121 | GWAS1467195_H | metabolite measurement QTL GWAS1467195 (human) | | 7e-13 | metabolite measurement | | 4 | 110413574 | 110413575 | Human |
596986107 | GWAS1105626_H | body mass index QTL GWAS1105626 (human) | | 1e-08 | body mass index | | 4 | 114202933 | 114202934 | Human |
596986106 | GWAS1105625_H | body mass index QTL GWAS1105625 (human) | | 7e-12 | body mass index | | 4 | 111770620 | 111770621 | Human |
597182697 | GWAS1278771_H | disorder of pharynx QTL GWAS1278771 (human) | | 2e-08 | disorder of pharynx | | 4 | 112220279 | 112220280 | Human |
597317870 | GWAS1413944_H | BMI-adjusted waist circumference QTL GWAS1413944 (human) | | 9e-11 | body size trait (VT:0100005) | | 4 | 123166618 | 123166619 | Human |
597289196 | GWAS1385270_H | stroke QTL GWAS1385270 (human) | | 0.0000004 | stroke | | 4 | 112810934 | 112810935 | Human |
597592297 | GWAS1649157_H | high density lipoprotein cholesterol measurement QTL GWAS1649157 (human) | | 4e-30 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 4 | 109657070 | 109657071 | Human |
597317869 | GWAS1413943_H | BMI-adjusted waist circumference QTL GWAS1413943 (human) | | 3e-08 | body size trait (VT:0100005) | | 4 | 123121264 | 123121265 | Human |
597432548 | GWAS1528622_H | protein measurement QTL GWAS1528622 (human) | | 1e-08 | protein measurement | | 4 | 131591604 | 131591605 | Human |
597211362 | GWAS1307436_H | triglyceride measurement QTL GWAS1307436 (human) | | 1e-12 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 4 | 109717608 | 109717609 | Human |
597199075 | GWAS1295149_H | electrocardiography QTL GWAS1295149 (human) | | 2e-29 | electrocardiography | | 4 | 113504778 | 113504779 | Human |
406897470 | GWAS546446_H | systolic blood pressure QTL GWAS546446 (human) | | 2e-08 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 4 | 119588124 | 119588125 | Human |
597321957 | GWAS1418031_H | cup-to-disc ratio measurement QTL GWAS1418031 (human) | | 6e-10 | cup-to-disc ratio measurement | | 4 | 125318831 | 125318832 | Human |
407221191 | GWAS870167_H | lymphocyte count QTL GWAS870167 (human) | | 3e-25 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 4 | 112192759 | 112192760 | Human |
407221190 | GWAS870166_H | lymphocyte count QTL GWAS870166 (human) | | 6e-25 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 4 | 109921984 | 109921985 | Human |
596965392 | GWAS1084911_H | total cholesterol measurement, diet measurement QTL GWAS1084911 (human) | | 0.000004 | total cholesterol measurement, diet measurement | | 4 | 118492283 | 118492284 | Human |
407053255 | GWAS702231_H | BMI-adjusted waist circumference QTL GWAS702231 (human) | | 7e-11 | body size trait (VT:0100005) | | 4 | 119820812 | 119820813 | Human |
407053254 | GWAS702230_H | BMI-adjusted waist circumference QTL GWAS702230 (human) | | 6e-11 | body size trait (VT:0100005) | | 4 | 119759795 | 119759796 | Human |
596953105 | GWAS1072624_H | size QTL GWAS1072624 (human) | | 1e-09 | size | | 4 | 119820087 | 119820088 | Human |
597461019 | GWAS1557093_H | body mass index QTL GWAS1557093 (human) | | 3e-11 | body mass index | body mass index (BMI) (CMO:0000105) | 4 | 111826763 | 111826764 | Human |
597288978 | GWAS1385052_H | triglycerides:total lipids ratio, high density lipoprotein cholesterol measurement QTL GWAS1385052 (human) | | 1e-09 | triglycerides:total lipids ratio, high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 4 | 109717668 | 109717669 | Human |
596989977 | GWAS1109496_H | platelet count QTL GWAS1109496 (human) | | 4e-24 | platelet count | | 4 | 109924690 | 109924691 | Human |
597399575 | GWAS1495649_H | low density lipoprotein cholesterol measurement QTL GWAS1495649 (human) | | 1e-09 | low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 4 | 119202262 | 119202263 | Human |
597473296 | GWAS1569370_H | heel bone mineral density QTL GWAS1569370 (human) | | 8e-11 | heel bone mineral density | bone mineral density (CMO:0001226) | 4 | 123613837 | 123613838 | Human |
597186581 | GWAS1282655_H | peak expiratory flow QTL GWAS1282655 (human) | | 4e-08 | peak expiratory flow | maximum mid-expiratory flow (MMEF) (CMO:0000253) | 4 | 118203565 | 118203566 | Human |
597473297 | GWAS1569371_H | heel bone mineral density QTL GWAS1569371 (human) | | 8e-13 | heel bone mineral density | bone mineral density (CMO:0001226) | 4 | 124619337 | 124619338 | Human |
597219351 | GWAS1315425_H | platelet count QTL GWAS1315425 (human) | | 4e-18 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 4 | 109973957 | 109973958 | Human |
597055495 | GWAS1151569_H | FEV/FVC ratio QTL GWAS1151569 (human) | | 2e-08 | FEV/FVC ratio | forced expiratory volume to forced vital capacity ratio (CMO:0000241) | 4 | 108429724 | 108429725 | Human |
596965381 | GWAS1084900_H | calcium measurement, diet measurement QTL GWAS1084900 (human) | | 0.000006 | calcium measurement, diet measurement | | 4 | 111131258 | 111131259 | Human |
597473294 | GWAS1569368_H | heel bone mineral density QTL GWAS1569368 (human) | | 3e-09 | heel bone mineral density | bone mineral density (CMO:0001226) | 4 | 108249911 | 108249912 | Human |
597039109 | GWAS1135183_H | systolic blood pressure QTL GWAS1135183 (human) | | 2e-08 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 4 | 108099542 | 108099543 | Human |
597473295 | GWAS1569369_H | heel bone mineral density QTL GWAS1569369 (human) | | 5e-09 | heel bone mineral density | bone mineral density (CMO:0001226) | 4 | 118868269 | 118868270 | Human |
597383171 | GWAS1479245_H | serum metabolite measurement QTL GWAS1479245 (human) | | 5e-13 | serum metabolite measurement | | 4 | 110414566 | 110414567 | Human |
597616646 | GWAS1673506_H | gastric ulcer, hemorrhage QTL GWAS1673506 (human) | | 2e-11 | gastric ulcer, hemorrhage | | 4 | 115240446 | 115240447 | Human |
597309446 | GWAS1405520_H | vaginal microbiome measurement QTL GWAS1405520 (human) | | 0.000007 | vaginal microbiome measurement | | 4 | 108166673 | 108166674 | Human |
597383172 | GWAS1479246_H | serum metabolite measurement QTL GWAS1479246 (human) | | 8e-11 | serum metabolite measurement | | 4 | 110430068 | 110430069 | Human |
597125175 | GWAS1221249_H | glycerophospholipid measurement QTL GWAS1221249 (human) | | 2e-26 | glycerophospholipid measurement | | 4 | 114542460 | 114542461 | Human |
597125174 | GWAS1221248_H | glycerophospholipid measurement QTL GWAS1221248 (human) | | 2e-26 | glycerophospholipid measurement | | 4 | 114541220 | 114541221 | Human |
597170234 | GWAS1266308_H | epidermal growth factor measurement QTL GWAS1266308 (human) | | 3e-14 | epidermal growth factor measurement | | 4 | 109933388 | 109933389 | Human |
597125173 | GWAS1221247_H | glycerophospholipid measurement QTL GWAS1221247 (human) | | 2e-26 | glycerophospholipid measurement | | 4 | 114576504 | 114576505 | Human |
597387321 | GWAS1483395_H | primary biliary cirrhosis QTL GWAS1483395 (human) | | 1e-11 | primary biliary cirrhosis | | 4 | 122628544 | 122628545 | Human |
597125172 | GWAS1221246_H | glycerophospholipid measurement QTL GWAS1221246 (human) | | 2e-26 | glycerophospholipid measurement | | 4 | 114546228 | 114546229 | Human |
597125171 | GWAS1221245_H | glycerophospholipid measurement QTL GWAS1221245 (human) | | 2e-26 | glycerophospholipid measurement | | 4 | 114579403 | 114579404 | Human |
597125170 | GWAS1221244_H | glycerophospholipid measurement QTL GWAS1221244 (human) | | 2e-26 | glycerophospholipid measurement | | 4 | 114560598 | 114560599 | Human |
597125183 | GWAS1221257_H | glycerophospholipid measurement QTL GWAS1221257 (human) | | 2e-25 | glycerophospholipid measurement | | 4 | 114493049 | 114493050 | Human |
597338162 | GWAS1434236_H | total cholesterol measurement QTL GWAS1434236 (human) | | 2e-08 | total cholesterol measurement | blood total cholesterol level (CMO:0000051) | 4 | 127977878 | 127977879 | Human |
597125182 | GWAS1221256_H | glycerophospholipid measurement QTL GWAS1221256 (human) | | 2e-25 | glycerophospholipid measurement | | 4 | 114492998 | 114492999 | Human |
597125181 | GWAS1221255_H | glycerophospholipid measurement QTL GWAS1221255 (human) | | 2e-25 | glycerophospholipid measurement | | 4 | 114552771 | 114552772 | Human |
597125180 | GWAS1221254_H | glycerophospholipid measurement QTL GWAS1221254 (human) | | 4e-26 | glycerophospholipid measurement | | 4 | 114494204 | 114494205 | Human |
597125179 | GWAS1221253_H | glycerophospholipid measurement QTL GWAS1221253 (human) | | 2e-26 | glycerophospholipid measurement | | 4 | 114578461 | 114578462 | Human |
597202996 | GWAS1299070_H | psoriasis QTL GWAS1299070 (human) | | 3e-19 | psoriasis | | 4 | 121833304 | 121833305 | Human |
597456944 | GWAS1553018_H | pelvic organ prolapse QTL GWAS1553018 (human) | | 2e-23 | pelvic organ prolapse | | 4 | 126003529 | 126003530 | Human |
597125178 | GWAS1221252_H | glycerophospholipid measurement QTL GWAS1221252 (human) | | 2e-26 | glycerophospholipid measurement | | 4 | 114578518 | 114578519 | Human |
597125177 | GWAS1221251_H | glycerophospholipid measurement QTL GWAS1221251 (human) | | 2e-26 | glycerophospholipid measurement | | 4 | 114560232 | 114560233 | Human |
597125176 | GWAS1221250_H | glycerophospholipid measurement QTL GWAS1221250 (human) | | 2e-26 | glycerophospholipid measurement | | 4 | 114542537 | 114542538 | Human |
597317674 | GWAS1413748_H | diastolic blood pressure QTL GWAS1413748 (human) | | 3e-17 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 4 | 110510288 | 110510289 | Human |
597383208 | GWAS1479282_H | BMI-adjusted waist circumference QTL GWAS1479282 (human) | | 0.000009 | body size trait (VT:0100005) | | 4 | 124199191 | 124199192 | Human |
597301293 | GWAS1397367_H | epidermal growth factor measurement QTL GWAS1397367 (human) | | 3e-25 | epidermal growth factor measurement | | 4 | 109967851 | 109967852 | Human |
597342247 | GWAS1438321_H | sarcoidosis QTL GWAS1438321 (human) | | 0.000004 | sarcoidosis | | 4 | 122800348 | 122800349 | Human |
407225339 | GWAS874315_H | beta-aminoisobutyric acid measurement QTL GWAS874315 (human) | | 0.0000006 | beta-aminoisobutyric acid measurement | | 4 | 107577683 | 107577684 | Human |
597338149 | GWAS1434223_H | irritable bowel syndrome, major depressive disorder QTL GWAS1434223 (human) | | 3e-09 | irritable bowel syndrome, major depressive disorder | | 4 | 122201701 | 122201702 | Human |
597481566 | GWAS1577640_H | mathematical ability QTL GWAS1577640 (human) | | 4e-08 | mathematical ability | | 4 | 111950250 | 111950251 | Human |
597047380 | GWAS1143454_H | BMI-adjusted waist-hip ratio QTL GWAS1143454 (human) | | 1e-09 | body size trait (VT:0100005) | | 4 | 119185193 | 119185194 | Human |
597207133 | GWAS1303207_H | wellbeing measurement QTL GWAS1303207 (human) | | 0.000005 | wellness/fitness trait (VT:1000152) | | 4 | 125346188 | 125346189 | Human |
597235807 | GWAS1331881_H | atrial fibrillation QTL GWAS1331881 (human) | | 1e-48 | atrial fibrillation | | 4 | 110707883 | 110707884 | Human |
597137489 | GWAS1233563_H | Hypoxanthine measurement QTL GWAS1233563 (human) | | 3e-08 | Hypoxanthine measurement | | 4 | 131223983 | 131223984 | Human |
597047377 | GWAS1143451_H | BMI-adjusted waist-hip ratio QTL GWAS1143451 (human) | | 9e-12 | body size trait (VT:0100005) | waist to hip ratio (WHR) (CMO:0000020) | 4 | 121705035 | 121705036 | Human |
597018706 | GWAS1114780_H | eosinophil count QTL GWAS1114780 (human) | | 5e-27 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 4 | 122680359 | 122680360 | Human |
597149788 | GWAS1245862_H | diet measurement, sex hormone-binding globulin measurement QTL GWAS1245862 (human) | | 0.0000009 | eating behavior trait (VT:0001431) | food intake measurement (CMO:0000772) | 4 | 127714844 | 127714845 | Human |
597125190 | GWAS1221264_H | glycerophospholipid measurement QTL GWAS1221264 (human) | | 2e-25 | glycerophospholipid measurement | | 4 | 114495547 | 114495548 | Human |
597125189 | GWAS1221263_H | glycerophospholipid measurement QTL GWAS1221263 (human) | | 2e-25 | glycerophospholipid measurement | | 4 | 114532641 | 114532642 | Human |
597125188 | GWAS1221262_H | glycerophospholipid measurement QTL GWAS1221262 (human) | | 2e-25 | glycerophospholipid measurement | | 4 | 114495414 | 114495415 | Human |
597125187 | GWAS1221261_H | glycerophospholipid measurement QTL GWAS1221261 (human) | | 2e-25 | glycerophospholipid measurement | | 4 | 114532620 | 114532621 | Human |
597125186 | GWAS1221260_H | glycerophospholipid measurement QTL GWAS1221260 (human) | | 2e-25 | glycerophospholipid measurement | | 4 | 114532551 | 114532552 | Human |
597514312 | GWAS1610386_H | vital capacity QTL GWAS1610386 (human) | | 8e-11 | vital capacity | | 4 | 124209285 | 124209286 | Human |
597125185 | GWAS1221259_H | glycerophospholipid measurement QTL GWAS1221259 (human) | | 2e-25 | glycerophospholipid measurement | | 4 | 114532477 | 114532478 | Human |
597125184 | GWAS1221258_H | glycerophospholipid measurement QTL GWAS1221258 (human) | | 2e-25 | glycerophospholipid measurement | | 4 | 114493188 | 114493189 | Human |
596965454 | GWAS1084973_H | lipoprotein A measurement, diet measurement QTL GWAS1084973 (human) | | 0.000002 | lipoprotein A measurement, diet measurement | | 4 | 129572458 | 129572459 | Human |
407315356 | GWAS964332_H | unipolar depression QTL GWAS964332 (human) | | 1e-09 | unipolar depression | | 4 | 130316226 | 130316227 | Human |
597383236 | GWAS1479310_H | monocyte count QTL GWAS1479310 (human) | | 3e-10 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 4 | 110020646 | 110020647 | Human |
597489788 | GWAS1585862_H | educational attainment QTL GWAS1585862 (human) | | 0.000009 | educational attainment | | 4 | 107916747 | 107916748 | Human |
597145719 | GWAS1241793_H | prostate carcinoma QTL GWAS1241793 (human) | | 3e-08 | prostate carcinoma | | 4 | 109889343 | 109889344 | Human |
597489789 | GWAS1585863_H | educational attainment QTL GWAS1585863 (human) | | 5e-08 | educational attainment | | 4 | 117355510 | 117355511 | Human |
596953205 | GWAS1072724_H | size QTL GWAS1072724 (human) | | 5e-08 | size | | 4 | 118204297 | 118204298 | Human |
597493884 | GWAS1589958_H | R-6-hydroxywarfarin measurement QTL GWAS1589958 (human) | | 0.000005 | R-6-hydroxywarfarin measurement | | 4 | 123651871 | 123651872 | Human |
597489790 | GWAS1585864_H | educational attainment QTL GWAS1585864 (human) | | 3e-10 | educational attainment | | 4 | 117508319 | 117508320 | Human |
597395581 | GWAS1491655_H | Calcium channel blocker use measurement QTL GWAS1491655 (human) | | 8e-14 | Calcium channel blocker use measurement | | 4 | 110465042 | 110465043 | Human |
597125247 | GWAS1221321_H | glycerophospholipid measurement QTL GWAS1221321 (human) | | 1e-22 | glycerophospholipid measurement | | 4 | 114532227 | 114532228 | Human |
597125246 | GWAS1221320_H | glycerophospholipid measurement QTL GWAS1221320 (human) | | 1e-22 | glycerophospholipid measurement | | 4 | 114503010 | 114503011 | Human |
597125245 | GWAS1221319_H | glycerophospholipid measurement QTL GWAS1221319 (human) | | 1e-22 | glycerophospholipid measurement | | 4 | 114490702 | 114490703 | Human |
597125244 | GWAS1221318_H | glycerophospholipid measurement QTL GWAS1221318 (human) | | 4e-24 | glycerophospholipid measurement | | 4 | 114568887 | 114568888 | Human |
597125243 | GWAS1221317_H | glycerophospholipid measurement QTL GWAS1221317 (human) | | 1e-22 | glycerophospholipid measurement | | 4 | 114490912 | 114490913 | Human |
597125242 | GWAS1221316_H | glycerophospholipid measurement QTL GWAS1221316 (human) | | 1e-22 | glycerophospholipid measurement | | 4 | 114490871 | 114490872 | Human |
597125241 | GWAS1221315_H | glycerophospholipid measurement QTL GWAS1221315 (human) | | 2e-23 | glycerophospholipid measurement | | 4 | 114485894 | 114485895 | Human |
597145720 | GWAS1241794_H | prostate carcinoma QTL GWAS1241794 (human) | | 4e-08 | prostate carcinoma | | 4 | 109927496 | 109927497 | Human |
597280886 | GWAS1376960_H | pelvic organ prolapse QTL GWAS1376960 (human) | | 1e-11 | pelvic organ prolapse | | 4 | 126146934 | 126146935 | Human |
597383284 | GWAS1479358_H | Red cell distribution width QTL GWAS1479358 (human) | | 6e-21 | Red cell distribution width | red blood cell distribution width- standard deviation (CMO:0003232) | 4 | 128306129 | 128306130 | Human |
597076068 | GWAS1172142_H | late-onset Alzheimers disease QTL GWAS1172142 (human) | | 0.000004 | late-onset Alzheimers disease | | 4 | 109534350 | 109534351 | Human |
597502063 | GWAS1598137_H | suicide QTL GWAS1598137 (human) | | 0.000004 | suicide | | 4 | 125969849 | 125969850 | Human |
597153891 | GWAS1249965_H | cholesterol:total lipids ratio, intermediate density lipoprotein measurement QTL GWAS1249965 (human) | | 8e-10 | cholesterol:total lipids ratio, intermediate density lipoprotein measurement | blood intermediate density lipoprotein cholesterol level (CMO:0001562) | 4 | 109657070 | 109657071 | Human |
597436520 | GWAS1532594_H | open-angle glaucoma QTL GWAS1532594 (human) | | 7e-15 | open-angle glaucoma | | 4 | 111042563 | 111042564 | Human |
597465192 | GWAS1561266_H | small vessel stroke QTL GWAS1561266 (human) | | 0.000008 | small vessel stroke | | 4 | 125155988 | 125155989 | Human |
597436521 | GWAS1532595_H | open-angle glaucoma QTL GWAS1532595 (human) | | 4e-12 | open-angle glaucoma | | 4 | 111886876 | 111886877 | Human |
597436522 | GWAS1532596_H | open-angle glaucoma QTL GWAS1532596 (human) | | 1e-09 | open-angle glaucoma | | 4 | 125994594 | 125994595 | Human |
407389104 | GWAS1038080_H | gut microbiome measurement, taxonomic microbiome measurement QTL GWAS1038080 (human) | | 4e-08 | gut microbiome measurement, taxonomic microbiome measurement | | 4 | 130578414 | 130578415 | Human |
597239908 | GWAS1335982_H | Myopia QTL GWAS1335982 (human) | | 0.000005 | Myopia | | 4 | 125625005 | 125625006 | Human |
597076072 | GWAS1172146_H | late-onset Alzheimers disease QTL GWAS1172146 (human) | | 0.0000008 | late-onset Alzheimers disease | | 4 | 109251730 | 109251731 | Human |
597385115 | GWAS1481189_H | body mass index QTL GWAS1481189 (human) | | 2e-10 | body mass index | body mass index (BMI) (CMO:0000105) | 4 | 111731920 | 111731921 | Human |
407094339 | GWAS743315_H | small vessel stroke QTL GWAS743315 (human) | | 0.0000007 | small vessel stroke | | 4 | 113472094 | 113472095 | Human |
597229464 | GWAS1325538_H | Hypermetropia, Myopia QTL GWAS1325538 (human) | | 0.0000007 | Hypermetropia, Myopia | | 4 | 119987548 | 119987549 | Human |
597069719 | GWAS1165793_H | lean body mass QTL GWAS1165793 (human) | | 0.000004 | body lean mass (VT:0010483) | total body lean mass (CMO:0003950) | 4 | 130920623 | 130920624 | Human |
597589916 | GWAS1646776_H | atrial fibrillation QTL GWAS1646776 (human) | | 1e-33 | atrial fibrillation | | 4 | 110793263 | 110793264 | Human |
597426073 | GWAS1522147_H | urate measurement QTL GWAS1522147 (human) | | 3e-11 | urate measurement | blood uric acid level (CMO:0000501) | 4 | 119599549 | 119599550 | Human |
597376914 | GWAS1472988_H | celiac disease QTL GWAS1472988 (human) | | 1e-14 | celiac disease | | 4 | 122588266 | 122588267 | Human |
597053340 | GWAS1149414_H | household income QTL GWAS1149414 (human) | | 5e-09 | household income | | 4 | 122175535 | 122175536 | Human |
597065626 | GWAS1161700_H | congenital heart disease QTL GWAS1161700 (human) | | 0.000008 | congenital heart disease | | 4 | 118330002 | 118330003 | Human |
597159835 | GWAS1255909_H | lipid measurement QTL GWAS1255909 (human) | | 0.000003 | lipid measurement | blood lipid measurement (CMO:0000050) | 4 | 124732439 | 124732440 | Human |
597016474 | GWAS1112548_H | cognitive decline measurement QTL GWAS1112548 (human) | | 0.000004 | cognitive behavior trait (VT:0010450) | | 4 | 110589931 | 110589932 | Human |
597270410 | GWAS1366484_H | diastolic blood pressure QTL GWAS1366484 (human) | | 3e-10 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 4 | 108096372 | 108096373 | Human |
597409678 | GWAS1505752_H | cortical thickness QTL GWAS1505752 (human) | | 6e-19 | cortical thickness | | 4 | 112512138 | 112512139 | Human |
597450635 | GWAS1546709_H | alkaline phosphatase measurement QTL GWAS1546709 (human) | | 4e-23 | alkaline phosphatase measurement | blood alkaline phosphatase activity level (CMO:0000576) | 4 | 110199010 | 110199011 | Human |
596967309 | GWAS1086828_H | systolic blood pressure QTL GWAS1086828 (human) | | 4e-08 | systolic blood pressure | | 4 | 120018331 | 120018332 | Human |
597286787 | GWAS1382861_H | inflammatory bowel disease QTL GWAS1382861 (human) | | 6e-19 | inflammatory bowel disease | | 4 | 122523884 | 122523885 | Human |
597278597 | GWAS1374671_H | testosterone measurement QTL GWAS1374671 (human) | | 1e-16 | testosterone measurement | serum testosterone level (CMO:0000568) | 4 | 124126476 | 124126477 | Human |
597016456 | GWAS1112530_H | cognitive decline measurement QTL GWAS1112530 (human) | | 0.0000009 | cognitive behavior trait (VT:0010450) | | 4 | 110589931 | 110589932 | Human |
597049227 | GWAS1145301_H | cervical carcinoma QTL GWAS1145301 (human) | | 0.000001 | cervical carcinoma | | 4 | 113726137 | 113726138 | Human |
597344186 | GWAS1440260_H | body mass index QTL GWAS1440260 (human) | | 0.000001 | body mass index | body mass index (BMI) (CMO:0000105) | 4 | 129895905 | 129895906 | Human |
596979635 | GWAS1099154_H | body height QTL GWAS1099154 (human) | | 6e-23 | body height | | 4 | 122904764 | 122904765 | Human |
597499835 | GWAS1595909_H | triglyceride measurement QTL GWAS1595909 (human) | | 2e-09 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 4 | 123720672 | 123720673 | Human |
596967356 | GWAS1086875_H | cortical thickness QTL GWAS1086875 (human) | | 8e-09 | cortical thickness | | 4 | 119920489 | 119920490 | Human |
596971453 | GWAS1090972_H | glomerular filtration rate, bipolar disorder QTL GWAS1090972 (human) | | 3e-08 | glomerular filtration rate, bipolar disorder | | 4 | 122596491 | 122596492 | Human |
596967357 | GWAS1086876_H | cortical thickness QTL GWAS1086876 (human) | | 3e-11 | cortical thickness | | 4 | 120773757 | 120773758 | Human |
597135291 | GWAS1231365_H | memory performance, sex interaction measurement QTL GWAS1231365 (human) | | 0.000003 | memory performance, sex interaction measurement | | 4 | 109132717 | 109132718 | Human |
597135290 | GWAS1231364_H | memory performance, sex interaction measurement QTL GWAS1231364 (human) | | 0.000003 | memory performance, sex interaction measurement | | 4 | 109131697 | 109131698 | Human |
597139385 | GWAS1235459_H | citrulline measurement QTL GWAS1235459 (human) | | 0.0000006 | citrulline measurement | blood amino acid measurement (CMO:0003730) | 4 | 108524921 | 108524922 | Human |
597135289 | GWAS1231363_H | memory performance, sex interaction measurement QTL GWAS1231363 (human) | | 0.000003 | memory performance, sex interaction measurement | | 4 | 109134293 | 109134294 | Human |
597135271 | GWAS1231345_H | diastolic blood pressure QTL GWAS1231345 (human) | | 7e-12 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 4 | 108146742 | 108146743 | Human |
597356458 | GWAS1452532_H | medication adherence behavior QTL GWAS1452532 (human) | | 0.000001 | medication adherence behavior | | 4 | 111199502 | 111199503 | Human |
407028849 | GWAS677825_H | age-related macular degeneration QTL GWAS677825 (human) | | 7e-11 | age-related macular degeneration | | 4 | 109669323 | 109669324 | Human |
597589927 | GWAS1646787_H | cardiac arrhythmia QTL GWAS1646787 (human) | | 3e-19 | cardiac arrhythmia | | 4 | 110774266 | 110774267 | Human |
597094319 | GWAS1190393_H | emphysema imaging measurement QTL GWAS1190393 (human) | | 0.000001 | emphysema imaging measurement | | 4 | 122028172 | 122028173 | Human |
597372839 | GWAS1468913_H | estradiol measurement QTL GWAS1468913 (human) | | 0.000009 | estradiol measurement | blood estradiol level (CMO:0000513) | 4 | 127399753 | 127399754 | Human |
597135273 | GWAS1231347_H | diastolic blood pressure QTL GWAS1231347 (human) | | 3e-08 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 4 | 119037654 | 119037655 | Human |
597135272 | GWAS1231346_H | diastolic blood pressure QTL GWAS1231346 (human) | | 2e-16 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 4 | 110319122 | 110319123 | Human |
597397467 | GWAS1493541_H | atrial fibrillation QTL GWAS1493541 (human) | | 1e-13 | atrial fibrillation | | 4 | 113507558 | 113507559 | Human |
597274587 | GWAS1370661_H | high density lipoprotein cholesterol measurement QTL GWAS1370661 (human) | | 1e-25 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 4 | 109717668 | 109717669 | Human |
597245915 | GWAS1341989_H | blood protein measurement QTL GWAS1341989 (human) | | 3e-12 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 4 | 119503425 | 119503426 | Human |
597188570 | GWAS1284644_H | educational attainment QTL GWAS1284644 (human) | | 5e-10 | educational attainment | | 4 | 121851158 | 121851159 | Human |
597274586 | GWAS1370660_H | high density lipoprotein cholesterol measurement QTL GWAS1370660 (human) | | 1e-21 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 4 | 109174464 | 109174465 | Human |
597188571 | GWAS1284645_H | educational attainment QTL GWAS1284645 (human) | | 4e-20 | educational attainment | | 4 | 122105714 | 122105715 | Human |
597589978 | GWAS1646838_H | appendicitis QTL GWAS1646838 (human) | | 4e-19 | appendicitis | | 4 | 110804662 | 110804663 | Human |
597188572 | GWAS1284646_H | educational attainment QTL GWAS1284646 (human) | | 5e-11 | educational attainment | | 4 | 122259374 | 122259375 | Human |
597188573 | GWAS1284647_H | educational attainment QTL GWAS1284647 (human) | | 2e-10 | educational attainment | | 4 | 122480614 | 122480615 | Human |
597589976 | GWAS1646836_H | disorder of appendix QTL GWAS1646836 (human) | | 4e-21 | disorder of appendix | | 4 | 110810809 | 110810810 | Human |
597188574 | GWAS1284648_H | educational attainment QTL GWAS1284648 (human) | | 2e-08 | educational attainment | | 4 | 126904030 | 126904031 | Human |
597589977 | GWAS1646837_H | appendicitis QTL GWAS1646837 (human) | | 1e-20 | appendicitis | | 4 | 110810809 | 110810810 | Human |
597188575 | GWAS1284649_H | educational attainment QTL GWAS1284649 (human) | | 2e-15 | educational attainment | | 4 | 128836670 | 128836671 | Human |
596975580 | GWAS1095099_H | stroke QTL GWAS1095099 (human) | | 2e-13 | stroke | | 4 | 110793263 | 110793264 | Human |
597049311 | GWAS1145385_H | major depressive disorder QTL GWAS1145385 (human) | | 2e-10 | depressive symptom measurement | | 4 | 122201701 | 122201702 | Human |
596983775 | GWAS1103294_H | memory performance QTL GWAS1103294 (human) | | 0.0000004 | memory performance | | 4 | 124882027 | 124882028 | Human |
597020633 | GWAS1116707_H | FEV/FVC ratio, response to bronchodilator QTL GWAS1116707 (human) | | 0.000005 | FEV/FVC ratio, response to bronchodilator | forced expiratory volume to forced vital capacity ratio (CMO:0000241) | 4 | 109767656 | 109767657 | Human |
597331924 | GWAS1427998_H | colorectal cancer QTL GWAS1427998 (human) | | 0.0000005 | colorectal cancer | | 4 | 120052597 | 120052598 | Human |
597528514 | GWAS1624588_H | FEV/FVC ratio QTL GWAS1624588 (human) | | 3e-18 | FEV/FVC ratio | forced expiratory volume to forced vital capacity ratio (CMO:0000241) | 4 | 123898452 | 123898453 | Human |
597127159 | GWAS1223233_H | glycerophospholipid measurement QTL GWAS1223233 (human) | | 9e-10 | glycerophospholipid measurement | | 4 | 114551671 | 114551672 | Human |
596971509 | GWAS1091028_H | major depressive disorder QTL GWAS1091028 (human) | | 2e-10 | major depressive disorder | | 4 | 130316226 | 130316227 | Human |
597127158 | GWAS1223232_H | glycerophospholipid measurement QTL GWAS1223232 (human) | | 8e-10 | glycerophospholipid measurement | | 4 | 114510521 | 114510522 | Human |
597127157 | GWAS1223231_H | glycerophospholipid measurement QTL GWAS1223231 (human) | | 8e-10 | glycerophospholipid measurement | | 4 | 114580888 | 114580889 | Human |
597127156 | GWAS1223230_H | glycerophospholipid measurement QTL GWAS1223230 (human) | | 7e-10 | glycerophospholipid measurement | | 4 | 114514506 | 114514507 | Human |
407221286 | GWAS870262_H | hematocrit QTL GWAS870262 (human) | | 9e-16 | hematocrit | hematocrit (CMO:0000037) | 4 | 114577301 | 114577302 | Human |
597127155 | GWAS1223229_H | glycerophospholipid measurement QTL GWAS1223229 (human) | | 6e-10 | glycerophospholipid measurement | | 4 | 114485362 | 114485363 | Human |
597127154 | GWAS1223228_H | glycerophospholipid measurement QTL GWAS1223228 (human) | | 5e-10 | glycerophospholipid measurement | | 4 | 114550195 | 114550196 | Human |
597127153 | GWAS1223227_H | glycerophospholipid measurement QTL GWAS1223227 (human) | | 4e-10 | glycerophospholipid measurement | | 4 | 114539953 | 114539954 | Human |
597127152 | GWAS1223226_H | glycerophospholipid measurement QTL GWAS1223226 (human) | | 4e-10 | glycerophospholipid measurement | | 4 | 114540944 | 114540945 | Human |
596971506 | GWAS1091025_H | major depressive disorder QTL GWAS1091025 (human) | | 8e-21 | major depressive disorder | | 4 | 122265238 | 122265239 | Human |
596983794 | GWAS1103313_H | memory performance QTL GWAS1103313 (human) | | 0.00001 | memory performance | | 4 | 124888134 | 124888135 | Human |
597512180 | GWAS1608254_H | vascular endothelial function measurement QTL GWAS1608254 (human) | | 8e-08 | vascular endothelial function measurement | | 4 | 132241773 | 132241774 | Human |
597164029 | GWAS1260103_H | lipid measurement QTL GWAS1260103 (human) | | 0.000003 | lipid measurement | blood lipid measurement (CMO:0000050) | 4 | 112764648 | 112764649 | Human |
407049256 | GWAS698232_H | glycerol measurement QTL GWAS698232 (human) | | 0.0000002 | glycerol measurement | blood glycerol level (CMO:0002679) | 4 | 125351750 | 125351751 | Human |
407049262 | GWAS698238_H | glycerol measurement QTL GWAS698238 (human) | | 0.000004 | glycerol measurement | blood glycerol level (CMO:0002679) | 4 | 125494759 | 125494760 | Human |
407163946 | GWAS812922_H | BMI-adjusted waist-hip ratio QTL GWAS812922 (human) | | 4e-08 | body size trait (VT:0100005) | | 4 | 123145793 | 123145794 | Human |
597336053 | GWAS1432127_H | COVID-19 QTL GWAS1432127 (human) | | 0.000008 | COVID-19 | | 4 | 129389669 | 129389670 | Human |
597139448 | GWAS1235522_H | major depressive disorder QTL GWAS1235522 (human) | | 1e-09 | major depressive disorder | | 4 | 130316226 | 130316227 | Human |
597049316 | GWAS1145390_H | low density lipoprotein cholesterol measurement QTL GWAS1145390 (human) | | 2e-08 | low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 4 | 108720535 | 108720536 | Human |
597336041 | GWAS1432115_H | COVID-19 QTL GWAS1432115 (human) | | 0.000005 | COVID-19 | | 4 | 113911048 | 113911049 | Human |
596983777 | GWAS1103296_H | memory performance QTL GWAS1103296 (human) | | 0.0000004 | memory performance | | 4 | 124883368 | 124883369 | Human |
596983776 | GWAS1103295_H | memory performance QTL GWAS1103295 (human) | | 0.0000004 | memory performance | | 4 | 124882886 | 124882887 | Human |
597127151 | GWAS1223225_H | glycerophospholipid measurement QTL GWAS1223225 (human) | | 4e-10 | glycerophospholipid measurement | | 4 | 114492647 | 114492648 | Human |
597188576 | GWAS1284650_H | educational attainment QTL GWAS1284650 (human) | | 2e-09 | educational attainment | | 4 | 129239551 | 129239552 | Human |
597491684 | GWAS1587758_H | educational attainment QTL GWAS1587758 (human) | | 2e-09 | educational attainment | | 4 | 129621796 | 129621797 | Human |
597127150 | GWAS1223224_H | glycerophospholipid measurement QTL GWAS1223224 (human) | | 4e-10 | glycerophospholipid measurement | | 4 | 114492457 | 114492458 | Human |
597188577 | GWAS1284651_H | educational attainment QTL GWAS1284651 (human) | | 1e-10 | educational attainment | | 4 | 129330640 | 129330641 | Human |
597491685 | GWAS1587759_H | educational attainment QTL GWAS1587759 (human) | | 1e-11 | educational attainment | | 4 | 129713268 | 129713269 | Human |
597262307 | GWAS1358381_H | mean corpuscular hemoglobin QTL GWAS1358381 (human) | | 5e-10 | mean corpuscular hemoglobin | mean corpuscular hemoglobin (CMO:0000290) | 4 | 121870446 | 121870447 | Human |
597188578 | GWAS1284652_H | educational attainment QTL GWAS1284652 (human) | | 1e-08 | educational attainment | | 4 | 129387520 | 129387521 | Human |
597491686 | GWAS1587760_H | educational attainment QTL GWAS1587760 (human) | | 1e-08 | educational attainment | | 4 | 129875770 | 129875771 | Human |
597188579 | GWAS1284653_H | educational attainment QTL GWAS1284653 (human) | | 5e-08 | educational attainment | | 4 | 129452572 | 129452573 | Human |
597491687 | GWAS1587761_H | educational attainment QTL GWAS1587761 (human) | | 3e-09 | educational attainment | | 4 | 130394262 | 130394263 | Human |
597249819 | GWAS1345893_H | corneal resistance factor QTL GWAS1345893 (human) | | 2e-08 | corneal resistance factor | | 4 | 118802505 | 118802506 | Human |
596967186 | GWAS1086705_H | cortical thickness QTL GWAS1086705 (human) | | 9e-10 | cortical thickness | | 4 | 120654416 | 120654417 | Human |
596959004 | GWAS1078523_H | response to warfarin QTL GWAS1078523 (human) | | 0.0000006 | response to warfarin | | 4 | 130374797 | 130374798 | Human |
597233429 | GWAS1329503_H | major depressive disorder QTL GWAS1329503 (human) | | 3e-24 | major depressive disorder | | 4 | 122201701 | 122201702 | Human |
597094171 | GWAS1190245_H | airway imaging measurement QTL GWAS1190245 (human) | | 5e-09 | airway imaging measurement | respiratory system measurement (CMO:0000094) | 4 | 126402153 | 126402154 | Human |
596983553 | GWAS1103072_H | memory performance QTL GWAS1103072 (human) | | 0.000004 | memory performance | | 4 | 124869106 | 124869107 | Human |
597483272 | GWAS1579346_H | reticulocyte measurement QTL GWAS1579346 (human) | | 4e-12 | reticulocyte morphology trait (VT:0002424) | red blood cell measurement (CMO:0001356) | 4 | 128330896 | 128330897 | Human |
596987648 | GWAS1107167_H | leukocyte count QTL GWAS1107167 (human) | | 6e-14 | leukocyte count | | 4 | 110020646 | 110020647 | Human |
596983552 | GWAS1103071_H | memory performance QTL GWAS1103071 (human) | | 0.000003 | memory performance | | 4 | 124861110 | 124861111 | Human |
597405454 | GWAS1501528_H | body mass index QTL GWAS1501528 (human) | | 1e-11 | body mass index | body mass index (BMI) (CMO:0000105) | 4 | 129838492 | 129838493 | Human |
597061386 | GWAS1157460_H | adolescent idiopathic scoliosis QTL GWAS1157460 (human) | | 5e-11 | adolescent idiopathic scoliosis | | 4 | 112239118 | 112239119 | Human |
597430017 | GWAS1526091_H | sex hormone-binding globulin measurement QTL GWAS1526091 (human) | | 2e-10 | sex hormone-binding globulin measurement | | 4 | 123845801 | 123845802 | Human |
597409595 | GWAS1505669_H | platelet count QTL GWAS1505669 (human) | | 5e-16 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 4 | 119464317 | 119464318 | Human |
406959328 | GWAS608304_H | androgenetic alopecia QTL GWAS608304 (human) | | 7e-10 | androgenetic alopecia | | 4 | 106961892 | 106961893 | Human |
597086005 | GWAS1182079_H | electrocardiography QTL GWAS1182079 (human) | | 6e-09 | electrocardiography | | 4 | 113489984 | 113489985 | Human |
406992103 | GWAS641079_H | mean corpuscular hemoglobin concentration QTL GWAS641079 (human) | | 1e-11 | mean corpuscular hemoglobin concentration | mean corpuscular hemoglobin concentration (CMO:0000291) | 4 | 121870446 | 121870447 | Human |
406910182 | GWAS559158_H | unipolar depression, bipolar disorder QTL GWAS559158 (human) | | 0.000008 | unipolar depression, bipolar disorder | | 4 | 125438301 | 125438302 | Human |
597098289 | GWAS1194363_H | protein measurement QTL GWAS1194363 (human) | | 1e-09 | protein measurement | | 4 | 120939887 | 120939888 | Human |
597409596 | GWAS1505670_H | platelet count QTL GWAS1505670 (human) | | 1e-13 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 4 | 123837618 | 123837619 | Human |
596959027 | GWAS1078546_H | facial morphology measurement QTL GWAS1078546 (human) | | 3e-08 | facial morphology measurement | | 4 | 125211057 | 125211058 | Human |
407114988 | GWAS763964_H | diastolic blood pressure QTL GWAS763964 (human) | | 0.000001 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 4 | 113288576 | 113288577 | Human |
597520181 | GWAS1616255_H | urate measurement QTL GWAS1616255 (human) | | 6e-09 | urate measurement | blood uric acid level (CMO:0000501) | 4 | 127147534 | 127147535 | Human |
597102397 | GWAS1198471_H | alkaline phosphatase measurement QTL GWAS1198471 (human) | | 1e-13 | alkaline phosphatase measurement | blood alkaline phosphatase activity level (CMO:0000576) | 4 | 128110416 | 128110417 | Human |
597102396 | GWAS1198470_H | alkaline phosphatase measurement QTL GWAS1198470 (human) | | 3e-11 | alkaline phosphatase measurement | blood alkaline phosphatase activity level (CMO:0000576) | 4 | 110207431 | 110207432 | Human |
597409590 | GWAS1505664_H | vaginal microbiome measurement QTL GWAS1505664 (human) | | 0.000007 | vaginal microbiome measurement | | 4 | 132191469 | 132191470 | Human |
597462829 | GWAS1558903_H | coronary artery disease QTL GWAS1558903 (human) | | 3e-08 | coronary artery disease | | 4 | 119980181 | 119980182 | Human |
597094180 | GWAS1190254_H | cerebral amyloid angiopathy QTL GWAS1190254 (human) | | 0.000007 | cerebral amyloid angiopathy | | 4 | 129419725 | 129419726 | Human |
596975395 | GWAS1094914_H | body height QTL GWAS1094914 (human) | | 4e-15 | body height | | 4 | 122823209 | 122823210 | Human |
597327661 | GWAS1423735_H | breast density QTL GWAS1423735 (human) | | 0.000001 | breast density | | 4 | 124653133 | 124653134 | Human |
597163823 | GWAS1259897_H | heart valve disease QTL GWAS1259897 (human) | | 5e-22 | heart valve disease | | 4 | 110725811 | 110725812 | Human |
406988024 | GWAS637000_H | Ischemic stroke, cardiac embolism QTL GWAS637000 (human) | | 1e-25 | Ischemic stroke, cardiac embolism | | 4 | 110737238 | 110737239 | Human |
597229346 | GWAS1325420_H | asthma QTL GWAS1325420 (human) | | 6e-19 | asthma | | 4 | 122219915 | 122219916 | Human |
597229348 | GWAS1325422_H | asthma QTL GWAS1325422 (human) | | 2e-21 | asthma | | 4 | 122432277 | 122432278 | Human |
597229349 | GWAS1325423_H | asthma QTL GWAS1325423 (human) | | 2e-18 | asthma | | 4 | 122438414 | 122438415 | Human |
597479202 | GWAS1575276_H | protein measurement QTL GWAS1575276 (human) | | 1e-08 | protein measurement | | 4 | 132318854 | 132318855 | Human |
597499741 | GWAS1595815_H | memory performance QTL GWAS1595815 (human) | | 0.000002 | memory performance | | 4 | 124874941 | 124874942 | Human |
597499740 | GWAS1595814_H | memory performance QTL GWAS1595814 (human) | | 0.0000003 | memory performance | | 4 | 128552943 | 128552944 | Human |
597065554 | GWAS1161628_H | eye color QTL GWAS1161628 (human) | | 0.000004 | eye color | | 4 | 110478442 | 110478443 | Human |
597016408 | GWAS1112482_H | body mass index QTL GWAS1112482 (human) | | 0.0000003 | body mass index | body mass index (BMI) (CMO:0000105) | 4 | 129895905 | 129895906 | Human |
597434184 | GWAS1530258_H | sex hormone-binding globulin measurement QTL GWAS1530258 (human) | | 0.000002 | sex hormone-binding globulin measurement | | 4 | 123845801 | 123845802 | Human |
597421891 | GWAS1517965_H | atrial fibrillation QTL GWAS1517965 (human) | | 1e-12 | atrial fibrillation | | 4 | 111172387 | 111172388 | Human |
597073742 | GWAS1169816_H | coronary artery disease QTL GWAS1169816 (human) | | 1e-14 | coronary artery disease | | 4 | 119988346 | 119988347 | Human |
597421890 | GWAS1517964_H | atrial fibrillation QTL GWAS1517964 (human) | | 7e-13 | atrial fibrillation | | 4 | 111085761 | 111085762 | Human |
597389120 | GWAS1485194_H | lung carcinoma QTL GWAS1485194 (human) | | 0.000002 | lung carcinoma | | 4 | 110592565 | 110592566 | Human |
597020494 | GWAS1116568_H | forced expiratory volume, response to bronchodilator QTL GWAS1116568 (human) | | 0.000003 | forced expiratory volume, response to bronchodilator | forced expiratory volume (CMO:0000254) | 4 | 122596078 | 122596079 | Human |
597397312 | GWAS1493386_H | facial morphology measurement QTL GWAS1493386 (human) | | 2e-09 | facial morphology trait (VT:0003743) | | 4 | 126014320 | 126014321 | Human |
597241668 | GWAS1337742_H | high density lipoprotein cholesterol measurement QTL GWAS1337742 (human) | | 3e-09 | sex hormone-binding globulin measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 4 | 109717608 | 109717609 | Human |
597421893 | GWAS1517967_H | atrial fibrillation QTL GWAS1517967 (human) | | 6e-13 | atrial fibrillation | | 4 | 113507558 | 113507559 | Human |
406897822 | GWAS546798_H | sudden cardiac arrest QTL GWAS546798 (human) | | 0.0000004 | sudden cardiac arrest | | 4 | 116333133 | 116333134 | Human |
597434179 | GWAS1530253_H | sex hormone-binding globulin measurement QTL GWAS1530253 (human) | | 8e-21 | sex hormone-binding globulin measurement | | 4 | 109345757 | 109345758 | Human |
597421892 | GWAS1517966_H | atrial fibrillation QTL GWAS1517966 (human) | | 2e-08 | atrial fibrillation | | 4 | 111257689 | 111257690 | Human |
597032821 | GWAS1128895_H | blood protein measurement QTL GWAS1128895 (human) | | 4e-34 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 4 | 109737911 | 109737912 | Human |
597061491 | GWAS1157565_H | adolescent idiopathic scoliosis QTL GWAS1157565 (human) | | 0.0000002 | adolescent idiopathic scoliosis | | 4 | 113329637 | 113329638 | Human |
597311356 | GWAS1407430_H | vaginal microbiome measurement QTL GWAS1407430 (human) | | 0.000003 | vaginal microbiome measurement | | 4 | 109225176 | 109225177 | Human |
597512059 | GWAS1608133_H | testosterone measurement QTL GWAS1608133 (human) | | 3e-08 | testosterone measurement | serum testosterone level (CMO:0000568) | 4 | 113038028 | 113038029 | Human |
406951080 | GWAS600056_H | trait in response to omacetaxine mepesuccinate, cytotoxicity measurement QTL GWAS600056 (human) | | 0.0000003 | trait in response to omacetaxine mepesuccinate, cytotoxicity measurement | | 4 | 126075715 | 126075716 | Human |
597249907 | GWAS1345981_H | body weight QTL GWAS1345981 (human) | | 5e-08 | body mass (VT:0001259) | body weight (CMO:0000012) | 4 | 121338887 | 121338888 | Human |
597376881 | GWAS1472955_H | inflammatory bowel disease QTL GWAS1472955 (human) | | 3e-13 | inflammatory bowel disease | | 4 | 122240464 | 122240465 | Human |
596955007 | GWAS1074526_H | triglyceride:HDL cholesterol ratio QTL GWAS1074526 (human) | | 6e-12 | triglyceride:HDL cholesterol ratio | | 4 | 109648464 | 109648465 | Human |
596967295 | GWAS1086814_H | diastolic blood pressure QTL GWAS1086814 (human) | | 3e-17 | diastolic blood pressure | | 4 | 110510288 | 110510289 | Human |
407102632 | GWAS751608_H | irritable bowel syndrome QTL GWAS751608 (human) | | 8e-08 | irritable bowel syndrome | | 4 | 123130312 | 123130313 | Human |
597266292 | GWAS1362366_H | cortical thickness QTL GWAS1362366 (human) | | 2e-08 | cortical thickness | | 4 | 120741206 | 120741207 | Human |
597061497 | GWAS1157571_H | adolescent idiopathic scoliosis QTL GWAS1157571 (human) | | 0.000001 | adolescent idiopathic scoliosis | | 4 | 130877448 | 130877449 | Human |
406959283 | GWAS608259_H | breast carcinoma QTL GWAS608259 (human) | | 0.0000003 | mammary gland integrity trait (VT:0010552) | | 4 | 121205653 | 121205654 | Human |
597192557 | GWAS1288631_H | cortical thickness QTL GWAS1288631 (human) | | 6e-11 | cortical thickness | | 4 | 120708831 | 120708832 | Human |
596959074 | GWAS1078593_H | response to warfarin QTL GWAS1078593 (human) | | 0.000007 | response to warfarin | | 4 | 112988363 | 112988364 | Human |
597344109 | GWAS1440183_H | color vision disorder QTL GWAS1440183 (human) | | 0.000002 | color vision disorder | | 4 | 107331993 | 107331994 | Human |
597335906 | GWAS1431980_H | smoking initiation QTL GWAS1431980 (human) | | 6e-26 | smoking initiation | | 4 | 111500989 | 111500990 | Human |
597335907 | GWAS1431981_H | smoking initiation QTL GWAS1431981 (human) | | 2e-10 | smoking initiation | | 4 | 115079942 | 115079943 | Human |
597499748 | GWAS1595822_H | memory performance QTL GWAS1595822 (human) | | 0.00001 | memory performance | | 4 | 124888134 | 124888135 | Human |
597213026 | GWAS1309100_H | mathematical ability QTL GWAS1309100 (human) | | 4e-10 | mathematical ability | | 4 | 115118452 | 115118453 | Human |
597213027 | GWAS1309101_H | mathematical ability QTL GWAS1309101 (human) | | 5e-10 | mathematical ability | | 4 | 122105714 | 122105715 | Human |
597159787 | GWAS1255861_H | lipid measurement QTL GWAS1255861 (human) | | 0.000008 | lipid measurement | blood lipid measurement (CMO:0000050) | 4 | 122878832 | 122878833 | Human |
597213028 | GWAS1309102_H | mathematical ability QTL GWAS1309102 (human) | | 5e-08 | mathematical ability | | 4 | 130364875 | 130364876 | Human |
597266278 | GWAS1362352_H | cup-to-disc ratio measurement QTL GWAS1362352 (human) | | 2e-09 | cup-to-disc ratio measurement | | 4 | 111478355 | 111478356 | Human |
597057385 | GWAS1153459_H | intelligence QTL GWAS1153459 (human) | | 0.000001 | intelligence | | 4 | 130143535 | 130143536 | Human |
597266072 | GWAS1362146_H | cortical thickness QTL GWAS1362146 (human) | | 4e-08 | cortical thickness | | 4 | 120722571 | 120722572 | Human |
597048981 | GWAS1145055_H | cervical carcinoma QTL GWAS1145055 (human) | | 0.0000007 | cervical carcinoma | | 4 | 113726137 | 113726138 | Human |
597425821 | GWAS1521895_H | electrocardiography QTL GWAS1521895 (human) | | 4e-11 | electrocardiography | | 4 | 113463172 | 113463173 | Human |
407094596 | GWAS743572_H | balding measurement QTL GWAS743572 (human) | | 7e-10 | hair amount (VT:0000416) | coat/hair morphological measurement (CMO:0001807) | 4 | 107493233 | 107493234 | Human |
597614231 | GWAS1671091_H | seborrheic keratosis QTL GWAS1671091 (human) | | 2e-16 | seborrheic keratosis | | 4 | 124698876 | 124698877 | Human |
597606037 | GWAS1662897_H | obesity QTL GWAS1662897 (human) | | 4e-13 | obesity | | 4 | 129818987 | 129818988 | Human |
407041358 | GWAS690334_H | survival time, non-small cell lung carcinoma QTL GWAS690334 (human) | | 0.0000003 | survival time, non-small cell lung carcinoma | | 4 | 113625548 | 113625549 | Human |
597503625 | GWAS1599699_H | severe acute respiratory syndrome, COVID-19 QTL GWAS1599699 (human) | | 0.000002 | severe acute respiratory syndrome, COVID-19 | | 4 | 119432971 | 119432972 | Human |
597225100 | GWAS1321174_H | BMI-adjusted waist-hip ratio QTL GWAS1321174 (human) | | 3e-08 | body size trait (VT:0100005) | | 4 | 119607172 | 119607173 | Human |
406889812 | GWAS538788_H | waist-hip ratio QTL GWAS538788 (human) | | 5e-08 | waist-hip ratio | waist to hip ratio (WHR) (CMO:0000020) | 4 | 123145793 | 123145794 | Human |
407094617 | GWAS743593_H | cardioembolic stroke QTL GWAS743593 (human) | | 2e-47 | cardioembolic stroke | | 4 | 110793263 | 110793264 | Human |
597073548 | GWAS1169622_H | coronary artery disease QTL GWAS1169622 (human) | | 0.0000009 | coronary artery disease | | 4 | 124978810 | 124978811 | Human |
597372549 | GWAS1468623_H | HIV viral set point measurement QTL GWAS1468623 (human) | | 0.000006 | HIV viral set point measurement | | 4 | 120120131 | 120120132 | Human |
597171899 | GWAS1267973_H | protein measurement QTL GWAS1267973 (human) | | 4e-13 | protein measurement | | 4 | 108004097 | 108004098 | Human |
406963554 | GWAS612530_H | atrial fibrillation QTL GWAS612530 (human) | | 2e-34 | atrial fibrillation | | 4 | 110840331 | 110840332 | Human |
597192379 | GWAS1288453_H | cortical thickness QTL GWAS1288453 (human) | | 5e-15 | cortical thickness | | 4 | 120793484 | 120793485 | Human |
597528249 | GWAS1624323_H | systolic blood pressure QTL GWAS1624323 (human) | | 9e-09 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 4 | 123873489 | 123873490 | Human |
597487288 | GWAS1583362_H | mean corpuscular hemoglobin QTL GWAS1583362 (human) | | 3e-17 | mean corpuscular hemoglobin | mean corpuscular hemoglobin (CMO:0000290) | 4 | 127625245 | 127625246 | Human |
597528248 | GWAS1624322_H | systolic blood pressure QTL GWAS1624322 (human) | | 1e-24 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 4 | 110461529 | 110461530 | Human |
597528247 | GWAS1624321_H | systolic blood pressure QTL GWAS1624321 (human) | | 3e-24 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 4 | 110416708 | 110416709 | Human |
597151416 | GWAS1247490_H | phospholipids:total lipids ratio, high density lipoprotein cholesterol measurement QTL GWAS1247490 (human) | | 4e-20 | phospholipids:total lipids ratio, high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 4 | 109657070 | 109657071 | Human |
596950692 | GWAS1070211_H | Red cell distribution width QTL GWAS1070211 (human) | | 2e-23 | Red cell distribution width | | 4 | 128306129 | 128306130 | Human |
597364394 | GWAS1460468_H | dental caries QTL GWAS1460468 (human) | | 0.000003 | dental caries | | 4 | 112605916 | 112605917 | Human |
597364393 | GWAS1460467_H | dental caries QTL GWAS1460467 (human) | | 0.000003 | dental caries | | 4 | 111359586 | 111359587 | Human |
597089954 | GWAS1186028_H | mean reticulocyte volume QTL GWAS1186028 (human) | | 6e-11 | reticulocyte morphology trait (VT:0002424) | mean corpuscular volume (CMO:0000038) | 4 | 122215361 | 122215362 | Human |
597089953 | GWAS1186027_H | mean reticulocyte volume QTL GWAS1186027 (human) | | 6e-57 | reticulocyte morphology trait (VT:0002424) | mean corpuscular volume (CMO:0000038) | 4 | 121877258 | 121877259 | Human |
597315234 | GWAS1411308_H | vaginal microbiome measurement QTL GWAS1411308 (human) | | 0.0000004 | vaginal microbiome measurement | | 4 | 107383042 | 107383043 | Human |
406947193 | GWAS596169_H | coronary artery disease QTL GWAS596169 (human) | | 0.000005 | coronary artery disease | | 4 | 110812980 | 110812981 | Human |
597266081 | GWAS1362155_H | cortical thickness QTL GWAS1362155 (human) | | 4e-12 | cortical thickness | | 4 | 120758655 | 120758656 | Human |
597315235 | GWAS1411309_H | vaginal microbiome measurement QTL GWAS1411309 (human) | | 0.0000004 | vaginal microbiome measurement | | 4 | 107467275 | 107467276 | Human |
597266085 | GWAS1362159_H | cortical thickness QTL GWAS1362159 (human) | | 2e-10 | cortical thickness | | 4 | 120722571 | 120722572 | Human |
597593760 | GWAS1650620_H | potassium measurement QTL GWAS1650620 (human) | | 8e-14 | potassium measurement | blood potassium level (CMO:0000496) | 4 | 108140367 | 108140368 | Human |
597225179 | GWAS1321253_H | chronotype measurement QTL GWAS1321253 (human) | | 1e-08 | chronotype measurement | | 4 | 113069787 | 113069788 | Human |
597532377 | GWAS1628451_H | pain QTL GWAS1628451 (human) | | 6e-10 | pain | | 4 | 111582716 | 111582717 | Human |
597618394 | GWAS1675254_H | artificial cardiac pacemaker QTL GWAS1675254 (human) | | 3e-12 | artificial cardiac pacemaker | | 4 | 113504778 | 113504779 | Human |
597118673 | GWAS1214747_H | bipolar disorder, ulcerative colitis QTL GWAS1214747 (human) | | 2e-12 | bipolar disorder, ulcerative colitis | | 4 | 122154852 | 122154853 | Human |
597618393 | GWAS1675253_H | artificial cardiac pacemaker QTL GWAS1675253 (human) | | 3e-12 | artificial cardiac pacemaker | | 4 | 110780642 | 110780643 | Human |
597397200 | GWAS1493274_H | vaginal microbiome measurement QTL GWAS1493274 (human) | | 0.000008 | vaginal microbiome measurement | | 4 | 120143632 | 120143633 | Human |
597532369 | GWAS1628443_H | alcohol use disorder measurement QTL GWAS1628443 (human) | | 3e-12 | alcohol use disorder measurement | | 4 | 111546456 | 111546457 | Human |
597102279 | GWAS1198353_H | platelet count QTL GWAS1198353 (human) | | 3e-09 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 4 | 109979991 | 109979992 | Human |
597151430 | GWAS1247504_H | lifestyle measurement, anxiety disorder measurement QTL GWAS1247504 (human) | | 5e-13 | anxiety-related behavior trait (VT:0010716) | | 4 | 122322628 | 122322629 | Human |
597466830 | GWAS1562904_H | atrial fibrillation QTL GWAS1562904 (human) | | 9e-09 | atrial fibrillation | | 4 | 113507558 | 113507559 | Human |
597466831 | GWAS1562905_H | atrial fibrillation QTL GWAS1562905 (human) | | 2e-09 | atrial fibrillation | | 4 | 113507558 | 113507559 | Human |
597434063 | GWAS1530137_H | protein measurement QTL GWAS1530137 (human) | | 3e-27 | protein measurement | | 4 | 121659570 | 121659571 | Human |
406963480 | GWAS612456_H | alopecia areata QTL GWAS612456 (human) | | 4e-08 | alopecia areata | | 4 | 122602720 | 122602721 | Human |
406971677 | GWAS620653_H | sporadic amyotrophic lateral sclerosis QTL GWAS620653 (human) | | 0.0000001 | sporadic amyotrophic lateral sclerosis | | 4 | 108706869 | 108706870 | Human |
597618370 | GWAS1675230_H | humerus fracture QTL GWAS1675230 (human) | | 7e-12 | humerus fracture | | 4 | 113504938 | 113504939 | Human |
597298887 | GWAS1394961_H | platelet count QTL GWAS1394961 (human) | | 4e-24 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 4 | 109924690 | 109924691 | Human |
406971679 | GWAS620655_H | sporadic amyotrophic lateral sclerosis QTL GWAS620655 (human) | | 0.000002 | sporadic amyotrophic lateral sclerosis | | 4 | 119030492 | 119030493 | Human |
597298885 | GWAS1394959_H | platelet count QTL GWAS1394959 (human) | | 3e-40 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 4 | 110027510 | 110027511 | Human |
597364475 | GWAS1460549_H | hemoglobin measurement QTL GWAS1460549 (human) | | 1e-12 | hemoglobin measurement | hemoglobin measurement (CMO:0000508) | 4 | 123835365 | 123835366 | Human |
597270264 | GWAS1366338_H | metabolite measurement QTL GWAS1366338 (human) | | 3e-52 | metabolite measurement | | 4 | 129109497 | 129109498 | Human |
597593853 | GWAS1650713_H | potassium measurement QTL GWAS1650713 (human) | | 1e-16 | potassium measurement | blood potassium level (CMO:0000496) | 4 | 108140367 | 108140368 | Human |
597110515 | GWAS1206589_H | Calcium channel blocker use measurement QTL GWAS1206589 (human) | | 5e-10 | Calcium channel blocker use measurement | | 4 | 110510288 | 110510289 | Human |
406983974 | GWAS632950_H | unipolar depression QTL GWAS632950 (human) | | 2e-10 | unipolar depression | | 4 | 130316226 | 130316227 | Human |
597061374 | GWAS1157448_H | metabolic syndrome QTL GWAS1157448 (human) | | 4e-08 | metabolic syndrome | | 4 | 119318723 | 119318724 | Human |
596983548 | GWAS1103067_H | memory performance QTL GWAS1103067 (human) | | 0.000003 | memory performance | | 4 | 124861382 | 124861383 | Human |
597061372 | GWAS1157446_H | metabolic syndrome QTL GWAS1157446 (human) | | 1e-08 | metabolic syndrome | | 4 | 111770620 | 111770621 | Human |
597049085 | GWAS1145159_H | neuroticism measurement QTL GWAS1145159 (human) | | 2e-08 | neuroticism measurement | | 4 | 118015036 | 118015037 | Human |
597061373 | GWAS1157447_H | metabolic syndrome QTL GWAS1157447 (human) | | 2e-09 | metabolic syndrome | | 4 | 118238526 | 118238527 | Human |
407082280 | GWAS731256_H | unipolar depression QTL GWAS731256 (human) | | 0.000005 | unipolar depression | | 4 | 127836228 | 127836229 | Human |
597327604 | GWAS1423678_H | X-14189--leucylalanine measurement QTL GWAS1423678 (human) | | 6e-12 | X-14189--leucylalanine measurement | | 4 | 110510288 | 110510289 | Human |
597122809 | GWAS1218883_H | bipolar disorder, Crohn's disease QTL GWAS1218883 (human) | | 4e-12 | intestine integrity trait (VT:0010554) | | 4 | 122154852 | 122154853 | Human |
597618417 | GWAS1675277_H | atrial fibrillation QTL GWAS1675277 (human) | | 1e-323 | atrial fibrillation | | 4 | 110720030 | 110720031 | Human |
597303016 | GWAS1399090_H | monocyte count QTL GWAS1399090 (human) | | 2e-18 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 4 | 110024100 | 110024101 | Human |
597532398 | GWAS1628472_H | color vision disorder QTL GWAS1628472 (human) | | 0.000003 | color vision disorder | | 4 | 108200574 | 108200575 | Human |
407217457 | GWAS866433_H | mean corpuscular hemoglobin concentration QTL GWAS866433 (human) | | 4e-31 | mean corpuscular hemoglobin concentration | mean corpuscular hemoglobin concentration (CMO:0000291) | 4 | 127878475 | 127878476 | Human |
597511915 | GWAS1607989_H | Agents acting on the renin-angiotensin system use measurement QTL GWAS1607989 (human) | | 4e-09 | Agents acting on the renin-angiotensin system use measurement | | 4 | 110420710 | 110420711 | Human |
597290735 | GWAS1386809_H | Crohn's disease QTL GWAS1386809 (human) | | 6e-09 | intestine integrity trait (VT:0010554) | | 4 | 122420959 | 122420960 | Human |
597585636 | GWAS1642496_H | eosinophil count QTL GWAS1642496 (human) | | 6e-18 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 4 | 122680359 | 122680360 | Human |
597397223 | GWAS1493297_H | vaginal microbiome measurement QTL GWAS1493297 (human) | | 0.0000007 | vaginal microbiome measurement | | 4 | 116138019 | 116138020 | Human |
597532385 | GWAS1628459_H | atopic eczema QTL GWAS1628459 (human) | | 1e-62 | atopic eczema | | 4 | 122465565 | 122465566 | Human |
597409510 | GWAS1505584_H | radiation-induced disorder QTL GWAS1505584 (human) | | 0.000006 | radiation-induced disorder | | 4 | 118888417 | 118888418 | Human |
597523997 | GWAS1620071_H | smoking initiation QTL GWAS1620071 (human) | | 6e-10 | smoking initiation | | 4 | 117807381 | 117807382 | Human |
597523996 | GWAS1620070_H | smoking initiation QTL GWAS1620070 (human) | | 3e-14 | smoking initiation | | 4 | 115629116 | 115629117 | Human |
407381450 | GWAS1030426_H | hematocrit QTL GWAS1030426 (human) | | 2e-12 | hematocrit | hematocrit (CMO:0000037) | 4 | 114598669 | 114598670 | Human |
597523999 | GWAS1620073_H | smoking initiation QTL GWAS1620073 (human) | | 3e-09 | smoking initiation | | 4 | 126727157 | 126727158 | Human |
597523998 | GWAS1620072_H | smoking initiation QTL GWAS1620072 (human) | | 2e-13 | smoking initiation | | 4 | 120650494 | 120650495 | Human |
597192223 | GWAS1288297_H | heart failure QTL GWAS1288297 (human) | | 4e-29 | heart failure | | 4 | 110748064 | 110748065 | Human |
596983314 | GWAS1102833_H | memory performance QTL GWAS1102833 (human) | | 0.000006 | memory performance | | 4 | 124891420 | 124891421 | Human |
597163536 | GWAS1259610_H | insomnia measurement QTL GWAS1259610 (human) | | 2e-08 | sleep behavior trait (VT:0001501) | | 4 | 129592716 | 129592717 | Human |
597065247 | GWAS1161321_H | type 1 diabetes mellitus QTL GWAS1161321 (human) | | 6e-13 | type 1 diabetes mellitus | | 4 | 122322441 | 122322442 | Human |
597044764 | GWAS1140838_H | refractive error QTL GWAS1140838 (human) | | 1e-10 | refractive error | | 4 | 119680603 | 119680604 | Human |
597044765 | GWAS1140839_H | refractive error QTL GWAS1140839 (human) | | 3e-12 | refractive error | | 4 | 119987548 | 119987549 | Human |
597192212 | GWAS1288286_H | heart failure QTL GWAS1288286 (human) | | 2e-09 | heart failure | | 4 | 113463172 | 113463173 | Human |
407369163 | GWAS1018139_H | venous thromboembolism QTL GWAS1018139 (human) | | 0.0000009 | venous thromboembolism | | 4 | 131174124 | 131174125 | Human |
597294612 | GWAS1390686_H | ceramide measurement QTL GWAS1390686 (human) | | 3e-13 | ceramide measurement | | 4 | 114553199 | 114553200 | Human |
597093915 | GWAS1189989_H | FEV/FVC ratio, response to bronchodilator QTL GWAS1189989 (human) | | 0.000002 | FEV/FVC ratio, response to bronchodilator | forced expiratory volume to forced vital capacity ratio (CMO:0000241) | 4 | 129479620 | 129479621 | Human |
597360148 | GWAS1456222_H | chronic lymphocytic leukemia QTL GWAS1456222 (human) | | 3e-09 | leukocyte integrity trait (VT:0010898) | | 4 | 113762688 | 113762689 | Human |
597294615 | GWAS1390689_H | ceramide measurement QTL GWAS1390689 (human) | | 2e-09 | ceramide measurement | | 4 | 114559783 | 114559784 | Human |
597057048 | GWAS1153122_H | eosinophil count QTL GWAS1153122 (human) | | 5e-23 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 4 | 122263256 | 122263257 | Human |
597057049 | GWAS1153123_H | eosinophil count QTL GWAS1153123 (human) | | 3e-10 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 4 | 123311945 | 123311946 | Human |
597286411 | GWAS1382485_H | Ischemic stroke QTL GWAS1382485 (human) | | 1e-08 | Ischemic stroke | | 4 | 112810934 | 112810935 | Human |
406947282 | GWAS596258_H | malignant epithelial tumor of ovary QTL GWAS596258 (human) | | 2e-08 | malignant epithelial tumor of ovary | | 4 | 119028805 | 119028806 | Human |
597294605 | GWAS1390679_H | ceramide measurement QTL GWAS1390679 (human) | | 1e-08 | ceramide measurement | | 4 | 114573629 | 114573630 | Human |
597282317 | GWAS1378391_H | COVID-19 QTL GWAS1378391 (human) | | 0.000003 | COVID-19 | | 4 | 120985638 | 120985639 | Human |
597294607 | GWAS1390681_H | ceramide measurement QTL GWAS1390681 (human) | | 1e-11 | ceramide measurement | | 4 | 114725282 | 114725283 | Human |
597093888 | GWAS1189962_H | 3-hydroxy-1-methylpropylmercapturic acid measurement QTL GWAS1189962 (human) | | 0.000001 | 3-hydroxy-1-methylpropylmercapturic acid measurement | | 4 | 123994124 | 123994125 | Human |
597294606 | GWAS1390680_H | ceramide measurement QTL GWAS1390680 (human) | | 3e-18 | ceramide measurement | | 4 | 114663873 | 114663874 | Human |
597229056 | GWAS1325130_H | BMI-adjusted waist-hip ratio QTL GWAS1325130 (human) | | 1e-09 | body size trait (VT:0100005) | | 4 | 119607172 | 119607173 | Human |
597192192 | GWAS1288266_H | cortical thickness QTL GWAS1288266 (human) | | 3e-09 | cortical thickness | | 4 | 120704578 | 120704579 | Human |
596950540 | GWAS1070059_H | major depressive disorder QTL GWAS1070059 (human) | | 2e-10 | depressive symptom measurement | | 4 | 122201701 | 122201702 | Human |
597024268 | GWAS1120342_H | alcohol use disorder measurement, response to trauma exposure QTL GWAS1120342 (human) | | 3e-08 | alcohol use disorder measurement, response to trauma exposure | | 4 | 129416904 | 129416905 | Human |
406910427 | GWAS559403_H | systemic lupus erythematosus QTL GWAS559403 (human) | | 0.000002 | systemic lupus erythematosus | | 4 | 108125804 | 108125805 | Human |
597417479 | GWAS1513553_H | protein measurement QTL GWAS1513553 (human) | | 2e-08 | protein measurement | | 4 | 116050074 | 116050075 | Human |
407168475 | GWAS817451_H | FEV/FVC ratio, allergen exposure measurement QTL GWAS817451 (human) | | 0.000002 | FEV/FVC ratio, allergen exposure measurement | forced expiratory volume to forced vital capacity ratio (CMO:0000241) | 4 | 118194762 | 118194763 | Human |
597204538 | GWAS1300612_H | asthma QTL GWAS1300612 (human) | | 5e-14 | asthma | | 4 | 122219915 | 122219916 | Human |
597331513 | GWAS1427587_H | Tinnitus QTL GWAS1427587 (human) | | 0.0000004 | Tinnitus | | 4 | 110681577 | 110681578 | Human |
597286460 | GWAS1382534_H | eosinophil count QTL GWAS1382534 (human) | | 4e-21 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 4 | 122408207 | 122408208 | Human |
597519928 | GWAS1616002_H | IGFBP-3 measurement QTL GWAS1616002 (human) | | 0.0000002 | IGFBP-3 measurement | | 4 | 123840924 | 123840925 | Human |
597143088 | GWAS1239162_H | Antihypertensive use measurement QTL GWAS1239162 (human) | | 2e-10 | Antihypertensive use measurement | | 4 | 108123712 | 108123713 | Human |
597392946 | GWAS1489020_H | lifestyle measurement QTL GWAS1489020 (human) | | 8e-09 | lifestyle measurement | | 4 | 129365346 | 129365348 | Human |
597290547 | GWAS1386621_H | lymphocyte measurement, neutrophil measurement QTL GWAS1386621 (human) | | 2e-14 | lymphocyte measurement, neutrophil measurement | | 4 | 112190016 | 112190017 | Human |
597392945 | GWAS1489019_H | lifestyle measurement QTL GWAS1489019 (human) | | 3e-09 | lifestyle measurement | | 4 | 117436249 | 117436250 | Human |
597401136 | GWAS1497210_H | spine bone mineral density QTL GWAS1497210 (human) | | 0.0000003 | spine bone mineral density | bone mineral density (CMO:0001226) | 4 | 125801465 | 125801466 | Human |
597413431 | GWAS1509505_H | metabolic syndrome QTL GWAS1509505 (human) | | 1e-11 | metabolic syndrome | | 4 | 129810129 | 129810130 | Human |
597511731 | GWAS1607805_H | total cholesterol measurement QTL GWAS1607805 (human) | | 3e-09 | total cholesterol measurement | blood total cholesterol level (CMO:0000051) | 4 | 119202262 | 119202263 | Human |
597302827 | GWAS1398901_H | mean corpuscular hemoglobin concentration QTL GWAS1398901 (human) | | 5e-12 | mean corpuscular hemoglobin concentration | mean corpuscular hemoglobin concentration (CMO:0000291) | 4 | 109921984 | 109921985 | Human |
407156214 | GWAS805190_H | gut microbiome measurement QTL GWAS805190 (human) | | 0.000003 | gut microbiome measurement | | 4 | 119309995 | 119309996 | Human |
597016098 | GWAS1112172_H | pulse pressure measurement QTL GWAS1112172 (human) | | 0.0000007 | pulse pressure measurement | pulse pressure (CMO:0000292) | 4 | 122671579 | 122671580 | Human |
597466662 | GWAS1562736_H | body mass index QTL GWAS1562736 (human) | | 2e-14 | body mass index | body mass index (BMI) (CMO:0000105) | 4 | 129843450 | 129843451 | Human |
597048874 | GWAS1144948_H | non-small cell lung carcinoma QTL GWAS1144948 (human) | | 0.000004 | non-small cell lung carcinoma | | 4 | 121873960 | 121873961 | Human |
597311015 | GWAS1407089_H | vaginal microbiome measurement QTL GWAS1407089 (human) | | 0.000001 | vaginal microbiome measurement | | 4 | 108166673 | 108166674 | Human |
597487196 | GWAS1583270_H | ceramide measurement QTL GWAS1583270 (human) | | 2e-08 | ceramide measurement | | 4 | 129692156 | 129692157 | Human |
597081684 | GWAS1177758_H | lymphocyte count QTL GWAS1177758 (human) | | 6e-10 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 4 | 122579931 | 122579932 | Human |
597081682 | GWAS1177756_H | lymphocyte count QTL GWAS1177756 (human) | | 6e-20 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 4 | 109914892 | 109914893 | Human |
597081683 | GWAS1177757_H | lymphocyte count QTL GWAS1177757 (human) | | 1e-25 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 4 | 112152543 | 112152544 | Human |
597196381 | GWAS1292455_H | memory performance QTL GWAS1292455 (human) | | 0.000008 | memory performance | | 4 | 124893791 | 124893792 | Human |
597196382 | GWAS1292456_H | memory performance QTL GWAS1292456 (human) | | 0.000008 | memory performance | | 4 | 124895966 | 124895967 | Human |
597216850 | GWAS1312924_H | childhood onset asthma QTL GWAS1312924 (human) | | 6e-36 | childhood onset asthma | | 4 | 122432277 | 122432278 | Human |
597048898 | GWAS1144972_H | allergic rhinitis QTL GWAS1144972 (human) | | 3e-15 | allergic rhinitis | | 4 | 122496409 | 122496410 | Human |
597286476 | GWAS1382550_H | COVID-19 QTL GWAS1382550 (human) | | 0.0000009 | COVID-19 | | 4 | 107808529 | 107808530 | Human |
597618240 | GWAS1675100_H | chronic pancreatitis QTL GWAS1675100 (human) | | 2e-12 | chronic pancreatitis | | 4 | 116090374 | 116090375 | Human |
597147208 | GWAS1243282_H | prostate carcinoma QTL GWAS1243282 (human) | | 0.000001 | prostate carcinoma | | 4 | 109927496 | 109927497 | Human |
597032564 | GWAS1128638_H | bipolar disorder QTL GWAS1128638 (human) | | 0.000006 | bipolar disorder | | 4 | 117740497 | 117740498 | Human |
597343867 | GWAS1439941_H | color vision disorder QTL GWAS1439941 (human) | | 0.000008 | color vision disorder | | 4 | 129487149 | 129487150 | Human |
597413503 | GWAS1509577_H | delta-5 desaturase measurement, response to polyunsaturated fatty acid supplementation QTL GWAS1509577 (human) | | 1e-09 | delta-5 desaturase measurement, response to polyunsaturated fatty acid supplementation | | 4 | 117452280 | 117452281 | Human |
597024381 | GWAS1120455_H | maximal voluntary ventilation, pulmonary function measurement QTL GWAS1120455 (human) | | 2e-09 | vital capacity | respiratory system measurement (CMO:0000094) | 4 | 120683279 | 120683280 | Human |
597266032 | GWAS1362106_H | triglyceride measurement QTL GWAS1362106 (human) | | 1e-44 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 4 | 109717668 | 109717669 | Human |
597081727 | GWAS1177801_H | gut microbiome measurement QTL GWAS1177801 (human) | | 0.000004 | gut microbiome measurement | | 4 | 118997805 | 118997806 | Human |
597499508 | GWAS1595582_H | diastolic blood pressure QTL GWAS1595582 (human) | | 0.0000007 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 4 | 123873489 | 123873490 | Human |
597024382 | GWAS1120456_H | forced expiratory volume QTL GWAS1120456 (human) | | 4e-09 | forced expiratory volume | forced expiratory volume (CMO:0000254) | 4 | 120683279 | 120683280 | Human |
597495408 | GWAS1591482_H | platelet count QTL GWAS1591482 (human) | | 1e-09 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 4 | 119334573 | 119334574 | Human |
597499507 | GWAS1595581_H | diastolic blood pressure QTL GWAS1595581 (human) | | 5e-27 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 4 | 110461529 | 110461530 | Human |
597323380 | GWAS1419454_H | cup-to-disc ratio measurement QTL GWAS1419454 (human) | | 5e-17 | cup-to-disc ratio measurement | | 4 | 125486143 | 125486144 | Human |
597499506 | GWAS1595580_H | diastolic blood pressure QTL GWAS1595580 (human) | | 2e-27 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 4 | 110416708 | 110416709 | Human |
597036646 | GWAS1132720_H | body mass index QTL GWAS1132720 (human) | | 3e-10 | body mass index | body mass index (BMI) (CMO:0000105) | 4 | 112392830 | 112392831 | Human |
597614190 | GWAS1671050_H | chronic laryngitis QTL GWAS1671050 (human) | | 7e-14 | chronic laryngitis | | 4 | 114913365 | 114913366 | Human |
597614191 | GWAS1671051_H | chronic laryngitis QTL GWAS1671051 (human) | | 4e-12 | chronic laryngitis | | 4 | 129677938 | 129677939 | Human |
597163619 | GWAS1259693_H | Ischemic stroke, factor VII measurement QTL GWAS1259693 (human) | | 1e-16 | Ischemic stroke, tissue plasminogen activator measurement | | 4 | 110775495 | 110775496 | Human |
597290606 | GWAS1386680_H | coronary artery disease QTL GWAS1386680 (human) | | 4e-08 | coronary artery disease | | 4 | 110757945 | 110757946 | Human |
597098095 | GWAS1194169_H | sex hormone-binding globulin measurement QTL GWAS1194169 (human) | | 3e-11 | sex hormone-binding globulin measurement | | 4 | 128110633 | 128110634 | Human |
597245538 | GWAS1341612_H | sex hormone-binding globulin measurement QTL GWAS1341612 (human) | | 1e-11 | sex hormone-binding globulin measurement | | 4 | 109104450 | 109104451 | Human |
597319068 | GWAS1415142_H | diastolic blood pressure, systolic blood pressure QTL GWAS1415142 (human) | | 2e-08 | diastolic blood pressure, systolic blood pressure | systolic blood pressure (CMO:0000004) | 4 | 119856151 | 119856152 | Human |
597294494 | GWAS1390568_H | ceramide measurement QTL GWAS1390568 (human) | | 2e-11 | ceramide measurement | | 4 | 114663873 | 114663874 | Human |
597314973 | GWAS1411047_H | retinal vasculature measurement QTL GWAS1411047 (human) | | 4e-08 | retina blood vessel morphology trait (VT:0002792) | | 4 | 119151914 | 119151915 | Human |
597265822 | GWAS1361896_H | cup-to-disc ratio measurement QTL GWAS1361896 (human) | | 1e-11 | cup-to-disc ratio measurement | | 4 | 125318831 | 125318832 | Human |
597163421 | GWAS1259495_H | guanosine measurement QTL GWAS1259495 (human) | | 0.00001 | guanosine measurement | | 4 | 113514721 | 113514722 | Human |
597368213 | GWAS1464287_H | balding measurement QTL GWAS1464287 (human) | | 2e-33 | hair amount (VT:0000416) | coat/hair morphological measurement (CMO:0001807) | 4 | 107131838 | 107131839 | Human |
597101976 | GWAS1198050_H | coronary artery disease QTL GWAS1198050 (human) | | 2e-08 | coronary artery disease | | 4 | 120015426 | 120015427 | Human |
596966788 | GWAS1086307_H | body mass index QTL GWAS1086307 (human) | | 1e-08 | body mass index | | 4 | 119738082 | 119738083 | Human |
597204360 | GWAS1300434_H | asthma QTL GWAS1300434 (human) | | 8e-12 | asthma | | 4 | 122432277 | 122432278 | Human |
597265804 | GWAS1361878_H | triglyceride measurement QTL GWAS1361878 (human) | | 3e-33 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 4 | 109174464 | 109174465 | Human |
597228941 | GWAS1325015_H | childhood trauma measurement QTL GWAS1325015 (human) | | 1e-08 | childhood trauma measurement | | 4 | 118266477 | 118266478 | Human |
597425539 | GWAS1521613_H | depressive symptom measurement, stressful life event measurement QTL GWAS1521613 (human) | | 0.000008 | depressive symptom measurement, stressful life event measurement | | 4 | 110061116 | 110061117 | Human |
597433735 | GWAS1529809_H | protein measurement QTL GWAS1529809 (human) | | 2e-183 | protein measurement | | 4 | 119360222 | 119360223 | Human |
597126536 | GWAS1222610_H | Crohn's disease QTL GWAS1222610 (human) | | 0.0000007 | intestine integrity trait (VT:0010554) | | 4 | 113154532 | 113154533 | Human |
407225946 | GWAS874922_H | response to carboplatin QTL GWAS874922 (human) | | 0.000006 | response to carboplatin | | 4 | 115920168 | 115920169 | Human |
407230055 | GWAS879031_H | autoimmune thyroid disease, type 1 diabetes mellitus QTL GWAS879031 (human) | | 4e-10 | autoimmune thyroid disease, type 1 diabetes mellitus | | 4 | 121392885 | 121392886 | Human |
596983223 | GWAS1102742_H | memory performance QTL GWAS1102742 (human) | | 0.000006 | memory performance | | 4 | 124897660 | 124897661 | Human |
597134773 | GWAS1230847_H | memory performance, sex interaction measurement QTL GWAS1230847 (human) | | 0.000004 | memory performance, sex interaction measurement | | 4 | 125584117 | 125584118 | Human |
597048757 | GWAS1144831_H | squamous cell lung carcinoma QTL GWAS1144831 (human) | | 0.0000005 | squamous cell lung carcinoma | | 4 | 121873960 | 121873961 | Human |
597343673 | GWAS1439747_H | color vision disorder QTL GWAS1439747 (human) | | 0.000006 | color vision disorder | | 4 | 125161562 | 125161563 | Human |
597102015 | GWAS1198089_H | Obsessive-compulsive trait QTL GWAS1198089 (human) | | 0.000009 | Obsessive-compulsive trait | | 4 | 107836793 | 107836794 | Human |
597593527 | GWAS1650387_H | macular degeneration QTL GWAS1650387 (human) | | 9e-27 | macular degeneration | | 4 | 109764664 | 109764665 | Human |
596983228 | GWAS1102747_H | memory performance QTL GWAS1102747 (human) | | 0.000006 | memory performance | | 4 | 124885712 | 124885713 | Human |
597327280 | GWAS1423354_H | fibrinopeptide A measurement QTL GWAS1423354 (human) | | 1e-12 | fibrinopeptide A measurement | | 4 | 110510288 | 110510289 | Human |
597327281 | GWAS1423355_H | fibrinopeptide A measurement QTL GWAS1423355 (human) | | 1e-42 | fibrinopeptide A measurement | | 4 | 110510288 | 110510289 | Human |
597503414 | GWAS1599488_H | caproate 6:0 measurement QTL GWAS1599488 (human) | | 0.000005 | caproate 6:0 measurement | | 4 | 132246564 | 132246565 | Human |
597015992 | GWAS1112066_H | late-onset Alzheimers disease QTL GWAS1112066 (human) | | 0.000002 | late-onset Alzheimers disease | | 4 | 109373310 | 109373311 | Human |
597405110 | GWAS1501184_H | uterine prolapse QTL GWAS1501184 (human) | | 4e-17 | uterine prolapse | | 4 | 126003911 | 126003912 | Human |
597409195 | GWAS1505269_H | Ischemic stroke QTL GWAS1505269 (human) | | 5e-14 | Ischemic stroke | | 4 | 110793263 | 110793264 | Human |
597409193 | GWAS1505267_H | cardioembolic stroke QTL GWAS1505267 (human) | | 5e-41 | cardioembolic stroke | | 4 | 110793263 | 110793264 | Human |
597327278 | GWAS1423352_H | fibrinopeptide A measurement QTL GWAS1423352 (human) | | 3e-15 | fibrinopeptide A measurement | | 4 | 110510288 | 110510289 | Human |
596975009 | GWAS1094528_H | 2-O-methylascorbic acid measurement, sex interaction measurement QTL GWAS1094528 (human) | | 0.0000008 | 2-O-methylascorbic acid measurement, sex interaction measurement | | 4 | 113095111 | 113095112 | Human |
597327279 | GWAS1423353_H | fibrinopeptide A measurement QTL GWAS1423353 (human) | | 8e-15 | fibrinopeptide A measurement | | 4 | 110485340 | 110485341 | Human |
597142959 | GWAS1239033_H | triglyceride measurement QTL GWAS1239033 (human) | | 7e-11 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 4 | 109648464 | 109648465 | Human |
597593510 | GWAS1650370_H | macular degeneration QTL GWAS1650370 (human) | | 5e-13 | macular degeneration | | 4 | 109764664 | 109764665 | Human |
597294497 | GWAS1390571_H | ceramide measurement QTL GWAS1390571 (human) | | 2e-08 | ceramide measurement | | 4 | 114553199 | 114553200 | Human |
597093804 | GWAS1189878_H | myocardial infarction QTL GWAS1189878 (human) | | 0.000009 | myocardial infarction | | 4 | 118789266 | 118789267 | Human |
597093805 | GWAS1189879_H | myocardial infarction QTL GWAS1189879 (human) | | 0.0000006 | myocardial infarction | | 4 | 118789266 | 118789267 | Human |
597200292 | GWAS1296366_H | restless legs syndrome QTL GWAS1296366 (human) | | 8e-11 | restless legs syndrome | | 4 | 115033802 | 115033803 | Human |
597093802 | GWAS1189876_H | myocardial infarction QTL GWAS1189876 (human) | | 0.000007 | myocardial infarction | | 4 | 118770469 | 118770470 | Human |
597429664 | GWAS1525738_H | platelet count QTL GWAS1525738 (human) | | 1e-17 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 4 | 119342213 | 119342215 | Human |
597200293 | GWAS1296367_H | restless legs syndrome QTL GWAS1296367 (human) | | 5e-08 | restless legs syndrome | | 4 | 118105491 | 118105492 | Human |
597429665 | GWAS1525739_H | platelet count QTL GWAS1525739 (human) | | 2e-11 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 4 | 123749526 | 123749527 | Human |
597429666 | GWAS1525740_H | platelet count QTL GWAS1525740 (human) | | 8e-12 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 4 | 123882996 | 123882997 | Human |
597368228 | GWAS1464302_H | balding measurement QTL GWAS1464302 (human) | | 4e-32 | hair amount (VT:0000416) | coat/hair morphological measurement (CMO:0001807) | 4 | 106635172 | 106635173 | Human |
597114280 | GWAS1210354_H | reticulocyte count QTL GWAS1210354 (human) | | 3e-18 | reticulocyte quantity (VT:0003135) | total reticulocyte count (CMO:0003020) | 4 | 109944309 | 109944310 | Human |
597212634 | GWAS1308708_H | celiac disease QTL GWAS1308708 (human) | | 4e-11 | celiac disease | | 4 | 122345366 | 122345367 | Human |
596975056 | GWAS1094575_H | major depressive disorder QTL GWAS1094575 (human) | | 3e-24 | major depressive disorder | | 4 | 122201701 | 122201702 | Human |
596983251 | GWAS1102770_H | memory performance QTL GWAS1102770 (human) | | 0.0000003 | memory performance | | 4 | 128552943 | 128552944 | Human |
597396956 | GWAS1493030_H | cortical thickness QTL GWAS1493030 (human) | | 3e-08 | cortical thickness | | 4 | 126550097 | 126550098 | Human |
597282248 | GWAS1378322_H | hemoglobin measurement QTL GWAS1378322 (human) | | 1e-10 | hemoglobin measurement | hemoglobin measurement (CMO:0000508) | 4 | 124004016 | 124004017 | Human |
406939157 | GWAS588133_H | hemoglobin measurement QTL GWAS588133 (human) | | 2e-18 | hemoglobin measurement | hemoglobin measurement (CMO:0000508) | 4 | 114616986 | 114616987 | Human |
597183949 | GWAS1280023_H | smoking cessation QTL GWAS1280023 (human) | | 9e-13 | smoking cessation | | 4 | 112122274 | 112122275 | Human |
597257671 | GWAS1353745_H | atrial fibrillation QTL GWAS1353745 (human) | | 9e-10 | atrial fibrillation | | 4 | 110491909 | 110491910 | Human |
597282247 | GWAS1378321_H | hemoglobin measurement QTL GWAS1378321 (human) | | 3e-11 | hemoglobin measurement | hemoglobin measurement (CMO:0000508) | 4 | 114551415 | 114551416 | Human |
597257670 | GWAS1353744_H | atrial fibrillation QTL GWAS1353744 (human) | | 2e-09 | atrial fibrillation | | 4 | 110485663 | 110485664 | Human |
597278200 | GWAS1374274_H | low density lipoprotein cholesterol measurement QTL GWAS1374274 (human) | | 4e-08 | low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 4 | 109997531 | 109997532 | Human |
597278203 | GWAS1374277_H | age-related macular degeneration, COVID-19 QTL GWAS1374277 (human) | | 2e-18 | age-related macular degeneration, COVID-19 | | 4 | 109737911 | 109737912 | Human |
597327353 | GWAS1423427_H | testicular hydrocele, filarial elephantiasis QTL GWAS1423427 (human) | | 0.0000009 | testicular hydrocele, filarial elephantiasis | | 4 | 112132236 | 112132237 | Human |
597286397 | GWAS1382471_H | body weight QTL GWAS1382471 (human) | | 3e-08 | body mass (VT:0001259) | body weight (CMO:0000012) | 4 | 109829417 | 109829418 | Human |
597417471 | GWAS1513545_H | reticulocyte count QTL GWAS1513545 (human) | | 3e-12 | reticulocyte quantity (VT:0003135) | total reticulocyte count (CMO:0003020) | 4 | 128330896 | 128330897 | Human |
597257724 | GWAS1353798_H | aminoadipic acid measurement QTL GWAS1353798 (human) | | 0.000001 | amino acid metabolism trait (VT:0010631) | | 4 | 117057786 | 117057787 | Human |
597286399 | GWAS1382473_H | body weight QTL GWAS1382473 (human) | | 9e-10 | body mass (VT:0001259) | body weight (CMO:0000012) | 4 | 122906887 | 122906888 | Human |
407389743 | GWAS1038719_H | atrial fibrillation QTL GWAS1038719 (human) | | 8e-46 | atrial fibrillation | | 4 | 110767596 | 110767597 | Human |
597286398 | GWAS1382472_H | body weight QTL GWAS1382472 (human) | | 1e-08 | body mass (VT:0001259) | body weight (CMO:0000012) | 4 | 114217955 | 114217956 | Human |
597224944 | GWAS1321018_H | platelet count QTL GWAS1321018 (human) | | 9e-21 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 4 | 109945564 | 109945565 | Human |
597421555 | GWAS1517629_H | blood protein measurement QTL GWAS1517629 (human) | | 8e-13 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 4 | 122625127 | 122625128 | Human |
597224945 | GWAS1321019_H | platelet count QTL GWAS1321019 (human) | | 1e-38 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 4 | 109990751 | 109990752 | Human |
597224946 | GWAS1321020_H | platelet count QTL GWAS1321020 (human) | | 1e-105 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 4 | 110027819 | 110027820 | Human |
597290483 | GWAS1386557_H | BMI-adjusted waist-hip ratio QTL GWAS1386557 (human) | | 5e-09 | body size trait (VT:0100005) | | 4 | 121701445 | 121701446 | Human |
597454327 | GWAS1550401_H | total cholesterol measurement QTL GWAS1550401 (human) | | 2e-09 | total cholesterol measurement | blood total cholesterol level (CMO:0000051) | 4 | 119210489 | 119210490 | Human |
597224947 | GWAS1321021_H | platelet count QTL GWAS1321021 (human) | | 9e-11 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 4 | 119502932 | 119502933 | Human |
597290485 | GWAS1386559_H | BMI-adjusted waist-hip ratio QTL GWAS1386559 (human) | | 9e-11 | body size trait (VT:0100005) | | 4 | 123124286 | 123124287 | Human |
597290484 | GWAS1386558_H | BMI-adjusted waist-hip ratio QTL GWAS1386558 (human) | | 4e-08 | body size trait (VT:0100005) | | 4 | 123002800 | 123002801 | Human |
597290487 | GWAS1386561_H | BMI-adjusted waist-hip ratio QTL GWAS1386561 (human) | | 7e-09 | body size trait (VT:0100005) | | 4 | 124118741 | 124118742 | Human |
597290486 | GWAS1386560_H | BMI-adjusted waist-hip ratio QTL GWAS1386560 (human) | | 2e-11 | body size trait (VT:0100005) | | 4 | 123166618 | 123166619 | Human |
597376489 | GWAS1472563_H | gut microbiome measurement QTL GWAS1472563 (human) | | 0.000004 | gut microbiome measurement | | 4 | 125703884 | 125703885 | Human |
597466607 | GWAS1562681_H | atrial fibrillation QTL GWAS1562681 (human) | | 4e-427 | atrial fibrillation | | 4 | 110796911 | 110796912 | Human |
597466600 | GWAS1562674_H | atrial fibrillation QTL GWAS1562674 (human) | | 2e-39 | atrial fibrillation | | 4 | 110796991 | 110796992 | Human |
596983265 | GWAS1102784_H | memory performance QTL GWAS1102784 (human) | | 0.000001 | memory performance | | 4 | 124874941 | 124874942 | Human |
597466602 | GWAS1562676_H | atrial fibrillation QTL GWAS1562676 (human) | | 6e-09 | atrial fibrillation | | 4 | 110791276 | 110791277 | Human |
597241327 | GWAS1337401_H | educational attainment QTL GWAS1337401 (human) | | 2e-09 | educational attainment | | 4 | 121769129 | 121769130 | Human |
596983277 | GWAS1102796_H | memory performance QTL GWAS1102796 (human) | | 0.000003 | memory performance | | 4 | 124858709 | 124858710 | Human |
597114350 | GWAS1210424_H | protein measurement QTL GWAS1210424 (human) | | 1e-11 | protein measurement | | 4 | 131061544 | 131061545 | Human |
597171682 | GWAS1267756_H | annexin A5 measurement QTL GWAS1267756 (human) | | 2e-57 | annexin A5 measurement | | 4 | 121695708 | 121695709 | Human |
596983279 | GWAS1102798_H | memory performance QTL GWAS1102798 (human) | | 0.000003 | memory performance | | 4 | 124862465 | 124862466 | Human |
597171683 | GWAS1267757_H | annexin A5 measurement QTL GWAS1267757 (human) | | 2e-11 | annexin A5 measurement | | 4 | 121698791 | 121698792 | Human |
597442018 | GWAS1538092_H | platelet count QTL GWAS1538092 (human) | | 1e-43 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 4 | 110020646 | 110020647 | Human |
596983275 | GWAS1102794_H | memory performance QTL GWAS1102794 (human) | | 0.000002 | memory performance | | 4 | 124856977 | 124856978 | Human |
597404959 | GWAS1501033_H | bilirubin measurement QTL GWAS1501033 (human) | | 7e-11 | bilirubin measurement | serum total bilirubin level (CMO:0000376) | 4 | 123849638 | 123849639 | Human |
597613851 | GWAS1670711_H | potassium measurement QTL GWAS1670711 (human) | | 2e-12 | potassium measurement | blood potassium level (CMO:0000496) | 4 | 108140367 | 108140368 | Human |
597040401 | GWAS1136475_H | small vessel stroke QTL GWAS1136475 (human) | | 1e-08 | small vessel stroke | | 4 | 113480773 | 113480774 | Human |
597073183 | GWAS1169257_H | feeling "fed-up" measurement QTL GWAS1169257 (human) | | 2e-08 | feeling "fed-up" measurement | | 4 | 122201701 | 122201702 | Human |
596974879 | GWAS1094398_H | memory performance QTL GWAS1094398 (human) | | 0.000007 | memory performance | | 4 | 124897660 | 124897661 | Human |
597581074 | GWAS1637934_H | type 2 diabetes mellitus QTL GWAS1637934 (human) | | 2e-08 | type 2 diabetes mellitus | | 4 | 129824994 | 129824995 | Human |
597437714 | GWAS1533788_H | nucleotide measurement QTL GWAS1533788 (human) | | 0.000003 | nucleotide metabolism trait (VT:0003806) | | 4 | 110518121 | 110518122 | Human |
597368085 | GWAS1464159_H | asthma QTL GWAS1464159 (human) | | 4e-15 | asthma | | 4 | 122084379 | 122084380 | Human |
596978949 | GWAS1098468_H | body mass index QTL GWAS1098468 (human) | | 2e-09 | body mass index | | 4 | 112402274 | 112402275 | Human |
597581068 | GWAS1637928_H | type 2 diabetes mellitus QTL GWAS1637928 (human) | | 1e-12 | type 2 diabetes mellitus | | 4 | 120841248 | 120841249 | Human |
597593357 | GWAS1650217_H | platelet count QTL GWAS1650217 (human) | | 5e-39 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 4 | 109927496 | 109927497 | Human |
597581069 | GWAS1637929_H | type 2 diabetes mellitus QTL GWAS1637929 (human) | | 1e-08 | type 2 diabetes mellitus | | 4 | 128251968 | 128251969 | Human |
597511433 | GWAS1607507_H | triglyceride measurement QTL GWAS1607507 (human) | | 7e-11 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 4 | 123720672 | 123720673 | Human |
597097731 | GWAS1193805_H | testosterone measurement QTL GWAS1193805 (human) | | 2e-11 | testosterone measurement | serum testosterone level (CMO:0000568) | 4 | 109717668 | 109717669 | Human |
597581067 | GWAS1637927_H | type 2 diabetes mellitus QTL GWAS1637927 (human) | | 3e-08 | type 2 diabetes mellitus | | 4 | 118071040 | 118071041 | Human |
597466372 | GWAS1562446_H | balding measurement QTL GWAS1562446 (human) | | 1e-09 | hair amount (VT:0000416) | coat/hair morphological measurement (CMO:0001807) | 4 | 106449528 | 106449529 | Human |
597396739 | GWAS1492813_H | total cholesterol measurement QTL GWAS1492813 (human) | | 6e-10 | total cholesterol measurement | blood total cholesterol level (CMO:0000051) | 4 | 119192945 | 119192946 | Human |
597191936 | GWAS1288010_H | lung disease severity measurement QTL GWAS1288010 (human) | | 0.000007 | lung integrity trait (VT:0010906) | | 4 | 119664980 | 119664981 | Human |
597466373 | GWAS1562447_H | balding measurement QTL GWAS1562447 (human) | | 3e-22 | hair amount (VT:0000416) | coat/hair morphological measurement (CMO:0001807) | 4 | 106645118 | 106645119 | Human |
597069071 | GWAS1165145_H | susceptibility to hepatitis B infection measurement QTL GWAS1165145 (human) | | 0.000003 | susceptibility to hepatitis B infection measurement | | 4 | 110859685 | 110859686 | Human |
597466374 | GWAS1562448_H | balding measurement QTL GWAS1562448 (human) | | 2e-25 | hair amount (VT:0000416) | coat/hair morphological measurement (CMO:0001807) | 4 | 107131838 | 107131839 | Human |
597327104 | GWAS1423178_H | fibrinopeptide A measurement QTL GWAS1423178 (human) | | 7e-15 | fibrinopeptide A measurement | | 4 | 110510288 | 110510289 | Human |
597327105 | GWAS1423179_H | fibrinopeptide A measurement QTL GWAS1423179 (human) | | 6e-17 | fibrinopeptide A measurement | | 4 | 110510288 | 110510289 | Human |
597044493 | GWAS1140567_H | venous thromboembolism QTL GWAS1140567 (human) | | 0.0000002 | venous thromboembolism | | 4 | 112933404 | 112933405 | Human |
597466375 | GWAS1562449_H | balding measurement QTL GWAS1562449 (human) | | 2e-10 | hair amount (VT:0000416) | coat/hair morphological measurement (CMO:0001807) | 4 | 124156708 | 124156709 | Human |
597331206 | GWAS1427280_H | appendicitis QTL GWAS1427280 (human) | | 2e-11 | appendicitis | | 4 | 110799841 | 110799842 | Human |
597503235 | GWAS1599309_H | right ventricular systolic volume measurement QTL GWAS1599309 (human) | | 7e-08 | right ventricular systolic volume measurement | | 4 | 113507558 | 113507559 | Human |
597343493 | GWAS1439567_H | forced expiratory volume QTL GWAS1439567 (human) | | 3e-13 | forced expiratory volume | forced expiratory volume (CMO:0000254) | 4 | 127731072 | 127731073 | Human |
597015860 | GWAS1111934_H | intraocular pressure measurement QTL GWAS1111934 (human) | | 3e-10 | intraocular pressure measurement | | 4 | 111042563 | 111042564 | Human |
596987190 | GWAS1106709_H | memory performance QTL GWAS1106709 (human) | | 0.000001 | memory performance | | 4 | 125705326 | 125705327 | Human |
597191997 | GWAS1288071_H | systemic lupus erythematosus QTL GWAS1288071 (human) | | 1e-09 | systemic lupus erythematosus | | 4 | 122587346 | 122587347 | Human |
597159217 | GWAS1255291_H | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement QTL GWAS1255291 (human) | | 4e-10 | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement | blood triglyceride level (CMO:0000118) | 4 | 109657070 | 109657071 | Human |
597306684 | GWAS1402758_H | total cholesterol measurement QTL GWAS1402758 (human) | | 4e-10 | total cholesterol measurement | blood total cholesterol level (CMO:0000051) | 4 | 119185611 | 119185612 | Human |
407082725 | GWAS731701_H | obsolete_red blood cell distribution width QTL GWAS731701 (human) | | 3e-09 | obsolete_red blood cell distribution width | | 4 | 122438414 | 122438415 | Human |
596987196 | GWAS1106715_H | memory performance QTL GWAS1106715 (human) | | 0.000002 | memory performance | | 4 | 125664944 | 125664945 | Human |
407017198 | GWAS666174_H | platelet count QTL GWAS666174 (human) | | 3e-43 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 4 | 109952770 | 109952771 | Human |
597257525 | GWAS1353599_H | cardioembolic stroke QTL GWAS1353599 (human) | | 8e-237 | cardioembolic stroke | | 4 | 110743002 | 110743003 | Human |
596987194 | GWAS1106713_H | memory performance QTL GWAS1106713 (human) | | 0.000001 | memory performance | | 4 | 125709483 | 125709484 | Human |
597454125 | GWAS1550199_H | age at first sexual intercourse measurement QTL GWAS1550199 (human) | | 4e-16 | age at first sexual intercourse measurement | | 4 | 111582716 | 111582717 | Human |
597032228 | GWAS1128302_H | waist-hip ratio QTL GWAS1128302 (human) | | 0.0000006 | waist-hip ratio | waist to hip ratio (WHR) (CMO:0000020) | 4 | 119495290 | 119495291 | Human |
597277992 | GWAS1374066_H | insomnia QTL GWAS1374066 (human) | | 5e-09 | insomnia | | 4 | 125465671 | 125465672 | Human |
407017200 | GWAS666176_H | platelet count QTL GWAS666176 (human) | | 7e-14 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 4 | 122595396 | 122595397 | Human |
596974880 | GWAS1094399_H | memory performance QTL GWAS1094399 (human) | | 0.000007 | memory performance | | 4 | 124885712 | 124885713 | Human |
597392685 | GWAS1488759_H | pulse pressure measurement QTL GWAS1488759 (human) | | 1e-08 | pulse pressure measurement | pulse pressure (CMO:0000292) | 4 | 110465042 | 110465043 | Human |
597073184 | GWAS1169258_H | feeling "fed-up" measurement QTL GWAS1169258 (human) | | 5e-08 | feeling "fed-up" measurement | | 4 | 122465996 | 122465997 | Human |
596974893 | GWAS1094412_H | memory performance QTL GWAS1094412 (human) | | 0.000008 | memory performance | | 4 | 124893791 | 124893792 | Human |
597290272 | GWAS1386346_H | Crohn's disease QTL GWAS1386346 (human) | | 2e-16 | intestine integrity trait (VT:0010554) | | 4 | 122523884 | 122523885 | Human |
596974892 | GWAS1094411_H | memory performance QTL GWAS1094411 (human) | | 0.000008 | memory performance | | 4 | 124874941 | 124874942 | Human |
597527844 | GWAS1623918_H | level of N-acetylgalactosamine in blood, level of N-acetylglucosamine in blood QTL GWAS1623918 (human) | | 7e-31 | level of N-acetylgalactosamine in blood, level of N-acetylglucosamine in blood | | 4 | 129109789 | 129109790 | Human |
597429542 | GWAS1525616_H | protein measurement QTL GWAS1525616 (human) | | 5e-32 | protein measurement | | 4 | 109915408 | 109915409 | Human |
596974894 | GWAS1094413_H | memory performance QTL GWAS1094413 (human) | | 0.000008 | memory performance | | 4 | 124895966 | 124895967 | Human |
597028137 | GWAS1124211_H | atrial fibrillation QTL GWAS1124211 (human) | | 8e-12 | atrial fibrillation | | 4 | 110733185 | 110733186 | Human |
597069141 | GWAS1165215_H | susceptibility to scarlet fever measurement QTL GWAS1165215 (human) | | 0.000009 | susceptibility to scarlet fever measurement | | 4 | 109544415 | 109544416 | Human |
597335389 | GWAS1431463_H | episodic memory QTL GWAS1431463 (human) | | 0.000002 | episodic memory | | 4 | 114002480 | 114002481 | Human |
597581142 | GWAS1638002_H | monocyte count QTL GWAS1638002 (human) | | 2e-26 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 4 | 109927496 | 109927497 | Human |
597613904 | GWAS1670764_H | potassium measurement QTL GWAS1670764 (human) | | 4e-15 | potassium measurement | blood potassium level (CMO:0000496) | 4 | 108140367 | 108140368 | Human |
407377563 | GWAS1026539_H | asthma QTL GWAS1026539 (human) | | 2e-08 | asthma | | 4 | 122194117 | 122194118 | Human |
597470536 | GWAS1566610_H | Bell's palsy QTL GWAS1566610 (human) | | 0.000006 | Bell's palsy | | 4 | 123516321 | 123516322 | Human |
596979020 | GWAS1098539_H | coronary artery disease QTL GWAS1098539 (human) | | 2e-09 | coronary artery disease | | 4 | 109616095 | 109616096 | Human |
597495108 | GWAS1591182_H | tiglylcarnitine (C5:1-DC) measurement QTL GWAS1591182 (human) | | 6e-08 | tiglylcarnitine (C5:1-DC) measurement | | 4 | 110977273 | 110977274 | Human |
407377554 | GWAS1026530_H | Epithelioid Cell Uveal Melanoma QTL GWAS1026530 (human) | | 0.000002 | Epithelioid Cell Uveal Melanoma | | 4 | 130547531 | 130547532 | Human |
597171525 | GWAS1267599_H | chronotype measurement, sun exposure measurement QTL GWAS1267599 (human) | | 0.0000002 | chronotype measurement, sun exposure measurement | | 4 | 114197705 | 114197706 | Human |
596954486 | GWAS1074005_H | coronary artery disease QTL GWAS1074005 (human) | | 4e-08 | coronary artery disease | | 4 | 110757945 | 110757946 | Human |
597265788 | GWAS1361862_H | low density lipoprotein cholesterol measurement QTL GWAS1361862 (human) | | 2e-08 | low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 4 | 127741641 | 127741642 | Human |
597486970 | GWAS1583044_H | ceramide measurement QTL GWAS1583044 (human) | | 2e-21 | ceramide measurement | | 4 | 114598115 | 114598116 | Human |
597613941 | GWAS1670801_H | alopecia areata QTL GWAS1670801 (human) | | 1e-11 | alopecia areata | | 4 | 126045378 | 126045379 | Human |
597179764 | GWAS1275838_H | response to sertraline, psychotic symptom measurement, response to olanzapine QTL GWAS1275838 (human) | | 0.000004 | response to sertraline, psychotic symptom measurement, response to olanzapine | | 4 | 119092116 | 119092117 | Human |
597523825 | GWAS1619899_H | sexual dimorphism measurement QTL GWAS1619899 (human) | | 5e-09 | sexual dimorphism measurement | | 4 | 121792708 | 121792709 | Human |
597314934 | GWAS1411008_H | cortical thickness QTL GWAS1411008 (human) | | 1e-11 | cortical thickness | | 4 | 123258359 | 123258360 | Human |
597532017 | GWAS1628091_H | color vision disorder QTL GWAS1628091 (human) | | 0.0000004 | color vision disorder | | 4 | 123509639 | 123509640 | Human |
596979064 | GWAS1098583_H | stroke QTL GWAS1098583 (human) | | 0.000001 | stroke | | 4 | 112810934 | 112810935 | Human |
597048674 | GWAS1144748_H | anxiety QTL GWAS1144748 (human) | | 7e-09 | anxiety | | 4 | 118015036 | 118015037 | Human |
597532010 | GWAS1628084_H | cannabis dependence QTL GWAS1628084 (human) | | 8e-11 | cannabis dependence | | 4 | 111546456 | 111546457 | Human |
597286254 | GWAS1382328_H | stroke QTL GWAS1382328 (human) | | 0.000001 | stroke | | 4 | 112810934 | 112810935 | Human |
597196128 | GWAS1292202_H | memory performance QTL GWAS1292202 (human) | | 0.0000005 | memory performance | | 4 | 124882027 | 124882028 | Human |
597593446 | GWAS1650306_H | disturbances of sensation of smell and taste QTL GWAS1650306 (human) | | 9e-12 | disturbances of sensation of smell and taste | | 4 | 125832302 | 125832303 | Human |
597196129 | GWAS1292203_H | memory performance QTL GWAS1292203 (human) | | 0.0000005 | memory performance | | 4 | 124882886 | 124882887 | Human |
597196130 | GWAS1292204_H | memory performance QTL GWAS1292204 (human) | | 0.0000005 | memory performance | | 4 | 124883368 | 124883369 | Human |
597527905 | GWAS1623979_H | fibrinopeptide A, des-ala(1) measurement QTL GWAS1623979 (human) | | 2e-14 | fibrinopeptide A, des-ala(1) measurement | | 4 | 110446685 | 110446686 | Human |
597220505 | GWAS1316579_H | bipolar I disorder QTL GWAS1316579 (human) | | 2e-09 | bipolar disorder | | 4 | 122154852 | 122154853 | Human |
597437599 | GWAS1533673_H | Ventricular arrhythmia QTL GWAS1533673 (human) | | 4e-11 | Ventricular arrhythmia | | 4 | 110791080 | 110791081 | Human |
597023888 | GWAS1119962_H | allergic disease QTL GWAS1119962 (human) | | 9e-27 | allergic disease | | 4 | 122394921 | 122394922 | Human |
597089424 | GWAS1185498_H | depressive symptom measurement QTL GWAS1185498 (human) | | 2e-09 | depressive symptom measurement | | 4 | 122467738 | 122467739 | Human |
597380252 | GWAS1476326_H | serum IgG glycosylation measurement QTL GWAS1476326 (human) | | 0.000002 | serum IgG glycosylation measurement | | 4 | 116928293 | 116928294 | Human |
597367955 | GWAS1464029_H | apolipoprotein B measurement QTL GWAS1464029 (human) | | 1e-10 | apolipoprotein B measurement | blood apoliprotein B level (CMO:0000522) | 4 | 123837618 | 123837619 | Human |
596974749 | GWAS1094268_H | endometriosis, major depressive disorder QTL GWAS1094268 (human) | | 5e-08 | endometriosis, major depressive disorder | | 4 | 130288732 | 130288733 | Human |
597232787 | GWAS1328861_H | Ischemic stroke QTL GWAS1328861 (human) | | 0.000002 | Ischemic stroke | | 4 | 110308365 | 110308366 | Human |
596982943 | GWAS1102462_H | memory performance QTL GWAS1102462 (human) | | 0.000006 | memory performance | | 4 | 124893791 | 124893792 | Human |
597617809 | GWAS1674669_H | prothrombin time measurement QTL GWAS1674669 (human) | | 1e-16 | prothrombin time measurement | prothrombin time (CMO:0000211) | 4 | 110791530 | 110791531 | Human |
597310602 | GWAS1406676_H | vaginal microbiome measurement QTL GWAS1406676 (human) | | 0.000007 | vaginal microbiome measurement | | 4 | 113348345 | 113348346 | Human |
597228680 | GWAS1324754_H | appendicular lean mass QTL GWAS1324754 (human) | | 3e-22 | appendicular lean mass | | 4 | 124035957 | 124035958 | Human |
597060743 | GWAS1156817_H | reaction time measurement QTL GWAS1156817 (human) | | 0.000004 | reaction time measurement | | 4 | 109249480 | 109249481 | Human |
407000912 | GWAS649888_H | polychlorinated biphenyls measurement QTL GWAS649888 (human) | | 0.0000001 | polychlorinated biphenyls measurement | | 4 | 117114403 | 117114404 | Human |
597310601 | GWAS1406675_H | vaginal microbiome measurement QTL GWAS1406675 (human) | | 0.000009 | vaginal microbiome measurement | | 4 | 113348345 | 113348346 | Human |
597597321 | GWAS1654181_H | lymphocyte count QTL GWAS1654181 (human) | | 2e-14 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 4 | 112183886 | 112183887 | Human |
597503110 | GWAS1599184_H | systolic blood pressure QTL GWAS1599184 (human) | | 0.0000001 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 4 | 132120954 | 132120955 | Human |
597462144 | GWAS1558218_H | body mass index QTL GWAS1558218 (human) | | 7e-13 | body mass index | body mass index (BMI) (CMO:0000105) | 4 | 129803585 | 129803586 | Human |
597175429 | GWAS1271503_H | acne QTL GWAS1271503 (human) | | 0.000008 | acne | | 4 | 123213554 | 123213555 | Human |
597060744 | GWAS1156818_H | reaction time measurement QTL GWAS1156818 (human) | | 0.000001 | reaction time measurement | | 4 | 110649067 | 110649068 | Human |
597077128 | GWAS1173202_H | P wave duration QTL GWAS1173202 (human) | | 4e-08 | P wave duration | P wave duration (CMO:0000264) | 4 | 113467664 | 113467665 | Human |
597466242 | GWAS1562316_H | BMI-adjusted waist-hip ratio QTL GWAS1562316 (human) | | 7e-08 | body size trait (VT:0100005) | | 4 | 119441806 | 119441807 | Human |
597228679 | GWAS1324753_H | appendicular lean mass QTL GWAS1324753 (human) | | 3e-11 | appendicular lean mass | | 4 | 107939926 | 107939927 | Human |
597064886 | GWAS1160960_H | alopecia areata QTL GWAS1160960 (human) | | 0.000001 | alopecia areata | | 4 | 122473886 | 122473887 | Human |
597245115 | GWAS1341189_H | neonatal abstinence syndrome QTL GWAS1341189 (human) | | 0.000003 | neonatal abstinence syndrome | | 4 | 115468815 | 115468816 | Human |
597429438 | GWAS1525512_H | pelvic organ prolapse QTL GWAS1525512 (human) | | 2e-22 | pelvic organ prolapse | | 4 | 126003529 | 126003530 | Human |
597056693 | GWAS1152767_H | allergic rhinitis QTL GWAS1152767 (human) | | 5e-15 | allergic rhinitis | | 4 | 122415763 | 122415764 | Human |
597367998 | GWAS1464072_H | BMI-adjusted waist circumference QTL GWAS1464072 (human) | | 3e-11 | body size trait (VT:0100005) | | 4 | 108535458 | 108535459 | Human |
597367997 | GWAS1464071_H | BMI-adjusted waist circumference QTL GWAS1464071 (human) | | 4e-08 | body size trait (VT:0100005) | | 4 | 108556623 | 108556624 | Human |
597499067 | GWAS1595141_H | systolic blood pressure QTL GWAS1595141 (human) | | 3e-12 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 4 | 110417121 | 110417122 | Human |
597265599 | GWAS1361673_H | cortical thickness QTL GWAS1361673 (human) | | 4e-13 | cortical thickness | | 4 | 120730658 | 120730659 | Human |
597154993 | GWAS1251067_H | diet measurement, sex hormone-binding globulin measurement QTL GWAS1251067 (human) | | 0.0000007 | eating behavior trait (VT:0001431) | food intake measurement (CMO:0000772) | 4 | 127714844 | 127714845 | Human |
596950205 | GWAS1069724_H | COVID-19 QTL GWAS1069724 (human) | | 0.000003 | COVID-19 | | 4 | 120985638 | 120985639 | Human |
597355702 | GWAS1451776_H | self reported educational attainment QTL GWAS1451776 (human) | | 0.000007 | self reported educational attainment | | 4 | 119344104 | 119344105 | Human |
597384375 | GWAS1480449_H | FEV/FVC ratio QTL GWAS1480449 (human) | | 1e-20 | FEV/FVC ratio | forced expiratory volume to forced vital capacity ratio (CMO:0000241) | 4 | 123898452 | 123898453 | Human |
597064888 | GWAS1160962_H | alopecia areata QTL GWAS1160962 (human) | | 5e-09 | alopecia areata | | 4 | 122602871 | 122602872 | Human |
597179561 | GWAS1275635_H | N-acetylneuraminate measurement QTL GWAS1275635 (human) | | 2e-08 | N-acetylneuraminate measurement | | 4 | 110098606 | 110098607 | Human |
596982944 | GWAS1102463_H | memory performance QTL GWAS1102463 (human) | | 0.000006 | memory performance | | 4 | 124895966 | 124895967 | Human |
407177085 | GWAS826061_H | waist-hip ratio QTL GWAS826061 (human) | | 5e-08 | waist-hip ratio | waist to hip ratio (WHR) (CMO:0000020) | 4 | 121702910 | 121702911 | Human |
597593252 | GWAS1650112_H | platelet count QTL GWAS1650112 (human) | | 2e-61 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 4 | 109927496 | 109927497 | Human |
597028009 | GWAS1124083_H | atrial fibrillation QTL GWAS1124083 (human) | | 5e-88 | atrial fibrillation | | 4 | 110631977 | 110631978 | Human |
597327013 | GWAS1423087_H | body mass index QTL GWAS1423087 (human) | | 6e-11 | body mass index | body mass index (BMI) (CMO:0000105) | 4 | 112402274 | 112402275 | Human |
597478620 | GWAS1574694_H | atrial fibrillation QTL GWAS1574694 (human) | | 3e-09 | atrial fibrillation | | 4 | 111533139 | 111533140 | Human |
597413082 | GWAS1509156_H | adolescent idiopathic scoliosis QTL GWAS1509156 (human) | | 9e-37 | adolescent idiopathic scoliosis | | 4 | 114347014 | 114347015 | Human |
597306587 | GWAS1402661_H | coronary artery disease QTL GWAS1402661 (human) | | 3e-16 | coronary artery disease | | 4 | 119988346 | 119988347 | Human |
407160581 | GWAS809557_H | BMI-adjusted waist-hip ratio QTL GWAS809557 (human) | | 0.000005 | body size trait (VT:0100005) | | 4 | 123145793 | 123145794 | Human |
597265624 | GWAS1361698_H | facial morphology measurement QTL GWAS1361698 (human) | | 9e-12 | facial morphology trait (VT:0003743) | | 4 | 126901674 | 126901675 | Human |
407160582 | GWAS809558_H | BMI-adjusted waist-hip ratio QTL GWAS809558 (human) | | 0.0000003 | body size trait (VT:0100005) | | 4 | 123145793 | 123145794 | Human |
406914819 | GWAS563795_H | smoking behavior QTL GWAS563795 (human) | | 0.000009 | smoking behavior | | 4 | 125510764 | 125510765 | Human |
597478618 | GWAS1574692_H | atrial fibrillation QTL GWAS1574692 (human) | | 1e-28 | atrial fibrillation | | 4 | 110603473 | 110603474 | Human |
597478619 | GWAS1574693_H | atrial fibrillation QTL GWAS1574693 (human) | | 2e-18 | atrial fibrillation | | 4 | 111004500 | 111004501 | Human |
597355735 | GWAS1451809_H | trait in response to cytarabine QTL GWAS1451809 (human) | | 0.000007 | trait in response to cytarabine | | 4 | 119691563 | 119691564 | Human |
597322964 | GWAS1419038_H | mannitol measurement, sorbitol measurement QTL GWAS1419038 (human) | | 0.000003 | mannitol measurement, sorbitol measurement | | 4 | 112447703 | 112447704 | Human |
406923027 | GWAS572003_H | cup-to-disc ratio measurement QTL GWAS572003 (human) | | 0.0000002 | cup-to-disc ratio measurement | | 4 | 125475115 | 125475116 | Human |
597482703 | GWAS1578777_H | lymphocyte count QTL GWAS1578777 (human) | | 5e-15 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 4 | 122760001 | 122760002 | Human |
597310665 | GWAS1406739_H | vaginal microbiome measurement QTL GWAS1406739 (human) | | 0.000009 | vaginal microbiome measurement | | 4 | 131705323 | 131705324 | Human |
597294285 | GWAS1390359_H | complement factor I measurement QTL GWAS1390359 (human) | | 2e-17 | complement protein amount (VT:0010033) | | 4 | 109735574 | 109735575 | Human |
597363919 | GWAS1459993_H | acute myeloid leukemia QTL GWAS1459993 (human) | | 1e-13 | leukocyte integrity trait (VT:0010898) | | 4 | 121985860 | 121985861 | Human |
597363918 | GWAS1459992_H | acute myeloid leukemia QTL GWAS1459992 (human) | | 5e-20 | leukocyte integrity trait (VT:0010898) | | 4 | 121985860 | 121985861 | Human |
597363917 | GWAS1459991_H | acute myeloid leukemia QTL GWAS1459991 (human) | | 5e-08 | leukocyte integrity trait (VT:0010898) | | 4 | 117598611 | 117598612 | Human |
597617862 | GWAS1674722_H | knee fracture QTL GWAS1674722 (human) | | 7e-13 | knee fracture | | 4 | 117485221 | 117485222 | Human |
407222045 | GWAS871021_H | atopic eczema QTL GWAS871021 (human) | | 0.000001 | atopic eczema | | 4 | 122576542 | 122576543 | Human |
597408961 | GWAS1505035_H | vaginal microbiome measurement QTL GWAS1505035 (human) | | 0.000001 | vaginal microbiome measurement | | 4 | 113045828 | 113045829 | Human |
597105867 | GWAS1201941_H | sex hormone-binding globulin measurement QTL GWAS1201941 (human) | | 2e-08 | sex hormone-binding globulin measurement | | 4 | 128122459 | 128122460 | Human |
597105866 | GWAS1201940_H | sex hormone-binding globulin measurement QTL GWAS1201940 (human) | | 1e-34 | sex hormone-binding globulin measurement | | 4 | 109717668 | 109717669 | Human |
597023944 | GWAS1120018_H | response to darapladib, cardiovascular event measurement QTL GWAS1120018 (human) | | 0.000002 | response to darapladib, cardiovascular event measurement | cardiovascular measurement (CMO:0000001) | 4 | 124644124 | 124644125 | Human |
597236935 | GWAS1333009_H | Hypermetropia QTL GWAS1333009 (human) | | 0.000002 | Hypermetropia | | 4 | 108429724 | 108429725 | Human |
597023946 | GWAS1120020_H | response to darapladib, cardiovascular event measurement QTL GWAS1120020 (human) | | 6e-09 | response to darapladib, cardiovascular event measurement | cardiovascular measurement (CMO:0000001) | 4 | 124644124 | 124644125 | Human |
597097718 | GWAS1193792_H | testosterone measurement QTL GWAS1193792 (human) | | 1e-19 | testosterone measurement | serum testosterone level (CMO:0000568) | 4 | 108117498 | 108117499 | Human |
597396731 | GWAS1492805_H | systolic blood pressure QTL GWAS1492805 (human) | | 6e-09 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 4 | 108328807 | 108328808 | Human |
597347578 | GWAS1443652_H | nephrolithiasis QTL GWAS1443652 (human) | | 3e-14 | nephrolithiasis | | 4 | 114667805 | 114667806 | Human |
407025443 | GWAS674419_H | atrial fibrillation QTL GWAS674419 (human) | | 7e-11 | atrial fibrillation | | 4 | 110799605 | 110799606 | Human |
597294330 | GWAS1390404_H | cardiac troponin T measurement QTL GWAS1390404 (human) | | 0.0000001 | cardiac troponin T measurement | blood troponin T level (CMO:0001284) | 4 | 118958433 | 118958434 | Human |
407222049 | GWAS871025_H | atopic eczema, psoriasis QTL GWAS871025 (human) | | 0.000001 | atopic eczema, psoriasis | | 4 | 122335010 | 122335011 | Human |
597114111 | GWAS1210185_H | behavioural disinhibition measurement QTL GWAS1210185 (human) | | 0.0000009 | behavioural disinhibition measurement | | 4 | 113934816 | 113934817 | Human |
597028094 | GWAS1124168_H | atrial fibrillation QTL GWAS1124168 (human) | | 1e-15 | atrial fibrillation | | 4 | 110815726 | 110815727 | Human |
597388528 | GWAS1484602_H | fat body mass QTL GWAS1484602 (human) | | 0.000003 | body fat mass (VT:0010482) | total body fat mass (CMO:0000305) | 4 | 129885831 | 129885832 | Human |
597294325 | GWAS1390399_H | cardiac troponin T measurement QTL GWAS1390399 (human) | | 0.0000008 | cardiac troponin T measurement | blood troponin T level (CMO:0001284) | 4 | 118958433 | 118958434 | Human |
597028088 | GWAS1124162_H | atrial fibrillation QTL GWAS1124162 (human) | | 1e-38 | atrial fibrillation | | 4 | 110859850 | 110859851 | Human |
597204215 | GWAS1300289_H | protein measurement QTL GWAS1300289 (human) | | 2e-08 | protein measurement | | 4 | 112377503 | 112377504 | Human |
406976305 | GWAS625281_H | mean corpuscular hemoglobin QTL GWAS625281 (human) | | 6e-18 | mean corpuscular hemoglobin | mean corpuscular hemoglobin (CMO:0000290) | 4 | 121808258 | 121808259 | Human |
407226164 | GWAS875140_H | unipolar depression QTL GWAS875140 (human) | | 0.000007 | unipolar depression | | 4 | 115213661 | 115213662 | Human |
597511404 | GWAS1607478_H | diastolic blood pressure QTL GWAS1607478 (human) | | 1e-10 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 4 | 119336584 | 119336585 | Human |
597097700 | GWAS1193774_H | sex hormone-binding globulin measurement QTL GWAS1193774 (human) | | 9e-41 | sex hormone-binding globulin measurement | | 4 | 109717668 | 109717669 | Human |
406976306 | GWAS625282_H | mean corpuscular hemoglobin QTL GWAS625282 (human) | | 3e-09 | mean corpuscular hemoglobin | mean corpuscular hemoglobin (CMO:0000290) | 4 | 127647811 | 127647812 | Human |
597396717 | GWAS1492791_H | systolic blood pressure QTL GWAS1492791 (human) | | 1e-14 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 4 | 110414448 | 110414449 | Human |
597515495 | GWAS1611569_H | smoking initiation QTL GWAS1611569 (human) | | 8e-11 | smoking initiation | | 4 | 129681552 | 129681553 | Human |
597613796 | GWAS1670656_H | connective tissue disease QTL GWAS1670656 (human) | | 2e-14 | connective tissue disease | | 4 | 129687742 | 129687743 | Human |
597023982 | GWAS1120056_H | allergic disease QTL GWAS1120056 (human) | | 5e-14 | allergic disease | | 4 | 122532955 | 122532959 | Human |
597052649 | GWAS1148723_H | anxiety QTL GWAS1148723 (human) | | 2e-08 | anxiety | | 4 | 118133633 | 118133634 | Human |
597027861 | GWAS1123935_H | blood protein measurement QTL GWAS1123935 (human) | | 5e-62 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 4 | 109965187 | 109965188 | Human |
597359642 | GWAS1455716_H | eosinophil percentage of leukocytes QTL GWAS1455716 (human) | | 5e-09 | eosinophil quantity (VT:0002602) | blood eosinophil count to total leukocyte count ratio (CMO:0000369) | 4 | 122639784 | 122639785 | Human |
597408799 | GWAS1504873_H | cortical thickness QTL GWAS1504873 (human) | | 9e-16 | cortical thickness | | 4 | 120645452 | 120645453 | Human |
597593112 | GWAS1649972_H | retinopathy QTL GWAS1649972 (human) | | 1e-11 | retinopathy | | 4 | 109764664 | 109764665 | Human |
597244945 | GWAS1341019_H | BMI-adjusted waist-hip ratio QTL GWAS1341019 (human) | | 2e-11 | body size trait (VT:0100005) | | 4 | 123124286 | 123124287 | Human |
597482517 | GWAS1578591_H | open-angle glaucoma QTL GWAS1578591 (human) | | 6e-10 | open-angle glaucoma | | 4 | 111042563 | 111042564 | Human |
597244944 | GWAS1341018_H | BMI-adjusted waist-hip ratio QTL GWAS1341018 (human) | | 5e-08 | body size trait (VT:0100005) | | 4 | 122860717 | 122860718 | Human |
597244947 | GWAS1341021_H | BMI-adjusted waist-hip ratio QTL GWAS1341021 (human) | | 1e-08 | body size trait (VT:0100005) | | 4 | 124118741 | 124118742 | Human |
407369676 | GWAS1018652_H | celiac disease QTL GWAS1018652 (human) | | 1e-08 | celiac disease | | 4 | 122340375 | 122340376 | Human |
597244946 | GWAS1341020_H | BMI-adjusted waist-hip ratio QTL GWAS1341020 (human) | | 1e-11 | body size trait (VT:0100005) | | 4 | 123166618 | 123166619 | Human |
597617682 | GWAS1674542_H | prothrombin time measurement QTL GWAS1674542 (human) | | 7e-37 | prothrombin time measurement | prothrombin time (CMO:0000211) | 4 | 110780277 | 110780278 | Human |
597199892 | GWAS1295966_H | post-traumatic stress disorder QTL GWAS1295966 (human) | | 7e-09 | post-traumatic stress disorder | | 4 | 122265238 | 122265239 | Human |
597081095 | GWAS1177169_H | neutrophil count QTL GWAS1177169 (human) | | 1e-11 | neutrophil quantity (VT:0000222) | blood neutrophil count (CMO:0000030) | 4 | 119234651 | 119234652 | Human |
407115734 | GWAS764710_H | cognitive decline measurement QTL GWAS764710 (human) | | 0.0000005 | cognitive behavior trait (VT:0010450) | | 4 | 121687103 | 121687104 | Human |
597244941 | GWAS1341015_H | BMI-adjusted waist-hip ratio QTL GWAS1341015 (human) | | 2e-08 | body size trait (VT:0100005) | | 4 | 119591353 | 119591354 | Human |
597474312 | GWAS1570386_H | cytokine measurement QTL GWAS1570386 (human) | | 0.000001 | cytokine measurement | blood cytokine measurement (CMO:0001924) | 4 | 125803384 | 125803385 | Human |
597244940 | GWAS1341014_H | BMI-adjusted waist-hip ratio QTL GWAS1341014 (human) | | 2e-10 | body size trait (VT:0100005) | | 4 | 119213641 | 119213642 | Human |
597335055 | GWAS1431129_H | COVID-19 QTL GWAS1431129 (human) | | 0.00001 | COVID-19 | | 4 | 127789647 | 127789648 | Human |
407025620 | GWAS674596_H | hair morphology QTL GWAS674596 (human) | | 0.000009 | hair morphology | coat/hair morphological measurement (CMO:0001807) | 4 | 109904478 | 109904479 | Human |
597294095 | GWAS1390169_H | cGMP-specific 3',5'-cyclic phosphodiesterase measurement QTL GWAS1390169 (human) | | 4e-12 | cGMP-specific 3',5'-cyclic phosphodiesterase measurement | | 4 | 119320694 | 119320695 | Human |
597244943 | GWAS1341017_H | BMI-adjusted waist-hip ratio QTL GWAS1341017 (human) | | 6e-09 | body size trait (VT:0100005) | | 4 | 121702910 | 121702911 | Human |
597244942 | GWAS1341016_H | BMI-adjusted waist-hip ratio QTL GWAS1341016 (human) | | 2e-09 | body size trait (VT:0100005) | | 4 | 119763897 | 119763898 | Human |
597154829 | GWAS1250903_H | high density lipoprotein cholesterol measurement QTL GWAS1250903 (human) | | 2e-11 | blood lipid amount (VT:0003949) | blood cholesterol level (CMO:0002280) | 4 | 109657070 | 109657071 | Human |
597593092 | GWAS1649952_H | retinal degeneration QTL GWAS1649952 (human) | | 2e-11 | retinal degeneration | | 4 | 114161723 | 114161724 | Human |
597183490 | GWAS1279564_H | reduced glutathione measurement QTL GWAS1279564 (human) | | 4e-08 | kidney glutathione amount (VT:0010706) | | 4 | 124355648 | 124355649 | Human |
597437447 | GWAS1533521_H | lipid measurement QTL GWAS1533521 (human) | | 0.000009 | lipid measurement | blood lipid measurement (CMO:0000050) | 4 | 107039415 | 107039416 | Human |
597040141 | GWAS1136215_H | apolipoprotein A 1 measurement QTL GWAS1136215 (human) | | 3e-20 | apolipoprotein A 1 measurement | blood apolipoprotein AI level (CMO:0000520) | 4 | 109648464 | 109648465 | Human |
597363718 | GWAS1459792_H | acute myeloid leukemia QTL GWAS1459792 (human) | | 9e-18 | leukocyte integrity trait (VT:0010898) | | 4 | 112776849 | 112776850 | Human |
597105672 | GWAS1201746_H | sex hormone-binding globulin measurement QTL GWAS1201746 (human) | | 6e-26 | sex hormone-binding globulin measurement | | 4 | 109717668 | 109717669 | Human |
597294139 | GWAS1390213_H | mean corpuscular hemoglobin QTL GWAS1390213 (human) | | 5e-51 | mean corpuscular hemoglobin | mean corpuscular hemoglobin (CMO:0000290) | 4 | 121875762 | 121875763 | Human |
597515323 | GWAS1611397_H | body mass index QTL GWAS1611397 (human) | | 8e-08 | body mass index | body mass index (BMI) (CMO:0000105) | 4 | 129803585 | 129803586 | Human |
596966460 | GWAS1085979_H | systolic blood pressure QTL GWAS1085979 (human) | | 1e-14 | systolic blood pressure | | 4 | 110414448 | 110414449 | Human |
597064764 | GWAS1160838_H | type 2 diabetes mellitus QTL GWAS1160838 (human) | | 0.0000005 | type 2 diabetes mellitus | | 4 | 128605841 | 128605842 | Human |
597031998 | GWAS1128072_H | body mass index QTL GWAS1128072 (human) | | 4e-10 | body mass index | body mass index (BMI) (CMO:0000105) | 4 | 119398279 | 119398280 | Human |
597077053 | GWAS1173127_H | Epstein-Barr virus infection QTL GWAS1173127 (human) | | 0.000001 | Epstein-Barr virus infection | | 4 | 129344227 | 129344228 | Human |
407082989 | GWAS731965_H | obsolete_red blood cell distribution width QTL GWAS731965 (human) | | 7e-19 | obsolete_red blood cell distribution width | | 4 | 128306129 | 128306130 | Human |
407144438 | GWAS793414_H | stroke QTL GWAS793414 (human) | | 0.000001 | stroke | | 4 | 112810934 | 112810935 | Human |
597580842 | GWAS1637702_H | lymphocyte count QTL GWAS1637702 (human) | | 1e-14 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 4 | 112194663 | 112194664 | Human |
597322799 | GWAS1418873_H | cup-to-disc ratio measurement QTL GWAS1418873 (human) | | 2e-18 | cup-to-disc ratio measurement | | 4 | 125478843 | 125478844 | Human |
597380141 | GWAS1476215_H | Red cell distribution width QTL GWAS1476215 (human) | | 1e-20 | Red cell distribution width | red blood cell distribution width- standard deviation (CMO:0003232) | 4 | 128306129 | 128306130 | Human |
597580841 | GWAS1637701_H | lymphocyte count QTL GWAS1637701 (human) | | 1e-14 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 4 | 109912954 | 109912955 | Human |
597445669 | GWAS1541743_H | diet measurement, bilirubin measurement QTL GWAS1541743 (human) | | 0.000002 | eating behavior trait (VT:0001431) | serum total bilirubin level (CMO:0000376) | 4 | 114333088 | 114333089 | Human |
597388321 | GWAS1484395_H | pursuit maintenance gain measurement QTL GWAS1484395 (human) | | 0.000003 | pursuit maintenance gain measurement | | 4 | 110340886 | 110340887 | Human |
407144446 | GWAS793422_H | stroke QTL GWAS793422 (human) | | 0.0000004 | stroke | | 4 | 112810934 | 112810935 | Human |
596966447 | GWAS1085966_H | body height QTL GWAS1085966 (human) | | 4e-08 | body height | | 4 | 128700992 | 128700993 | Human |
597109803 | GWAS1205877_H | Calcium channel blocker use measurement QTL GWAS1205877 (human) | | 5e-08 | Calcium channel blocker use measurement | | 4 | 108081403 | 108081404 | Human |
407386100 | GWAS1035076_H | obsolete_red blood cell distribution width QTL GWAS1035076 (human) | | 2e-23 | obsolete_red blood cell distribution width | | 4 | 128306129 | 128306130 | Human |
407369722 | GWAS1018698_H | chronic lymphocytic leukemia QTL GWAS1018698 (human) | | 6e-10 | leukocyte integrity trait (VT:0010898) | | 4 | 113777540 | 113777541 | Human |
597031978 | GWAS1128052_H | mood instability measurement QTL GWAS1128052 (human) | | 3e-08 | mood instability measurement | | 4 | 122258745 | 122258746 | Human |
596958292 | GWAS1077811_H | Red cell distribution width QTL GWAS1077811 (human) | | 1e-20 | Red cell distribution width | | 4 | 128306129 | 128306130 | Human |
596978772 | GWAS1098291_H | stroke QTL GWAS1098291 (human) | | 2e-15 | stroke | | 4 | 110793263 | 110793264 | Human |
597519452 | GWAS1615526_H | body fat percentage QTL GWAS1615526 (human) | | 3e-08 | body fat mass (VT:0010482) | body fat percentage (CMO:0000302) | 4 | 123822104 | 123822105 | Human |
407000966 | GWAS649942_H | systolic blood pressure QTL GWAS649942 (human) | | 1e-08 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 4 | 108104223 | 108104224 | Human |
597277789 | GWAS1373863_H | age-related macular degeneration, COVID-19 QTL GWAS1373863 (human) | | 3e-18 | age-related macular degeneration, COVID-19 | | 4 | 109737911 | 109737912 | Human |
597609562 | GWAS1666422_H | monocyte count QTL GWAS1666422 (human) | | 3e-14 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 4 | 109927496 | 109927497 | Human |
596958291 | GWAS1077810_H | Red cell distribution width QTL GWAS1077810 (human) | | 2e-09 | Red cell distribution width | red blood cell distribution width- standard deviation (CMO:0003232) | 4 | 122438414 | 122438415 | Human |
406902673 | GWAS551649_H | diastolic blood pressure QTL GWAS551649 (human) | | 9e-19 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 4 | 119588124 | 119588125 | Human |
597056580 | GWAS1152654_H | eosinophil count QTL GWAS1152654 (human) | | 1e-40 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 4 | 122451978 | 122451979 | Human |
597392457 | GWAS1488531_H | asthma, Eczematoid dermatitis, allergic rhinitis QTL GWAS1488531 (human) | | 1e-29 | asthma, Eczematoid dermatitis, allergic rhinitis | | 4 | 122465565 | 122465566 | Human |
596958279 | GWAS1077798_H | Red cell distribution width QTL GWAS1077798 (human) | | 8e-08 | Red cell distribution width | red blood cell distribution width- standard deviation (CMO:0003232) | 4 | 121820188 | 121820189 | Human |
597593162 | GWAS1650022_H | degeneration of macula and posterior pole QTL GWAS1650022 (human) | | 3e-16 | degeneration of macula and posterior pole | | 4 | 109764664 | 109764665 | Human |
597056579 | GWAS1152653_H | eosinophil count QTL GWAS1152653 (human) | | 1e-18 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 4 | 122111201 | 122111202 | Human |
597154891 | GWAS1250965_H | cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement QTL GWAS1250965 (human) | | 5e-10 | cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 4 | 109657070 | 109657071 | Human |
597531773 | GWAS1627847_H | atrial fibrillation QTL GWAS1627847 (human) | | 4e-714 | atrial fibrillation | | 4 | 110789811 | 110789812 | Human |
597208184 | GWAS1304258_H | childhood onset asthma QTL GWAS1304258 (human) | | 2e-14 | childhood onset asthma | | 4 | 122456327 | 122456328 | Human |
597384314 | GWAS1480388_H | facial morphology measurement QTL GWAS1480388 (human) | | 2e-09 | facial morphology trait (VT:0003743) | | 4 | 121076949 | 121076950 | Human |
597531774 | GWAS1627848_H | atrial fibrillation QTL GWAS1627848 (human) | | 4e-15 | atrial fibrillation | | 4 | 113507558 | 113507559 | Human |
597466233 | GWAS1562307_H | hypertension QTL GWAS1562307 (human) | | 3e-08 | hypertension | | 4 | 110409934 | 110409935 | Human |
597269630 | GWAS1365704_H | metabolite measurement QTL GWAS1365704 (human) | | 7e-18 | metabolite measurement | | 4 | 129109497 | 129109498 | Human |
597126270 | GWAS1222344_H | renal carcinoma QTL GWAS1222344 (human) | | 9e-10 | renal carcinoma | | 4 | 108791438 | 108791439 | Human |
597019769 | GWAS1115843_H | body mass index QTL GWAS1115843 (human) | | 4e-08 | body mass index | body mass index (BMI) (CMO:0000105) | 4 | 112390634 | 112390635 | Human |
597089400 | GWAS1185474_H | monocyte percentage of leukocytes QTL GWAS1185474 (human) | | 3e-09 | monocyte quantity (VT:0000223) | blood monocyte count to total leukocyte count ratio (CMO:0000374) | 4 | 109990411 | 109990412 | Human |
597322858 | GWAS1418932_H | non-high density lipoprotein cholesterol measurement QTL GWAS1418932 (human) | | 5e-12 | non-high density lipoprotein cholesterol measurement | blood non-high density lipoprotein cholesterol level (CMO:0003967) | 4 | 109717668 | 109717669 | Human |
597195880 | GWAS1291954_H | memory performance QTL GWAS1291954 (human) | | 0.0000004 | memory performance | | 4 | 124882027 | 124882028 | Human |
597470317 | GWAS1566391_H | rheumatoid arthritis QTL GWAS1566391 (human) | | 4e-08 | rheumatoid arthritis | | 4 | 112286121 | 112286122 | Human |
597195881 | GWAS1291955_H | memory performance QTL GWAS1291955 (human) | | 0.0000004 | memory performance | | 4 | 124882886 | 124882887 | Human |
597363817 | GWAS1459891_H | acute myeloid leukemia QTL GWAS1459891 (human) | | 2e-19 | leukocyte integrity trait (VT:0010898) | | 4 | 117598611 | 117598612 | Human |
597195882 | GWAS1291956_H | memory performance QTL GWAS1291956 (human) | | 0.0000004 | memory performance | | 4 | 124883368 | 124883369 | Human |
597322857 | GWAS1418931_H | non-high density lipoprotein cholesterol measurement QTL GWAS1418931 (human) | | 5e-10 | non-high density lipoprotein cholesterol measurement | blood non-high density lipoprotein cholesterol level (CMO:0003967) | 4 | 109174464 | 109174465 | Human |
597429353 | GWAS1525427_H | sex hormone-binding globulin measurement QTL GWAS1525427 (human) | | 4e-18 | sex hormone-binding globulin measurement | | 4 | 109345757 | 109345758 | Human |
597425250 | GWAS1521324_H | complement factor H-related protein 3 measurement QTL GWAS1521324 (human) | | 0.000009 | complement factor H-related protein 3 measurement | | 4 | 128538939 | 128538940 | Human |
406906811 | GWAS555787_H | bilirubin measurement QTL GWAS555787 (human) | | 0.000002 | bilirubin measurement | serum total bilirubin level (CMO:0000376) | 4 | 125072347 | 125072348 | Human |
597195879 | GWAS1291953_H | memory performance QTL GWAS1291953 (human) | | 0.0000004 | memory performance | | 4 | 124883182 | 124883183 | Human |